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General introduction
Introduction 
14
BACKGROUND
Physical activity, defined as any bodily movement requiring energy expenditure above the resting 
state,1 is an important factor associated with health. Worldwide, insufficient levels of physical 
activity are estimated to cause 6% of the burden of disease, including coronary heart disease, colon 
cancer and breast cancer, and 9% of the premature mortality.2 Conversely, engaging in sufficient 
physical activity can decrease the risk of bone fractures and is related to better cardiovascular 
health.3 For adults, it is therefore recommended to be physically active at moderate to vigorous 
intensity for 30 minutes/day, on most days of the week.4 However, globally, many  individuals do 
not meet these guidelines5 and in the Netherlands, around 42% of older adults fail to meet these 
recommendations.6 Gaining more insight in the levels of physical activity and the types of physical 
activity that adults engage in can help to create targeted interventions and recommendations, with 
the aim to achieve health benefits. This is especially important in older adults, who more often 
have difficulties in engaging in exercise or sports. For these adults, knowing more about the 
benefits of other types of activity is of importance. The population of older adults is growing 
rapidly, which is accompanied by a rise in health care costs associated with diseases in later life.7 A 
modifiable lifestyle factor like physical activity could contribute to enhance healthy aging.8 
In addition to physical activity, the 24-hour cycle of activity consists of sedentary behavior 
and sleep (Figure 1.1). Sedentary behavior is defined as engaging in sitting, reclining or lying 
behaviors during the waking hours, which result in little energy expenditure above the basal 
metabolic rate.9 Current trends of population ageing, urbanization and automatization of daily 
activities have contributed to a predominantly sedentary lifestyle, with low levels of physical 
activity, high levels sedentary behavior and an unhealthy nighttime sleep duration.10 However, 
whereas the activity guidelines specifically promote at least 30 minutes of physical activity per day4
and 7-8 hours of nighttime sleep per day,11 this leaves approximately 16 hours of unaccounted 
time, with a vague and non-quantified recommendation to refrain from too much sedentary 
behavior.12 Moreover, still little is known about the health effects related to sedentary behavior in 
older adults. Therefore, more information is required on the determinants associated with 
inactivity and the health effects associated with all activity domains. 
 
Figure 1.1. 24-hour activity distribution 
Sedentary behavior
Sleep
Physical activity
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MEASUREMENT OF ACTIVITY 
For practical reasons, physical activity is often measured by questionnaire.13 In addition, 
accelerometers are increasingly being used to gain more objective measures of physical activity 
levels,13,14 and can provide information on the intensity and duration of physical activity levels.15 
An accelerometer is a small device worn on the body that measures changes in gravitational 
acceleration. In most previous studies, accelerometers have been worn on the hip and had to be 
removed for sleeping.16,17 Wrist-worn devices have the advantage that they can be worn day and 
night, thereby allowing for collection of 24-hour of activity data.  
However, when comparing activity measures obtained by questionnaire with objective 
methods applied in large populations, major discrepancies emerge.18,19 The inconsistency might be 
related to recall-bias, a phenomenon in which information on the variable of interest is reported 
differently across subgroups of the population.20 Population characteristics such as age, sex and 
health status might be related to the extent that the information is reported correctly.13 In 
addition, the inconsistency might be derived from the fact that accelerometers cannot measure all 
physical activity accurately.21 For example, weight lifting and cycling are generally underestimated 
by wrist-worn accelerometers.21 Considering the increased use of accelerometers in current 
research,13 it is important to understand and quantify how physical activity assessed using 
questionnaires and accelerometers differ and how these differences might be related to population 
characteristics.22 This is especially relevant in older adults, because the higher likelihood of 
cognitive impairment23 might lead to more recall bias and reporting errors.  
 
FACTORS ASSOCIATED WITH ACTIVITY 
With the information collected from wrist-worn accelerometers, we can shed more light on the 
daily distribution of physical activity, sedentary behavior and sleep in older adults, as well as the 
factors associated with these activities domains. To date, several studies have examined factors 
associated with objectively assessed physical activity in adults aged 60 years and over,16,17,24 and 
showed that physical activity levels decrease with increasing age and across increasing levels of 
body mass index (BMI). However, it has not yet been investigated what factors are associated with 
activity in the very old (aged 77 and over), a population with generally lower activity levels and 
more disability. Moreover, the demographic and health factors associated with sleep and 
sedentary behavior have not been addressed jointly with physical activity in the elderly. 
Additionally, it is still unclear which environmental factors are associated with these different 
activity domains. Physical activity has a seasonal pattern, with higher levels of physical activity in 
the summer and less physical activity in the winter,25 but it is unclear whether this is at the 
expense of sedentary behavior or sleep. It is also still unclear which meteorological factors are 
related to this seasonal pattern of activity in older adults, and it remains unknown whether the 
seasonality of activity might have an effect on health outcomes.  
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ACTIVITY AND MORTALITY 
There is extensive literature on the association between physical activity and mortality.26 However, 
there is limited information on what type of physical activities are beneficially associated with 
mortality after retirement in an elderly population, and more specifically if the association 
between physical activity and mortality differs by cause of death. In particular, information is 
currently lacking on whether physical activity is associated with reduced mortality related to 
dementia and chronic lung disease.27-29  
Furthermore, information on the association between sedentary behavior and mortality 
currently mostly relies on studies using self-reported measures of sedentary behavior30 and studies 
using accelerometers have only a limited follow-up time, up to an average of 4.5 years.31-33 Self-
reported sedentary behavior might be influenced by information and recall bias34 and the limited 
follow-up time in studies using accelerometers increases the likelihood of the results being 
influenced by reverse causation. An underlying disease or disability might be related to both 
sedentary behavior and a higher mortality risk. Therefore, it is important to examine the 
association between sedentary behavior and all-cause mortality with longer follow-up, by using 
objective measures of sedentary behavior. 
 
ACTIVITY AND CARDIOVASCULAR HEALTH 
The inverse association between higher physical activity levels and lower risk of cardiovascular 
diseases (CVDs) has been well documented in literature.3 According to recent meta-analyses, 
regular physical activity of moderate to vigorous intensity may contribute to up to 27% reduced 
risk of coronary heart disease.35,36 However, it remains unclear whether all cardiovascular 
conditions, including atrial fibrillation, benefit from physical activity. Atrial fibrillation is the most 
common chronic cardiac arrhythmia with significant morbidity and mortality.37 Since known risk 
factors of atrial fibrillation, such as heart failure and myocardial infarction are directly influenced 
by the level of physical activity,38 high levels of physical activity might also reduce the risk of atrial 
fibrillation.  
Previous studies on the association between physical activity and CVDs have mainly focused 
on the effect of overall leisure time physical activity, whereas it remains unclear what specific 
physical activity types contribute most to the beneficial effects of physical activity. Only a few 
studies have addressed the impact of different types of physical activity on CVD39,40 or specifically 
coronary heart disease41 or atrial fibrillation.42 Several studies documented a beneficial association 
between walking and risk of coronary heart disease43 or atrial fibrillation,44 but evidence of the 
influence of cycling and domestic work remains scarce among the elderly,39,45 whereas domestic 
work is an important domain contributing to the daily physical activity of older adults.46 
Additionally, in order to provide comprehensive information for public and individual health care 
planning, measures of the lifetime consequences of physical activity, including life expectancy 
estimates, are most informative. Since individuals with CVD have a lower quality of life,47 
information on the life years with and without CVD is of relevance in this matter. 
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Furthermore, it has been suggested that physical activity might counterbalance the CVD 
risk associated with overweight and obesity,48 but information among the elderly is scarce. In 
older adults, it has been suggested that the risks of myocardial infarction and stroke associated 
with overweight and obesity are attenuated,49 possibly because in older adults BMI is a poor 
indicator of body composition. Therefore, we examined the role of physical activity in the 
association of overweight and obesity with CVD in elderly adults. 
 
ACTIVITY AND MENTAL HEALTH AND WELLBEING  
Physical activity and sedentary behavior have been associated with health-related quality of life 
(HRQL) and mental health outcomes such as depression, anxiety and cognitive function. HRQL is 
defined as an individuals’ perspective of well-being in physical, mental and social domains of 
life.50 Recent studies have shown a consistent association between physical activity and HRQL.51,52 
However, it remains unclear what specific physical activity types contribute most to the beneficial 
effects of physical activity in older adults.  
Regarding mental health, higher levels of self-reported sedentary behavior have been 
associated with a higher risk to develop depression53 and anxiety disorders54 and with a lower risk 
to decrease in cognitive functioning.55 However, most studies performed thus far were cross-
sectional, making it impossible to infer temporality. In addition, only a limited number of studies 
adjusted for disability status, which can be considered an important confounder influencing both 
the sedentary behavior and the mental health measures. Furthermore, the use of subjective 
measures of sedentary behavior, which are usually assessed by probing types of sitting behavior 
(e.g. television viewing, car driving), might have influenced the associations.56,57 In this regard, the 
reported associations might be driven more by the social context of sitting than sedentary 
behavior. Therefore, using objective measures of sedentary behavior, while carefully adjusting the 
associations for important confounders such as disability, can provide additional information on 
the association between sedentary behavior and mental health measures. 
Furthermore, sleep has received interest as a possible modifiable factor that might influence 
body weight.58,59 Short sleep duration has been associated with obesity,58 giving rise to the idea that 
chronic sleep deprivation might contribute to the obesity epidemic.59 However, studies assessing 
the association between sleep and obesity have mostly been cross-sectional, thus the temporality 
of the relation between sleep and adiposity could not be explored.58,60 Second, prospective studies 
performed thus far have relied on self-reported measures, which are prone to information and 
recall bias.61 Moreover, adiposity most probably impacts sleep, but very few studies have examined 
the hypothesis that the association between sleep and adiposity might be bidirectional.62-64 
Prospective studies using objectively measured sleep and body composition are required. 
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The inverse association between higher physical activity levels and lower risk of cardiovascular 
diseases (CVDs) has been well documented in literature.3 According to recent meta-analyses, 
regular physical activity of moderate to vigorous intensity may contribute to up to 27% reduced 
risk of coronary heart disease.35,36 However, it remains unclear whether all cardiovascular 
conditions, including atrial fibrillation, benefit from physical activity. Atrial fibrillation is the most 
common chronic cardiac arrhythmia with significant morbidity and mortality.37 Since known risk 
factors of atrial fibrillation, such as heart failure and myocardial infarction are directly influenced 
by the level of physical activity,38 high levels of physical activity might also reduce the risk of atrial 
fibrillation.  
Previous studies on the association between physical activity and CVDs have mainly focused 
on the effect of overall leisure time physical activity, whereas it remains unclear what specific 
physical activity types contribute most to the beneficial effects of physical activity. Only a few 
studies have addressed the impact of different types of physical activity on CVD39,40 or specifically 
coronary heart disease41 or atrial fibrillation.42 Several studies documented a beneficial association 
between walking and risk of coronary heart disease43 or atrial fibrillation,44 but evidence of the 
influence of cycling and domestic work remains scarce among the elderly,39,45 whereas domestic 
work is an important domain contributing to the daily physical activity of older adults.46 
Additionally, in order to provide comprehensive information for public and individual health care 
planning, measures of the lifetime consequences of physical activity, including life expectancy 
estimates, are most informative. Since individuals with CVD have a lower quality of life,47 
information on the life years with and without CVD is of relevance in this matter. 
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Furthermore, it has been suggested that physical activity might counterbalance the CVD 
risk associated with overweight and obesity,48 but information among the elderly is scarce. In 
older adults, it has been suggested that the risks of myocardial infarction and stroke associated 
with overweight and obesity are attenuated,49 possibly because in older adults BMI is a poor 
indicator of body composition. Therefore, we examined the role of physical activity in the 
association of overweight and obesity with CVD in elderly adults. 
 
ACTIVITY AND MENTAL HEALTH AND WELLBEING  
Physical activity and sedentary behavior have been associated with health-related quality of life 
(HRQL) and mental health outcomes such as depression, anxiety and cognitive function. HRQL is 
defined as an individuals’ perspective of well-being in physical, mental and social domains of 
life.50 Recent studies have shown a consistent association between physical activity and HRQL.51,52 
However, it remains unclear what specific physical activity types contribute most to the beneficial 
effects of physical activity in older adults.  
Regarding mental health, higher levels of self-reported sedentary behavior have been 
associated with a higher risk to develop depression53 and anxiety disorders54 and with a lower risk 
to decrease in cognitive functioning.55 However, most studies performed thus far were cross-
sectional, making it impossible to infer temporality. In addition, only a limited number of studies 
adjusted for disability status, which can be considered an important confounder influencing both 
the sedentary behavior and the mental health measures. Furthermore, the use of subjective 
measures of sedentary behavior, which are usually assessed by probing types of sitting behavior 
(e.g. television viewing, car driving), might have influenced the associations.56,57 In this regard, the 
reported associations might be driven more by the social context of sitting than sedentary 
behavior. Therefore, using objective measures of sedentary behavior, while carefully adjusting the 
associations for important confounders such as disability, can provide additional information on 
the association between sedentary behavior and mental health measures. 
Furthermore, sleep has received interest as a possible modifiable factor that might influence 
body weight.58,59 Short sleep duration has been associated with obesity,58 giving rise to the idea that 
chronic sleep deprivation might contribute to the obesity epidemic.59 However, studies assessing 
the association between sleep and obesity have mostly been cross-sectional, thus the temporality 
of the relation between sleep and adiposity could not be explored.58,60 Second, prospective studies 
performed thus far have relied on self-reported measures, which are prone to information and 
recall bias.61 Moreover, adiposity most probably impacts sleep, but very few studies have examined 
the hypothesis that the association between sleep and adiposity might be bidirectional.62-64 
Prospective studies using objectively measured sleep and body composition are required. 
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STUDY DESIGN: THE ROTTERDAM STUDY 
The Rotterdam Study (RS) is a prospective population-based cohort, among subjects aged 55 
years or older in the well-defined Ommoord neighborhood, in the municipality of Rotterdam, the 
Netherlands.65 The Rotterdam Study started in 1990 and was set up to study risk factors of 
cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, 
oncological, and respiratory diseases. In the original study cohort, 7,983 participants aged 55 years 
and older were enrolled, which constituted 78% of all 10,215 invitees. In 2000-2001, the 
Rotterdam Study was extended with 3,011 participants out of 4,472 invitees who were ≥55 years 
old or had moved into the study district. In 2006 a third study cohort was initiated, in which 3,932 
adults aged 45 years and older were included.65 Physical activity was assessed for the first time by 
questionnaire during the third examination of the original cohort (RS-I-3, between 1997 and 
1999) and during the baseline examination of the extended cohort (RS-II-1, between 2000 and 
2001). Objective measures of activity were obtained for the first time between 2002 and 2008, in a 
subset of participants from each of the cohorts. From 2012 on forwards, objective data on physical 
activity has been collected in all participants who agreed to wear a wrist-worn accelerometer.  
Data on clinical outcomes, including cardiovascular disease, depression and dementia, were 
collected through a follow-up system involving digital linkage of the study database to medical 
records maintained by general practitioners working in the research area. Trained research 
assistants collected notes, outpatient clinic reports, hospital discharge letters, electrocardiograms, 
and imaging results from general practitioner records and hospital records. Other health-related 
measurements were obtained during the home-interview or at the research center. 
 
OVERALL AIM OF THIS THESIS 
The overall aim of this thesis was to study the factors associated with activity in older age and to 
examine the association of activity domains with mortality, cardiovascular disorders and mental 
health outcomes. In Chapter 2, we discuss differences between objectively and subjectively 
measured physical activity, as well as provide an overview of the 24-hour activity distribution in 
an elderly population and report which factors are associated with physical activity, sedentary 
behavior and sleep. In Chapter 3, we discuss the association between physical activity and 
sedentary behavior with all-cause and cause-specific mortality. In Chapter 4, we discuss the 
association of overall physical activity and specific physical activity types with several 
cardiovascular health outcomes. In Chapter 5, we study the association of physical activity and 
sedentary behavior with mental health and wellbeing, including health-related quality of life, 
depression, anxiety and cognition. Last, in the general discussion in Chapter 6, we address 
methodological considerations, practical implications of our findings and suggestions for future 
research. 
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ABSTRACT 
Background: The agreement between questionnaires and accelerometers to measure physical 
activity (PA) differs between studies and might be related to demographic, lifestyle and health 
characteristics, including disability and depressive symptoms. 
Methods: We included 1,410 individuals aged 51-94 years from the population-based 
Rotterdam Study. Participants completed the LASA Physical Activity questionnaire (LAPAQ) 
and wore a wrist-worn accelerometer on the non-dominant wrist for one week thereafter. We 
compared the Spearman correlation and disagreement (level and direction) for total PA 
across levels of demographic, lifestyle and health variables. The level of disagreement was 
defined as the absolute difference between questionnaire- and accelerometer-derived PA, 
whereas the direction was defined as questionnaire PA minus accelerometer PA. We used 
linear regression analyses with the level and direction of disagreement as outcome, including 
all demographic, lifestyle and health variables in the model. 
Results: We observed a Spearman correlation of 0.30 between questionnaire- and 
accelerometer-derived PA in the total population. The level of disagreement (ie absolute 
difference) was 941.9 (standard deviation [SD]=747.0)  minutes/week and the PA reported by 
questionnaire was on average 529.4 minutes/week (SD=1079.5) lower than PA obtained by 
the accelerometer. The level of disagreement decreased with higher educational levels. 
Additionally, participants with obesity and those with higher disability scores and more 
depressive symptoms underestimated their self-reported PA more than their healthier 
counterparts. 
Conclusion: We observed large differences in PA time as derived from the LAPAQ and the 
wrist-worn accelerometer. Differences between the methods were related to body mass index, 
level of disability, and presence of depressive symptoms. Future studies using questionnaires 
and/or accelerometers should account for of these differences. 
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INTRODUCTION 
Physical activity (PA) is an important modifiable risk factor in the prevention of diseases, 
including cardiovascular disease, diabetes mellitus and several types of cancer.1 For practical 
reasons, PA is often measured subjectively, by questionnaire.2 However, self-reported PA can 
suffer from reporting bias, partially attributable to the cognitive challenge of estimating the 
frequency, intensity and duration of PA.3 Moreover, activities of light intensity are hard to recall 
and might not be reported.4,5 Objective methods, including accelerometers, offer a solution to 
these problems and can give objective estimates on duration and intensity of PA. Therefore, 
accelerometers are increasingly being used in current research.2,6 However, when comparing 
questionnaire data with objective methods applied in large populations, major discrepancies 
emerge.7,8 The inconsistency might be related to recall-bias, which can be influenced by 
population characteristics, such as age, sex and health status.2,9 In addition, the inconsistency 
might stem from the fact that accelerometers cannot measure all PA accurately.10,11 For example, 
weight lifting and cycling are generally underestimated by accelerometers worn on the upper 
body.12 Considering the increased use of accelerometers in current research,2,6 it is important to 
understand and quantify how PA assessed with questionnaires and accelerometers differ and how 
these difference relate to population characteristics.13  
Previous studies showed that the correlation between self-reported and objectively 
measured PA differs by age, sex, ethnicity, socio-economic status and level of PA.8,9 However, 
results presented refer to correlation coefficients, which are a measure of the extent to which two 
variables are linearly related, but do not take into account their measurement scales. Hence, these 
studies do not provide information regarding the level of agreement and the direction of 
disagreement of the two methods.14 A study that accounted for the direction of disagreement 
between objective and subjective measured PA in young adults suggested that overweight adults 
have the tendency to overestimate the time spent in vigorous PA more than normal weight 
individuals.15 Information from older adults, a population with different PA patterns than 
younger adults,16 is currently lacking. Moreover, the effect of socioeconomic-status and mental 
and physical health on the agreement between accelerometer and questionnaire remains unclear. 
Therefore we aimed to quantify the level and direction of disagreement between 
questionnaire-assessed PA and accelerometer-assessed PA and to investigate if differences in 
agreement are explained by sociodemographic, lifestyle and health factors.  
 
METHODS 
Study Population  
This paper utilizes data from the Rotterdam Study, a population based cohort designed to 
examine the onset and risk factors of diseases in older adults.17 The Rotterdam Study has been 
approved by the medical ethics committee according to the Wet Bevolkingsonderzoek ERGO 
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(Population Study Act Rotterdam Study), executed by the Ministry of Health, Welfare and Sport 
of the Netherlands. Trained research assistants interviewed the participants at home to collect the 
baseline information and individuals visited the research center twice, where clinical 
measurements were obtained. 
Participants were invited to wear an accelerometer and fill out a PA questionnaire, between 
June 2011 and June 2014 (wave 1) and between July 2014 and May 2016 (wave 2). Participants 
were included in the analysis if they had valid accelerometer data (>1200 min/day) for at least 4 
days, including one weekend day. Twenty-four cases were excluded because of unreliable high (ie 
higher than the mean + three times the standard deviation) levels of data on self-reported PA 
(Figure 2.1.1).  
Since the PA questionnaire used in the Rotterdam Study did not cover occupational activity, 
we also excluded participants with paid occupation (n=389) or without information on 
occupational status (n=27). Additionally, because 72 participants participated in both waves, we 
excluded the observation from the second wave of these participants, to avoid clustering of data. 
In the current analyses, we included 1,410 adults aged 50+ years with data on both objective and 
subjective PA. All subjects gave written informed consent.  
Questionnaire physical activity 
After the home interview, participants received the PA questionnaire and were requested to hand 
in their questionnaire during their first research center visit. Questionnaire PA was assessed with 
the self-administered LASA Physical Activity Questionnaire (LAPAQ), a validated questionnaire 
with a reasonably good test-retest reliability (0.65–0.75).18 The correlations with a pedometer and 
7-day diary were 0.56 and 0.68, respectively.18 The LAPAQ includes questions on the frequency 
and duration of walking, cycling, sports (including two open-ended questions in which 
participants could report “other sports” they participated in), gardening, and housework. 
Participants reported how many hours/week they spent in each activity in the previous two weeks. 
Detailed information on the assessment of questionnaire-derived PA can be found elsewhere.19 
We used metabolic equivalent of task (MET) to quantify activity intensity. MET-values were 
assigned to all activities in the questionnaire, using a compendium of activity energy costs.20 Of all 
mentioned other activities, 18 (3.2%) were not sports and 28 (5.1%) were not in the compendium 
(eg ‘physiotherapy training, ‘indoor sports’, ‘revalidation). No MET-values were assigned to these 
activities and they were not included in the analyses. Duration in total PA was computed by 
summing time spent in all activities mentioned in the questionnaire. 
To be able to evaluate whether differences in total PA were driven by a particular intensity 
category (ie light, moderate or vigorous PA), we categorized activities in three groups. Activities 
with MET-values lower than 3 METs, were coded as light intensity PA; for values from 3 to 6 
METs, activity was coded as moderate intensity PA; and for values of 6 and higher, the activity 
was coded as vigorous intensity PA.21 
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Figure 2.1.1. Flow chart of participant inclusion for the Rotterdam Study 
* The ActiWatch (Actiwatch model AW4; Cambridge Technology, Cambridge, UK)) is a one-dimensional device and could 
not be used to measure physical activity. 
3,507 Participants invited to wear an 
accelerometer between June 2011 and June 
2014 (wave 1) and between July 2014 and 
May 2016 (wave 2), of which 482 
participants were invited twice 
3,989 Observations 
2,110 Observations 
833 Observations excluded from participants 
that did not want to participate 
x 306 Participants declined in wave 1 
x 485 Participants declined in wave 2 
x 21 Participants declined in both waves 
729 Observations excluded that were obtained 
with the ActiWatch*  
2,427 Observations 317 Observations that were not valid:   
x 55 Observations excluded with a 
malfunctioning device 
x 30 Participants did not complete one 
week of wearing 
x 157 Observations with invalid data  i.e. 
not having 4 days with >1200 minutes per 
day, including at least one weekend day 
x 8 Participants lost their device 
x 29 Observations lost due to processing 
error 
x 38 Observations for whom it’s unclear 
why no valid data   
1,410 Observations included in the analyses 
389 Observations from participants with paid 
occupation and 27 from participants without 
information on occupational status 
3,156 Observations (79%) 
x 188 Observations without questionnaire 
data 
x 24 Observations with unreliable 
questionnaire data 
1,482 Observations 
72 Observations from participants with data 
on two visits. 
1,898 Observations 
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Accelerometer-assessed physical activity 
At the first center visit, participants were requested to wear a triaxial accelerometer (GeneActiv; 
Activinsights Ltd, Kimbolton, Cambridgeshire, United Kingdom, http://www.geneactiv.org/) on 
the non-dominant wrist for 7 consecutive days and nights. Since the GeneActiv device is 
waterproof, the device could also be worn while bathing and swimming. The accelerometer was 
sampled at 50 Hz and acceleration was expressed relative to gravity (g units; 1 g =9.81 m/s2).9,22,23 
Data were extracted from the first wearing day up to seven days later and all days with ≥1200 
minutes of data were included.  
To quantify the acceleration related to the registered movement, we calculated the high-pass 
filtered vector magnitude (HPFVM). This approach applies a high-pass filter with a cut-off 
frequency of 0.2 Hertz to the acceleration signal, treating gravity as a low-frequency component 
that is filtered out.24 
Accelerometer data were processed in Python (2.6.6), with the open access PAMPRO 
software, a program for the systematic analysis of PA data collected in epidemiological studies.25  
Non-wear time was defined as all time periods where the standard deviation of acceleration in 
each of the three axes fell below 13mg for over 1 hour.24 Any non-wear period was excluded from 
analyses. The pattern of non-wear time was accounted for by balancing the weighting of the data 
according to the diurnal profile.26 
Activity was categorized into sedentary (<48 mg), light (48 < 154 mg), moderate (154 <389 
mg) and vigorous activity (>389 mg), based on a recent validation study in 1695 middle-aged 
adults (mean age: 50 years).24 Because not all participants wore the watch for 7 days, data were 
recoded as such that our measures reflected PA over a 1-week course, to match with the 
questionnaire data. The average duration in light, moderate and vigorous PA was calculated for 
weekdays and weekend days. Consequently, the weekly accelerometer-assessed total PA was 
calculated as [(5x mean daily duration in total PA on weekdays) + (2 x mean daily duration in 
total PA on weekend days)]. 
Assessment of factors 
Self-reported alcohol use was obtained with a food frequency questionnaire, expressed in 
grams/day and categorized in tertiles. Socioeconomic status was evaluated by education, assessed 
in consonance with the international standard classification of education and categorized as 
primary, lower, intermediate and higher education.27 Smoking was categorized in three categories: 
current, former and never. Body mass index (BMI) (kg/m2) was calculated using height and 
weight and defined as normal weight (<25 kg/m2), overweight (25–30 kg/m2) and obese (≥30 
kg/m2). Marital status was defined as living with a partner or not. Disability was assessed by 
activities of daily living, from the Stanford Health Assessment Questionnaire Disability Index.28 
For descriptive purposes, disability was defined as disability index higher than 0.5 and severe 
disability as an index higher than 1.0.29 The presence of coronary heart disease, diabetes, stroke 
and cancer were determined using medical records up to the year 2012, to define the number of 
comorbidities. Depressive symptoms were assessed with the Center for Epidemiologic Studies 
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Depression (CES-D) scale,30 a self-report scale with 20 items and a maximum score of 60. A score 
of 16 or greater is traditionally accepted as cut off to define clinical depression31 and was used for 
descriptive purposes. Cognitive function was assessed with the Mini Mental State Examination 
(MMSE).32 MMSE-scores range from 0-30, with a higher score indicating better cognitive 
performance. We used a cut-off of 26 to categorize participants as having a cognitive impairment 
in our descriptive analysis.33 
Statistical analyses 
Descriptive statistics were used to characterize the sample. The difference in time spent in PA 
according to questionnaire and accelerometer was examined using a paired samples t-test and the 
Bland-Altman method was used to visualize the level of (dis)agreement between questionnaire- 
and accelerometer-derived PA levels. We assessed the Spearman correlation between 
questionnaire- and accelerometer-derived PA in the total population and separately for the 
following categories: age-group (ie 50-60 years, 60-70 years; 70-80 years, older than 80 years), sex, 
education, marital status, smoking status, BMI category, alcohol consumption, disability, 
prevalent chronic disease, cognitive function and prevalent depression. Since the Spearman 
correlation coefficient is equal to the slope of the regression between the ranked values of the 
questionnaire and accelerometer, we used linear regression models to obtain the correlation 
coefficients and corresponding 95% confidence intervals (95%CI) using accelerometer-derived PA 
as dependent variable.  
For our main analyses, we devised two measures of disagreement, in resemblance with 
previous research.34 First, we computed the ‘level of disagreement’, expressed as the absolute time 
difference between questionnaire- and accelerometer-assessed PA. Second, we computed the 
‘direction of disagreement’, indicating whether an individual had the tendency to overestimate or 
underestimate PA, by subtracting accelerometer-assessed PA from questionnaire-derived PA 
levels. To assess the association between assessed factors and the level and direction of 
disagreement, we used linear regression analyses with the level and direction of disagreement as 
outcome variables, including all demographic, lifestyle and health variables, total PA measured by 
the accelerometer, time between interview date and the first accelerometer wear date, cohort and 
wave. Age, the CES-D score, disability index, MMSE-score and number of comorbidities were 
used as continuous variables in these analyses. To quantify if the association is dependent on the 
level of PA, the β (95%CI) for the association of accelerometer-derived PA, expressed in 
hours/week, with the level and direction of disagreement will also be obtained from these 
analyses. 
We performed several sensitivity analyses. We compared baseline characteristics for those 
agreeing to wear an accelerometer versus those who rejected, and in those with paid occupation 
versus those without paid occupation. Next, we examined the level and direction of disagreement 
in each intensity category of PA (light, moderate and vigorous). Additionally, we repeated the 
analyses in a population also including participants with paid occupation. In these analyses, we 
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Accelerometer-assessed physical activity 
At the first center visit, participants were requested to wear a triaxial accelerometer (GeneActiv; 
Activinsights Ltd, Kimbolton, Cambridgeshire, United Kingdom, http://www.geneactiv.org/) on 
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comorbidities. Depressive symptoms were assessed with the Center for Epidemiologic Studies 
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Depression (CES-D) scale,30 a self-report scale with 20 items and a maximum score of 60. A score 
of 16 or greater is traditionally accepted as cut off to define clinical depression31 and was used for 
descriptive purposes. Cognitive function was assessed with the Mini Mental State Examination 
(MMSE).32 MMSE-scores range from 0-30, with a higher score indicating better cognitive 
performance. We used a cut-off of 26 to categorize participants as having a cognitive impairment 
in our descriptive analysis.33 
Statistical analyses 
Descriptive statistics were used to characterize the sample. The difference in time spent in PA 
according to questionnaire and accelerometer was examined using a paired samples t-test and the 
Bland-Altman method was used to visualize the level of (dis)agreement between questionnaire- 
and accelerometer-derived PA levels. We assessed the Spearman correlation between 
questionnaire- and accelerometer-derived PA in the total population and separately for the 
following categories: age-group (ie 50-60 years, 60-70 years; 70-80 years, older than 80 years), sex, 
education, marital status, smoking status, BMI category, alcohol consumption, disability, 
prevalent chronic disease, cognitive function and prevalent depression. Since the Spearman 
correlation coefficient is equal to the slope of the regression between the ranked values of the 
questionnaire and accelerometer, we used linear regression models to obtain the correlation 
coefficients and corresponding 95% confidence intervals (95%CI) using accelerometer-derived PA 
as dependent variable.  
For our main analyses, we devised two measures of disagreement, in resemblance with 
previous research.34 First, we computed the ‘level of disagreement’, expressed as the absolute time 
difference between questionnaire- and accelerometer-assessed PA. Second, we computed the 
‘direction of disagreement’, indicating whether an individual had the tendency to overestimate or 
underestimate PA, by subtracting accelerometer-assessed PA from questionnaire-derived PA 
levels. To assess the association between assessed factors and the level and direction of 
disagreement, we used linear regression analyses with the level and direction of disagreement as 
outcome variables, including all demographic, lifestyle and health variables, total PA measured by 
the accelerometer, time between interview date and the first accelerometer wear date, cohort and 
wave. Age, the CES-D score, disability index, MMSE-score and number of comorbidities were 
used as continuous variables in these analyses. To quantify if the association is dependent on the 
level of PA, the β (95%CI) for the association of accelerometer-derived PA, expressed in 
hours/week, with the level and direction of disagreement will also be obtained from these 
analyses. 
We performed several sensitivity analyses. We compared baseline characteristics for those 
agreeing to wear an accelerometer versus those who rejected, and in those with paid occupation 
versus those without paid occupation. Next, we examined the level and direction of disagreement 
in each intensity category of PA (light, moderate and vigorous). Additionally, we repeated the 
analyses in a population also including participants with paid occupation. In these analyses, we 
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additionally included occupational status as covariate. Moreover, because accelerometers do not 
to measure cycling accurately, we repeated the analyses in those that did not report any cycling.  
Our data contained 49.1% missing data on alcohol use. Other covariates had <2% missing 
data. We imputed missing data using Markov Chain Monte Carlo multiple imputation (n=20 
imputations). All analyses were performed using IBM SPSS Statistics for Windows (IBM SPSS 
Statistics for Windows, Armonk, NY: IBM Corp) and R version 3.2.1 (R Foundation for Statistical 
Computing, Vienna, Austria). Statistical significance was accepted at p <0.05. 
 
RESULTS 
Participants who agreed to wear an accelerometer were slightly younger, more often men, and 
showed a better health profile with regard to the MMSE score, CESD score and disability score, 
than those who did not agree to wear an accelerometer (Supplement 2.1.1). The participants 
included in our study had a mean age of 73.8 years (SD: 7.6) and 742 (52.6%) were female (Table 
2.1.1).  
The mean (SD) daily wear-time of the accelerometer was 23.8 (0.3 hours) and the median 
time difference between the interview and the first accelerometer wear date was 8.7 weeks 
(interquartile range: 5.1-13.7). The mean (SD) weekly time spent in PA was 1579.3 (386.1) 
minutes according accelerometer and 1049.9 (1108.3) minutes according questionnaire (p<0.001), 
indicating that overall, total PA was underestimated in the questionnaire. This is also visualized in 
the Bland-Altman plot in Supplement 2.1.2.The Spearman correlation was 0.30 (0.25, 0.34) in the 
total sample and differed as a function of education, disability, smoking status, depressive 
symptoms and cognitive function (Table 2.1.2).  
Per one hour/week more accelerometer-derived PA the level of disagreement was 30.2 
minutes/week more (95%CI: 23.6, 36.7; p <0.001). Independent of the PA volume, those with 
intermediate and higher education showed smaller differences between the questionnaire PA and 
accelerometer PA than those with primary education (Figure 2.1.2). No other determinants were 
associated with the level of disagreement.  
Per one hour/week more accelerometer-derived PA, questionnaire PA was underestimated 
more by 29.1 minutes (95%CI: -38.6. -19.6; p <0.001). The results of the regression analyses with 
the direction of the disagreement are presented in Figure 2.1.3. Independent of the PA volume, 
obese participants underestimated their self-reported PA levels more than normal weight 
participants (β= -234.3 minutes/week; 95%CI: -398.2, -70.5; p =0.002). Additionally, the 
underestimation of self-reported PA in the questionnaire was larger for participants with higher 
levels of the disability score and CES-D score (Figure 2.1.3).  
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Table 2.1.1. Characteristics of the study population (n=1,410) 
Characteristic 
Demographic factors 
Age (years) 73.8 (7.6) 
Female, n (%) 742 (52.6) 
Education 
  Elementary 86 (6.1)  
  Lower secondary 571 (40.5)  
  Higher secondary 434 (30.8)  
  Tertiary 319 (22.6)  
Living with partner, n (%) 989 (70.1) 
Lifestyle factors 
Smoking, n (%) 
   Never smoker 471 (33.4)  
   Former smoker 833 (59.1)  
   Current smoker 106 (7.5)  
BMI, n (%) 
   Normal weight 418 (29.6)  
   Overweight 668 (47.4)  
   Obese 324 (23.0)  
Alcohol consumption, n (%)  
   Low 502 (35.6) 
   Medium 464 (32.9) 
   High 444 (31.5) 
Health factors 
Disability score 0.64 (0.68) 
Prevalent cancer, CVD or diabetes, n (%) 635 (45.0) 
MMSE score 28.1 (1.7) 
CESD score 5.0 (6.3)  
Physical activity variables 
Total PA according questionnaire (minutes/week) 1049.9 (1108.3) 
Total PA according accelerometer (minutes/week) 1579.3 (386.1) 
Level of disagreement between questionnaire and accelerometer 941.9 (747.0) 
Direction of disagreement between questionnaire and 
accelerometer -529.4 (1079.5) 
Time between interview and first accelerometer wear date 
(weeks), median (IQR) 8.7 (5.1-13.7)  
Data are presented as mean (SD) unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CVD, cardiovascular disease; 
IQR, interquartile range; MMSE, mini mental state examination; n, number; PA, physical activity; SD, standard deviation 
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additionally included occupational status as covariate. Moreover, because accelerometers do not 
to measure cycling accurately, we repeated the analyses in those that did not report any cycling.  
Our data contained 49.1% missing data on alcohol use. Other covariates had <2% missing 
data. We imputed missing data using Markov Chain Monte Carlo multiple imputation (n=20 
imputations). All analyses were performed using IBM SPSS Statistics for Windows (IBM SPSS 
Statistics for Windows, Armonk, NY: IBM Corp) and R version 3.2.1 (R Foundation for Statistical 
Computing, Vienna, Austria). Statistical significance was accepted at p <0.05. 
 
RESULTS 
Participants who agreed to wear an accelerometer were slightly younger, more often men, and 
showed a better health profile with regard to the MMSE score, CESD score and disability score, 
than those who did not agree to wear an accelerometer (Supplement 2.1.1). The participants 
included in our study had a mean age of 73.8 years (SD: 7.6) and 742 (52.6%) were female (Table 
2.1.1).  
The mean (SD) daily wear-time of the accelerometer was 23.8 (0.3 hours) and the median 
time difference between the interview and the first accelerometer wear date was 8.7 weeks 
(interquartile range: 5.1-13.7). The mean (SD) weekly time spent in PA was 1579.3 (386.1) 
minutes according accelerometer and 1049.9 (1108.3) minutes according questionnaire (p<0.001), 
indicating that overall, total PA was underestimated in the questionnaire. This is also visualized in 
the Bland-Altman plot in Supplement 2.1.2.The Spearman correlation was 0.30 (0.25, 0.34) in the 
total sample and differed as a function of education, disability, smoking status, depressive 
symptoms and cognitive function (Table 2.1.2).  
Per one hour/week more accelerometer-derived PA the level of disagreement was 30.2 
minutes/week more (95%CI: 23.6, 36.7; p <0.001). Independent of the PA volume, those with 
intermediate and higher education showed smaller differences between the questionnaire PA and 
accelerometer PA than those with primary education (Figure 2.1.2). No other determinants were 
associated with the level of disagreement.  
Per one hour/week more accelerometer-derived PA, questionnaire PA was underestimated 
more by 29.1 minutes (95%CI: -38.6. -19.6; p <0.001). The results of the regression analyses with 
the direction of the disagreement are presented in Figure 2.1.3. Independent of the PA volume, 
obese participants underestimated their self-reported PA levels more than normal weight 
participants (β= -234.3 minutes/week; 95%CI: -398.2, -70.5; p =0.002). Additionally, the 
underestimation of self-reported PA in the questionnaire was larger for participants with higher 
levels of the disability score and CES-D score (Figure 2.1.3).  
 
 
 
Comparing physical activity derived from questionnaires and accelerometers 
33 
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   High 444 (31.5) 
Health factors 
Disability score 0.64 (0.68) 
Prevalent cancer, CVD or diabetes, n (%) 635 (45.0) 
MMSE score 28.1 (1.7) 
CESD score 5.0 (6.3)  
Physical activity variables 
Total PA according questionnaire (minutes/week) 1049.9 (1108.3) 
Total PA according accelerometer (minutes/week) 1579.3 (386.1) 
Level of disagreement between questionnaire and accelerometer 941.9 (747.0) 
Direction of disagreement between questionnaire and 
accelerometer -529.4 (1079.5) 
Time between interview and first accelerometer wear date 
(weeks), median (IQR) 8.7 (5.1-13.7)  
Data are presented as mean (SD) unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CVD, cardiovascular disease; 
IQR, interquartile range; MMSE, mini mental state examination; n, number; PA, physical activity; SD, standard deviation 
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Sensitivity analyses showed that light and vigorous PA were underestimated by the questionnaire 
(mean (SD) -708.4 (484.3) minutes/week and -25.6 (338.1) minutes/week, respectively), whereas 
the level of moderate PA was on average overestimated with 204.6 minutes/week (SD: 780.8) 
(Supplement 2.1.3). In the analyses with light, moderate and vigorous PA, factors associated with 
the level and direction of disagreement were similar as in the main analyses (Supplement 2.1.4 – 
Supplement 2.1.5).  
When comparing those with and without paid occupation, we observed that those with paid 
occupation were younger, higher educated and showed a better health profile regarding the CESD 
score, MMSE score and disability score (Supplement 2.1.6). In sensitivity analyses including those 
with paid occupation (n=1823), the level and direction of disagreement were larger compared to 
the main analyses (mean [SD]= 971.8 [788.0] minutes/week and -589.0 [1104.0] minutes/week, 
respectively).  
 
Table 2.1.2. Spearman correlation between questionnaire-assessed total physical activity and 
accelerometer-assessed total physical activity, according to characteristics of the study population 
 Total population, factors, and physical activity n Spearman’s r 95% CI 
Total population 1,410 0.30 0.25, 0.34 
Demographic factors 
Age group 
  50-60 years 62 0.24 0.01, 0.48 
  60-70 years 334 0.26 0.16, 0.37 
  70-80 years 756 0.28 0.21, 0.34 
  older than 80 years 258 0.24 0.13, 0.36 
Sex   
  Male 668 0.32 0.25, 0.39 
  Female 742 0.27 0.20, 0.33 
Education  
  Elementary 86 0.46 0.28, 0.64 
  Lower secondary 571 0.27 0.19, 0.35 
  Higher secondary 434 0.28 0.19, 0.37 
  Tertiary 319 0.31 0.21, 0.42 
Marital status  
  Living alone 421 0.31 0.27, 0.36 
  Living with someone 989 0.28 0.26, 0.31 
Lifestyle factors  
Smoking  
  Never smoker 472 0.28 0.22, 0.35 
  Former smoker 833 0.32 0.29, 0.35 
  Current smoker 106 0.17 0.08, 0.26 
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Table 2.1.2 (continued). Spearman correlation between questionnaire-assessed total physical 
activity and accelerometer-assessed total physical activity, according to characteristics of the study 
population 
 Total population, factors, and physical activity n Spearman’s r 95% CI 
BMI    
  Normal weight 418 0.27 0.18, 0.36 
  Overweight 668 0.29 0.21, 0.36 
  Obese 324 0.26 0.16, 0.36 
Alcohol consumption    
   Low   502 0.29 0.20, 0.37 
   Medium 646 0.29 0.19, 0.4 
   High  444 0.31 0.21, 0.42 
Health factors    
Disability    
  Not disabled 743 0.27 0.21, 0.34 
  Disabled 300 0.31 0.26, 0.36 
  Severely disabled 367 0.23 0.14, 0.33 
Prevalent chronic disease    
  No prevalent chronic disease 775 0.28 0.21, 0.35 
  Prevalent cancer, CVD or diabetes 635 0.29 0.22, 0.36 
Cognitive function    
  MMSE score below 26 97 0.43 0.25, 0.61 
  MMSE score of 26 or higher 1,313 0.29 0.23, 0.34 
Depression    
  No depression 1,304 0.29 0.27, 0.32 
  Depression present 106 0.33 0.15, 0.51 
Physical activity    
Self-reported PAa    
  Low 485 0.16 0.07, 0.25 
  Medium 445 0.16 0.07, 0.25 
  High 480 0.10 0.01, 0.19 
Accelerometer-derived PAb    
  Low 514 0.23 0.14, 0.31 
  Medium 485 0.08 -0.01, 0.16 
  High 411 0.11 0.02, 0.20 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CI, confidence interval; CVD, 
cardiovascular disease; MMSE, mini mental state examination; PA, physical activity 
a The median reported level of physical activity across the low, medium and high category were 210, 765 and 1807 
minutes/week. 
b The median accelerometer-derived level of physical activity across the low, medium and high category were 1229, 1601 and 
2003 minutes/week. 
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In sensitivity analyses including those with paid occupation (n=1,823), the level and direction of 
disagreement were larger compared to the main analyses (mean [SD]= 971.8 [788.0] 
minutes/week and -589.0 [1104.0] minutes/week, respectively). The factors associated with the 
disagreement were similar compared to the sample included in the main analyses (Supplement 
2.1.7). In those not reporting cycling (n=692), factors associated with the direction of 
disagreement were equal compared to the sample included in the study (Supplement 2.1.8), 
although some associations were no longer significant. 
 
Figure 2.1.2. Factors associated with the level of disagreement (i.e. absolute difference) between 
accelerometer and questionnaire physical activity 
Notes: A positive difference indicates a larger absolute difference between the questionnaire and the accelerometer compared 
to the reference, whereas a negative difference indicates a smaller difference. Analyses included all demographics: lifestyle and 
health variables, total accelerometer-derived physical activity, time between interview date and first accelerometer-wear date, 
cohort, and wave. The coefficient for women was relative to men, and the coefficient for paid occupation relative to those 
without. For continuous variables (age, disability score, number of chronic diseases, MMSE score, and CESD score), values 
correspond to a 1-unit increase in the determinant. 
Abbreviations: BMI, body-mass index; CESD, Center for Epidemiologic Studies Depression; MMSE, Mini-Mental State 
Examination; PA: physical activity; ref, reference. 
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Figure 2.1.3. Factors associated with the direction of disagreement between accelerometer and 
questionnaire physical activity 
Notes: Considering the average direction of disagreement equaled –529.4 minutes/week, positive disagreement indicates less 
underestimation in the questionnaire. Relative to the accelerometer. Negative disagreement indicates more underestimation 
in the questionnaire compared to the accelerometer. Analyses included all demographic, lifestyle, and health variables, total 
accelerometer-derived physical activity, time between interview date and first accelerometer-wear date, cohort, and wave. The 
coefficient for women was relative to men and the coefficient for paid occupation relative to those without paid occupation. 
For continuous variables (age, disability score, number of chronic diseases, MMSE-score, and CESD-score), values correspond 
with a 1-unit increase in the determinant. 
Abbreviations: BMI, body-mass index; CESD, Center for Epidemiologic Studies Depression; MMSE, Mini-Mental State 
Examination; PA, physical activity. 
 
DISCUSSION 
The aim of the current study was to quantify the level and direction of disagreement between 
questionnaire- and accelerometer-assessed PA and to investigate if sociodemographic, lifestyle 
and health factors could explain differences in agreement. We found that the overall agreement 
between the LASA Physical Activity Questionnaire and a wrist-worn accelerometer was low and 
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In sensitivity analyses including those with paid occupation (n=1,823), the level and direction of 
disagreement were larger compared to the main analyses (mean [SD]= 971.8 [788.0] 
minutes/week and -589.0 [1104.0] minutes/week, respectively). The factors associated with the 
disagreement were similar compared to the sample included in the main analyses (Supplement 
2.1.7). In those not reporting cycling (n=692), factors associated with the direction of 
disagreement were equal compared to the sample included in the study (Supplement 2.1.8), 
although some associations were no longer significant. 
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accelerometer and questionnaire physical activity 
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health variables, total accelerometer-derived physical activity, time between interview date and first accelerometer-wear date, 
cohort, and wave. The coefficient for women was relative to men, and the coefficient for paid occupation relative to those 
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that it differed across lifestyle and health variables. The level of disagreement was higher in less 
educated individuals. In addition, obese individuals,  those with higher disability, and those with 
more depressive symptoms underreported PA more in the questionnaire compared to the 
reference group. Moreover, with higher levels of accelerometer-derived PA, the underestimation 
of PA in the questionnaire was more obvious. 
The low correlation between accelerometer- and questionnaire-derived PA observed in the 
current study (r=0.30) is similar to results reported in previous studies in older adults,2,9 but lower 
than another study using the LAPAQ in 439 adults aged 69-92 years (r=0.56).18 This difference 
might be related to the study design, as participants in the study of Stel et al. wore a pedometer 
directly after filling out the LAPAQ,18 whereas in the current study the time between 
questionnaire- and accelerometer-assessment had a median value of 8.7 weeks. Moreover, in the 
study of Stel et al,18 participants additionally completed a 7-day diary while wearing the 
pedometer, which might have altered their PA patterns, due to increased awareness.  
Furthermore, in contrast to most studies, but similar to the study of Sabia et al,9 our participants 
wore the accelerometer around the wrist.  There is general consensus that a wrist-worn 
accelerometer is worse in estimating activity during large-muscle, dynamic activities like cycling 
than a hip-worn device.35 This could lead to an underestimation of PA performed solely by the 
legs.10,11 Moreover, when the wrist is constrained during PA, for example when carrying a 
briefcase or groceries, the PA level will likely be underestimated.35 Considering the fact that these 
activities are usually of light to moderate activity, the agreement between questionnaire and 
accelerometer might be different for hip-worn accelerometers for these intensity domains.  
However, an advantage of the wrist-worn accelerometer is that it allows for 24-hours of 
data-collection per day, including during water-based activities, leading to a comprehensive 
overview of daily PA. This is in contrast to hip-worn devices that have to be removed during the 
night and are usually not waterproof. However, since the correlation between PA derived from 
questionnaire and accelerometer observed in the current study is similar to the correlation in 
studies using hip-worn devices,2,9 the high compliance of the wrist-worn accelerometers is 
unlikely to enhance the comparability between questionnaire and accelerometer. 
In the total population, we found that, compared to the accelerometer, the questionnaire on 
average underestimated PA levels with 529 minutes/week, equivalent to 76 minutes/day. This 
difference could be explained by missing items on the questionnaire that are measured by the 
accelerometer, including climbing stairs, walking within shops, playing with domestic animals 
and dressing and cleaning oneself. These kinds of activities could add up to over one hour per day. 
An additional explanation for the underestimation of PA in the questionnaire could be that some 
activities are of very short duration (<1 minute) and therefore might not be recalled by the 
participants when filling in the questionnaire, whereas the accelerometer accumulates all these 
small bouts of activity. These two explanations might be especially important for light activity, for 
which we found that in the total population, weekly light PA was 708 minutes/week 
(corresponding to 1 ¾ hour per day) lower according to questionnaire compared to the 
accelerometer (Supplement 2.1.4), which is in line with previous evidence.36,37 
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To our knowledge, we are the first to report that more depressive symptoms and disability are 
associated to a larger underestimation in the questionnaire compared to the accelerometer. An 
explanation could be that those with depressive symptoms or disability have a more pessimistic 
estimate of their PA levels than their counterparts. In other research domains, depressive 
symptoms have also been associated with reporting bias38 and it has been suggested that 
individuals suffering from depression process information about the self in a maladaptive fashion 
compared to their healthier counterparts.39  
In other research domains, depressive symptoms have also been associated with reporting 
bias38 and it has been suggested that individuals suffering from depression process information 
about the self in a maladaptive fashion compared to their healthier counterparts.39 For example, in 
a study regarding the agreement between self-reported and actigraphic assessed sleep, participants 
with more depressive symptoms reported a lower sleep duration than was measured using 
actigraphy.34 In the same study, higher levels of functional disability were associated with a larger 
absolute difference between self-reported and actigraphic sleep, indicating that being disabled 
might affect self-reported levels in domains other than PA as well. 
Furthermore, our findings show that the absolute difference between questionnaire and 
accelerometer is highest in those with primary education, although there was no difference 
between educational groups regarding the direction of this disagreement. This indicates that the 
degree of underreporting differs for participants with a low education, which is cancelled out in 
the absolute difference between questionnaire and accelerometer. Finally, obese individuals 
underreported their total PA more than normal weight participants, which is contradictory to 
previous research showing over reporting of PA in questionnaires.15,40 However, in line with our 
observation, a study among 365 young and middle-aged adults found that participants who 
underestimated their PA levels were more likely to have a higher BMI.41 In this regard, it’s possible 
that those with obesity perceive their PA levels as inadequate, because of the belief that they could 
not have been obese with adequate PA levels.41,42  
The results of our study can have implications for current and future practice on PA 
measurements. Considering the increase in the use of accelerometers in current research, 
researchers need to be aware that results between studies using either questionnaire or 
accelerometer should be compared with caution. Importantly, the disagreement increased with 
higher levels of accelerometer-derived PA. More detailed instructions in the questionnaire may be 
needed43 and questionnaires might need to be improved to better capture the overall PA pattern of 
older adults. To this aim, future studies should focus on enhancing the agreement between 
questionnaire- and accelerometer-derived PA levels. Moreover, individuals working in clinical 
practice should be aware that especially those with worse perceived health might not have a 
realistic view of their PA levels. Asking more thoroughly about their activities could provide more 
information than a simple question on whether they perceive their PA as sufficient or not. 
Furthermore, the large discrepancy between accelerometer- and questionnaire-derived PA in 
those with paid occupation found in our sensitivity analysis implies that studies using 
questionnaires in working populations should always include occupational PA.  
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The use of accelerometers could also be improved in future studies to more accurately 
measure activities solely performed with the lower extremities. The bias between questionnaire 
and accelerometer might be reduced by future efforts to develop specified algorithms that can 
identify these activities, taking into account their specific rhythm when wearing an accelerometer. 
Moreover, our findings that (perceived) health and educational status can influence reported PA 
stresses the importance of taking into account these factors in in future studies and analyses. 
Finally, regardless of the (dis)agreement between questionnaires and accelerometers, both 
methods should be used simultaneously in research to gain the most information. Whereas 
accelerometers provide an accurate distribution of intensity and duration, questionnaires might 
more accurately reflect the perceived PA. In order to be able to influence the PA levels of 
individuals, both sources of information are important. We would therefore recommend for all 
individuals, including those with higher BMI, more depressive symptoms and more disability, to 
measure PA by using both methods whenever possible. 
Our study contains several strengths. We are one of the first to examine both the correlation 
and disagreement between PA as derived from questionnaire and a wrist-worn accelerometer in a 
large community-based cohort of older adults, using a wide variety of determinants. Moreover, 
the use of a waterproof wrist-worn accelerometer ensured high compliance. Consequently, the 
high compliance ensures a low amount of non-wear periods in which assumptions would have to 
be made on whether this time was spent active or sedentary.44,45 As a result, PA is generally 
assessed more precisely.45  
However, some limitations also have to be acknowledged. First, the PA estimates as derived 
from accelerometer and questionnaire were not obtained in the same week. This might have 
contributed to the low agreement in the current study. However, addressing questionnaire and 
accelerometer simultaneously might make participants more aware of their behavior and could 
result in larger agreement than otherwise obtained.43 Second, we did not have up-to-date 
information on cancer, cardiovascular disease and diabetes. Consequently, some residual 
confounding might be present which could result in bias towards the null. Third, our results are 
based on the difference between the LASA Physical Activity Questionnaire and the wrist-worn 
GeneActiv accelerometer. Our findings might therefore not be generalized to other questionnaires 
or hip-worn accelerometers. Fourth, using accelerometers providing raw output in milligravity is 
relatively new and therefore the cut-off points to define activity intensity have not been firmly 
established. Therefore, the use of different cut-offs might shift the distribution of time spent in 
light, moderate and vigorous PA according the accelerometer. Furthermore, we measured PA 
during one week, which might not represent overall engagement in PA. Additionally, participants 
that agreed to wear an accelerometer were more often men and showed a better health profile 
regarding the MMSE score, CESD score and disability score. This might affect the generalizability 
towards the total population of older adults. Finally, the current participants were from a Dutch 
population, with relatively high levels of PA compared to other Western countries.46 Considering 
the fact that the disagreement in the current was higher for higher levels of accelerometer-derived 
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PA, the disagreement between questionnaire- and accelerometer-derived PA might be lower in 
countries with generally lower PA levels. 
Conclusions 
In conclusion, we observed that the correspondence between questionnaire- and accelerometer-
derived PA is low. In the total population, the number of minutes per week spent in PA was in 
general underestimated in the questionnaire. This was a consequence of underreporting light PA, 
whereas moderate PA was over reported in the questionnaire. These differences were partly 
explained by BMI, disability and depressive symptoms, as participants with higher BMI and more 
disability and depressive symptoms underestimated their self-reported PA more than their 
healthier counterparts. Moreover, the underestimation was larger with higher levels of 
accelerometer-derived PA. Future studies using questionnaires and/or accelerometers to measure 
PA should be aware of these differences. 
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Supplement 2.1.1. Characteristics of participants who agreed to participate and those who did not 
agree to participate 
 
Did not agree to 
participate 
Agreed to 
participate* 
p 
Participants 833 3,156  
Age (years) 72.70 (22.7) 70.78 (9.0) <0.001 
Women, n (%) 528 (63.6) 1,669 (52.9) <0.001 
Education   <0.001 
  Elementary 66 (8.1) 197 (6.3)  
  Lower secondary 374 (46.0) 1,202 (38.5)  
  Higher secondary 239 (29.4) 966 (30.9)  
  Tertiary 134 (16.5) 757 (24.2)  
BMI, n (%)   0.06 
   Normal weight 258 (31.3) 880 (27.9)  
   Overweight 358 (43.4) 1,507 (47.8)  
   Obese 209 (25.3) 768 (24.3)  
Smoking, n (%)   0.002 
   Non smoker 296 (35.8) 1,048 (33.3)  
   Former smoker 424 (51.3) 1,800 (57.2)  
   Current smoker 107 (12.9) 301 (9.6)  
Disability score 0.75 (0.87) 0.55 (0.65) <0.001 
Living with partner, n (%) 508 (61.4) 2,261 (71.7) <0.001 
Currently with job, n (%) 120 (16.7) 599 (20.6) 0.02 
Prevalent cancer, CVD or diabetes, n 
(%) 352 (42.3) 1276 (40.4) 0.36 
MMSE score 27.51 (2.40) 28.12 (1.74) <0.001 
CESD score 6.44 (7.30) 5.35 (6.79) <0.001 
Total PA according questionnaire 
(minutes/week), 970.19 (1176.5) 1110.09 (1486.5) 0.02 
Data are presented as mean (SD) unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CVD, cardiovascular disease; 
IQR, interquartile range; MMSE, mini mental state examination; n, number; PA, physical activity; SD, standard deviation. 
* The study sample agreeing to participate also includes participants that wore an Actiwatch device. 
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Supplement 2.1.2. Bland-Altman plot for total physical activity 
 
Mean physical activity level (minutes/week) 
Abbreviation: SD, standard deviation. 
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Supplement 2.1.3. Physical activity characteristics of light, moderate and vigorous physical 
activity in the total population  
Characteristic Mean (SD) 
Physical activity according questionnaire  
  Light PA (minutes) 316.1 (473.1) 
  Moderate PA (minutes) 651.8 (800.8) 
  Vigorous PA (minutes) 82.0 (338.7) 
Physical activity according accelerometer  
  Light PA (minutes) 1024.4 (218.1) 
  Moderate PA (minutes) 447.3 (139.2) 
  Vigorous PA (minutes) 107.6 (53.7) 
Level of disagreement between questionnaire and accelerometer  
  Light PA (minutes) 781.6 (354.1) 
  Moderate PA (minutes) 405.8 (697.6) 
  Vigorous PA (minutes) 131.0 (312.7) 
Direction of disagreement between questionnaire and accelerometer  
  Light PA (minutes) -708.4 (484.3) 
  Moderate PA (minutes) 204.6 (780.8) 
  Vigorous PA (minutes) -25.6 (338.1) 
*Paired t-tests indicated significant differences between light, moderate and vigorous physical activity as measured by 
questionnaire and accelerometer. 
Abbreviations: PA, physical activity; SD, standard deviation 
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Supplement 2.1.3. Physical activity characteristics of light, moderate and vigorous physical 
activity in the total population  
Characteristic Mean (SD) 
Physical activity according questionnaire  
  Light PA (minutes) 316.1 (473.1) 
  Moderate PA (minutes) 651.8 (800.8) 
  Vigorous PA (minutes) 82.0 (338.7) 
Physical activity according accelerometer  
  Light PA (minutes) 1024.4 (218.1) 
  Moderate PA (minutes) 447.3 (139.2) 
  Vigorous PA (minutes) 107.6 (53.7) 
Level of disagreement between questionnaire and accelerometer  
  Light PA (minutes) 781.6 (354.1) 
  Moderate PA (minutes) 405.8 (697.6) 
  Vigorous PA (minutes) 131.0 (312.7) 
Direction of disagreement between questionnaire and accelerometer  
  Light PA (minutes) -708.4 (484.3) 
  Moderate PA (minutes) 204.6 (780.8) 
  Vigorous PA (minutes) -25.6 (338.1) 
*Paired t-tests indicated significant differences between light, moderate and vigorous physical activity as measured by 
questionnaire and accelerometer. 
Abbreviations: PA, physical activity; SD, standard deviation 
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Supplement 2.1.6. Characteristics of the study population, stratified by occupational status 
 Without paid 
occupation 
With paid 
occupation* 
p 
Participants 1,410 386  
Age (years) 73.81 (7.61) 60.31 (6.17) <0.001 
Female, n (%) 742 (52.6) 174 (45.1) 0.01 
Education   <0.001 
  Elementary 85 (6.1) 15 (3.9)  
  Lower secondary 562 (40.5) 94 (24.5)  
  Higher secondary 428 (30.8) 120 (31.2)  
  Tertiary 314 (22.6) 155 (40.4)  
BMI, n (%)   0.70 
   Normal weight 418 (29.6) 111 (28.8)  
   Overweight 668 (47.4) 192 (49.7)  
   Obese 324 (23.0) 83 (21.5)  
Smoking, n (%)   0.005 
   Never smoker 471 (33.4) 115 (29.8)  
   Former smoker 832 (59.0) 222 (57.5)  
   Current smoker 106 (7.5) 49 (12.7)  
Disability score 0.64 (0.68) 0.25 (0.38) <0.001 
Living with partner, n (%) 988 (70.1) 323 (83.7) <0.001 
Prevalent cancer, CVD or diabetes, n (%) 635 (45.0) 79 (20.5) <0.001 
MMSE score 28.10 (1.74) 28.61 (1.28) <0.001 
CESD score 5.04 (6.30) 4.24 (5.74) 0.03 
Total PA according questionnaire 
(minutes/week) 1049.9 (1108.3) 970.9 (1149.9) 0.22 
Total PA according accelerometer 
(minutes/week) 1579.3 (386.1) 1779.2 (396.7) <0.001 
Data are presented as mean (SD) unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CVD, cardiovascular disease; 
IQR, interquartile range; MMSE, mini mental state examination; n, number; PA, physical activity; SD, standard deviation. 
* The fact that the number of participants is different from the number mentioned in the flowchart is related to the fact that a 
second observation was excluded for 3 additional participants. 
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Supplement 2.1.6. Characteristics of the study population, stratified by occupational status 
 Without paid 
occupation 
With paid 
occupation* 
p 
Participants 1,410 386  
Age (years) 73.81 (7.61) 60.31 (6.17) <0.001 
Female, n (%) 742 (52.6) 174 (45.1) 0.01 
Education   <0.001 
  Elementary 85 (6.1) 15 (3.9)  
  Lower secondary 562 (40.5) 94 (24.5)  
  Higher secondary 428 (30.8) 120 (31.2)  
  Tertiary 314 (22.6) 155 (40.4)  
BMI, n (%)   0.70 
   Normal weight 418 (29.6) 111 (28.8)  
   Overweight 668 (47.4) 192 (49.7)  
   Obese 324 (23.0) 83 (21.5)  
Smoking, n (%)   0.005 
   Never smoker 471 (33.4) 115 (29.8)  
   Former smoker 832 (59.0) 222 (57.5)  
   Current smoker 106 (7.5) 49 (12.7)  
Disability score 0.64 (0.68) 0.25 (0.38) <0.001 
Living with partner, n (%) 988 (70.1) 323 (83.7) <0.001 
Prevalent cancer, CVD or diabetes, n (%) 635 (45.0) 79 (20.5) <0.001 
MMSE score 28.10 (1.74) 28.61 (1.28) <0.001 
CESD score 5.04 (6.30) 4.24 (5.74) 0.03 
Total PA according questionnaire 
(minutes/week) 1049.9 (1108.3) 970.9 (1149.9) 0.22 
Total PA according accelerometer 
(minutes/week) 1579.3 (386.1) 1779.2 (396.7) <0.001 
Data are presented as mean (SD) unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CVD, cardiovascular disease; 
IQR, interquartile range; MMSE, mini mental state examination; n, number; PA, physical activity; SD, standard deviation. 
* The fact that the number of participants is different from the number mentioned in the flowchart is related to the fact that a 
second observation was excluded for 3 additional participants. 
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Supplement 2.1.7. Factors associated with the level and direction of disagreement between 
accelerometer and questionnaire physical activity, including participants with paid occupation 
(n=1,823) 
  Level of disagreement Direction of disagreement 
  β 95%CI p β 95%CI p 
Demographic factors    
Age 0.84 -8.8, 10.5 0.86 -8.8 -22.4, 4.8 0.21 
Women -66.4 -149.3, 16.5 0.12 120.0 2.6, 237.4 0.05 
Education    
  Primary  Ref Ref   
  Lower -176.1 -340.2, -12.1 0.04 -59.9 -291.8, 171.9 0.61 
  Intermediate -268.6 -436.3, -101 0.002 -115.1 -352.0, 121.8 0.34 
  Higher -241.5 -413.9, -69.0 0.01 -101.9 -345.4, 141.6 0.41 
Paid occupation 185.0 72.7, 297.3 0.001 -312.7 -471.5, -154 <0.001 
Living with partner -44.4 -131.9, 43.1 0.32 1.0 -122.7, 124.8 0.99 
Lifestyle factors    
Smoking    
   Never smoker Ref Ref   
   Former smoker -2.5 -82.2, 77.3 0.95 -18.3 -131.0, 94.5 0.75 
   Current smoker 88.1 -53.1, 229.4 0.22 -12.6 -212.5, 187.3 0.90 
BMI    
   Normal weight Ref Ref   
   Overweight 19.4 -65.6, 104.5 0.65 -109.0 -229.2, 11.1 0.08 
   Obese 49.2 -55.9, 154.3 0.36 -260.2 -408.9, -111.6 0.001 
Alcohol consumption    
   Low   Ref Ref   
   Medium -16.3 -121.5, 89.0 0.76 -46.3 -191.7, 99.2 0.53 
   High  -14.6 -116.7, 87.6 0.78 -28.4 -176.6, 119.8 0.71 
Health factors    
Disability score -15.6 -79.3, 48.1 0.63 -134.7 -224.7, -44.6 0.003 
Number of chronic 
diseases 19.9 -38.2, 78.0 0.50 -3.4 -85.44, 78.7 0.94 
MMSE score -4.6 -27.0, 17.9 0.69 21.6 -10.3, 53.5 0.18 
CESD score 2.4 -3.7, 8.5 0.44 -12.5 -21.1, -3.95 0.004 
Analyses were adjusted for all included demographic, lifestyle and health variables, total accelerometer-derived physical 
activity, time between interview date and the first accelerometer wear date, cohort and wave. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression Scale; MMSE, mini mental state 
examination; PA, physical activity 
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Supplement 2.1.8. Factors associated with the level and direction of disagreement between 
accelerometer and questionnaire physical activity, in those not reporting cycling (n=692) 
  Level of disagreement Direction of disagreement 
  β 95%CI p β 95%CI p 
Demographic factors    
Age -0.4 -14.1, 13.3 0.96 -21.2 -40.7, -1.7 0.03 
Women -31.6 -165.1, 101.9 0.64 94.5 -95.1, 284.1 0.33 
Education       
  Primary  Ref   Ref   
  Lower 3.0 -216.2, 222.3 0.98 186.0 -124.8, 496.8 0.24 
  Intermediate -89.7 -316.3, 136.9 0.44 10.0 -311.0, 331.1 0.95 
  Higher -80.5 -323.1, 162.1 0.52 129.3 -214.2, 472.9 0.46 
Living with partner -77.8 -203.9, 48.3 0.23 -132.5 -311.2, 46.2 0.15 
Lifestyle factors       
Smoking       
   Never smoker Ref   Ref   
   Former smoker 8.4 -113.8, 130.6 0.89 -15.2 -188.3, 158.0 0.86 
   Current smoker 162.4 -47.9, 372.7 0.13 83.6 -214.5, 381.7 0.58 
BMI       
   Normal weight Ref   Ref   
   Overweight -81.4 -214.0, 51.2 0.23 -149.3 -337.1, 38.6 0.12 
   Obese -14.9 -170.0, 140.3 0.85 -283.7 -503.4, -63.9 0.01 
Alcohol consumption       
   Low   Ref   Ref   
   Medium 10.4 -154.7, 175.5 0.90 -27.6 -282.9, 227.7 0.83 
   High  -42.5 -224.1, 139.1 0.64 -26.9 -287.8, 234.0 0.84 
Health factors       
Disability score 5.0 -74.5, 84.4 0.90 -91.9 -204.6, 20.8 0.11 
Number of chronic diseases 37.6 -46.6, 121.8 0.38 49.9 -69.5, 169.2 0.41 
MMSE score 8.3 -23.3, 39.8 0.61 26.0 -18.7, 70.7 0.25 
CESD score -1.0 -9.5, 7.6 0.83 -15.3 -27.4, -3.19 0.01 
Analyses were adjusted for all included demographic, lifestyle and health variables, total accelerometer-derived physical 
activity, time between interview date and the first accelerometer wear date, cohort and wave. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression Scale; MMSE, mini mental state 
examination; PA, physical activity 
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ABSTRACT 
Background: Little is known about the distribution of activity over the full 24-hour spectrum 
in late old age and its association with demographic and health factors. Therefore, we aimed 
to evaluate the distribution of physical activity (PA), sedentary behavior, and sleep, and 
associated factors in the elderly population. 
Methods: Our study included 1,210 participants (51.9% women) aged 70-94 years [mean age 
77.5 years, standard deviation (SD) 5.0] from the population-based Rotterdam Study. 
Participants wore a triaxial accelerometer (GENEActiv) around the wrist for 7 days between 
July 2014 and June 2016. We examined if PA, sedentary behavior, and sleep differed by age, 
sex, body mass index (BMI), smoking status, alcohol consumption, education, season, 
disability status, marital status, presence of chronic disease, and use of sleep medication. 
Results: Mean total PA, expressed in milli-gravity (mg) units, was slightly higher for women 
(20.3, SD 5.6) than for men (19.3, SD 5.2, P < .01). Mean (SD) daily duration spent in 
sedentary behavior and light and moderate-to-vigorous PA was 13.3 (1.5) h/d, 147.5 (31.5) 
min/d, and 75.0 (25.5) min/d, respectively, among women; and 13.8 (1.6) h/d, 140.5 (31.1) 
min/d, and 71.5 (24.5) min/d, respectively, among men. Women spent on average 6.7 (SD 
1.1) h/d sleeping and men 6.6 (1.4) h/d. Across increasing categories of age and BMI and in 
participants with chronic disease and disability, time spent in light and moderate-to-vigorous 
PA was decreased. Higher age and BMI were associated with more sedentary time. In 
addition, obese men spent slightly more time sleeping than their normal weight counterparts 
and women spent slightly less time sleeping in the summer than in spring. 
Conclusion: PA and sedentary behavior in the elderly differed by sex, age, BMI, prevalence 
of chronic disease, and disability, whereas there were no clear patterns for sleep. On average, 
our participants spent up to 79.5% of their time awake being sedentary and 7%-8% in 
moderate-to-vigorous PA. Replacing sedentary behavior with light PA would be a good 
starting point for those with the lowest level of PA. Older adults, those with high BMI and 
worse health could benefit from targeted interventions to increase PA. 
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INTRODUCTION 
Physical activity (PA) plays a major role in healthy aging, by preventing disease, reducing 
disability and improving well-being.1-3 Given the importance of PA in older adulthood, 
understanding the levels of PA in elderly adults might provide information for public health 
institutions to create targeted recommendations. In epidemiological studies, PA is usually 
assessed by questionnaires.4 However, these data are known to be prone to reporting errors and 
recall bias, especially for low intensity behaviors.5,6 These limitations may be exacerbated in older 
populations, in whom cognitive impairment is more likely.7 Therefore, accelerometers are 
increasingly used to measure PA and sedentary behavior objectively.8 
To date, several studies objectively assessed PA and sedentary behavior using accelerometers 
in adults aged 60 years and over9-19 and examined the associations with demographic and health 
factors. It has been shown that PA levels decrease with increasing age9-13,16,19 and across increasing 
levels of BMI.9-12,14 Whereas these studies provided useful information, the associations were often 
obtained from unadjusted analyses. Moreover, there is limited information on the 24-hour 
activity spectrum in the elderly, including PA, sedentary behavior and sleep. It remains unknown 
how these factors are interrelated and how they are distributed across age-groups and other 
demographic and health factors. In previous studies, accelerometers have most often been worn 
on the hip and had to be removed for sleeping. Wrist-worn devices can be worn day and night, 
thereby allowing for collection of 24-hour of activity data, recently shown to be valid indicators of 
activity energy expenditure.20,21 Additionally, wrist-worn devices have been argued to promote 
better compliance of device wear.22 
The Rotterdam Study is one of the first large population studies to objectively assess PA in 
an elderly population of adults aged 70-94 years using a triaxial accelerometer. The main aim of 
this study was to provide a description of objectively measured activity in elderly adults from the 
Rotterdam Study, over the complete 24-hour period. Additionally, we examined the demographic 
and health factors associated with activity measures in this cohort. 
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study, a prospective population-based cohort in the 
Netherlands. The main aim of this study was to examine the incidence of risk factors for 
neurological, cardiovascular, psychiatric, and other chronic diseases. Details of the study have 
been published previously.23 For the current study, 1,900 successive participants of the Rotterdam 
Study were invited to participate, from July 2014 to May 2016, of which 506 did not consent. For 
1,210 participants valid data (>1200 min/day) on at least 4 days was available (See Figure 2.2.1).  
All subjects gave written informed consent, and the study protocol was approved by the 
medical ethics committee of Erasmus University, Rotterdam. Detailed information on the design 
of the Rotterdam Study can be found elsewhere.23 
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Accelerometer-assessed physical activity 
All participants were asked to wear a triaxial accelerometer (GeneActiv; Activinsights Ltd, 
Kimbolton, Cambridgeshire, UK, http://www.geneactiv.org/) on the non-dominant wrist for 7 
consecutive days and nights and to complete a 7-day sleep diary to report overnight sleep periods. 
The accelerometer sampled at 50 Hz and as in previous studies18,24,25 acceleration was expressed 
relative to gravity (g units; 1 g =9.81 m/s2 at this location in the Netherlands26), since the sensors 
are calibrated relative to gravity. Calibration error was estimated based on static periods in the 
data and corrected if necessary.27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.1. Flow chart of participant inclusion for the Rotterdam Study. 
  
506 Participants did not want to 
participate 
33 Participants excluded with a 
malfunctioning device 
123 Participants without valid data:   
x 18 Participants did not complete one 
week of wearing 
x 99 Participants with invalid data  i.e. 
not having 4 days with >1200 
minutes/day of data 
x 6 Participants lost their device 
28 Participants excluded due to 
processing error 
 
1,900 Participants invited to participate from July 
2014 to June 2016  
1,394 Participants 
1,361 Participants 
1,238 Participants 
1,210 Participants included in the analyses 
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We used two vector magnitude-based measures to quantify the acceleration related to the 
movement registered. The first was the Euclidean norm minus 1 g with negative numbers 
rounded to zero (ENMO).21 In addition, we calculated the high-pass filtered vector magnitude 
(HPFVM), which applies a high-pass filter to the acceleration signal with a cut-off frequency of 
0.2 Hertz, treating gravity as a low-frequency component to be filtered out.20  
Accelerometer data were processed in Python (2.6.6) using the open access PAMPRO 
software. Pampro is a software program for the systematic analysis of physical activity data 
collected in epidemiological studies.28 Data was extracted from the first wearing day up to seven 
days later. Non-wear time was estimated as time periods where the standard deviation of 
acceleration in all three axes fell below 13mg for longer than 1 hour,20 and any non-wear period 
was excluded from analyses. The pattern of non-wear time was accounted for by balancing the 
weighting of the data according to the diurnal profile.29 
Assessment of factors 
Information on health behaviors was collected through home interviews or measured at the study 
center, as described previously.30,31 Alcohol use was defined as the number of times drinking 
alcohol per time unit (i.e. never drinking alcohol; drinking 1-4 per month; drinking 2-4 per week). 
Education was assessed in line with the International Standard Classification of Education and 
categorized as primary, lower, intermediate and higher education.32 Smoking was divided in three 
categories: current, former and never. Height and weight were measured to calculate body mass 
index (BMI) (kg/m2) and categorised as normal weight (<25 kg/m2), overweight (25–30 kg/m2) 
and obese (>30 kg/m2). Marital status was defined as living with a partner or not. Disability status 
was assessed by the Activities of Daily Living from the Stanford Health Assessment Questionnaire 
Disability Index (HAQ-DI).33 In accordance with literature we used a HAQ-DI 0.5 ≥1.0 to define a 
participant as disabled and a HAQ-DI ≥ 1.0 to define a participant as severely disabled.34 Use of 
sleep medication was obtained from the sleep diary, and used as a binary variable (not in the past 
7 days/at least one day in the past 7 days). The presence of cardiovascular disease (CVD), diabetes 
mellitus (DM) and cancer were determined using medical records, to define presence of chronic 
disease. The LASA Physical Activity Questionnaire (LAPAQ) was used to determine total self-
reported PA and was expressed in MET·hours·week-1. The questionnaire included questions on 
walking, cycling, housekeeping, sports and gardening. Finally, using the first wearing date of the 
GeneActiv, we classified the season according to the light definition, centered at equinoxes 
(winter: November 6 to February 4, spring: February 5 to May 6, summer: May 7 to August 5 and 
autumn: August 6 to November 5.35 
Data analysis 
Descriptive statistics for continuous PA variables are presented as mean and standard deviation 
(SD) or median and interquartile range (IQR) if data were not normally distributed. We created 9 
intervals, to visually evaluate the distribution of time spent in overall PA, and how it varied by 
gender and age-group.  Additionally, we categorized activity based on HPFVM in sedentary (<48 
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Accelerometer-assessed physical activity 
All participants were asked to wear a triaxial accelerometer (GeneActiv; Activinsights Ltd, 
Kimbolton, Cambridgeshire, UK, http://www.geneactiv.org/) on the non-dominant wrist for 7 
consecutive days and nights and to complete a 7-day sleep diary to report overnight sleep periods. 
The accelerometer sampled at 50 Hz and as in previous studies18,24,25 acceleration was expressed 
relative to gravity (g units; 1 g =9.81 m/s2 at this location in the Netherlands26), since the sensors 
are calibrated relative to gravity. Calibration error was estimated based on static periods in the 
data and corrected if necessary.27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.1. Flow chart of participant inclusion for the Rotterdam Study. 
  
506 Participants did not want to 
participate 
33 Participants excluded with a 
malfunctioning device 
123 Participants without valid data:   
x 18 Participants did not complete one 
week of wearing 
x 99 Participants with invalid data  i.e. 
not having 4 days with >1200 
minutes/day of data 
x 6 Participants lost their device 
28 Participants excluded due to 
processing error 
 
1,900 Participants invited to participate from July 
2014 to June 2016  
1,394 Participants 
1,361 Participants 
1,238 Participants 
1,210 Participants included in the analyses 
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We used two vector magnitude-based measures to quantify the acceleration related to the 
movement registered. The first was the Euclidean norm minus 1 g with negative numbers 
rounded to zero (ENMO).21 In addition, we calculated the high-pass filtered vector magnitude 
(HPFVM), which applies a high-pass filter to the acceleration signal with a cut-off frequency of 
0.2 Hertz, treating gravity as a low-frequency component to be filtered out.20  
Accelerometer data were processed in Python (2.6.6) using the open access PAMPRO 
software. Pampro is a software program for the systematic analysis of physical activity data 
collected in epidemiological studies.28 Data was extracted from the first wearing day up to seven 
days later. Non-wear time was estimated as time periods where the standard deviation of 
acceleration in all three axes fell below 13mg for longer than 1 hour,20 and any non-wear period 
was excluded from analyses. The pattern of non-wear time was accounted for by balancing the 
weighting of the data according to the diurnal profile.29 
Assessment of factors 
Information on health behaviors was collected through home interviews or measured at the study 
center, as described previously.30,31 Alcohol use was defined as the number of times drinking 
alcohol per time unit (i.e. never drinking alcohol; drinking 1-4 per month; drinking 2-4 per week). 
Education was assessed in line with the International Standard Classification of Education and 
categorized as primary, lower, intermediate and higher education.32 Smoking was divided in three 
categories: current, former and never. Height and weight were measured to calculate body mass 
index (BMI) (kg/m2) and categorised as normal weight (<25 kg/m2), overweight (25–30 kg/m2) 
and obese (>30 kg/m2). Marital status was defined as living with a partner or not. Disability status 
was assessed by the Activities of Daily Living from the Stanford Health Assessment Questionnaire 
Disability Index (HAQ-DI).33 In accordance with literature we used a HAQ-DI 0.5 ≥1.0 to define a 
participant as disabled and a HAQ-DI ≥ 1.0 to define a participant as severely disabled.34 Use of 
sleep medication was obtained from the sleep diary, and used as a binary variable (not in the past 
7 days/at least one day in the past 7 days). The presence of cardiovascular disease (CVD), diabetes 
mellitus (DM) and cancer were determined using medical records, to define presence of chronic 
disease. The LASA Physical Activity Questionnaire (LAPAQ) was used to determine total self-
reported PA and was expressed in MET·hours·week-1. The questionnaire included questions on 
walking, cycling, housekeeping, sports and gardening. Finally, using the first wearing date of the 
GeneActiv, we classified the season according to the light definition, centered at equinoxes 
(winter: November 6 to February 4, spring: February 5 to May 6, summer: May 7 to August 5 and 
autumn: August 6 to November 5.35 
Data analysis 
Descriptive statistics for continuous PA variables are presented as mean and standard deviation 
(SD) or median and interquartile range (IQR) if data were not normally distributed. We created 9 
intervals, to visually evaluate the distribution of time spent in overall PA, and how it varied by 
gender and age-group.  Additionally, we categorized activity based on HPFVM in sedentary (<48 
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mg), light (48 < 154 mg), moderate (154 <389 mg) and vigorous activity (>389 mg), based on a 
recent study.20 For the current study, we combined moderate and vigorous activity in our main 
analyses. Sleep duration was assessed with a validated algorithm,36 using information on bed time 
and awake time from the sleep diary, and was subtracted from total sedentary behavior. 
To describe our data and test differences in average time per day spent in sedentary 
behavior, light PA, moderate-to-vigorous PA and sleep across two categories or across three or 
more categories of the health-related and socio-demographic variables, we used t-tests and 
Analyses of variance (ANOVA), respectively. We further examined the robustness of the 
individual associations by mutually adjusting for all demographic and health factors in linear 
regression analyses. All determinants were entered as categorical variables  and the activity 
variables were the outcome variables in these analyses. To evaluate the explained variance by the 
determinants, we obtained the adjusted R-squared. We decided a priori to present the results 
stratified by sex for comparability with previous and future studies. The average time/d in each 
activity level was plotted as a portion of the 1440 minutes of the day to graphically inspect the 
distribution of activity levels across age-groups and BMI-groups. The average time across BMI-
groups was adjusted for age.  
In sensitivity analyses, we tested whether the health-related and socio-demographic 
characteristics differed between men and women, to be able to explain any gender differences. We 
also tested whether those participating differed from those not agreeing to participate, in regard to 
baseline characteristics. Furthermore, we repeated the linear regression analyses stratified by age 
(older or younger than 80 years), to examine if the associations in the oldest old (i.e. 80 years or 
older) were different than in those younger than 80 years. We also repeated the linear regression 
analyses stratified by a BMI of 27 kg/m2, the median level in the population.  
Analyses were conducted using SPSS software version 20 (IBM SPSS Statistics for Windows, 
Armonk, NY: IBM Corp), R version 3.2.1 (R Foundation for Statistical Computing, Vienna, 
Austria) and Stata version 14.1 SE (StataCorp LP, College Station, Texas).37 A double-sided p < 
0.05 was considered statistically significant. 
 
RESULTS 
Participants who agreed to participate in the study were more often men and less often disabled 
than those who did not agree to wear an accelerometer (Supplement 2.2.1). In the total sample of 
1200 participants, a total of 71,232 valid days were recorded, in accordance with an average of 5.9 
(SD: 0.4) days per participant. The proportion of males in the sample was 48.1% and the mean age 
was 77.5 (SD: 5.0). The median (IQR) accelerometer wear-time was slightly higher in men 
registering 154.2 hours (152.6, 156.4) than in women registering 153.6 hours (151.6, 156.0), p 
<0.001. Furthermore, participating women were more often obese or disabled than men, whereas 
men more often had prevalent chronic disease (Supplement 2.2.2). The proportion of participants 
who reported engaging in walking, cycling, housework, gardening and sports in the LAPAQ is 
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shown in Supplement 2.2.3. Men participated significantly more in cycling and gardening than 
women (p<0.05). 
Total PA, expressed in mg, was slightly higher for women (20.3, SD:5.5) than for men (19.3, 
SD: 5.2, p=0.002). Figure 2.2.2 and Figure 2.2.3 show the acceleration distribution of time spent in 
9 systematic intervals (including time spent sleeping), stratified by sex and age category, 
respectively. Women spent less time in the interval with the lowest acceleration (0-100 mg), and 
spent more time in each other interval than men. For the age-categories, the oldest age-group (≥ 
85 years) spent the most time in the lowest interval (0-100 mg) and spent less time in each other 
interval.   
Mean (SD) time per day spent in sedentary behavior and light and moderate-to-vigorous 
intensity PA was 13.3 (1.5) hours/d, 147.5 (31.5) minutes/d and 75.0 (25.5) minutes/d, 
respectively, among women (Table 2.2.1); and 13.8 (1.6) hours/d, 140.5 (31.1) minutes/d and 71.5 
(24.5) minutes/d, respectively, among men (Table 2.2.2). Time spent in moderate and vigorous 
PA separately and in total sedentary behavior (including sleep) is presented in Supplement 2.2.4 
(women) and Supplement 2.2.5 (men). Women spent 6.7 hours/d (SD: 1.4) sleeping and men (6.6 
hours/d, SD: 1.4), p = 0.12. Men spent significant more minutes in sedentary behavior (p<0.001) 
and less time in light (p<0.001) and moderate PA (p<0.004). The time spent in vigorous PA did 
not differ significantly between men and women. The percentage of awake time spent sedentary 
was 79.5% for men and 78.2% for women (Supplement 2.2.6 - Supplement 2.2.7) and  6.9% and 
7.4% of the waking time was spent in moderate-to-vigorous PA in men and women, respectively. 
Table 2.2.1 (women) and Table 2.2.2 (men) show the results from the univariate analyses 
(ANOVA and t-test), and show that PA levels decreased across higher strata of age and BMI and 
with worsening health in both men and women. None of the variables was associated with sleep 
duration in these analyses. The distribution of the respective activity levels across age-groups and 
BMI categories is visually presented in Figure 2.2.4 and 2.2.5.  
Table 2.2.3 (women) and Table 2.2.4 (men) show the results from the linear regression 
analyses with mutual adjustment for all demographic and health factors. The explained variance 
by the determinants was highest for moderate-to-vigorous PA in men (16.6%) and women 
(22.2%). Factors significantly associated with total PA (expressed in mg) and light and moderate-
to-vigorous PA were age, BMI, disability status and prevalent chronic disease. Older participants, 
those with higher BMI and those with chronic disease or disability were less physically active. 
Moreover, in women, living with a partner was associated with significant higher levels of total PA 
and light and moderate-to-vigorous PA and lower time spent sedentary. Sedentary time increased 
across higher strata of age and BMI and was higher in those with chronic disease (women). 
Regarding sleep duration, obese men spent more hours sleeping than normal weight men (Table 
2.2.4) and women spent slightly less time sleeping in the summer, compared to spring (Table 
2.2.3).  
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mg), light (48 < 154 mg), moderate (154 <389 mg) and vigorous activity (>389 mg), based on a 
recent study.20 For the current study, we combined moderate and vigorous activity in our main 
analyses. Sleep duration was assessed with a validated algorithm,36 using information on bed time 
and awake time from the sleep diary, and was subtracted from total sedentary behavior. 
To describe our data and test differences in average time per day spent in sedentary 
behavior, light PA, moderate-to-vigorous PA and sleep across two categories or across three or 
more categories of the health-related and socio-demographic variables, we used t-tests and 
Analyses of variance (ANOVA), respectively. We further examined the robustness of the 
individual associations by mutually adjusting for all demographic and health factors in linear 
regression analyses. All determinants were entered as categorical variables  and the activity 
variables were the outcome variables in these analyses. To evaluate the explained variance by the 
determinants, we obtained the adjusted R-squared. We decided a priori to present the results 
stratified by sex for comparability with previous and future studies. The average time/d in each 
activity level was plotted as a portion of the 1440 minutes of the day to graphically inspect the 
distribution of activity levels across age-groups and BMI-groups. The average time across BMI-
groups was adjusted for age.  
In sensitivity analyses, we tested whether the health-related and socio-demographic 
characteristics differed between men and women, to be able to explain any gender differences. We 
also tested whether those participating differed from those not agreeing to participate, in regard to 
baseline characteristics. Furthermore, we repeated the linear regression analyses stratified by age 
(older or younger than 80 years), to examine if the associations in the oldest old (i.e. 80 years or 
older) were different than in those younger than 80 years. We also repeated the linear regression 
analyses stratified by a BMI of 27 kg/m2, the median level in the population.  
Analyses were conducted using SPSS software version 20 (IBM SPSS Statistics for Windows, 
Armonk, NY: IBM Corp), R version 3.2.1 (R Foundation for Statistical Computing, Vienna, 
Austria) and Stata version 14.1 SE (StataCorp LP, College Station, Texas).37 A double-sided p < 
0.05 was considered statistically significant. 
 
RESULTS 
Participants who agreed to participate in the study were more often men and less often disabled 
than those who did not agree to wear an accelerometer (Supplement 2.2.1). In the total sample of 
1200 participants, a total of 71,232 valid days were recorded, in accordance with an average of 5.9 
(SD: 0.4) days per participant. The proportion of males in the sample was 48.1% and the mean age 
was 77.5 (SD: 5.0). The median (IQR) accelerometer wear-time was slightly higher in men 
registering 154.2 hours (152.6, 156.4) than in women registering 153.6 hours (151.6, 156.0), p 
<0.001. Furthermore, participating women were more often obese or disabled than men, whereas 
men more often had prevalent chronic disease (Supplement 2.2.2). The proportion of participants 
who reported engaging in walking, cycling, housework, gardening and sports in the LAPAQ is 
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shown in Supplement 2.2.3. Men participated significantly more in cycling and gardening than 
women (p<0.05). 
Total PA, expressed in mg, was slightly higher for women (20.3, SD:5.5) than for men (19.3, 
SD: 5.2, p=0.002). Figure 2.2.2 and Figure 2.2.3 show the acceleration distribution of time spent in 
9 systematic intervals (including time spent sleeping), stratified by sex and age category, 
respectively. Women spent less time in the interval with the lowest acceleration (0-100 mg), and 
spent more time in each other interval than men. For the age-categories, the oldest age-group (≥ 
85 years) spent the most time in the lowest interval (0-100 mg) and spent less time in each other 
interval.   
Mean (SD) time per day spent in sedentary behavior and light and moderate-to-vigorous 
intensity PA was 13.3 (1.5) hours/d, 147.5 (31.5) minutes/d and 75.0 (25.5) minutes/d, 
respectively, among women (Table 2.2.1); and 13.8 (1.6) hours/d, 140.5 (31.1) minutes/d and 71.5 
(24.5) minutes/d, respectively, among men (Table 2.2.2). Time spent in moderate and vigorous 
PA separately and in total sedentary behavior (including sleep) is presented in Supplement 2.2.4 
(women) and Supplement 2.2.5 (men). Women spent 6.7 hours/d (SD: 1.4) sleeping and men (6.6 
hours/d, SD: 1.4), p = 0.12. Men spent significant more minutes in sedentary behavior (p<0.001) 
and less time in light (p<0.001) and moderate PA (p<0.004). The time spent in vigorous PA did 
not differ significantly between men and women. The percentage of awake time spent sedentary 
was 79.5% for men and 78.2% for women (Supplement 2.2.6 - Supplement 2.2.7) and  6.9% and 
7.4% of the waking time was spent in moderate-to-vigorous PA in men and women, respectively. 
Table 2.2.1 (women) and Table 2.2.2 (men) show the results from the univariate analyses 
(ANOVA and t-test), and show that PA levels decreased across higher strata of age and BMI and 
with worsening health in both men and women. None of the variables was associated with sleep 
duration in these analyses. The distribution of the respective activity levels across age-groups and 
BMI categories is visually presented in Figure 2.2.4 and 2.2.5.  
Table 2.2.3 (women) and Table 2.2.4 (men) show the results from the linear regression 
analyses with mutual adjustment for all demographic and health factors. The explained variance 
by the determinants was highest for moderate-to-vigorous PA in men (16.6%) and women 
(22.2%). Factors significantly associated with total PA (expressed in mg) and light and moderate-
to-vigorous PA were age, BMI, disability status and prevalent chronic disease. Older participants, 
those with higher BMI and those with chronic disease or disability were less physically active. 
Moreover, in women, living with a partner was associated with significant higher levels of total PA 
and light and moderate-to-vigorous PA and lower time spent sedentary. Sedentary time increased 
across higher strata of age and BMI and was higher in those with chronic disease (women). 
Regarding sleep duration, obese men spent more hours sleeping than normal weight men (Table 
2.2.4) and women spent slightly less time sleeping in the summer, compared to spring (Table 
2.2.3).  
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Figure 2.2.2. Activity distribution of time spent in acceleration (mg) categories (intensity) 
stratified by sex.  
ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; IQR, interquartile range. 
Dark bars represent men and white bars represent women. 
 
 
Figure 2.2.3. Activity distribution of time spent in acceleration (mg) categories (intensity) 
stratified by age-group 
ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; IQR, interquartile range. 
From left to right, bars represent adults aged ≤74 years, 75-79 years, 80-84 years and ≥85 years. 
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Table 2.2.1. Objectively assessed physical activity subcomponents and sedentary time in women 
(n=628), according to characteristics of the study population  
n 
 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
Total 628 20.3 (5.6) 13.3 (1.5) 147.5 (31.5) 75 (25.5) 6.7 (1.4) 
Age-group     
   70-74                       200 22.3 (6.2) 13.3 (1.4) 153.5 (30.7) 85.2 (27.0) 6.6 (1.2) 
   75-79                       226 20.2 (5.1) 13.2 (1.6) 147.7 (31.2) 75.0 (23.3) 6.8 (1.4) 
   80-84                       130 18.9 (4.5) 13.4 (1.4) 144.5 (30.4) 67.7 (21.0) 6.8 (1.4) 
   ≥85                       72 17.5 (4.9) 13.6 (1.6) 135.7 (33.1) 59.7 (23.6) 6.9 (1.5) 
p <0.001 0.33 <0.001 <0.001 0.19 
Education     
   Primary  41 18.1 (5.3) 13.7 (1.8) 135.2 (31.9) 64.8 (25.9) 6.7 (1.6) 
   Lower  337 20.1 (5.1) 13.3 (1.4) 147.0 (30.7) 74.5 (23.9) 6.8 (1.3) 
   Intermediate   163 20.3 (5.9) 13.4 (1.5) 146.0 (30.5) 74.3 (26.1) 6.7 (1.3) 
   Higher  75 21.5 (6.0) 13.3 (1.5) 157.1 (33.8) 82.2 (27.2) 6.5 (1.4) 
p 0.02 0.31 0.003 0.004 0.47 
Season     
   Spring                      163 20.2 (5.2) 13.2 (1.6) 146.7 (31.3) 75.0 (24.7) 6.9 (1.4) 
   Summer                     74 21.3 (6.5) 13.4 (1.6) 148.1 (30.9) 78.0 (27.5) 6.6 (1.5) 
   Autumn                     206 19.9 (5.9) 13.3 (1.4) 145.5 (32.6) 73.0 (27.1) 6.7 (1.3) 
   Winter                      182 20.3 (5.0) 13.4 (1.4) 149.4 (30.5) 75.4 (23.3) 6.6 (1.3) 
p  0.38 0.56 0.67 0.52 0.44 
BMI       
   Normal weight         183 22.4 (5.9) 12.8 (1.3) 157.9 (29.9) 84.0 (25.7) 6.9 (1.3) 
   Overweight               265 20.3 (5.4) 13.3 (1.5) 148.2 (30.7) 75.2 (25.4) 6.7 (1.4) 
   Obese                       179 18.2 (4.6) 13.9 (1.5) 136.1 (30.3) 65.7 (21.7) 6.6 (1.4) 
p  <0.001 <0.001 <0.001 <0.001 0.10 
Smoking       
   Non smoker              282 20.7 (5.6) 13.1 (1.4) 150.8 (31.3) 76.7 (25.5) 6.8 (1.4) 
   Former smoker        310 20.1 (5.5) 13.5 (1.4) 145.4 (31.4) 74.0 (25.4) 6.6 (1.3) 
   Current smoker       36 19.0 (5.5) 13.6 (2.0) 139.3 (32.1) 70.1 (25.9) 6.7 (1.7) 
p  0.14 0.01 0.03 0.22 0.15 
Alcohol 
consumption       
   Never  123 19.7 (4.7) 13.3 (1.5) 145.2 (30.3) 72.1 (22.9) 6.8 (1.4) 
   1-4 times/month 217 19.5 (5.2) 13.4 (1.4) 142.5 (31.7) 71.5 (24.5) 6.8 (1.4) 
   2-4 time/week   288 21.2 (6.0) 13.3 (1.6) 152.2 (31.4) 78.8 (26.8) 6.6 (1.3) 
p  0.001 0.83 0.002 0.002 0.27 
Disability status       
   Not disabled             243 21.5 (5.4) 13.2 (1.3) 152.0 (30.3) 81.1 (25.5) 6.7 (1.3) 
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Figure 2.2.2. Activity distribution of time spent in acceleration (mg) categories (intensity) 
stratified by sex.  
ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; IQR, interquartile range. 
Dark bars represent men and white bars represent women. 
 
 
Figure 2.2.3. Activity distribution of time spent in acceleration (mg) categories (intensity) 
stratified by age-group 
ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; IQR, interquartile range. 
From left to right, bars represent adults aged ≤74 years, 75-79 years, 80-84 years and ≥85 years. 
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Table 2.2.1. Objectively assessed physical activity subcomponents and sedentary time in women 
(n=628), according to characteristics of the study population  
n 
 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
Total 628 20.3 (5.6) 13.3 (1.5) 147.5 (31.5) 75 (25.5) 6.7 (1.4) 
Age-group     
   70-74                       200 22.3 (6.2) 13.3 (1.4) 153.5 (30.7) 85.2 (27.0) 6.6 (1.2) 
   75-79                       226 20.2 (5.1) 13.2 (1.6) 147.7 (31.2) 75.0 (23.3) 6.8 (1.4) 
   80-84                       130 18.9 (4.5) 13.4 (1.4) 144.5 (30.4) 67.7 (21.0) 6.8 (1.4) 
   ≥85                       72 17.5 (4.9) 13.6 (1.6) 135.7 (33.1) 59.7 (23.6) 6.9 (1.5) 
p <0.001 0.33 <0.001 <0.001 0.19 
Education     
   Primary  41 18.1 (5.3) 13.7 (1.8) 135.2 (31.9) 64.8 (25.9) 6.7 (1.6) 
   Lower  337 20.1 (5.1) 13.3 (1.4) 147.0 (30.7) 74.5 (23.9) 6.8 (1.3) 
   Intermediate   163 20.3 (5.9) 13.4 (1.5) 146.0 (30.5) 74.3 (26.1) 6.7 (1.3) 
   Higher  75 21.5 (6.0) 13.3 (1.5) 157.1 (33.8) 82.2 (27.2) 6.5 (1.4) 
p 0.02 0.31 0.003 0.004 0.47 
Season     
   Spring                      163 20.2 (5.2) 13.2 (1.6) 146.7 (31.3) 75.0 (24.7) 6.9 (1.4) 
   Summer                     74 21.3 (6.5) 13.4 (1.6) 148.1 (30.9) 78.0 (27.5) 6.6 (1.5) 
   Autumn                     206 19.9 (5.9) 13.3 (1.4) 145.5 (32.6) 73.0 (27.1) 6.7 (1.3) 
   Winter                      182 20.3 (5.0) 13.4 (1.4) 149.4 (30.5) 75.4 (23.3) 6.6 (1.3) 
p  0.38 0.56 0.67 0.52 0.44 
BMI       
   Normal weight         183 22.4 (5.9) 12.8 (1.3) 157.9 (29.9) 84.0 (25.7) 6.9 (1.3) 
   Overweight               265 20.3 (5.4) 13.3 (1.5) 148.2 (30.7) 75.2 (25.4) 6.7 (1.4) 
   Obese                       179 18.2 (4.6) 13.9 (1.5) 136.1 (30.3) 65.7 (21.7) 6.6 (1.4) 
p  <0.001 <0.001 <0.001 <0.001 0.10 
Smoking       
   Non smoker              282 20.7 (5.6) 13.1 (1.4) 150.8 (31.3) 76.7 (25.5) 6.8 (1.4) 
   Former smoker        310 20.1 (5.5) 13.5 (1.4) 145.4 (31.4) 74.0 (25.4) 6.6 (1.3) 
   Current smoker       36 19.0 (5.5) 13.6 (2.0) 139.3 (32.1) 70.1 (25.9) 6.7 (1.7) 
p  0.14 0.01 0.03 0.22 0.15 
Alcohol 
consumption       
   Never  123 19.7 (4.7) 13.3 (1.5) 145.2 (30.3) 72.1 (22.9) 6.8 (1.4) 
   1-4 times/month 217 19.5 (5.2) 13.4 (1.4) 142.5 (31.7) 71.5 (24.5) 6.8 (1.4) 
   2-4 time/week   288 21.2 (6.0) 13.3 (1.6) 152.2 (31.4) 78.8 (26.8) 6.6 (1.3) 
p  0.001 0.83 0.002 0.002 0.27 
Disability status       
   Not disabled             243 21.5 (5.4) 13.2 (1.3) 152.0 (30.3) 81.1 (25.5) 6.7 (1.3) 
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Table 2.2.1 (continued). Objectively assessed physical activity subcomponents and sedentary 
time in women (n=628), according to characteristics of the study population  
n 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
   Disabled                    139 20.8 (5.7) 13.1 (1.6) 150.6 (29.2) 77.0 (24.5) 6.9 (1.5) 
   Severely disabled         245 18.9 (5.4) 13.6 (1.5) 141.2 (33.1) 67.8 (24.4) 6.7 (1.3) 
p                   <0.001 0.003 <0.001 <0.001 0.40 
Prevalent CVD, DM or cancer    
   Not present 336 21.3 (5.7) 13.1 (1.4) 151.4 (30.7) 79.3 (25.7) 6.8 (1.3) 
   Present 292 19.1 (5.1) 13.5 (1.5) 143.0 (31.9) 70.0 (24.3) 6.7 (1.4) 
p  <0.001 0.001 0.001 <0.001 0.42 
Marital status      
   Living alone 309 19.2 (5.4) 13.5 (1.6) 141.1 (31.9) 69.7 (25.0) 6.8 (1.4) 
   Living with partner 319 21.3 (5.6) 13.2 (1.4) 153.7 (29.9) 80.1 (25.0) 6.7 (1.3) 
p  <0.001 0.02 <0.001 <0.001 0.41 
Sleep medication      
   Not using any  459 20.5 (5.3) 13.5 (1.2) 148.9 (31.6) 76.2 (24.8) 6.6 (1.1) 
   Using ≥1 day/week 135 19.7 (6.2) 13.7 (1.4) 142.7 (30.1) 71.6 (27.3) 6.5 (1.2) 
p  0.16 0.13 0.04 0.06 0.36 
Abbreviations: BMI, body mass index; ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; n, 
number; PA, physical activity. Body mass index was calculated as weight in kilograms divided by height in meters squared. 
Categories were defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2. Results are 
obtained from t-tests for determinants with two categories and analysis of variance (ANOVA) for determinants with 3 or 
more categories. Data are mean (SD). Total N varies due to variation in the amount of missing data for different covariates. 
 
 
Figure 2.2.4. Distribution of activity across the 24-hour period in men and women, according to 
age-group. 
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Figure 2.2.5. Distribution of activity across the 24-hour period in men and women, according to 
normal weight, overweight and obesity 
Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were defined as 
normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2, and obese: ≥30 kg/m2. The average time spent in each activity 
level was adjusted for age 
 
Sensitivity analyses 
In sensitivity analyses split by age, we observed that in the oldest old (i.e. 80 years and older), there 
were less gender differences and there was no effect of season, compared to those younger than 80 
years (Supplement 2.2.8 - Supplement 2.2.9). Moreover, in the oldest old, disability status and 
marital status were not associated with sedentary behavior or PA, whereas these were associated 
with activity in participants younger than 80 years.  
In the analyses split by BMI, we observed that marital status was not associated with activity 
in participants with a BMI < 27 kg/m2, whereas it was associated with activity in those with higher 
BMI (Supplement 2.2.10 - Supplement 2.2.11). In contrast, smoking status was a determinant of 
activity in those with BMI< 27 kg/m2 and not in participants with ≥ 27 kg/m2. 
 
DISCUSSION 
The aim of this study was to provide a comprehensive description of objectively measured activity 
in old participants from the Rotterdam Study, by socio-demographic characteristics and other 
health-related variables. We show that sedentary behavior and light and moderate-to-vigorous PA 
vary by age-group, sex, BMI, prevalence of disease and disability status, whereas we observed no 
clear differences between categories for sleep duration. Overall, men and women spent 13.8 
(79.5%) hours and 13.3 (78.2%) hours of their waking time in sedentary behavior, respectively, 
and around 70 minutes of their waking time (7-8%) in moderate-to-vigorous PA.  
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Table 2.2.1 (continued). Objectively assessed physical activity subcomponents and sedentary 
time in women (n=628), according to characteristics of the study population  
n 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
   Disabled                    139 20.8 (5.7) 13.1 (1.6) 150.6 (29.2) 77.0 (24.5) 6.9 (1.5) 
   Severely disabled         245 18.9 (5.4) 13.6 (1.5) 141.2 (33.1) 67.8 (24.4) 6.7 (1.3) 
p                   <0.001 0.003 <0.001 <0.001 0.40 
Prevalent CVD, DM or cancer    
   Not present 336 21.3 (5.7) 13.1 (1.4) 151.4 (30.7) 79.3 (25.7) 6.8 (1.3) 
   Present 292 19.1 (5.1) 13.5 (1.5) 143.0 (31.9) 70.0 (24.3) 6.7 (1.4) 
p  <0.001 0.001 0.001 <0.001 0.42 
Marital status      
   Living alone 309 19.2 (5.4) 13.5 (1.6) 141.1 (31.9) 69.7 (25.0) 6.8 (1.4) 
   Living with partner 319 21.3 (5.6) 13.2 (1.4) 153.7 (29.9) 80.1 (25.0) 6.7 (1.3) 
p  <0.001 0.02 <0.001 <0.001 0.41 
Sleep medication      
   Not using any  459 20.5 (5.3) 13.5 (1.2) 148.9 (31.6) 76.2 (24.8) 6.6 (1.1) 
   Using ≥1 day/week 135 19.7 (6.2) 13.7 (1.4) 142.7 (30.1) 71.6 (27.3) 6.5 (1.2) 
p  0.16 0.13 0.04 0.06 0.36 
Abbreviations: BMI, body mass index; ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; n, 
number; PA, physical activity. Body mass index was calculated as weight in kilograms divided by height in meters squared. 
Categories were defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2. Results are 
obtained from t-tests for determinants with two categories and analysis of variance (ANOVA) for determinants with 3 or 
more categories. Data are mean (SD). Total N varies due to variation in the amount of missing data for different covariates. 
 
 
Figure 2.2.4. Distribution of activity across the 24-hour period in men and women, according to 
age-group. 
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Figure 2.2.5. Distribution of activity across the 24-hour period in men and women, according to 
normal weight, overweight and obesity 
Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were defined as 
normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2, and obese: ≥30 kg/m2. The average time spent in each activity 
level was adjusted for age 
 
Sensitivity analyses 
In sensitivity analyses split by age, we observed that in the oldest old (i.e. 80 years and older), there 
were less gender differences and there was no effect of season, compared to those younger than 80 
years (Supplement 2.2.8 - Supplement 2.2.9). Moreover, in the oldest old, disability status and 
marital status were not associated with sedentary behavior or PA, whereas these were associated 
with activity in participants younger than 80 years.  
In the analyses split by BMI, we observed that marital status was not associated with activity 
in participants with a BMI < 27 kg/m2, whereas it was associated with activity in those with higher 
BMI (Supplement 2.2.10 - Supplement 2.2.11). In contrast, smoking status was a determinant of 
activity in those with BMI< 27 kg/m2 and not in participants with ≥ 27 kg/m2. 
 
DISCUSSION 
The aim of this study was to provide a comprehensive description of objectively measured activity 
in old participants from the Rotterdam Study, by socio-demographic characteristics and other 
health-related variables. We show that sedentary behavior and light and moderate-to-vigorous PA 
vary by age-group, sex, BMI, prevalence of disease and disability status, whereas we observed no 
clear differences between categories for sleep duration. Overall, men and women spent 13.8 
(79.5%) hours and 13.3 (78.2%) hours of their waking time in sedentary behavior, respectively, 
and around 70 minutes of their waking time (7-8%) in moderate-to-vigorous PA.  
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Table 2.2.2. Objectively assessed physical activity subcomponents and sedentary time in men 
(n=582), according to characteristics of the study population 
n 
 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
Total 582 19.3 (5.2) 13.8 (1.6) 140.5 (31.1) 71.5 (24.5) 6.6 (1.4) 
Age-group     
   70-74                       201 20.2 (5.3) 13.8 (1.5) 140.2 (30.2) 76.0 (25.1) 6.5 (1.3) 
   75-79                       203 20.0 (4.9) 13.5 (1.7) 144.2 (30.3) 74.8 (23.3) 6.8 (1.6) 
   80-84                       130 18.2 (5.0) 13.9 (1.4) 137.2 (32.0) 65.6 (22.8) 6.6 (1.3) 
   ≥85                       48 16.0 (4.6) 14.2 (1.6) 134.6 (34.5) 54.5 (21.6) 6.5 (1.4) 
p <0.001 0.01 0.11 <0.001 0.10 
Education     
   Primary  22 17.2 (4.3) 13.7 (1.4) 133.3 (32.7) 61.8 (19.5) 6.9 (1.6) 
   Lower  146 19.3 (5.0) 13.8 (1.5) 140.6 (28.7) 71.0 (24.3) 6.6 (1.4) 
   Intermediate   224 19.1 (5.2) 13.7 (1.7) 139.9 (32.3) 71.0 (24.7) 6.6 (1.5) 
   Higher  180 19.8 (5.4) 13.9 (1.6) 141.7 (31.7) 73.2 (25.1) 6.5 (1.3) 
p 0.16 0.81 0.68 0.22 0.38 
Season     
   Spring                      140 18.4 (5.0) 13.9 (1.6) 136.3 (28.0) 67.7 (23.7) 6.6 (1.5) 
   Summer                     64 20.7 (5.6) 13.1 (1.9) 143.9 (32.8) 77.1 (26.9) 7.0 (1.8) 
   Autumn                     163 19.7 (5.3) 13.8 (1.6) 142.4 (31.8) 72.8 (24.9) 6.5 (1.5) 
   Winter                      213 19.4 (5.0) 13.9 (1.3) 140.7 (31.9) 71.4 (23.9) 6.5 (1.2) 
p  0.02 0.01 0.27 0.07 0.06 
BMI       
   Normal weight         167 20.6 (5.7) 13.5 (1.6) 146.8 (31.3) 77.3 (26.9) 6.6 (1.3) 
   Overweight               298 19.4 (4.8) 13.7 (1.5) 140.7 (29.7) 71.8 (22.4) 6.7 (1.4) 
   Obese                       117 17.5 (4.9) 14.3 (1.8) 130.6 (32.0) 62.4 (23.8) 6.4 (1.7) 
p  <0.001 <0.001 <0.001 <0.001 0.16 
Smoking       
   Non smoker              127 19.4 (5.2) 13.8 (1.5) 139.6 (27.4) 72.0 (24.2) 6.6 (1.4) 
   Former smoker        425 19.4 (5.2) 13.7 (1.6) 141.4 (31.7) 71.8 (24.5) 6.6 (1.4) 
   Current smoker       28 17.4 (5.5) 13.8 (1.6) 129.5 (36.9) 62.0 (25.4) 6.8 (1.4) 
p  0.13 0.82 0.14 0.12 0.75 
Alcohol consumption      
   Never  66 19.7 (6.2) 13.7 (1.8) 145.2 (31.2) 72.4 (30.1) 6.6 (1.5) 
   1-4 times/month 128 18.7 (4.9) 13.9 (1.7) 134.6 (30.8) 68.9 (23.1) 6.6 (1.5) 
   2-4 time/week   387 19.5 (5.1) 13.7 (1.5) 141.7 (31.0) 72.1 (24.0) 6.6 (1.4) 
p  0.27 0.64 0.04 0.41 0.94 
Disability status       
   Not disabled             302 20.6 (5.0) 13.6 (1.5) 145.3 (29.7) 77.5 (23.7) 6.6 (1.3) 
   Disabled                    87 18.0 (5.2) 13.8 (1.6) 137.2 (32.5) 65.4 (23.5) 6.8 (1.4) 
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Table 2.2.2 (continued). Objectively assessed physical activity subcomponents and sedentary 
time in men (n=582), according to characteristics of the study population 
n 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
   Severely  disabled        192 18.0 (5.1) 14.0 (1.7) 134.5 (31.6) 64.6 (23.9) 6.6 (1.6) 
p                   <0.001 0.07 <0.001 <0.001 0.49 
Prevalent CVD, DM or cancer     
   Not present 232 20.5 (5.1) 13.7 (1.6) 145.3 (29.0) 76.8 (22.9) 6.6 (1.4) 
   Present 350 18.5 (5.1) 13.8 (1.6) 137.2 (32.0) 67.9 (25.0) 6.6 (1.4) 
p  <0.001 0.16 0.002 <0.001 0.53 
Marital status       
   Living alone 100 18.5 (5.5) 13.8 (1.7) 138.6 (32.1) 66.7 (26.0) 6.6 (1.5) 
   Living with partner 481 19.5 (5.1) 13.8 (1.6) 140.9 (30.9) 72.4 (24.1) 6.6 (1.4) 
p  0.08 0.70 0.51 0.03 0.28 
Sleep medication       
   Not using any  504 19.3 (5.2) 13.9 (1.4) 140.3 (31.2) 71.4 (24.5) 6.4 (1.1) 
   Using ≥1 day/week 53 19.7 (4.8) 13.9 (1.6) 144.9 (28.2) 74.0 (22.4) 6.4 (1.3) 
p  0.62 0.70 0.30 0.45 0.75 
Abbreviations: BMI, body mass index; ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; n, 
number; PA, physical activity. Body mass index was calculated as weight in kilograms divided by height in meters squared. 
Categories were defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2. Results are 
obtained from t-tests for determinants with two categories and analysis of variance (ANOVA) for determinants with 3 or 
more categories. Data are mean (SD). Total N varies due to variation in the amount of missing data for different covariates. 
 
When examining differences by age-groups, we found the lowest PA volume in the oldest age-
group (aged ≥ 85 years), which is in accordance with literature indicating that PA declines with 
increasing age.9,10,12,16,19 In men and women, the time spent in light, moderate and vigorous 
intensity PA declined with age, whereas the absolute time spent sedentary increased with age. 
Considering that sleep time was constant across age groups, the increase in sedentary behavior 
was at the extent of both light and moderate-to-vigorous PA. Since literature indicates that total 
sleep time decreases with age,38 it is possible that the algorithm used to detect sleep overestimated 
sleep time, if participants lay motionless, but awake, in bed at night.36 If this is the case, older 
adults were actually sleeping inefficiently during their time in bed. A better understanding of the 
distribution of activity across the 24-hour time span might benefit public health interventions. 
Since daily PA might enhance sleep quality,39,40 replacing sedentary behavior with light or 
moderate activity might improve PA levels and sleep quality simultaneously. Future studies are 
required to identify activities in which elderly adults can engage in to improve PA levels. 
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Table 2.2.2. Objectively assessed physical activity subcomponents and sedentary time in men 
(n=582), according to characteristics of the study population 
n 
 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
Total 582 19.3 (5.2) 13.8 (1.6) 140.5 (31.1) 71.5 (24.5) 6.6 (1.4) 
Age-group     
   70-74                       201 20.2 (5.3) 13.8 (1.5) 140.2 (30.2) 76.0 (25.1) 6.5 (1.3) 
   75-79                       203 20.0 (4.9) 13.5 (1.7) 144.2 (30.3) 74.8 (23.3) 6.8 (1.6) 
   80-84                       130 18.2 (5.0) 13.9 (1.4) 137.2 (32.0) 65.6 (22.8) 6.6 (1.3) 
   ≥85                       48 16.0 (4.6) 14.2 (1.6) 134.6 (34.5) 54.5 (21.6) 6.5 (1.4) 
p <0.001 0.01 0.11 <0.001 0.10 
Education     
   Primary  22 17.2 (4.3) 13.7 (1.4) 133.3 (32.7) 61.8 (19.5) 6.9 (1.6) 
   Lower  146 19.3 (5.0) 13.8 (1.5) 140.6 (28.7) 71.0 (24.3) 6.6 (1.4) 
   Intermediate   224 19.1 (5.2) 13.7 (1.7) 139.9 (32.3) 71.0 (24.7) 6.6 (1.5) 
   Higher  180 19.8 (5.4) 13.9 (1.6) 141.7 (31.7) 73.2 (25.1) 6.5 (1.3) 
p 0.16 0.81 0.68 0.22 0.38 
Season     
   Spring                      140 18.4 (5.0) 13.9 (1.6) 136.3 (28.0) 67.7 (23.7) 6.6 (1.5) 
   Summer                     64 20.7 (5.6) 13.1 (1.9) 143.9 (32.8) 77.1 (26.9) 7.0 (1.8) 
   Autumn                     163 19.7 (5.3) 13.8 (1.6) 142.4 (31.8) 72.8 (24.9) 6.5 (1.5) 
   Winter                      213 19.4 (5.0) 13.9 (1.3) 140.7 (31.9) 71.4 (23.9) 6.5 (1.2) 
p  0.02 0.01 0.27 0.07 0.06 
BMI       
   Normal weight         167 20.6 (5.7) 13.5 (1.6) 146.8 (31.3) 77.3 (26.9) 6.6 (1.3) 
   Overweight               298 19.4 (4.8) 13.7 (1.5) 140.7 (29.7) 71.8 (22.4) 6.7 (1.4) 
   Obese                       117 17.5 (4.9) 14.3 (1.8) 130.6 (32.0) 62.4 (23.8) 6.4 (1.7) 
p  <0.001 <0.001 <0.001 <0.001 0.16 
Smoking       
   Non smoker              127 19.4 (5.2) 13.8 (1.5) 139.6 (27.4) 72.0 (24.2) 6.6 (1.4) 
   Former smoker        425 19.4 (5.2) 13.7 (1.6) 141.4 (31.7) 71.8 (24.5) 6.6 (1.4) 
   Current smoker       28 17.4 (5.5) 13.8 (1.6) 129.5 (36.9) 62.0 (25.4) 6.8 (1.4) 
p  0.13 0.82 0.14 0.12 0.75 
Alcohol consumption      
   Never  66 19.7 (6.2) 13.7 (1.8) 145.2 (31.2) 72.4 (30.1) 6.6 (1.5) 
   1-4 times/month 128 18.7 (4.9) 13.9 (1.7) 134.6 (30.8) 68.9 (23.1) 6.6 (1.5) 
   2-4 time/week   387 19.5 (5.1) 13.7 (1.5) 141.7 (31.0) 72.1 (24.0) 6.6 (1.4) 
p  0.27 0.64 0.04 0.41 0.94 
Disability status       
   Not disabled             302 20.6 (5.0) 13.6 (1.5) 145.3 (29.7) 77.5 (23.7) 6.6 (1.3) 
   Disabled                    87 18.0 (5.2) 13.8 (1.6) 137.2 (32.5) 65.4 (23.5) 6.8 (1.4) 
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Table 2.2.2 (continued). Objectively assessed physical activity subcomponents and sedentary 
time in men (n=582), according to characteristics of the study population 
n 
Acceler-
ation 
(mg/day) 
Sedentary 
time 
(h/day) 
Light PA 
(min/day) 
Moderate-
vigorous 
PA 
(min/day) 
Sleep 
time 
(h/day) 
   Severely  disabled        192 18.0 (5.1) 14.0 (1.7) 134.5 (31.6) 64.6 (23.9) 6.6 (1.6) 
p                   <0.001 0.07 <0.001 <0.001 0.49 
Prevalent CVD, DM or cancer     
   Not present 232 20.5 (5.1) 13.7 (1.6) 145.3 (29.0) 76.8 (22.9) 6.6 (1.4) 
   Present 350 18.5 (5.1) 13.8 (1.6) 137.2 (32.0) 67.9 (25.0) 6.6 (1.4) 
p  <0.001 0.16 0.002 <0.001 0.53 
Marital status       
   Living alone 100 18.5 (5.5) 13.8 (1.7) 138.6 (32.1) 66.7 (26.0) 6.6 (1.5) 
   Living with partner 481 19.5 (5.1) 13.8 (1.6) 140.9 (30.9) 72.4 (24.1) 6.6 (1.4) 
p  0.08 0.70 0.51 0.03 0.28 
Sleep medication       
   Not using any  504 19.3 (5.2) 13.9 (1.4) 140.3 (31.2) 71.4 (24.5) 6.4 (1.1) 
   Using ≥1 day/week 53 19.7 (4.8) 13.9 (1.6) 144.9 (28.2) 74.0 (22.4) 6.4 (1.3) 
p  0.62 0.70 0.30 0.45 0.75 
Abbreviations: BMI, body mass index; ENMO, The Euclidean norm minus 1 g with negative numbers rounded to zero; n, 
number; PA, physical activity. Body mass index was calculated as weight in kilograms divided by height in meters squared. 
Categories were defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2. Results are 
obtained from t-tests for determinants with two categories and analysis of variance (ANOVA) for determinants with 3 or 
more categories. Data are mean (SD). Total N varies due to variation in the amount of missing data for different covariates. 
 
When examining differences by age-groups, we found the lowest PA volume in the oldest age-
group (aged ≥ 85 years), which is in accordance with literature indicating that PA declines with 
increasing age.9,10,12,16,19 In men and women, the time spent in light, moderate and vigorous 
intensity PA declined with age, whereas the absolute time spent sedentary increased with age. 
Considering that sleep time was constant across age groups, the increase in sedentary behavior 
was at the extent of both light and moderate-to-vigorous PA. Since literature indicates that total 
sleep time decreases with age,38 it is possible that the algorithm used to detect sleep overestimated 
sleep time, if participants lay motionless, but awake, in bed at night.36 If this is the case, older 
adults were actually sleeping inefficiently during their time in bed. A better understanding of the 
distribution of activity across the 24-hour time span might benefit public health interventions. 
Since daily PA might enhance sleep quality,39,40 replacing sedentary behavior with light or 
moderate activity might improve PA levels and sleep quality simultaneously. Future studies are 
required to identify activities in which elderly adults can engage in to improve PA levels. 
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In our study, men and women spent around 70 minutes per day in moderate-to vigorous 
PA. In similar study populations in Iceland,9 Norway16 and the United Kingdom12 these numbers 
were up to 15, 36  and 23 minutes per day, respectively. Comparisons are hampered by the 
different study population characteristics (e.g. age), use of different devices and anatomical 
placements, the use of counts per minute and the stratification into sedentary time and light, 
moderate and vigorous activity by different cut-offs. Consequently, we cannot be sure whether 
participants in our study were really more active, or that the different estimates are the result of 
the different cut-points. Because the Ommoord district in which most participants live is a safe 
neighborhood with opportunity to walk and cycle in a safe manner, it could be expected that the 
participants from our study were indeed more active in comparison to other studies.  
In our study, we found higher levels of acceleration in women compared to men, in all age-
groups. This is in contrast with most studies in older adults,9,12,14,41 but in agreement with two 
others.11,19 In addition, in the total population, we found that women spent more time in moderate 
PA than men. An explanation for the higher activity in women compared to men might be 
traditional gender roles, in which women are more involved in household activities than men. 
Chen et al. indicated that the discrepancies between the studies might be related to cultural 
lifestyle differences.11 Nevertheless, they performed their study among Japanese elderly and our 
participants come from a Western population, in which men often are reported to be more active 
than women.9,12,14,41 The results from the current study might be explained by the fact that men 
more often had chronic disease than women (60.1% vs. 46.5%). However, women were more 
often disabled and obese than men, both variables associated with lower PA levels.  
Another explanation for the difference might be related to the fact that men reported 
significantly more cycling than women (47.3% in men versus 33.6% in women) in the current 
study. A wrist-worn accelerometer is known to underestimate activities performed with the lower 
extremities.42 Future studies are needed to examine whether the observed results reflect a true 
difference between sexes. Moreover, more research is needed to be able to identify lower body 
activities with wrist-worn accelerometers. 
Important correlates of sedentary behavior and PA were BMI, age, disability status and the 
prevalence of chronic disease in both sexes. Obese individuals had a lower acceleration and lower 
levels of light and moderate-to-vigorous PA, compared to their normal weight counterparts. 
These results are in agreement with existing data.9-12,14 Moreover, in women, living with a partner 
was associated with more time spent in light and moderate-to-vigorous PA. In sensitivity analyses 
split by age and BMI, we showed that living with a partner was also associated with activity in 
participants younger than 80 years and in those with BMI ≥27 kg/m2. These results suggest 
opportunities for focused intervention, targeting specifically those with higher BMI and age, as 
well as those suffering from a chronic condition or disability. The fact that women living with a 
partner were more active than those living alone, might indicate that women are more likely to 
engage in PA socially. Public health programs might provide opportunities for specific sub-groups 
with the lowest levels of PA, including organized PA programs. Furthermore, in sensitivity 
analyses in the oldest old, we observed no gender differences for PA levels. However, in these 
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participants, being obese was associated with larger decreases in light and moderate-to-vigorous 
PA than in participants younger than 80 years. Possibly, the additional weight is more of a burden 
in the oldest old. This stresses the importance of a healthy weight, even in old age. 
This study has several strengths. It is one of the first studies providing a detailed description 
of the full intensity distribution of PA in this age-range of participants over the 24-hour period. 
Additionally, since the accelerometer device was waterproof and was worn day and night, we 
could collect comprehensive information of all activity performed. However, some limitations 
also have to be acknowledged. Using raw accelerometer derived data to describe activity is 
relatively new and therefore the cut-off points to define intensity of behavior have not been firmly 
established. Moreover, as in other studies using objectively measured PA, not all PA can be 
accurately captured. For example, cycling or other activities mostly performed with the legs will be 
underestimated.42 Additionally, since no method exists for differentiating between the postural 
allocations of sitting, standing and lying down from triaxial wrist acceleration signals in this 
population, we were unable to distinguish socializing from driving. Furthermore, we used an 
algorithm to define sleep, in which we defined sleep as an absence of change in arm angle greater 
than 5 degrees for 5 minutes or more.36 Using another sleep definition may influence estimated 
sleep time and hence the sedentary time observed in our participants. Although van Hees et al36 
made extensive effort to validate their algorithm in the Whitehall II Study using 
polysomnography, future studies are needed to optimize the used algorithm.  
Another limitation is that we did not have up-to-date information on cancer, cardiovascular 
disease and diabetes. Therefore, some residual confounding might be present and might have 
resulted in bias towards the null for those comparisons. Additionally, participants that agreed to 
participate were less often disabled and more often men. This might affect the generalizability 
towards the total population of older adults. Finally, participants attending these visits of the 
Rotterdam Study might have a better health-status than the general population, an issue often 
occurring in cohort studies. 
 
Conclusions 
In conclusion, in this population based cohort study of elderly individuals, men spent significantly 
more time in sedentary behavior and less time in light and moderate-to-vigorous PA compared to 
women. However, whereas this difference was significant, it was of small numeric value, 
indicating that both men and women spent a high proportion of their day sedentary. 
Furthermore, our findings suggest that sedentary behavior and light and moderate-to-vigorous 
PA patterns differ according to age, BMI, disability status and presence of disease, whereas sleep 
duration did not differ according demographic factors and health behaviors. Replacing sedentary 
behavior with light PA would be a good starting point for those with the lowest level of PA. Older 
adults, those with high BMI and worse health could benefit from targeted interventions to 
increase PA. 
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also have to be acknowledged. Using raw accelerometer derived data to describe activity is 
relatively new and therefore the cut-off points to define intensity of behavior have not been firmly 
established. Moreover, as in other studies using objectively measured PA, not all PA can be 
accurately captured. For example, cycling or other activities mostly performed with the legs will be 
underestimated.42 Additionally, since no method exists for differentiating between the postural 
allocations of sitting, standing and lying down from triaxial wrist acceleration signals in this 
population, we were unable to distinguish socializing from driving. Furthermore, we used an 
algorithm to define sleep, in which we defined sleep as an absence of change in arm angle greater 
than 5 degrees for 5 minutes or more.36 Using another sleep definition may influence estimated 
sleep time and hence the sedentary time observed in our participants. Although van Hees et al36 
made extensive effort to validate their algorithm in the Whitehall II Study using 
polysomnography, future studies are needed to optimize the used algorithm.  
Another limitation is that we did not have up-to-date information on cancer, cardiovascular 
disease and diabetes. Therefore, some residual confounding might be present and might have 
resulted in bias towards the null for those comparisons. Additionally, participants that agreed to 
participate were less often disabled and more often men. This might affect the generalizability 
towards the total population of older adults. Finally, participants attending these visits of the 
Rotterdam Study might have a better health-status than the general population, an issue often 
occurring in cohort studies. 
 
Conclusions 
In conclusion, in this population based cohort study of elderly individuals, men spent significantly 
more time in sedentary behavior and less time in light and moderate-to-vigorous PA compared to 
women. However, whereas this difference was significant, it was of small numeric value, 
indicating that both men and women spent a high proportion of their day sedentary. 
Furthermore, our findings suggest that sedentary behavior and light and moderate-to-vigorous 
PA patterns differ according to age, BMI, disability status and presence of disease, whereas sleep 
duration did not differ according demographic factors and health behaviors. Replacing sedentary 
behavior with light PA would be a good starting point for those with the lowest level of PA. Older 
adults, those with high BMI and worse health could benefit from targeted interventions to 
increase PA. 
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Supplement 2.2.1. Characteristics of participants who agreed to participate and those who did not 
agree to participate 
 
Did not agree to 
participate 
Agreed to 
participate p 
Participants 506 1,394  
Women, n (%) 334 (66.3) 733 (52.6) <0.001 
Age, mean (SD) 77.6 (27.2) 77.7 (5.0)  0.91 
Education, n (%)   <0.001 
   Primary  44 (9.0) 71 (5.2)  
   Lower  241 (49.1) 560 (40.9)  
   Intermediate  145 (29.5) 447 (32.7)  
   Higher  61 (12.4) 291 (21.3)  
BMI, n (%)    0.53 
   Normal weight 156 (31.3) 409 (29.4)  
   Overweight 217 (43.5) 646 (46.4)  
   Obese 126 (25.3) 338 (24.3)  
Smoking, n (%)    0.008 
   Non smoker 195 (38.7) 473 (34.0)  
   Former smoker 268 (53.2) 842 (60.5)  
   Current smoker 41 (8.1) 77 (5.5)  
Alcohol use, n (%)        0.002 
   Never  104 (20.6)  213 (15.3)   
   1-4 times/month 160 (31.7)  400 (28.7)   
   2-4 time/week   240 (47.6)  779 (56.0)   
Health status, n (%)   <0.001 
   Not disabled                177 (35.1)  632 (45.4)   
   Disabled                    116 (23.0)  258 (18.5)   
   Severely disabled           211 (41.9)  502 (36.1)   
Prevalent CVD, DM or cancer, n 
(%) 
266 (52.6)  734 (52.7)   1.00 
Living with partner, n (%) 269 (53.4)  904 (64.9)  <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.2. Characteristics of men and women included in the study 
 Men Women p 
n 582 628  
Age, mean (SD) 77.4 (4.8) 77.7 (5.1)  0.28 
Education, n (%)       <0.001 
   Primary  22 ( 3.8)  41 ( 6.7)   
   Lower  46 (25.5)  337 (54.7)   
   Intermediate  224 (39.2)  163 (26.5)   
   Higher  180 (31.5)  75 (12.2)   
BMI, n (%)        0.001 
   Normal weight 167 (28.7)  183 (29.2)   
   Overweight 298 (51.2)  265 (42.3)   
   Obese 117 (20.1)  179 (28.5)   
Smoking, n (%)       <0.001 
   Non smoker 127 (21.9)  282 (44.9)   
   Former smoker 425 (73.3)  310 (49.4)   
   Current smoker 28 ( 4.8)  36 ( 5.7)   
Alcohol use, n (%)       <0.001 
   Never  66 (11.4)  123 (19.6)   
   1-4 times/month 128 (22.0)  217 (34.6)   
   2-4 time/week   387 (66.6)  288 (45.9)   
Health status, n (%)       <0.001 
   Not disabled 302 (52.0)  243 (38.8)   
   Disabled 87 (15.0)  139 (22.2)   
   Severely disabled 192 (33.0)  245 (39.1)   
Prevalent CVD, DM or cancer, n (%) 350 (60.1)  292 (46.5)  <0.001 
Living with partner, n (%) 481 (82.8)  319 (50.8)  <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Total N varies due to variation in the amount of missing data for different covariates. 
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   Overweight 217 (43.5) 646 (46.4)  
   Obese 126 (25.3) 338 (24.3)  
Smoking, n (%)    0.008 
   Non smoker 195 (38.7) 473 (34.0)  
   Former smoker 268 (53.2) 842 (60.5)  
   Current smoker 41 (8.1) 77 (5.5)  
Alcohol use, n (%)        0.002 
   Never  104 (20.6)  213 (15.3)   
   1-4 times/month 160 (31.7)  400 (28.7)   
   2-4 time/week   240 (47.6)  779 (56.0)   
Health status, n (%)   <0.001 
   Not disabled                177 (35.1)  632 (45.4)   
   Disabled                    116 (23.0)  258 (18.5)   
   Severely disabled           211 (41.9)  502 (36.1)   
Prevalent CVD, DM or cancer, n 
(%) 
266 (52.6)  734 (52.7)   1.00 
Living with partner, n (%) 269 (53.4)  904 (64.9)  <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.2. Characteristics of men and women included in the study 
 Men Women p 
n 582 628  
Age, mean (SD) 77.4 (4.8) 77.7 (5.1)  0.28 
Education, n (%)       <0.001 
   Primary  22 ( 3.8)  41 ( 6.7)   
   Lower  46 (25.5)  337 (54.7)   
   Intermediate  224 (39.2)  163 (26.5)   
   Higher  180 (31.5)  75 (12.2)   
BMI, n (%)        0.001 
   Normal weight 167 (28.7)  183 (29.2)   
   Overweight 298 (51.2)  265 (42.3)   
   Obese 117 (20.1)  179 (28.5)   
Smoking, n (%)       <0.001 
   Non smoker 127 (21.9)  282 (44.9)   
   Former smoker 425 (73.3)  310 (49.4)   
   Current smoker 28 ( 4.8)  36 ( 5.7)   
Alcohol use, n (%)       <0.001 
   Never  66 (11.4)  123 (19.6)   
   1-4 times/month 128 (22.0)  217 (34.6)   
   2-4 time/week   387 (66.6)  288 (45.9)   
Health status, n (%)       <0.001 
   Not disabled 302 (52.0)  243 (38.8)   
   Disabled 87 (15.0)  139 (22.2)   
   Severely disabled 192 (33.0)  245 (39.1)   
Prevalent CVD, DM or cancer, n (%) 350 (60.1)  292 (46.5)  <0.001 
Living with partner, n (%) 481 (82.8)  319 (50.8)  <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.4. Objectively assessed moderate and vigorous intensity physical activity in 
women 
n 
Moderate 
PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile range] 
Total 
sedentary 
time (h/day)* 
Total 628 61.3 (19.2) 8.8 [17.1, 17.1] 20.0 (0.9) 
Age group  
   70-74                       200 68.6 (19.8) 10.9 [20.3, 20.3] 19.8 (0.9) 
   75-79                       226 61.4 (17.8) 9.2 [16.7, 16.7] 20.0 (0.9) 
   80-84                       130 56.2 (16.5) 7.9 [14.4, 14.4] 20.2 (0.9) 
   ≥85                       72 49.9 (18.4) 6.2 [11.5, 11.5] 20.5 (1.0) 
p <0.001 <0.001 <0.001 
Education  
   Primary  41 53.3 (19.8) 7.1 [15.6, 15.6] 20.4 (0.9) 
   Lower  337 61.0 (18.3) 9.2 [17.1, 17.1] 20.0 (0.9) 
   Intermediate  163 60.6 (19.1) 8.3 [16.3, 16.3] 20.1 (0.9) 
   Higher  75 66.9 (20.5) 10.2 [19.0, 19.0] 19.8 (1.0) 
p 0.003 0.02 0.006 
Season  
   Spring                      163 61.1 (18.8) 13.0 [9.1, 17.5] 20.0 (1.0) 
   Summer                      74 63.4 (20.4) 13.0 [9.8, 18.2] 20.0 (1.0) 
   Autumn                      206 60.0 (20.5) 11.9 [8.0, 16.1] 20.1 (1.0) 
   Winter                      182 61.7 (17.5) 12.9 [9.0, 16.7] 20.0 (0.9) 
p 0.60 0.19 0.73 
BMI  
   Normal weight               183 68.3 (19.1) 10.9 [19.7, 19.7] 19.7 (0.9) 
   Overweight                  265 61.6 (19.1) 8.7 [17.2, 17.2] 20.0 (1.0) 
   Obese                       179 54.0 (16.6) 8.1 [14.4, 14.4] 20.4 (0.8) 
p <0.001 <0.001 <0.001 
Smoking  
   Non smoker                  282 62.7 (19.1) 8.8 [17.4, 17.4] 20.0 (0.9) 
   Former smoker               310 60.5 (19.2) 8.8 [16.6, 16.6] 20.1 (0.9) 
   Current smoker              36 57.5 (20.0) 8.4 [16.6, 16.6] 20.3 (1.0) 
p 0.19 0.48 0.05 
Alcohol consumption  
   Never  123 59.3 (17.7) 8.4 [15.9, 15.9] 20.1 (1.0) 
   1-4 times/month 217 58.7 (18.8) 8.3 [16.0, 16.0] 20.2 (0.9) 
   2-4 time/week   288 64.2 (19.8) 9.3 [18.2, 18.2] 19.9 (0.9) 
p 0.003 0.02 0.005 
Health status  
   Not disabled                243 65.9 (19.0) 10.1 [19.4, 19.4] 19.9 (0.9) 
   Disabled                    139 62.9 (18.2) 9.8 [17.3, 17.3] 20.0 (0.9) 
   Severely disabled           245 55.8 (18.8) 7.7 [15.5, 15.5] 20.2 (1.0) 
p                   <0.001 <0.001 <0.001 
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Supplement 2.2.4. Objectively assessed moderate and vigorous intensity physical activity in 
women 
n 
Moderate 
PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile range] 
Total 
sedentary 
time (h/day)* 
Total 628 61.3 (19.2) 8.8 [17.1, 17.1] 20.0 (0.9) 
Age group  
   70-74                       200 68.6 (19.8) 10.9 [20.3, 20.3] 19.8 (0.9) 
   75-79                       226 61.4 (17.8) 9.2 [16.7, 16.7] 20.0 (0.9) 
   80-84                       130 56.2 (16.5) 7.9 [14.4, 14.4] 20.2 (0.9) 
   ≥85                       72 49.9 (18.4) 6.2 [11.5, 11.5] 20.5 (1.0) 
p <0.001 <0.001 <0.001 
Education  
   Primary  41 53.3 (19.8) 7.1 [15.6, 15.6] 20.4 (0.9) 
   Lower  337 61.0 (18.3) 9.2 [17.1, 17.1] 20.0 (0.9) 
   Intermediate  163 60.6 (19.1) 8.3 [16.3, 16.3] 20.1 (0.9) 
   Higher  75 66.9 (20.5) 10.2 [19.0, 19.0] 19.8 (1.0) 
p 0.003 0.02 0.006 
Season  
   Spring                      163 61.1 (18.8) 13.0 [9.1, 17.5] 20.0 (1.0) 
   Summer                      74 63.4 (20.4) 13.0 [9.8, 18.2] 20.0 (1.0) 
   Autumn                      206 60.0 (20.5) 11.9 [8.0, 16.1] 20.1 (1.0) 
   Winter                      182 61.7 (17.5) 12.9 [9.0, 16.7] 20.0 (0.9) 
p 0.60 0.19 0.73 
BMI  
   Normal weight               183 68.3 (19.1) 10.9 [19.7, 19.7] 19.7 (0.9) 
   Overweight                  265 61.6 (19.1) 8.7 [17.2, 17.2] 20.0 (1.0) 
   Obese                       179 54.0 (16.6) 8.1 [14.4, 14.4] 20.4 (0.8) 
p <0.001 <0.001 <0.001 
Smoking  
   Non smoker                  282 62.7 (19.1) 8.8 [17.4, 17.4] 20.0 (0.9) 
   Former smoker               310 60.5 (19.2) 8.8 [16.6, 16.6] 20.1 (0.9) 
   Current smoker              36 57.5 (20.0) 8.4 [16.6, 16.6] 20.3 (1.0) 
p 0.19 0.48 0.05 
Alcohol consumption  
   Never  123 59.3 (17.7) 8.4 [15.9, 15.9] 20.1 (1.0) 
   1-4 times/month 217 58.7 (18.8) 8.3 [16.0, 16.0] 20.2 (0.9) 
   2-4 time/week   288 64.2 (19.8) 9.3 [18.2, 18.2] 19.9 (0.9) 
p 0.003 0.02 0.005 
Health status  
   Not disabled                243 65.9 (19.0) 10.1 [19.4, 19.4] 19.9 (0.9) 
   Disabled                    139 62.9 (18.2) 9.8 [17.3, 17.3] 20.0 (0.9) 
   Severely disabled           245 55.8 (18.8) 7.7 [15.5, 15.5] 20.2 (1.0) 
p                   <0.001 <0.001 <0.001 
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Supplement 2.2.4 (continued). Objectively assessed moderate and vigorous intensity physical 
activity in women 
 n 
Moderate 
PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile range] 
Total 
sedentary 
time (h/day)* 
Prevalent CVD, DM or cancer    
   Not present 336 64.6 (19.1) 13.5 [9.8, 18.1] 19.9 (0.9) 
   Present 292 57.5 (18.7) 11.9 [8.1, 15.8] 20.2 (1.0) 
p  <0.001 <0.001 <0.001 
Marital status     
   Living alone 309 57.2 (19.0) 11.6 [7.8, 15.3] 20.2 (1.0) 
   Living with partner 319 65.3 (18.6) 13.7 [9.9, 18.6] 19.9 (0.9) 
p  <0.001 <0.001 <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
* Total sedentary time is the sum of sedentary time while awake and sleep time. 
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Supplement 2.2.5. Objectively assessed moderate and vigorous intensity physical activity in men 
n 
Moderate PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile 
range] 
Total 
sedentary time 
(h/day)* 
Total 582 58.3 (18.6) 8.7 [16.8, 16.8] 20.4 (0.9) 
Age group  
   70-74                       201 61.1 (18.9) 10.4 [18.8, 18.8] 20.3 (0.9) 
   75-79                       203 60.9 (17.8) 9.8 [17.0, 17.0] 20.3 (0.9) 
   80-84                       130 54.3 (17.6) 7.5 [13.9, 13.9] 20.5 (0.9) 
   ≥85                       48 46.2 (17.4) 5.9 [10.1, 10.1] 20.8 (0.9) 
p <0.001 <0.001 0.001 
Education  
   Primary  22 51.3 (15.2) 7.5 [12.6, 12.6] 20.6 (0.9) 
   Lower  146 57.9 (18.2) 8.3 [17.8, 17.8] 20.4 (0.8) 
   Intermediate  224 58.0 (18.9) 8.5 [16.2, 16.2] 20.4 (0.9) 
   Higher  180 59.4 (19.1) 9.1 [17.6, 17.6] 20.3 (0.9) 
p 0.28 0.13 0.59 
Season  
   Spring                      140 55.4 (17.9) 11.5 [7.6, 15.8] 20.5 (0.8) 
   Summer                      64 62.2 (20.4) 13.8 [10.4, 19.3] 20.2 (1.0) 
   Autumn                      163 59.5 (18.9) 12.4 [8.7, 16.6] 20.3 (0.9) 
   Winter                      213 58.2 (18.2) 11.8 [8.9, 16.9] 20.4 (0.9) 
p 0.07 0.06 0.07 
BMI  
   Normal weight               167 62.7 (20.0) 8.8 [19.5, 19.5] 20.2 (0.9) 
   Overweight                  298 58.5 (17.1) 9.4 [16.5, 16.5] 20.3 (0.9) 
   Obese                       117 51.4 (18.6) 6.8 [14.0, 14.0] 20.7 (0.9) 
p <0.001 <0.001 <0.001 
Smoking  
   Non smoker                  127 58.6 (18.1) 9.4 [16.8, 16.8] 20.4 (0.9) 
   Former smoker               425 58.6 (18.7) 8.8 [17.0, 17.0] 20.3 (0.9) 
   Current smoker              28 51.3 (20.0) 6.2 [13.6, 13.6] 20.6 (1.1) 
p 0.13 0.11 0.31 
Alcohol consumption  
   Never  66 59.3 (22.8) 7.4 [15.7, 15.7] 20.2 (1.0) 
   1-4 times/month 128 56.0 (17.4) 8.9 [16.1, 16.1] 20.5 (0.9) 
   2-4 time/week   387 58.8 (18.2) 9.0 [17.0, 17.0] 20.3 (0.9) 
p 0.30 0.48 0.09 
Health status  
   Not disabled                302 62.8 (18.0) 10.5 [18.7, 18.7] 20.2 (0.9) 
   Disabled                    87 53.9 (17.5) 7.0 [14.2, 14.2] 20.5 (0.9) 
   Severely disabled           192 53.1 (18.3) 7.4 [14.5, 14.5] 20.6 (0.9) 
p                  <0.001 <0.001 <0.001 
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Supplement 2.2.4 (continued). Objectively assessed moderate and vigorous intensity physical 
activity in women 
 n 
Moderate 
PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile range] 
Total 
sedentary 
time (h/day)* 
Prevalent CVD, DM or cancer    
   Not present 336 64.6 (19.1) 13.5 [9.8, 18.1] 19.9 (0.9) 
   Present 292 57.5 (18.7) 11.9 [8.1, 15.8] 20.2 (1.0) 
p  <0.001 <0.001 <0.001 
Marital status     
   Living alone 309 57.2 (19.0) 11.6 [7.8, 15.3] 20.2 (1.0) 
   Living with partner 319 65.3 (18.6) 13.7 [9.9, 18.6] 19.9 (0.9) 
p  <0.001 <0.001 <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
* Total sedentary time is the sum of sedentary time while awake and sleep time. 
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Supplement 2.2.5. Objectively assessed moderate and vigorous intensity physical activity in men 
n 
Moderate PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile 
range] 
Total 
sedentary time 
(h/day)* 
Total 582 58.3 (18.6) 8.7 [16.8, 16.8] 20.4 (0.9) 
Age group  
   70-74                       201 61.1 (18.9) 10.4 [18.8, 18.8] 20.3 (0.9) 
   75-79                       203 60.9 (17.8) 9.8 [17.0, 17.0] 20.3 (0.9) 
   80-84                       130 54.3 (17.6) 7.5 [13.9, 13.9] 20.5 (0.9) 
   ≥85                       48 46.2 (17.4) 5.9 [10.1, 10.1] 20.8 (0.9) 
p <0.001 <0.001 0.001 
Education  
   Primary  22 51.3 (15.2) 7.5 [12.6, 12.6] 20.6 (0.9) 
   Lower  146 57.9 (18.2) 8.3 [17.8, 17.8] 20.4 (0.8) 
   Intermediate  224 58.0 (18.9) 8.5 [16.2, 16.2] 20.4 (0.9) 
   Higher  180 59.4 (19.1) 9.1 [17.6, 17.6] 20.3 (0.9) 
p 0.28 0.13 0.59 
Season  
   Spring                      140 55.4 (17.9) 11.5 [7.6, 15.8] 20.5 (0.8) 
   Summer                      64 62.2 (20.4) 13.8 [10.4, 19.3] 20.2 (1.0) 
   Autumn                      163 59.5 (18.9) 12.4 [8.7, 16.6] 20.3 (0.9) 
   Winter                      213 58.2 (18.2) 11.8 [8.9, 16.9] 20.4 (0.9) 
p 0.07 0.06 0.07 
BMI  
   Normal weight               167 62.7 (20.0) 8.8 [19.5, 19.5] 20.2 (0.9) 
   Overweight                  298 58.5 (17.1) 9.4 [16.5, 16.5] 20.3 (0.9) 
   Obese                       117 51.4 (18.6) 6.8 [14.0, 14.0] 20.7 (0.9) 
p <0.001 <0.001 <0.001 
Smoking  
   Non smoker                  127 58.6 (18.1) 9.4 [16.8, 16.8] 20.4 (0.9) 
   Former smoker               425 58.6 (18.7) 8.8 [17.0, 17.0] 20.3 (0.9) 
   Current smoker              28 51.3 (20.0) 6.2 [13.6, 13.6] 20.6 (1.1) 
p 0.13 0.11 0.31 
Alcohol consumption  
   Never  66 59.3 (22.8) 7.4 [15.7, 15.7] 20.2 (1.0) 
   1-4 times/month 128 56.0 (17.4) 8.9 [16.1, 16.1] 20.5 (0.9) 
   2-4 time/week   387 58.8 (18.2) 9.0 [17.0, 17.0] 20.3 (0.9) 
p 0.30 0.48 0.09 
Health status  
   Not disabled                302 62.8 (18.0) 10.5 [18.7, 18.7] 20.2 (0.9) 
   Disabled                    87 53.9 (17.5) 7.0 [14.2, 14.2] 20.5 (0.9) 
   Severely disabled           192 53.1 (18.3) 7.4 [14.5, 14.5] 20.6 (0.9) 
p                  <0.001 <0.001 <0.001 
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Supplement 2.2.5 (continued). Objectively assessed moderate and vigorous intensity physical 
activity in men 
 n 
Moderate PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile 
range] 
Total 
sedentary time 
(h/day)* 
Prevalent CVD, DM or cancer    
   Not present 232 62.1 (17.1) 13.5 [10.3, 18.5] 20.2 (0.8) 
   Present 350 55.8 (19.2) 11.0 [7.7, 15.4] 20.5 (0.9) 
p  <0.001 <0.001 0.001 
Marital status     
   Living alone 100 55.0 (19.7) 10.5 [7.3, 13.6] 20.4 (0.9) 
   Living with partner 481 58.9 (18.4) 12.7 [9.1, 17.1] 20.3 (0.9) 
p  0.05 0.001 0.36 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
* Total sedentary time is the sum of sedentary time while awake and sleep time. 
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Supplement 2.2.6. Objectively assessed physical activity subcomponents and sedentary time in 
women, expressed in percentages of awake time  
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-vigorous 
PA 
Total 628 77.6 (5.6) 14.9 (3.3) 6.2 (2.0) 1.3 [0.9, 1.7] 7.5 (2.6) 
Age group 
   70-74                       200 76.7 (5.4) 15.0 (3.0) 6.7 (1.9) 1.5 [1.1, 2.0] 8.3 (2.6) 
   75-79                       226 77.6 (5.3) 14.9 (3.2) 6.2 (1.8) 1.3 [0.9, 1.7] 7.6 (2.4) 
   80-84                       130 78.0 (5.4) 15.0 (3.4) 5.8 (1.8) 1.1 [0.8, 1.5] 7.0 (2.3) 
   ≥85                       72 79.5 (6.7) 14.2 (4.0) 5.3 (2.2) 0.9 [0.7, 1.2] 6.3 (2.8) 
p 0.003 0.37 <0.001 <0.001 <0.001 
Education 
   Primary  41 79.8 (6.1) 13.7 (3.5) 5.4 (2.2) 0.9 [0.7, 1.4] 6.6 (2.8) 
   Lower  337 77.6 (5.3) 14.9 (3.2) 6.2 (1.8) 1.3 [0.9, 1.7] 7.5 (2.4) 
   Intermediate  163 77.7 (5.7) 14.8 (3.3) 6.1 (2.0) 1.2 [0.9, 1.7] 7.5 (2.7) 
   Higher  75 76.4 (6.0) 15.5 (3.5) 6.6 (2.1) 1.4 [1.0, 1.9] 8.1 (2.7) 
p 0.02 0.04 0.02 0.01 0.02 
Season       
   Spring                      163 77.6 (5.7) 14.8 (3.3) 6.2 (2.0) 1.3 [0.9, 1.8] 7.6 (2.6) 
   Summer                     74 77.5 (5.5) 14.8 (3.3) 6.3 (2.0) 1.3 [1.0, 1.7] 7.7 (2.6) 
   Autumn                     206 77.5 (6.1) 15.0 (3.6) 6.2 (2.1) 1.2 [0.8, 1.6] 7.5 (2.8) 
   Winter                      182 77.9 (4.9) 14.7 (2.9) 6.1 (1.7) 1.3 [0.9, 1.7] 7.4 (2.3) 
p 0.89 0.80 0.87 0.45 0.82 
BMI 
   Normal weight         183 75.3 (5.2) 16.2 (3.0) 7.0 (1.9) 1.5 [1.1, 2.0] 8.6 (2.6) 
   Overweight               265 77.5 (5.6) 14.9 (3.3) 6.2 (2.0) 1.3 [0.9, 1.7] 7.6 (2.6) 
   Obese                       179 80.1 (4.8) 13.5 (3.0) 5.3 (1.6) 1.1 [0.8, 1.4] 6.5 (2.1) 
p <0.001 <0.001 <0.001 <0.001 <0.001 
Smoking 
   Non smoker              282 76.9 (5.4) 15.3 (3.2) 6.4 (1.9) 1.3 [0.9, 1.8] 7.8 (2.5) 
   Former smoker        310 78.1 (5.5) 14.5 (3.2) 6.1 (1.9) 1.2 [0.9, 1.7] 7.4 (2.6) 
   Current smoker       36 79.0 (6.7) 14.0 (3.8) 5.8 (2.3) 1.2 [0.8, 1.7] 7.1 (3.0) 
p 0.01 0.004 0.08 0.25 0.12 
Alcohol consumption 
   Never  123 78.1 (5.3) 14.7 (3.2) 6.0 (1.8) 1.2 [0.9, 1.6] 7.3 (2.3) 
   1-4 times/month 217 78.4 (5.6) 14.4 (3.3) 5.9 (1.9) 1.2 [0.8, 1.6] 7.2 (2.5) 
   2-4 time/week   288 76.8 (5.6) 15.3 (3.3) 6.4 (2.0) 1.3 [0.9, 1.8] 7.9 (2.7) 
p 0.005 0.009 0.007 0.02 0.006 
Health status 
   Not disabled             243 76.8 (5.1) 15.2 (3.0) 6.6 (1.8) 1.4 [1.0, 1.9] 8.1 (2.5) 
   Disabled                    139 77.0 (5.2) 15.3 (3.1) 6.4 (1.8) 1.3 [1.0, 1.7] 7.8 (2.5) 
   Severely disabled      245 78.8 (6.0) 14.3 (3.6) 5.7 (2.0) 1.1 [0.8, 1.6] 6.9 (2.6) 
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Supplement 2.2.5 (continued). Objectively assessed moderate and vigorous intensity physical 
activity in men 
 n 
Moderate PA 
(min/day), 
mean (SD) 
Vigorous PA 
(min/day), median 
[interquartile 
range] 
Total 
sedentary time 
(h/day)* 
Prevalent CVD, DM or cancer    
   Not present 232 62.1 (17.1) 13.5 [10.3, 18.5] 20.2 (0.8) 
   Present 350 55.8 (19.2) 11.0 [7.7, 15.4] 20.5 (0.9) 
p  <0.001 <0.001 0.001 
Marital status     
   Living alone 100 55.0 (19.7) 10.5 [7.3, 13.6] 20.4 (0.9) 
   Living with partner 481 58.9 (18.4) 12.7 [9.1, 17.1] 20.3 (0.9) 
p  0.05 0.001 0.36 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
* Total sedentary time is the sum of sedentary time while awake and sleep time. 
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Supplement 2.2.6. Objectively assessed physical activity subcomponents and sedentary time in 
women, expressed in percentages of awake time  
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-vigorous 
PA 
Total 628 77.6 (5.6) 14.9 (3.3) 6.2 (2.0) 1.3 [0.9, 1.7] 7.5 (2.6) 
Age group 
   70-74                       200 76.7 (5.4) 15.0 (3.0) 6.7 (1.9) 1.5 [1.1, 2.0] 8.3 (2.6) 
   75-79                       226 77.6 (5.3) 14.9 (3.2) 6.2 (1.8) 1.3 [0.9, 1.7] 7.6 (2.4) 
   80-84                       130 78.0 (5.4) 15.0 (3.4) 5.8 (1.8) 1.1 [0.8, 1.5] 7.0 (2.3) 
   ≥85                       72 79.5 (6.7) 14.2 (4.0) 5.3 (2.2) 0.9 [0.7, 1.2] 6.3 (2.8) 
p 0.003 0.37 <0.001 <0.001 <0.001 
Education 
   Primary  41 79.8 (6.1) 13.7 (3.5) 5.4 (2.2) 0.9 [0.7, 1.4] 6.6 (2.8) 
   Lower  337 77.6 (5.3) 14.9 (3.2) 6.2 (1.8) 1.3 [0.9, 1.7] 7.5 (2.4) 
   Intermediate  163 77.7 (5.7) 14.8 (3.3) 6.1 (2.0) 1.2 [0.9, 1.7] 7.5 (2.7) 
   Higher  75 76.4 (6.0) 15.5 (3.5) 6.6 (2.1) 1.4 [1.0, 1.9] 8.1 (2.7) 
p 0.02 0.04 0.02 0.01 0.02 
Season       
   Spring                      163 77.6 (5.7) 14.8 (3.3) 6.2 (2.0) 1.3 [0.9, 1.8] 7.6 (2.6) 
   Summer                     74 77.5 (5.5) 14.8 (3.3) 6.3 (2.0) 1.3 [1.0, 1.7] 7.7 (2.6) 
   Autumn                     206 77.5 (6.1) 15.0 (3.6) 6.2 (2.1) 1.2 [0.8, 1.6] 7.5 (2.8) 
   Winter                      182 77.9 (4.9) 14.7 (2.9) 6.1 (1.7) 1.3 [0.9, 1.7] 7.4 (2.3) 
p 0.89 0.80 0.87 0.45 0.82 
BMI 
   Normal weight         183 75.3 (5.2) 16.2 (3.0) 7.0 (1.9) 1.5 [1.1, 2.0] 8.6 (2.6) 
   Overweight               265 77.5 (5.6) 14.9 (3.3) 6.2 (2.0) 1.3 [0.9, 1.7] 7.6 (2.6) 
   Obese                       179 80.1 (4.8) 13.5 (3.0) 5.3 (1.6) 1.1 [0.8, 1.4] 6.5 (2.1) 
p <0.001 <0.001 <0.001 <0.001 <0.001 
Smoking 
   Non smoker              282 76.9 (5.4) 15.3 (3.2) 6.4 (1.9) 1.3 [0.9, 1.8] 7.8 (2.5) 
   Former smoker        310 78.1 (5.5) 14.5 (3.2) 6.1 (1.9) 1.2 [0.9, 1.7] 7.4 (2.6) 
   Current smoker       36 79.0 (6.7) 14.0 (3.8) 5.8 (2.3) 1.2 [0.8, 1.7] 7.1 (3.0) 
p 0.01 0.004 0.08 0.25 0.12 
Alcohol consumption 
   Never  123 78.1 (5.3) 14.7 (3.2) 6.0 (1.8) 1.2 [0.9, 1.6] 7.3 (2.3) 
   1-4 times/month 217 78.4 (5.6) 14.4 (3.3) 5.9 (1.9) 1.2 [0.8, 1.6] 7.2 (2.5) 
   2-4 time/week   288 76.8 (5.6) 15.3 (3.3) 6.4 (2.0) 1.3 [0.9, 1.8] 7.9 (2.7) 
p 0.005 0.009 0.007 0.02 0.006 
Health status 
   Not disabled             243 76.8 (5.1) 15.2 (3.0) 6.6 (1.8) 1.4 [1.0, 1.9] 8.1 (2.5) 
   Disabled                    139 77.0 (5.2) 15.3 (3.1) 6.4 (1.8) 1.3 [1.0, 1.7] 7.8 (2.5) 
   Severely disabled      245 78.8 (6.0) 14.3 (3.6) 5.7 (2.0) 1.1 [0.8, 1.6] 6.9 (2.6) 
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Supplement 2.2.6 (continued). Objectively assessed physical activity subcomponents and 
sedentary time in women, expressed in percentages of awake time  
 n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-vigorous 
PA 
p                   <0.001 0.006 <0.001 <0.001 <0.001 
Prevalent CVD, DM or cancer     
   Not present 336 76.8 (5.5) 15.2 (3.2) 6.5 (1.9) 1.4 [1.0, 1.8] 8.0 (2.6) 
   Present 292 78.5 (5.6) 14.4 (3.3) 5.8 (1.9) 1.2 [0.8, 1.6] 7.1 (2.5) 
p  <0.001 0.002 <0.001 <0.001 <0.001 
Marital status       
   Living alone 309 78.6 (6.0) 14.3 (3.5) 5.8 (2.0) 1.2 [0.8, 1.6] 7.1 (2.7) 
   Living with 
partner 319 76.7 (5.0) 15.4 (2.9) 6.5 (1.8) 1.4 [1.0, 1.8] 8.0 (2.4) 
p  <0.001 <0.001 <0.001 <0.001 <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.7. Objectively assessed physical activity subcomponents and sedentary time in 
men, expressed in percentages of awake time  
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-
vigorous 
PA 
Total 582 79.1 (5.3) 13.9 (3.2) 5.7 (1.8) 1.2 [0.9, 1.7] 7.0 (2.4) 
Age group 
70-74                       201 79.2 (5.3) 13.5 (3.1) 5.9 (1.9) 1.3 [1.0, 1.8] 7.3 (2.5) 
75-79                       203 78.4 (5.0) 14.2 (3.0) 6.0 (1.7) 1.2 [1.0, 1.7] 7.4 (2.3) 
80-84                       130 79.5 (5.2) 13.9 (3.3) 5.5 (1.7) 1.0 [0.8, 1.4] 6.6 (2.2) 
≥85                       48 80.5 (5.9) 13.9 (3.9) 4.8 (1.9) 0.8 [0.5, 1.0] 5.6 (2.3) 
p                           0.05 0.15 <0.001 <0.001 <0.001 
Education 
Primary  22 79.9 (6.1) 13.8 (4.3) 5.3 (1.7) 1.0 [0.7, 1.3] 6.3 (2.1) 
Lower  146 79.2 (4.7) 13.8 (2.8) 5.7 (1.7) 1.1 [0.9, 1.7] 7.0 (2.3) 
Intermediate  224 79.1 (5.5) 13.9 (3.4) 5.8 (1.9) 1.2 [0.9, 1.6] 7.0 (2.4) 
Higher  180 79.0 (5.3) 13.9 (3.2) 5.8 (1.9) 1.2 [0.9, 1.7] 7.2 (2.5) 
p                           0.89 1.00 0.61 0.27 0.49 
Season 
Spring                      140 79.9 (4.9) 13.5 (2.9) 5.5 (1.7) 1.2 [0.8, 1.5] 6.7 (2.3) 
Summer                      64 77.5 (5.7) 14.7 (3.5) 6.3 (2.0) 1.4 [1.1, 1.8] 7.8 (2.6) 
Autumn                      163 78.4 (5.6) 14.3 (3.5) 6.0 (1.9) 1.2 [0.9, 1.7] 7.3 (2.5) 
Winter                      213 79.5 (4.9) 13.6 (3.0) 5.6 (1.7) 1.2 [0.9, 1.6] 6.9 (2.2) 
p                           0.005 0.01 0.005 0.01 0.006 
BMI 
Normal weight              167 77.8 (5.4) 14.5 (3.2) 6.2 (2.0) 1.3 [0.9, 1.9] 7.6 (2.6) 
Overweight                  298 78.9 (5.0) 14.0 (3.1) 5.8 (1.7) 1.2 [0.9, 1.6] 7.1 (2.2) 
Obese                       117 81.3 (5.2) 12.7 (3.1) 5.0 (1.8) 1.0 [0.7, 1.4] 6.0 (2.3) 
p                           <0.001 <0.001 <0.001 <0.001 <0.001 
Smoking 
Non smoker                  127 79.2 (4.9) 13.7 (2.8) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.4) 
Former smoker              425 78.9 (5.3) 14.0 (3.3) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.4) 
Current smoker             28 81.2 (5.9) 12.7 (3.5) 5.0 (2.0) 1.0 [0.6, 1.4] 6.1 (2.5) 
p                           0.07 0.07 0.11 0.09 0.10 
Alcohol consumption 
   Never  66 78.3 (5.9) 14.5 (3.3) 5.9 (2.3) 1.1 [0.7, 1.7] 7.2 (3.0) 
   1-4 times/month 128 80.1 (4.9) 13.2 (3.1) 5.5 (1.7) 1.2 [0.9, 1.6] 6.7 (2.2) 
   2-4 time/week   387 78.9 (5.2) 14.0 (3.2) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.3) 
p                           0.05 0.02 0.17 0.42 0.26 
Health status 
Not disabled                302 78.2 (4.9) 14.2 (2.9) 6.1 (1.7) 1.3 [1.0, 1.8] 7.6 (2.3) 
Disabled                    87 79.6 (5.7) 13.8 (3.6) 5.4 (1.9) 1.0 [0.7, 1.4] 6.6 (2.4) 
Severely disabled           192 80.1 (5.4) 13.4 (3.4) 5.3 (1.8) 1.1 [0.7, 1.4] 6.4 (2.4) 
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Supplement 2.2.6 (continued). Objectively assessed physical activity subcomponents and 
sedentary time in women, expressed in percentages of awake time  
 n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-vigorous 
PA 
p                   <0.001 0.006 <0.001 <0.001 <0.001 
Prevalent CVD, DM or cancer     
   Not present 336 76.8 (5.5) 15.2 (3.2) 6.5 (1.9) 1.4 [1.0, 1.8] 8.0 (2.6) 
   Present 292 78.5 (5.6) 14.4 (3.3) 5.8 (1.9) 1.2 [0.8, 1.6] 7.1 (2.5) 
p  <0.001 0.002 <0.001 <0.001 <0.001 
Marital status       
   Living alone 309 78.6 (6.0) 14.3 (3.5) 5.8 (2.0) 1.2 [0.8, 1.6] 7.1 (2.7) 
   Living with 
partner 319 76.7 (5.0) 15.4 (2.9) 6.5 (1.8) 1.4 [1.0, 1.8] 8.0 (2.4) 
p  <0.001 <0.001 <0.001 <0.001 <0.001 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.7. Objectively assessed physical activity subcomponents and sedentary time in 
men, expressed in percentages of awake time  
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-
vigorous 
PA 
Total 582 79.1 (5.3) 13.9 (3.2) 5.7 (1.8) 1.2 [0.9, 1.7] 7.0 (2.4) 
Age group 
70-74                       201 79.2 (5.3) 13.5 (3.1) 5.9 (1.9) 1.3 [1.0, 1.8] 7.3 (2.5) 
75-79                       203 78.4 (5.0) 14.2 (3.0) 6.0 (1.7) 1.2 [1.0, 1.7] 7.4 (2.3) 
80-84                       130 79.5 (5.2) 13.9 (3.3) 5.5 (1.7) 1.0 [0.8, 1.4] 6.6 (2.2) 
≥85                       48 80.5 (5.9) 13.9 (3.9) 4.8 (1.9) 0.8 [0.5, 1.0] 5.6 (2.3) 
p                           0.05 0.15 <0.001 <0.001 <0.001 
Education 
Primary  22 79.9 (6.1) 13.8 (4.3) 5.3 (1.7) 1.0 [0.7, 1.3] 6.3 (2.1) 
Lower  146 79.2 (4.7) 13.8 (2.8) 5.7 (1.7) 1.1 [0.9, 1.7] 7.0 (2.3) 
Intermediate  224 79.1 (5.5) 13.9 (3.4) 5.8 (1.9) 1.2 [0.9, 1.6] 7.0 (2.4) 
Higher  180 79.0 (5.3) 13.9 (3.2) 5.8 (1.9) 1.2 [0.9, 1.7] 7.2 (2.5) 
p                           0.89 1.00 0.61 0.27 0.49 
Season 
Spring                      140 79.9 (4.9) 13.5 (2.9) 5.5 (1.7) 1.2 [0.8, 1.5] 6.7 (2.3) 
Summer                      64 77.5 (5.7) 14.7 (3.5) 6.3 (2.0) 1.4 [1.1, 1.8] 7.8 (2.6) 
Autumn                      163 78.4 (5.6) 14.3 (3.5) 6.0 (1.9) 1.2 [0.9, 1.7] 7.3 (2.5) 
Winter                      213 79.5 (4.9) 13.6 (3.0) 5.6 (1.7) 1.2 [0.9, 1.6] 6.9 (2.2) 
p                           0.005 0.01 0.005 0.01 0.006 
BMI 
Normal weight              167 77.8 (5.4) 14.5 (3.2) 6.2 (2.0) 1.3 [0.9, 1.9] 7.6 (2.6) 
Overweight                  298 78.9 (5.0) 14.0 (3.1) 5.8 (1.7) 1.2 [0.9, 1.6] 7.1 (2.2) 
Obese                       117 81.3 (5.2) 12.7 (3.1) 5.0 (1.8) 1.0 [0.7, 1.4] 6.0 (2.3) 
p                           <0.001 <0.001 <0.001 <0.001 <0.001 
Smoking 
Non smoker                  127 79.2 (4.9) 13.7 (2.8) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.4) 
Former smoker              425 78.9 (5.3) 14.0 (3.3) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.4) 
Current smoker             28 81.2 (5.9) 12.7 (3.5) 5.0 (2.0) 1.0 [0.6, 1.4] 6.1 (2.5) 
p                           0.07 0.07 0.11 0.09 0.10 
Alcohol consumption 
   Never  66 78.3 (5.9) 14.5 (3.3) 5.9 (2.3) 1.1 [0.7, 1.7] 7.2 (3.0) 
   1-4 times/month 128 80.1 (4.9) 13.2 (3.1) 5.5 (1.7) 1.2 [0.9, 1.6] 6.7 (2.2) 
   2-4 time/week   387 78.9 (5.2) 14.0 (3.2) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.3) 
p                           0.05 0.02 0.17 0.42 0.26 
Health status 
Not disabled                302 78.2 (4.9) 14.2 (2.9) 6.1 (1.7) 1.3 [1.0, 1.8] 7.6 (2.3) 
Disabled                    87 79.6 (5.7) 13.8 (3.6) 5.4 (1.9) 1.0 [0.7, 1.4] 6.6 (2.4) 
Severely disabled           192 80.1 (5.4) 13.4 (3.4) 5.3 (1.8) 1.1 [0.7, 1.4] 6.4 (2.4) 
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Supplement 2.2.7 (continued) Objectively assessed physical activity subcomponents and 
sedentary time in men, expressed in percentages of awake time (n=582) 
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-
vigorous 
PA 
p  <0.001 0.03 <0.001 <0.001 <0.001 
Prevalent CVD, 
DM or cancer       
   Not present 232 78.2 (4.9) 14.3 (2.9) 6.1 (1.7) 1.3 [1.1, 1.8] 7.5 (2.3) 
   Present 350 79.7 (5.4) 13.6 (3.3) 5.5 (1.9) 1.1 [0.8, 1.5] 6.7 (2.4) 
p  0.001 0.02 <0.001 <0.001 <0.001 
Marital status       
   Living alone 100 79.5 (5.6) 13.9 (3.4) 5.5 (2.0) 1.0 [0.7, 1.5] 6.7 (2.6) 
   Living with 
partner 481 79.0 (5.2) 13.9 (3.1) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.3) 
p  0.42 1.00 0.12 0.002 0.07 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
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Supplement 2.2.7 (continued) Objectively assessed physical activity subcomponents and 
sedentary time in men, expressed in percentages of awake time (n=582) 
n Sedentary Light PA 
Moderate 
PA Vigorous PA 
Moderate-
to-
vigorous 
PA 
p  <0.001 0.03 <0.001 <0.001 <0.001 
Prevalent CVD, 
DM or cancer       
   Not present 232 78.2 (4.9) 14.3 (2.9) 6.1 (1.7) 1.3 [1.1, 1.8] 7.5 (2.3) 
   Present 350 79.7 (5.4) 13.6 (3.3) 5.5 (1.9) 1.1 [0.8, 1.5] 6.7 (2.4) 
p  0.001 0.02 <0.001 <0.001 <0.001 
Marital status       
   Living alone 100 79.5 (5.6) 13.9 (3.4) 5.5 (2.0) 1.0 [0.7, 1.5] 6.7 (2.6) 
   Living with 
partner 481 79.0 (5.2) 13.9 (3.1) 5.8 (1.8) 1.2 [0.9, 1.7] 7.1 (2.3) 
p  0.42 1.00 0.12 0.002 0.07 
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; n, number; SD, standard 
deviation. Body mass index was calculated as weight in kilograms divided by height in meters squared. Categories were 
defined as normal weight: 18.5 < 25 kg/m2, overweight: 25 < 30 kg/m2 and obese: ≥ 30 kg/m2.  
Data are mean (SD) or median (interquartile range).  
Total N varies due to variation in the amount of missing data for different covariates. 
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ABSTRACT 
Introduction: Physical activity (PA) and sedentary behavior (SB) have seasonal patterns. It 
remains unclear how these patterns are associated with sleep, meteorological factors, and 
health.  
Methods: Activity levels were continuously measured with an accelerometer for seven days 
between July 2011 and May 2016, among middle-aged (50-64 years), young-elderly (65-74 
years) and old-elderly (≥75 years) participants of a population-based Dutch cohort study 
(n=1,116). Meteorological factors (ambient temperature, wind speed, sunlight hours, 
precipitation, and minimum visibility) were locally recorded. We first examined the 
seasonality of PA, SB, and nighttime sleep, stratified by age group. Second, we examined the 
influence of meteorological factors. Third, we modeled the potential seasonality of the all-
cause mortality risk due to the seasonality of PA and SB, by using previously published 
relative risks. 
Results: Levels of light and moderate-to-vigorous PA were higher in summer than in winter 
among middle-aged (seasonal variation=18.1 and 14.8 minutes/day) and young-elderly adults 
(12.8 and 8.6 minutes/day). The pattern was explained by ambient temperature and sunlight 
hours. Nighttime sleep was 31.8 minutes/day longer in winter among middle-aged adults. SB 
did not show a seasonal pattern. No seasonality in activity levels was observed among old-
elderly adults. The all-cause mortality risk may be higher in winter than in summer due to the 
accumulation of low levels of moderate to vigorous PA and high levels of SB.  
Conclusion: PA has a larger degree of seasonality than SB and nighttime sleep among middle-
aged and young-elderly adults. SB appears strongly ingrained in daily routine. Recommending 
the interruption of SB with light PA might be a good starting point for public health 
institutions. 
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INTRODUCTION 
Population ageing, urbanization, and automatization of daily activities have contributed to a 
predominantly sedentary lifestyle with low levels of physical activity (PA), and high levels of 
sedentary behavior (SB), but also to suboptimal nighttime sleep duration (i.e. not sleeping 7-8 
hours).1,2 However, although low levels of PA cluster with high SB and suboptimal nighttime sleep 
duration,1,3 these are partly independent phenomena. Moreover, the proportions of the various 
types of daily (in)activity (i.e. PA, SB, sleep) may influence cardio-metabolic health, beyond their 
independent effects.4-6 Therefore, there is increasing interest in the factors determining the 
composition of daily activity levels. 
Objective measurements with accelerometers have demonstrated that levels of PA and SB 
are not constant throughout the year. Studies performed in young and middle-aged populations 
report that time spent in PA decreases in winter,7,8 whereas sedentary time increases.9,10 However, 
it is unclear whether sleep duration is related to this variation, because previous studies have used 
sleep diaries10 rather than objective measures or because sleep was omitted from the daily routine.9 
Several factors determine the seasonality of activity levels. For example, with increasing age, 
time spent in PA and nighttime sleep tend to decrease, while sedentary behavior increases.11,12 
Retirement may also explain this pattern, as leisure PA is more sensitive to seasonal changes than 
occupational PA.8 Additionally, age interacts with meteorological factors to influence PA levels13,14 
and the seasonality of PA is more marked in geographical regions with more climatic 
variation.15,16 However, an age-specific assessment of the impact of meteorological factors on the 
seasonality of activity levels has not been performed. 
The seasonality of activity levels is of relevance to public health, as PA is often prescribed as 
a first means to improve health, e.g. to reduce dyslipidemia and high blood pressure.17 Indeed, it is 
hypothesized that the seasonal pattern of cardio-metabolic risk and mortality can be partly 
explained by the seasonality of PA.7,18 Nevertheless, it is not clear whether this seasonality is large 
enough to influence all-cause mortality on a seasonal basis.  
We therefore examined the seasonality of objectively measured daily levels of PA, SB, and 
nighttime sleep duration according to age, using around-the-clock measurements. Furthermore, 
we examined to what extent  meteorological factors explained the seasonality of activity levels. 
Finally, we modeled the seasonality of the all-cause mortality risk produced by the seasonal 
variation in levels of moderate-to-vigorous PA and SB. 
 
METHODS 
Study design 
We performed a cross-sectional study to analyze the annual seasonal variation in PA, SB and 
nighttime sleep duration. This study was embedded in the Rotterdam Study (RS), a prospective 
population-based cohort established in 1989, which has invited all middle-aged and elderly people 
living in the Ommoord district of Rotterdam, the Netherlands. Baseline invitations sent to all the 
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home addresses within the district, including senior housing facilities, retirement homes and 
assisted living facilities. The aim of the Rotterdam Study was to examine the incidence of risk 
factors for neurological, cardiovascular, psychiatric, and other chronic diseases.19 The study is 
composed by three cohorts (RS-I, RS-II and RS-III) and follow-up visits are performed every five 
years.19 The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus 
MC (MEC 02.1015) and by the Ministry of Health, Welfare and Sport of the Netherlands, 
implementing the Wet Bevolkingsonderzoek: ERGO (Population Studies Act: Rotterdam Study). 
All participants provided written informed consent to their involvement in the study and to 
obtain information from their treating physicians. 
Between June-2011 and June-2014 (wave 1) and between July-2014 and May-2016 (wave 2), 
3,507 participants were invited to wear an accelerometer for seven days, to measure their activity 
levels; 482 participants were invited in both waves. Along with wearing the accelerometer, 
participants reported overnight sleep periods in a sleep diary. For the current study, we selected 
1,166 sets of observations (48 from participants who participated in both wave 1 and wave 2) 
obtained from non-disabled participants. Disability was defined as having a disability index > 
0.5.20 The participation flowchart is provided in Supplement 2.3.1.  
Physical activity, sedentary behavior and nighttime sleep duration 
To measure activity, we used a GENEActiv device (GENEActiv; Activinsights Ltd, Kimbolton, 
Cambridgeshire, UK, http://www.GENEActiv.org/), a tri-axial accelerometer that can be worn like 
a watch. The GENEActiv was sampled at 50 Hz and acceleration was expressed relative to gravity 
(g units; 1 g =9.81 m/s2).21-23 To quantify acceleration related to the movement registered, we 
computed the high-pass filtered vector magnitude (HPFVM).  
Participants were instructed to wear the accelerometer on the non-dominant wrist for 7 
consecutive days and nights. Accelerometer data were processed in Python (2.6.6) using the open 
access PAMPRO software.24 Data were extracted from the first wearing day up to seven days later. 
Participants were included in the analysis if they wore the watch for >1,200 min/day, for at least 4 
days.   Activity was categorized into sedentary (<48 mg), light (48 < 154 mg), moderate (154 <389 
mg) and vigorous activity (>389 mg), based on a recent validation study.25 Nighttime sleep 
duration was detected using a validated algorithm,26 which combines the accelerometer data and 
the time when participants reported they went to bed and woke up from the sleep diary. Time-in-
bed was also extracted from sleep diaries. Sleep efficiency was calculated as (nighttime sleep 
duration/time-in-bed)*100. 
Meteorological factors 
Daily information on meteorological factors in Rotterdam was obtained from the Koninklijk 
Nederlands Meteorologisch Instituut (KNMI).27 The monitor is located approximately 8km from 
the Ommoord district (coordinates: 51° 58' N.B. 04° 27' O.L). The daily meteorological data were 
linked to the dates on which the accelerometer was worn. In the current study, we included daily 
average temperature (˚C), average relative humidity (percentage), total number of sunlight hours, 
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accumulated precipitation (mm), average wind speed (m/s), and minimum visibility (km), 
classified as <1.8km, 1.8-3.9km, 3.9-7km, 7-12km and ≥12km.  
 
Covariates 
Data on covariates were collected through home interviews or measured in the Rotterdam Study 
research center by trained research assistants.19 Height and weight were measured and were used 
to calculate body mass index (BMI; calculated as weight divided by height squared). History of 
cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease (COPD) and 
cancer at the visit date was obtained from medical records. Smoking behavior was categorized as 
never, current or former and requested via questionnaires. Housing condition was classified as 
living independent vs. living in assisted living facilities (i.e., service flat, nursing home). A 
disability index was calculated using the Stanford Health Assessment Questionnaire.20 Depression 
was screened during the home interview using the Center for Epidemiology Studies Depression 
Scale (CES-D Scale).28 Alcohol intake was obtained using the AUDIT tool.29 
Statistical methods 
All analyses were stratified by age group: 50–64 years (middle-aged), 65–74 years (young-elderly) 
and aged 75 years or older (old-elderly). General characteristics of the population are presented as 
absolute frequencies and percentage for categorical variables and as median and interquartile 
range (25th and 75th percentile) for continuous variables. Differences in distributions between the 
age-groups were evaluated using the Kruskal-Wallis test for continuous variables and the χ2 test 
for categorical variables. 
In our analysis, we first examined the seasonality of light and moderate-to-vigorous PA, SB, 
and nighttime sleep duration (in minutes/day) using a linear mixed effects model to account for 
the correlation within days contributed per participant. We used the participant id as clustering 
variable. Because 48 participants wore the accelerometer in both waves, we accounted for the 
correlation between these repeated measurements by adding a second random intercept, using the 
wave as a clustering variable. The seasonality was evaluated using a cosinor model assuming a 
sinusoidal pattern with a period of one year,8 by adding sine and cosine terms of the accelerometer 
wear-date in the fixed part of the model.30 All models were adjusted for the covariates listed above, 
plus the day of the week (weekday or weekend day).  
The seasonality is reported as the seasonal variation, corresponding to the peak-to-nadir 
difference in activity levels throughout the year. Procedures to estimate the seasonal variation are 
provided elsewhere.30 A subgroup analysis stratified by sex was performed, including the seasonal 
variation in time-in-bed (minutes/day) and sleep efficiency (%). 
Second, to examine to what extent the meteorological factors explained the seasonality of 
activity levels, we included one meteorological factor at a time in the fully adjusted model. Then, 
we calculated the difference of the seasonal variation before and after the inclusion of the 
meteorological factor. The influence of a meteorological factor on the seasonality of activity levels 
was considered significant if the seasonal variation became non-significant or was reduced by 
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Second, to examine to what extent the meteorological factors explained the seasonality of 
activity levels, we included one meteorological factor at a time in the fully adjusted model. Then, 
we calculated the difference of the seasonal variation before and after the inclusion of the 
meteorological factor. The influence of a meteorological factor on the seasonality of activity levels 
was considered significant if the seasonal variation became non-significant or was reduced by 
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more than 5%. Average temperature was categorized in quintiles to account for the non-linear 
association. Wind speed, sunlight hours, precipitation, and humidity were converted to z-scores 
and added as continuous variables.  
Finally, we examined the potential seasonality of the all-cause mortality risk as a function of 
moderate-to-vigorous PA and SB, as described in detail in Supplement 2.3.2. Briefly, we first 
multiplied the time/day spent in moderate-to-vigorous PA and in SB with the log transformed 
relative risk (RR) for the association of moderate-to-vigorous PA (RR=0.72) and SB (RR=1.24) 
with all-cause mortality, as obtained from published meta-analyses.31,32 The sum of these products 
was considered the hypothetical all-cause mortality risk due to moderate-to-vigorous PA and SB 
combined. Next, we modeled the seasonality of this hypothetical all-cause mortality risk using 
cosinor analysis, adjusted for the covariates listed above, and stratified by age-group. Using the 
seasonal variation obtained in the previous step, we calculated the hypothetical all-cause mortality 
risk at the peak and the nadir of the seasonal variation and, using standard lifetables, we calculated 
the corresponding life expectancy at each extreme. The difference between the life expectancy at 
the peak and at the nadir is expressed in months. The analyses were repeated for PA and SB 
separately and using the lower and upper boundaries of the 95% confidence interval of the RRs. 
All analyses were performed in Stata version 14.1 SE (StataCorp LP, College Station, Texas).33  
 
RESULTS 
General characteristics 
A total of 1,166 sets of measurements were made; 34% (n=394) were among middle-aged adults, 
39% among young-elderly (n=449), and 28% among old-elderly participants (n=323). Old-elderly 
adults more often participated in the study during winter than during summer (43.6% vs. 6.2% of 
the days contributed). The other age-groups did not show this difference in participation across 
the seasons. Additionally, old-elderly adults were more often living in assisted living facilities and 
were less often in paid employment than middle-aged and young-elderly adults (Table 2.3.1).  
Seasonal variation in activity levels 
Among middle-aged participants, levels of light PA were highest in early-August (seasonal 
variation=18.1 minutes/day (standard error (SE)=4.0)), and levels of moderate-to-vigorous PA 
were highest in late-July (seasonal variation=14.8 minutes/day (SE=3.8)), whereas nighttime sleep 
duration was highest mid-January (seasonal variation=31.8 minutes/day (SE=6.6)). No significant 
seasonal variation in SB was observed (Figure 2.3.1). Among young-elderly adults, levels of light 
PA and of moderate-to-vigorous PA were highest in late-July (seasonal variation= 12.8 
minutes/day (SE=3.9) and 9.9 minutes/day (SE=3.3), respectively), but no significant seasonal 
variation was observed for nighttime sleep duration. Among old-elderly participants, no 
significant seasonal variation was observed for any activity level. No large sex differences in the 
seasonality of activity levels were observed (Supplement 2.3.3). 
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more than 5%. Average temperature was categorized in quintiles to account for the non-linear 
association. Wind speed, sunlight hours, precipitation, and humidity were converted to z-scores 
and added as continuous variables.  
Finally, we examined the potential seasonality of the all-cause mortality risk as a function of 
moderate-to-vigorous PA and SB, as described in detail in Supplement 2.3.2. Briefly, we first 
multiplied the time/day spent in moderate-to-vigorous PA and in SB with the log transformed 
relative risk (RR) for the association of moderate-to-vigorous PA (RR=0.72) and SB (RR=1.24) 
with all-cause mortality, as obtained from published meta-analyses.31,32 The sum of these products 
was considered the hypothetical all-cause mortality risk due to moderate-to-vigorous PA and SB 
combined. Next, we modeled the seasonality of this hypothetical all-cause mortality risk using 
cosinor analysis, adjusted for the covariates listed above, and stratified by age-group. Using the 
seasonal variation obtained in the previous step, we calculated the hypothetical all-cause mortality 
risk at the peak and the nadir of the seasonal variation and, using standard lifetables, we calculated 
the corresponding life expectancy at each extreme. The difference between the life expectancy at 
the peak and at the nadir is expressed in months. The analyses were repeated for PA and SB 
separately and using the lower and upper boundaries of the 95% confidence interval of the RRs. 
All analyses were performed in Stata version 14.1 SE (StataCorp LP, College Station, Texas).33  
 
RESULTS 
General characteristics 
A total of 1,166 sets of measurements were made; 34% (n=394) were among middle-aged adults, 
39% among young-elderly (n=449), and 28% among old-elderly participants (n=323). Old-elderly 
adults more often participated in the study during winter than during summer (43.6% vs. 6.2% of 
the days contributed). The other age-groups did not show this difference in participation across 
the seasons. Additionally, old-elderly adults were more often living in assisted living facilities and 
were less often in paid employment than middle-aged and young-elderly adults (Table 2.3.1).  
Seasonal variation in activity levels 
Among middle-aged participants, levels of light PA were highest in early-August (seasonal 
variation=18.1 minutes/day (standard error (SE)=4.0)), and levels of moderate-to-vigorous PA 
were highest in late-July (seasonal variation=14.8 minutes/day (SE=3.8)), whereas nighttime sleep 
duration was highest mid-January (seasonal variation=31.8 minutes/day (SE=6.6)). No significant 
seasonal variation in SB was observed (Figure 2.3.1). Among young-elderly adults, levels of light 
PA and of moderate-to-vigorous PA were highest in late-July (seasonal variation= 12.8 
minutes/day (SE=3.9) and 9.9 minutes/day (SE=3.3), respectively), but no significant seasonal 
variation was observed for nighttime sleep duration. Among old-elderly participants, no 
significant seasonal variation was observed for any activity level. No large sex differences in the 
seasonality of activity levels were observed (Supplement 2.3.3). 
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Impact of meteorological factors on the seasonality of activity levels 
Among middle-aged adults, the seasonality of levels of light PA was explained by ambient 
temperature (seasonal variation change=-16.3%) and sunlight hours (-16.0%). The seasonality of 
levels of moderate-to-vigorous PA was explained by sunlight hours (-21.5%) and the seasonality 
of nighttime sleep duration was explained by ambient temperature (-49.4%). Among young-
elderly participants, the seasonality of levels of light PA was explained by ambient temperature (-
46.7%) and relative humidity (-17.7%), and the seasonality of levels of moderate-to-vigorous PA 
was explained by ambient temperature (-14.0%), minimal visibility (-12.7%), and relative 
humidity (-11.0%). The meteorological factors had a large significant association with PA levels 
among the old-elderly, but none explained the seasonality (Tables 2.3.2 and 2.3.3). 
Seasonal variation in the all-cause mortality risk and life expectancy as a function of the 
seasonality of activity levels  
If the all-cause mortality risk depended entirely on the levels of moderate-to-vigorous PA and SB, 
it would increase by 1.09 (95%CI: 0.99, 1.21) times in winter compared with summer among 
middle-aged participants, 1.11 (95%CI: 1.01, 1.21) times in winter compared with summer among 
young-elderly participants, and 1.04 (95%CI: 0.95, 1.15) times in autumn compared to spring 
among old-elderly participants (Table 2.3.4). The estimates were similar when using the 95%CI of 
the RR (Supplement 2.3.4). 
 
DISCUSSION 
In this population-based cohort, middle-aged and young-elderly participants spent more time in 
light and moderate-to-vigorous PA in summer than in winter, but no seasonality of PA was 
observed among old-elderly adults. Also, no seasonality was observed for SB in any age group. 
Nighttime sleep duration was higher in winter than in summer among middle-aged participants. 
The seasonality of PA and nighttime sleep duration was mostly explained by ambient temperature 
and sunlight hours. The modeled all-cause mortality risk might increase in winter because of the 
accumulation of low levels of moderate-to-vigorous PA and high levels of SB. 
The heterogeneous seasonal patterns according to activity levels and age group can be 
explained by several factors. First, the magnitude of the seasonal variation in PA decreased with 
age, which can be explained by the age-specific domain composition of PA (i.e. occupational, 
transportation, leisure, and household). Indeed, while up to 30% of daily PA among middle-aged 
adults correspond to occupational PA,11 this domain nearly disappears after retirement, around 
age 65 (i.e. the young-elderly).11 Therefore, the summer increase in PA among middle-aged 
participants, and to a lesser extent among young-elderly participants, likely reflects an increase in 
leisure, household, and transportation PA, while levels of occupational PA remain constant. In 
contrast, because old-elderly adults have less structured daily PA (due to absence of occupational 
PA), they are less sensitive to the variation led by holidays and vacations.  
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Impact of meteorological factors on the seasonality of activity levels 
Among middle-aged adults, the seasonality of levels of light PA was explained by ambient 
temperature (seasonal variation change=-16.3%) and sunlight hours (-16.0%). The seasonality of 
levels of moderate-to-vigorous PA was explained by sunlight hours (-21.5%) and the seasonality 
of nighttime sleep duration was explained by ambient temperature (-49.4%). Among young-
elderly participants, the seasonality of levels of light PA was explained by ambient temperature (-
46.7%) and relative humidity (-17.7%), and the seasonality of levels of moderate-to-vigorous PA 
was explained by ambient temperature (-14.0%), minimal visibility (-12.7%), and relative 
humidity (-11.0%). The meteorological factors had a large significant association with PA levels 
among the old-elderly, but none explained the seasonality (Tables 2.3.2 and 2.3.3). 
Seasonal variation in the all-cause mortality risk and life expectancy as a function of the 
seasonality of activity levels  
If the all-cause mortality risk depended entirely on the levels of moderate-to-vigorous PA and SB, 
it would increase by 1.09 (95%CI: 0.99, 1.21) times in winter compared with summer among 
middle-aged participants, 1.11 (95%CI: 1.01, 1.21) times in winter compared with summer among 
young-elderly participants, and 1.04 (95%CI: 0.95, 1.15) times in autumn compared to spring 
among old-elderly participants (Table 2.3.4). The estimates were similar when using the 95%CI of 
the RR (Supplement 2.3.4). 
 
DISCUSSION 
In this population-based cohort, middle-aged and young-elderly participants spent more time in 
light and moderate-to-vigorous PA in summer than in winter, but no seasonality of PA was 
observed among old-elderly adults. Also, no seasonality was observed for SB in any age group. 
Nighttime sleep duration was higher in winter than in summer among middle-aged participants. 
The seasonality of PA and nighttime sleep duration was mostly explained by ambient temperature 
and sunlight hours. The modeled all-cause mortality risk might increase in winter because of the 
accumulation of low levels of moderate-to-vigorous PA and high levels of SB. 
The heterogeneous seasonal patterns according to activity levels and age group can be 
explained by several factors. First, the magnitude of the seasonal variation in PA decreased with 
age, which can be explained by the age-specific domain composition of PA (i.e. occupational, 
transportation, leisure, and household). Indeed, while up to 30% of daily PA among middle-aged 
adults correspond to occupational PA,11 this domain nearly disappears after retirement, around 
age 65 (i.e. the young-elderly).11 Therefore, the summer increase in PA among middle-aged 
participants, and to a lesser extent among young-elderly participants, likely reflects an increase in 
leisure, household, and transportation PA, while levels of occupational PA remain constant. In 
contrast, because old-elderly adults have less structured daily PA (due to absence of occupational 
PA), they are less sensitive to the variation led by holidays and vacations.  
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Second, the summer reduction in nighttime sleep duration among middle-aged adults suggests its 
seasonality is led by PA, which appears to replace sleep time in summer. Third, a small and non-
statistically significant seasonality of SB was observed in our population (about 10minutes/day), 
which is in contrast with O’Connell et al., who reported a winter increment of SB of about 30 
minutes/day.10 This difference could be explained by the large proportion of the waking time our 
population spent in SB (around 77%), and because we classified the non-sleep time-at-bed as SB 
time. Taken together, our findings suggest that middle-aged and young-elderly participants 
replaced their nighttime sleep with more light PA and moderate-to-vigorous PA, and that SB is 
much more ingrained in the daily routine of the population. 
We found a discrete influence of meteorological factors on the seasonality of activity levels. 
Klenk et al.,34 similarly found a strong association of objectively measured daily walking time with 
several meteorological factors, but not with season, among elderly German participants.  
 
Table 2.3.4. Variation of life expectancy along with seasonal variation of moderate-to-vigorous 
PA and SB, The Rotterdam Study, The Netherlands, 2011-2016 
Age group a,b 
Peak-to-nadir all-cause  
mortality risk ratio c 
Peak 
LE at the 
peak of the 
variation 
(years) 
LE at the 
nadir of the 
variation 
(years) 
Peak-to-
nadir 
difference of 
LEd 
(months) 
SV (95% CI) 
(a) Variation due to both moderate-to-vigorous PA and sedentary behavior 
combined  
Middle-aged 1.09 (0.99, 1.21) 23-Feb 16.6 17.2 -8.2 
Young-elderly 1.11 (1.01, 1.21) 4-Feb 8.1 8.5 -4.5 
Old-elderly 1.04 (0.95, 1.15) 13-Sep 2.6 2.7 -1.4 
(b) Variation due to moderate-to-vigorous PA alone 
Middle-aged 1.08 (1.04, 1.13) 25-Jan 27.5 28.0 -6.3 
Young-elderly 1.06 (1.02, 1.09) 27-Jan 16.1 16.4 -3.7 
Old-elderly 1.02 (0.99, 1.06) 18-Sep 9.1 9.3 -2.4 
(c) Variation due to sedentary behavior alone 
Middle-aged 1.04 (0.97, 1.12) 27-Apr 19.2 20.0 -9.0 
Young-elderly 1.05 (0.98, 1.12) 13-Feb 18.7 19.3 -7.8 
Old-elderly 1.02 (0.95, 1.10) 8-Sep 18.6 19.0 -5.3 
CI: Confidence interval. LE: Life expectancy. PA: Physical activity. SV: Seasonal variation. Bold estimates are statistically 
significant at 95% confidence level. a Age groups are: middle-aged (40-64 years), young-elderly (65-75 years) and old-elderly 
(≥76 years). bFor middle-aged and young-elderly, estimates are calculated at the middle of the range: 57 years and 69.5 years, 
respectively. For old-elderly, estimates are obtained at 79 years for analysis with moderate-to-vigorous PA component, and at 
80 years for analysis with light-to-moderate PA component. c Represents the risk ratio of all-cause mortality at the peak of the 
seasonal variation, compared with its nadir. d Life expectancy for Dutch population at each age categories was 24.4, 13.8 and 
7.1 years, respectively, using mortality rates from literature.46  
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The domain composition of activity levels could contribute to this finding. For example, while 
active transportation might be sensitive to meteorological factors, it represents a small proportion 
of the daily PA. In contrast, indoors occupational PA would be less sensitive to meteorological 
factors, but corresponds to a larger proportion of daily PA. Leisure PA could also be sensitive to 
meteorological conditions,16 but people will remain sedentary if it is ingrained in their daily 
occupational routine,35,36 irrespective of favorable weather. Therefore, although meteorological 
factors have a strong influence on daily activity levels, they may be less relevant than the domain 
composition of PA and SB to explain the seasonality in activity levels. 
Previous evidence suggested that the seasonality of PA plays a role in the well-described 
seasonality of cardiovascular disease and mortality.7,18,37 Our results suggest that the all-cause 
mortality risk will increase in winter among middle-aged and young-elderly adults, due the 
accumulation of low levels of moderate-to-vigorous PA and high levels of SB. Our results need to 
be interpreted cautiously, because this approach does not take into account physical fitness, as a 
measure of functional reserve.38 
 
 
Figure 2.3.1 Seasonal pattern of activity levels according to age group 
Monthly averages of A) light physical activity; B) moderate-to-vigorous physical activity; C) Sedentary behavior; D) Nighttime 
sleep behavior. PA: Physical activity. All estimates are adjusted for cosinor terms, sex, age, body mass index, prevalent 
comorbidities (cancer, cardiovascular disease, diabetes, chronic obstructive pulmonary disease), smoking behavior, housing 
status, occupation, alcohol intake, disability index and day of the week. Middle-aged participants (circles) included those aged 
50-64 years, young-elderly participants (squares) included those aged 65-74 years and old-elderly (triangles) included adults 
aged ≥75 years. 
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We assumed a linear association of PA with all-cause mortality risk, although it is suggested 
that the association is steeper at lower than at higher PA levels.32 Nevertheless, this analysis 
illustrates the potential seasonality of all-cause mortality risk as a function of the seasonal 
variation in activity levels. Consequently, these findings suggest that season and age should be 
taken into consideration when interventions are designed to improve activity levels both in 
clinical practice and in public health. For example, interventions can be designed to avoid people 
replacing active time with SB. Strategies may include promoting active transportation, by offering 
facilities to change wet clothes, fans and showers, encouraging people to wear lighter clothes 
during warm and humid days, and ensuring safe transportation during adverse climate conditions 
(e.g. snow and high wind speed). People can also be encouraged to exercise (e.g. yoga and strength 
training) and to undertake regular activities of daily living of light and moderate intensity, such as 
housework. These interventions could also contribute to interrupting long bouts of SB, since SB is 
also associated with several adverse health outcomes.4-6,39 
There is an ongoing discussion regarding the potential of accelerometers and other wearable 
devices that measure activity levels within interventions aimed to promote PA and reduce SB. 
Based on our findings, wearable devices could provide feedback regarding the declining levels of 
PA in winter and could prompt people to interrupt long SB periods, even in real time. The high 
compliance with accelerometer use in our study showed the relative ease of evaluating activity in a 
middle-aged and elderly population, using a device with a minimal burden for the participant, as 
it is worn as a watch and participants did not have to remove it during the measurement week. 
This improves the precision of the measurements40 and avoids the need for assumptions to be 
made about activity levels when the device is not being worn.40,41 Nevertheless, there is 
controversy regarding the effectiveness of interventions based on wearable devices to change 
behavior,42,43 partly because these changes appear not to be sustained in the longer term.44 
Additionally, it is yet to be examined whether there are differences in the effectiveness of 
interventions using standard feedback based on average individual data42 and that of personalized 
feedback and targets. These issues are sensitive to an elderly population, for whom standard 
targets for moderate-to-high intensity PA may be less feasible than improving light PA43 and 
reducing long SB periods; but also because barriers, either individual (e.g. lack of self-efficacy, 
frailty, or fear of falling) or environmental (e.g. meteorological conditions and built 
environment).45 may hamper the effectiveness of such interventions. Therefore, improving PA 
and reducing SB through the use of wearable devices may be a promising strategy in clinical 
practice. Nevertheless, long-term clinical trials are required of interventions with user-friendly, 
precise, and low-cost devices,42 with relevant, age-appropriate targets for PA and SB. 
The main strength of our study is the objective round-the-clock measurement of activity 
levels in middle-aged and elderly adults, allowing us to evaluate the seasonality of 24-hour age-
specific activity levels. Moreover, we improved the accuracy of SB and nighttime sleep 
measurements, because our participants were instructed not to remove the accelerometer during 
the measurement week and because we calculated non-sleep time-in-bed, which seemed to 
contribute to overall sedentary time. Second, to our knowledge, we are the first to examine the 
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seasonality of the all-cause mortality risk and life expectancy, under the assumption that it will 
depend solely on levels of moderate-to-vigorous PA and SB. In these analyses, we used RR 
estimates obtained from comprehensive systematic reviews with meta-analysis,31,32 thereby 
enhancing the representativeness of our modeling. Third, all our participants were resident in a 
single area, the Ommoord district, which reduces the variation in activity levels that can be 
attributed to other determinants, such as the built environment.  
Nevertheless, we acknowledge several limitations. First, we could not test which domains of 
PA and SB might explain the seasonality. Furthermore, we had repeated sets of measurements of 
activity in only 48 participants and each participant contributed only one week of data in each 
wave. Given their uneven participation throughout the year, this might lead to under- or over-
representation of certain traits at specific periods of the year. Therefore, some seasonal variation 
could be explained by residual confounding or selection bias. The lack of detailed information on 
the type of jobs participants engaged in and the lack of information on community-based seasonal 
activities (e.g. walking or cycling events) might also have contributed to residual confounding. 
Second, our all-cause mortality risk estimations are based on a modeled distribution of the all-
cause mortality risk, and were assumed to be determined only by the seasonality of activity levels. 
Moreover, although we adjusted all our estimates by several covariates, the generalizability of our 
findings is limited to middle-aged and elderly adults with rather high BMI and a high prevalence 
of comorbidities. Third, we used the same cut-offs to define activity intensity in middle-aged, 
young-elderly and old-elderly adults, whereas it might be argued that a particular activity would 
be experienced as vigorous by old-elderly adults, but as moderate activity by middle-aged adults. 
Consequently, we might have some misclassification of activity. Finally, not all physical activities 
are captured by the device, as it depends on acceleration of the wrist to detect the movement. 
Therefore, we may have not captured activities performed mostly by the legs, such as cycling, 
which is a common mode of transport in the Netherlands. 
Conclusions 
In conclusion, middle-aged and young-elderly adults spent more time in light and moderate-to-
vigorous PA in the summer than in the winter. In the summer, PA appears to replace nighttime 
sleep, especially among middle-aged adults. The small seasonal variation observed in SB may be 
explained by the large proportion of the day dedicated to SB, as this is a behavior strongly 
ingrained in the daily routine. Meteorological factors had a discrete impact on the seasonality of 
activity levels. However, on a daily basis, the meteorological factors had a strong association with 
PA and SB, especially among old-elderly individuals. The all-cause mortality risk would increase 
in winter due to the accumulation of low levels of PA and high levels of SB. The use of wearable 
devices may contribute to the design of interventions to improve PA and reduce SB, which are 
relevant targets within clinical practice to improve health. These interventions should be designed 
to attend to specific needs according to season and age. Since we observed the largest seasonality 
in levels of light PA, recommending the interruption of SB with light PA might be a good starting 
point for public health interventions.  
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Supplement 2.3.1. Flow chart of participant inclusion for the Rotterdam Study 
 
† The ActiWatch is a one-dimensional device and could not be used to measure physical activity.
* The 1,166 observations included 49 participants with two observations.  
‡In wave 1, participants from the fifth follow-up visit of RS-I (RS-I-5), the third visit of RS-II (RS-II-3), and the second visit of 
RS-III (RS-III-2) were invited. In wave 2, participants from the sixth follow-up visit of RS-I (RS-I-6) and the fourth visit of RS-
II (RS-II-4) were invited.   
833 Observations excluded from 
participants that did not want to participate 
x 306 Participants declined in wave 1 
x 485 Participants declined in wave 2 
x 21 Participants declined in both waves 
729 Observations excluded that were 
obtained with the ActiWatch†  
55 participants excluded due to 
malfunctioning device 
29 Observations lost due to processing error 
3,156 Observations 
2,427 Observations 
 
2,372 Observations 
2,113 Observations with valid data 
230 participants without valid data:   
x 30 participants did not complete one 
week of wearing 
x 154 participants with invalid data i.e. 
not having 4 days with >1200 min/day 
x 8 participants lost their device 
x 38 participants for whom it is unclear 
why no valid data 
2,142 Observations 
1,166 Observations included in the 
analysis* 
947 Observations excluded from 
participants considered disabled (disability 
index >0.5) 
3,989 Observations 
 
3,507 Participants invited to wear an accelerometer 
between June 2011 and June 2014 (wave 1) and 
between July 2014 and May 2016 (wave 2) ‡, of 
which 482 participants were invited in both waves 
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Supplement 2.3.2. Procedures for the modeling of the all-cause mortality risk and LE as function 
of moderate-to-vigorous PA and SB 
To examine the potential health impact of the seasonality of moderate-to-vigorous PA and SB, we 
modeled the all-cause mortality risk using risk ratios (RR) and the estimates for the 95% 
confidence interval (95%CI) obtained from literature. For moderate-to-vigorous PA, we extracted 
the RR (95%CI) of 0.72 (0.65, 0.80) from a recently published systematic review with meta-
analysis.1 The RR expresses the all-cause mortality risk of those achieving an equivalent of 150 
minutes of moderate-to-vigorous PA per week, compared to those not achieving this equivalent. 
We assumed the RR was equivalent to achieving 30 minute/day of moderate-to-vigorous PA,2 to 
be able to use our daily data.  
For SB, we used the RR (95%CI) of 1.24 (1.09, 1.41) reported in a recent review and meta-
analysis.3 It expresses the all-cause mortality risk of people with high SB levels compared to those 
with low SB. Because no specific cut-off was provided to define high SB, we used the median of 
the cut-offs indicated in the primary studies included in the review to define high versus low SB (8 
hours/day). 
 
Hypothetical all-cause mortality risk due to moderate-to-vigorous PA 
For each participant, we modeled the all-cause mortality risk due to moderate-to-vigorous PA. To 
do so, we multiplied the time/day spent in moderate-to-vigorous PA with the natural log 
transformed risk ratio of the association of moderate-to-vigorous PA with all-cause mortality, 
estimated by Hupin et al.1 (RR=0.72; log transformed = -0.33). Because the RR represents the 
association between accumulating 150 minutes/week of moderate-to-vigorous PA vs. less than 
150 minutes/week, we did two assumptions: 1) that the RR would be equivalent if the person 
accumulated 30minutes/day of moderate-to-vigorous, 2) that the association is linear, and the RR 
represents the reduction of the risk when accumulating 150 minutes per day, and could increase 
or reduce linearly and proportionally to the levels of moderate-to-vigorous PA of the participants. 
To fulfill these assumptions, we first centered the moderate-to-vigorous variable at 30 
minutes/day, by subtracting 30 and then, dividing the difference by 60, to express the difference in 
hours. To model the lower and upper boundary of the 95% confidence interval (95%CI), we used 
the lower and upper boundary of the 95%CI of the risk ratio (0.65 and 0.80). 
Hypothetical all-cause mortality risk due to SB 
For each participant, we modeled the all-cause mortality risk due to SB. To do so, we repeated the 
previous process but using the SB variable and the natural log transformed risk ratio of the 
association between SB and all-cause mortality, as estimated by Biswas et al3 (RR=1.24; log 
transformed = 0.22). We modeled the 95%CI by using the lower and upper boundary of the 
95%CI of the risk obtained risk ratio (1.09 and 1.41). The RR calculated by Biswas et al. represents 
the increment of the all-cause mortality risk at high levels of SB, compared to low. They meta-
analyzed the RR at the levels of high SB as defined by every paper included in the meta-analysis, so 
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the definition of high SB corresponds to a range of categories between >=4hours/day to >=11 
hours/day. We defined high SB at the median of the cut-offs of the studies included in the meta-
analysis, at 8 hours/day. Therefore, for the calculation of the daily individual mortality risk due to 
SB, the time was centered at 8 hours/day. 
Hypothetical all-cause mortality risk due to PA and SB 
The newly generated variables of the modeled all-cause mortality risk per participant and day 
recorded are summed up between them.  
Example: The average middle-aged participant of the study had 99minutes/day of moderate-to-
vigorous PA and 805minutes/day of SB. The centered time of moderate-to-vigorous PA would be 
calculated as (99-30)/60=1.15, and for SB would be (805-480)/60=5.4. Therefore, the all-cause 
mortality risk due to moderate-to-vigorous PA would be ln(0.72)*1.15=-0.38, and for SB would be 
ln(1.24)*5.4=1.16. Therefore, the overall all-cause mortality risk would be (-0.38)+1.16=0.78. This 
procedure was performed for each participant for each day contributed per participant. Also, the 
procedure was calculated using the lower and upper boundaries of the 95% confidence intervals of 
the RR for both moderate-to-vigorous PA and SB, for sensitivity analyses. 
Seasonality of the hypothetical all-cause mortality risk 
The seasonality of the modeled overall (PA and SB) all-cause mortality risk was calculated using 
the standard cosinor analysis. The seasonal variation (peak-to-nadir difference of the risk) was 
estimated in this analysis. The difference between the modeled risk at the peak and at the nadir 
represents the seasonal variation of the modeled all-cause mortality risk. Because the difference is 
expressed in log units, the exponential of this difference represents the quotient between the risk 
at the peak and at the nadir of the variation, it means, the risk ratio for the modeled mortality risk. 
Therefore, a RR higher than one can be interpreted as the number of times the modeled all-cause 
mortality risk ratio increases at the peak compared to the nadir of the variation. Because the PA 
seasonal patterns were different for each age group, the seasonality of the modeled all-cause 
mortality risk was calculated stratified according to age group, the same way the seasonality of the 
activity levels was calculated. 
Seasonality of the life expectancy as a consequence of the hypothetical all-cause mortality risk 
To calculate how the variation of the modeled all-cause mortality risk would impact the life 
expectancy (LE), we created a hypothetical baseline scenario, using the age-specific mortality rates 
in the Dutch population in 2015, obtained from the Global Burden of Disease (GBD) data. Using 
these mortality rates, a standard life table was constructed.  
Then, to calculate how would be the LE at the peak of the seasonality of the hypothetical 
mortality risk, we multiplied the mortality rate of each group by the exponential of the sum of the 
predicted all-cause mortality risk of each age group plus the amplitude of the seasonal variation 
[mortality rate (expressed in deaths/100,000) * exp(average adjusted all-cause mortality 
risk+amplitude of the seasonality of all-cause mortality risk)]. The average adjusted all-cause 
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mortality risk was obtained with the Stata postestimation command margins after fitting the 
cosinor model of the all-cause mortality risk. The amplitude corresponds to the seasonal variation 
divided by two. The updated mortality rates at the peak of the seasonality of the all-cause 
mortality risk provided the LE at the peak of the seasonal pattern.  
To calculate how would be the LE at the nadir of the seasonality of the hypothetical 
mortality rsik, we multiplied the mortality rate of each group by the exponential of the difference 
between the predicted all-cause mortality risk of each age group (same as defined above) and the 
amplitude of the seasonal variation (same as defined above) [mortality rate (expressed in 
deaths/100,000) * exp(average adjusted all-cause mortality risk - amplitude of the seasonality of 
all-cause mortality risk)]. The updated mortality rates were used to calculate the LE at the nadir of 
the seasonal pattern. 
Finally, the difference in months of the LE was calculated as the difference between the peak 
and the nadir of the seasonal variation of the all-cause mortality risk. 
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Supplement 2.3.4. Potential seasonality of all-cause mortality risk as a function of moderate-to-
vigorous PA and SB, sensitivity analyses 
Age group a,b 
Peak-to-nadir all-cause  
mortality risk ratio c 
Peak 
LE at the 
peak of the 
variation 
(years) 
LE at the 
nadir of the 
variation 
(years) 
Peak-to-
nadir 
difference of 
LEd 
(months) 
SV (95% CI) 
Sensitivity analysis 1: Lower 95%CI boundary of all-cause mortality risk estimates 
(a) Variation due to both moderate-to-vigorous PA and sedentary behavior combined 
Middle-aged 1.11 (1.03, 1.20) 04-feb 23.3 24.1 -8.6 
Young-elderly 1.09 (1.03, 1.17) 31-jan 12.6 13 -4.9 
Old-elderly 1.04 (0.97, 1.11) 15-sep 6.0 6.2 -2.6 
(b) Variation due to moderate-to-vigorous PA alone 
Middle-aged 1.11 (1.05, 1.18) 25-jan 28.5 29.2 -8.2 
Young-elderly 1.07 (1.02, 1.12) 27-jan 16.9 17.3 -5.0 
Old-elderly 1.03 (0.98, 1.08) 18-sep 9.8 10.1 -3.4 
(c) Variation due to sedentary behavior alone 
Middle-aged 1.02 (0.99, 1.05) 27-apr 39.6 40.2 -6.4 
Young-elderly 1.02 (0.99, 1.05) 13-feb 39.4 39.8 -5.6 
Old-elderly 1.01 (0.98, 1.04) 08-sep 39.3 39.7 -4.4 
Sensitivity analysis 2: Upper 95%CI boundary of all-cause mortality risk estimates 
(a) Variation due to both moderate-to-vigorous PA and sedentary behavior combined 
Middle-aged 1.09 (0.96, 1.24) 18-Mar 10.6 11.2 -7.3 
Young-elderly 1.12 (1.00, 1.26) 08-feb 5.1 5.5 -4.3 
Old-elderly 1.05 (0.92, 1.20) 11-sep 1.1 1.2 -0.7 
(b) Variation due to moderate-to-vigorous PA alone 
Middle-aged 1.06 (1.03, 1.09) 25-jan 26.5 26.8 -4.3 
Young-elderly 1.04 (1.01, 1.06) 27-jan 15.3 15.5 -2.4 
Old-elderly 1.01 (0.99, 1.04) 18-sep 8.4 8.5 -1.5 
(c) Variation due to sedentary behavior alone 
Middle-aged 1.07 (0.96, 1.19) 27-apr 9.6 10.2 -7.8 
Young-elderly 1.08 (0.98, 1.20) 13-feb 8.9 9.5 -7.3 
Old-elderly 1.04 (0.92, 1.17) 08-sep 8.8 9.1 -4.0 
CI: Confidence interval. LE: Life expectancy. SV: Seasonal variation. Bold estimates are statistically significant. 1 Age groups 
are: middle-aged (40-64 years), young-elderly (65-75 years) and old-elderly (>=76 years). 2For middle-aged and young-elderly, 
estimates are calculated at the middle of the range: 57 years and 69.5 years, respectively. For old-elderly, estimates are obtained 
at 79 years for analysis with moderate-to-vigorous PA component, and at 80 years for analysis with light-to-moderate PA 
component. 3 Represents the risk ratio of all-cause mortality at the peak of the seasonal variation, compared with its nadir. 4 
Life expectancy for Dutch population at each age categories was 24.4, 13.8 and 7.1 years, respectively, using mortality rates 
from.4  
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Supplement 2.3.4. Potential seasonality of all-cause mortality risk as a function of moderate-to-
vigorous PA and SB, sensitivity analyses 
Age group a,b 
Peak-to-nadir all-cause  
mortality risk ratio c 
Peak 
LE at the 
peak of the 
variation 
(years) 
LE at the 
nadir of the 
variation 
(years) 
Peak-to-
nadir 
difference of 
LEd 
(months) 
SV (95% CI) 
Sensitivity analysis 1: Lower 95%CI boundary of all-cause mortality risk estimates 
(a) Variation due to both moderate-to-vigorous PA and sedentary behavior combined 
Middle-aged 1.11 (1.03, 1.20) 04-feb 23.3 24.1 -8.6 
Young-elderly 1.09 (1.03, 1.17) 31-jan 12.6 13 -4.9 
Old-elderly 1.04 (0.97, 1.11) 15-sep 6.0 6.2 -2.6 
(b) Variation due to moderate-to-vigorous PA alone 
Middle-aged 1.11 (1.05, 1.18) 25-jan 28.5 29.2 -8.2 
Young-elderly 1.07 (1.02, 1.12) 27-jan 16.9 17.3 -5.0 
Old-elderly 1.03 (0.98, 1.08) 18-sep 9.8 10.1 -3.4 
(c) Variation due to sedentary behavior alone 
Middle-aged 1.02 (0.99, 1.05) 27-apr 39.6 40.2 -6.4 
Young-elderly 1.02 (0.99, 1.05) 13-feb 39.4 39.8 -5.6 
Old-elderly 1.01 (0.98, 1.04) 08-sep 39.3 39.7 -4.4 
Sensitivity analysis 2: Upper 95%CI boundary of all-cause mortality risk estimates 
(a) Variation due to both moderate-to-vigorous PA and sedentary behavior combined 
Middle-aged 1.09 (0.96, 1.24) 18-Mar 10.6 11.2 -7.3 
Young-elderly 1.12 (1.00, 1.26) 08-feb 5.1 5.5 -4.3 
Old-elderly 1.05 (0.92, 1.20) 11-sep 1.1 1.2 -0.7 
(b) Variation due to moderate-to-vigorous PA alone 
Middle-aged 1.06 (1.03, 1.09) 25-jan 26.5 26.8 -4.3 
Young-elderly 1.04 (1.01, 1.06) 27-jan 15.3 15.5 -2.4 
Old-elderly 1.01 (0.99, 1.04) 18-sep 8.4 8.5 -1.5 
(c) Variation due to sedentary behavior alone 
Middle-aged 1.07 (0.96, 1.19) 27-apr 9.6 10.2 -7.8 
Young-elderly 1.08 (0.98, 1.20) 13-feb 8.9 9.5 -7.3 
Old-elderly 1.04 (0.92, 1.17) 08-sep 8.8 9.1 -4.0 
CI: Confidence interval. LE: Life expectancy. SV: Seasonal variation. Bold estimates are statistically significant. 1 Age groups 
are: middle-aged (40-64 years), young-elderly (65-75 years) and old-elderly (>=76 years). 2For middle-aged and young-elderly, 
estimates are calculated at the middle of the range: 57 years and 69.5 years, respectively. For old-elderly, estimates are obtained 
at 79 years for analysis with moderate-to-vigorous PA component, and at 80 years for analysis with light-to-moderate PA 
component. 3 Represents the risk ratio of all-cause mortality at the peak of the seasonal variation, compared with its nadir. 4 
Life expectancy for Dutch population at each age categories was 24.4, 13.8 and 7.1 years, respectively, using mortality rates 
from.4  
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ABSTRACT 
Background: Physical activity (PA) is associated with lower risk for all-cause mortality. 
However, in elderly people, it remains unknown which types of PA are associated with 
mortality and whether the association between PA and mortality differs by cause of death.  
Methods: We assessed the association of total PA, walking, cycling, domestic work, sports and 
gardening with all-cause mortality and the association of total PA with cause-specific 
mortality using Cox proportional hazard models among 7,225 older adults (mean age: 70 
years) from the prospective population-based Rotterdam Study. Deaths were classified as due 
to cardiovascular diseases (CVDs), cancer, infections, external causes, dementia, chronic lung 
diseases or other causes. Activities were categorized into tertiles (lowest tertile as reference). 
To account for the possibility of reverse causation, we excluded the first 5 and 10 years of 
follow-up. 
Results: Over a median of 13.1 years of follow-up (interquartile range: 8.4-14.6 years), 3,261 
participants died. The hazard ratios (HRs) and 95% confidence intervals (95%CIs) associated 
with high total PA compared to low were 0.69 (0.63, 0.75), 0.69 (0.58, 0.81), 0.44 (0.27, 0.71), 
0.47 (0.32, 0.71) and 0.56 (0.46, 0.69) for mortality from all-causes, CVDs, chronic lung 
diseases, infections and other causes, respectively. With longer exclusion times, the strength 
of these associations was attenuated. All PA types were associated with lower all-cause 
mortality risk.  
Conclusion: Engagement in higher PA levels was associated with lower risk of mortality from 
CVDs, chronic lung diseases, infections and other causes. Participating in any PA might 
reduce mortality risk in older adults. 
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INTRODUCTION 
Being physically active at moderate intensity at the recommended level of 150 to 300 
minutes/week1 can reduce the all-cause mortality risk by up to 26%.2,3 However, most studies have 
focused on the effect of overall physical activity (PA). Thus, it remains unclear which specific PA 
types relate to mortality.4-7 Differences in frequency, intensity, duration and context in which one 
is engaged in specific PA types8,9 might lead to different associations with mortality. For older 
people who are unable to engage in recreational or leisure time PA, information on the health 
effects of other PA types could help public health institutes create recommendations specially 
targeted at older adults.  
Recently, one study investigated the association between different PA domains and 
mortality among adults (16-92 years) and found a beneficial association of leisure time PA with 
all-cause mortality, but not with work-related PA or commuting.7 In two other studies, cycling to 
work 4 and walking or cycling for transportation6 were associated with a lower all-cause mortality 
risk. The described studies were performed mostly in middle-aged adults and less is known about 
what kind of activities are beneficially associated with mortality in an elderly population. This is 
important since PA levels tend to decrease with age and PA types in which older adults engage 
differ markedly from the activities performed by younger and middle-aged adults.10 Additionally, 
information is lacking on whether PA is associated with specific causes of death, including 
mortality related to dementia and chronic lung diseases.11-13 
We examined the association of PA with all-cause and cause-specific mortality in a middle-
aged and elderly population. Furthermore, we assessed independent associations of walking, 
cycling, sports, domestic work and gardening with all-cause mortality. 
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study (RS), a prospective population-based cohort, 
among subjects aged 55 years or older in the municipality of Rotterdam, the Netherlands. The aim 
of the study was to examine the incidence of risk factors for neurological, cardiovascular, 
psychiatric and other chronic diseases. Details of the study have been published previously.14 
Between 1997 and 2001, 7,808 participants were invited for the research examinations, of which 
7310 participants completed a PA questionnaire (Figure 3.1.1). Subsequently, 52 subjects were 
excluded due to not provided or withdrawn informed consent for follow-up data collection, and 
33 participants were excluded due to unreliable PA data. Finally, 7,225 subjects were included in 
the analyses. To collect baseline information, trained research assistants interviewed the 
participants at home.  
All subjects gave written informed consent, and the study was approved by the institutional 
review board (Medical Ethics Committee) of the Erasmus Medical Center and by the review board 
of The Netherlands Ministry of Health, Welfare and Sports. 
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ABSTRACT 
Background: Physical activity (PA) is associated with lower risk for all-cause mortality. 
However, in elderly people, it remains unknown which types of PA are associated with 
mortality and whether the association between PA and mortality differs by cause of death.  
Methods: We assessed the association of total PA, walking, cycling, domestic work, sports and 
gardening with all-cause mortality and the association of total PA with cause-specific 
mortality using Cox proportional hazard models among 7,225 older adults (mean age: 70 
years) from the prospective population-based Rotterdam Study. Deaths were classified as due 
to cardiovascular diseases (CVDs), cancer, infections, external causes, dementia, chronic lung 
diseases or other causes. Activities were categorized into tertiles (lowest tertile as reference). 
To account for the possibility of reverse causation, we excluded the first 5 and 10 years of 
follow-up. 
Results: Over a median of 13.1 years of follow-up (interquartile range: 8.4-14.6 years), 3,261 
participants died. The hazard ratios (HRs) and 95% confidence intervals (95%CIs) associated 
with high total PA compared to low were 0.69 (0.63, 0.75), 0.69 (0.58, 0.81), 0.44 (0.27, 0.71), 
0.47 (0.32, 0.71) and 0.56 (0.46, 0.69) for mortality from all-causes, CVDs, chronic lung 
diseases, infections and other causes, respectively. With longer exclusion times, the strength 
of these associations was attenuated. All PA types were associated with lower all-cause 
mortality risk.  
Conclusion: Engagement in higher PA levels was associated with lower risk of mortality from 
CVDs, chronic lung diseases, infections and other causes. Participating in any PA might 
reduce mortality risk in older adults. 
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INTRODUCTION 
Being physically active at moderate intensity at the recommended level of 150 to 300 
minutes/week1 can reduce the all-cause mortality risk by up to 26%.2,3 However, most studies have 
focused on the effect of overall physical activity (PA). Thus, it remains unclear which specific PA 
types relate to mortality.4-7 Differences in frequency, intensity, duration and context in which one 
is engaged in specific PA types8,9 might lead to different associations with mortality. For older 
people who are unable to engage in recreational or leisure time PA, information on the health 
effects of other PA types could help public health institutes create recommendations specially 
targeted at older adults.  
Recently, one study investigated the association between different PA domains and 
mortality among adults (16-92 years) and found a beneficial association of leisure time PA with 
all-cause mortality, but not with work-related PA or commuting.7 In two other studies, cycling to 
work 4 and walking or cycling for transportation6 were associated with a lower all-cause mortality 
risk. The described studies were performed mostly in middle-aged adults and less is known about 
what kind of activities are beneficially associated with mortality in an elderly population. This is 
important since PA levels tend to decrease with age and PA types in which older adults engage 
differ markedly from the activities performed by younger and middle-aged adults.10 Additionally, 
information is lacking on whether PA is associated with specific causes of death, including 
mortality related to dementia and chronic lung diseases.11-13 
We examined the association of PA with all-cause and cause-specific mortality in a middle-
aged and elderly population. Furthermore, we assessed independent associations of walking, 
cycling, sports, domestic work and gardening with all-cause mortality. 
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study (RS), a prospective population-based cohort, 
among subjects aged 55 years or older in the municipality of Rotterdam, the Netherlands. The aim 
of the study was to examine the incidence of risk factors for neurological, cardiovascular, 
psychiatric and other chronic diseases. Details of the study have been published previously.14 
Between 1997 and 2001, 7,808 participants were invited for the research examinations, of which 
7310 participants completed a PA questionnaire (Figure 3.1.1). Subsequently, 52 subjects were 
excluded due to not provided or withdrawn informed consent for follow-up data collection, and 
33 participants were excluded due to unreliable PA data. Finally, 7,225 subjects were included in 
the analyses. To collect baseline information, trained research assistants interviewed the 
participants at home.  
All subjects gave written informed consent, and the study was approved by the institutional 
review board (Medical Ethics Committee) of the Erasmus Medical Center and by the review board 
of The Netherlands Ministry of Health, Welfare and Sports. 
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Figure 3.1.1. Flowchart of participant inclusion for the Rotterdam Study (RS), 1997–2012.  
RS-I, original cohort; RS-II, extended cohort. 
 
Physical activity assessment  
PA levels were assessed at baseline with an adapted version of the Zutphen Physical Activity 
Questionnaire.15 This questionnaire has been validated with a test-retest reliability of 0.93. The 
correlation with doubly labelled water, the golden standard for measuring PA, was 0.61.16 The 
original Zutphen questionnaire contains questions on walking, cycling, sports, gardening and 
hobbies. In the current, study questions on housekeeping activities were added to attain a more 
complete assessment of PA levels. Detailed information on the collection of PA data has been 
described previously.17 
To quantify activity intensity, we used metabolic equivalent of task (MET). We assigned 
MET-values to all activities mentioned in the questionnaire.18 Sports that were not in this 
compendium and to which no MET-value could be assigned (e.g. underwater hockey, roller 
skiing) were not used in the analyses (n=33; 2.8%).  
498 Participants Did Not Complete 
Physical Activity Data Collection 
 
85 Participants Excluded 
    52 Participants Did Not Provide  
    or  Withdrew Informed Consent  
    33 Participants Excluded Because  
         of Unreliable Completion of  
         Physical Activity Data  
         Collection 
7,808 Total Participants 
4,797 at RS-I visit 3 (1997-1999) 
3,011 at RS-II visit 1 (2000-2001) 
 
7,310 Participants With Physical Activity Data 
7,225 Participants Included in Analyses 
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Finally, we multiplied MET-values of specific activities with time (in hours) per week spent 
in that activity to calculate MET∙hours∙week-1 in total PA and in every PA type (cycling, walking, 
sports, domestic work, gardening).  
Assessment of covariates 
Information on covariates was collected through home interviews or was measured at the study 
centre visit as described previously.19,20 Alcohol use was defined as the amount of glasses per day 
and used as a continuous variable. We assessed marital status as a dichotomous variable 
describing whether the participant lived alone or not. Education was divided in primary, junior 
vocational/academic education and higher vocational/academic education. Smoking was divided 
into three categories: current, former and never. Body mass index (BMI) was calculated using 
measured height and weight (kg/m2) and used continuously. Presence of diabetes was determined 
using medical records and used as binary variable (present/not present). Concentration of serum 
total cholesterol and high-density lipoprotein cholesterol was determined using an automated 
enzymatic procedure (Boehringer Mannheid System, Mannheim, Germany), expressed in 
mmol/L and used as a continuous variable. Two seated blood pressure measurements were 
obtained at the right brachial artery using a random zero sphygmomanometer and the mean of 
two consecutive measurements expressed in mmHg was used in analyses as a continuous variable. 
Activities of daily living (ADL) were measured with the Stanford Health Assessment 
Questionnaire and used to indicate general health.21 In accordance with literature, we used a score 
≥ 0.5 to define participants as disabled.22,23 Dietary information was not collected at the same time 
as PA data collection. Therefore we used diet information measured in the first wave (1989-1993) 
of the original cohort (RS-I) and in the third wave (2011-2012) of the extended cohort (RS-II). 
Information on diet was obtained through a 170-item validated semi quantitative food frequency 
questionnaire.24 From the questionnaire an overall healthy diet score representing adherence to 
the Dutch dietary guidelines was calculated, as described previously,25 which was used as a 
continuous variable. Medication use was assessed during the home interview, and use of blood 
pressure lowering medication was used as a binary variable (yes/no). 
 A history of cardiovascular disease was defined as a history of myocardial infraction, 
coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, heart failure or 
stroke before the date of inclusion, as previously described.26 Information on cancer prevalence 
was obtained through the general practitioners and by linkage with a nationwide registry of histo- 
and cytopathology in the Netherlands (PALGA). Prevalence of chronic obstructive pulmonary 
disease (COPD) was based on an obstructive spirometry ([forced expiratory volume in 1 
second]/[forced vital capacity]ௗ<ௗ0.7, assessed by prebronchodilator) during the visit at the 
research center or on information collected continuously from medical records of general 
practitioners and lung physicians.27,28 
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measured height and weight (kg/m2) and used continuously. Presence of diabetes was determined 
using medical records and used as binary variable (present/not present). Concentration of serum 
total cholesterol and high-density lipoprotein cholesterol was determined using an automated 
enzymatic procedure (Boehringer Mannheid System, Mannheim, Germany), expressed in 
mmol/L and used as a continuous variable. Two seated blood pressure measurements were 
obtained at the right brachial artery using a random zero sphygmomanometer and the mean of 
two consecutive measurements expressed in mmHg was used in analyses as a continuous variable. 
Activities of daily living (ADL) were measured with the Stanford Health Assessment 
Questionnaire and used to indicate general health.21 In accordance with literature, we used a score 
≥ 0.5 to define participants as disabled.22,23 Dietary information was not collected at the same time 
as PA data collection. Therefore we used diet information measured in the first wave (1989-1993) 
of the original cohort (RS-I) and in the third wave (2011-2012) of the extended cohort (RS-II). 
Information on diet was obtained through a 170-item validated semi quantitative food frequency 
questionnaire.24 From the questionnaire an overall healthy diet score representing adherence to 
the Dutch dietary guidelines was calculated, as described previously,25 which was used as a 
continuous variable. Medication use was assessed during the home interview, and use of blood 
pressure lowering medication was used as a binary variable (yes/no). 
 A history of cardiovascular disease was defined as a history of myocardial infraction, 
coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, heart failure or 
stroke before the date of inclusion, as previously described.26 Information on cancer prevalence 
was obtained through the general practitioners and by linkage with a nationwide registry of histo- 
and cytopathology in the Netherlands (PALGA). Prevalence of chronic obstructive pulmonary 
disease (COPD) was based on an obstructive spirometry ([forced expiratory volume in 1 
second]/[forced vital capacity]ௗ<ௗ0.7, assessed by prebronchodilator) during the visit at the 
research center or on information collected continuously from medical records of general 
practitioners and lung physicians.27,28 
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Assessment of cause-specific mortality 
General practitioners report events of interest by means of a computerized system or notify new 
events annually. Trained research assistants subsequently collected information from medical 
records at the general practitioners' offices, hospitals and nursing homes. Two research physicians 
independently coded the events according to the International Classification of Diseases, Tenth 
Revision (ICD-10). Thereafter, a senior physician reviewed all coded events. Information on vital 
status of the participants was obtained from the clinical follow-up data collection described above 
and from municipal records. Coded information on cause-specific mortality was available until 
January 1st, 2014. 
Cause-specific mortality was recoded according to the ICD-10 codes. We categorized the 
events as deaths due to cardiovascular diseases (CVDs), cancer, external causes, dementia, 
infections, chronic lung diseases and other causes29 The ICD-10 codes associated with each of the 
7 causes of death were I05-I30.0, I31, I32, I32.8, I34-I37, I42-I79, I81-I99, G95.1, F01 for 
cardiovascular diseases (cardio- and cerebrovascular diseases); codes C00-D09.9 for cancer; codes 
J21.9, J39.9, J40, J42-J84.9, J90-J96 for chronic lung diseases (COPD comprised 56% of this 
group); codes F00, F02, F03, F05.1, G30 for dementia (81.1% Alzheimer's disease); codes S00-T98 
except T82.7, V03.1, V13, W10, W17, W19, X10, X59-X61, X67, X69, X70, X80, X83, X84 for 
external causes (64.1% fatal fractures); and codes A00-B99, G00-G09, I30.1, I32.0, I32.1, I33.0, 
J15-J18, J85–86, J41, K35-K38, K57.0, K75.0, I38-I41, I80, M00.9, M86, N71, T82.7 for infectious 
diseases (pneumonia comprised 63.6% of this group). Other causes (a heterogeneous group 
including mainly unspecified, unattended and sudden death, as well as a minority of nontumoral 
renal, gastrointestinal, hematological, and cerebral diseases, cachexia and senility) included codes 
D10-D48.9, E00-E90, D50-D89.9, G10-G26, G31, G35, G40.3, G41.9, G61, G62.9, G70, G83.9, 
G91.9, I33, K22-K34, K40-K52, K55-K57, K63.1, K64, K70, K72-K74, K80, K83, K86.1, K92, L12, 
L51.1, L71, L88 L89, M05, M06, M31, M34, M35, N03, N04, N10, N17-N19, N28, N30, N39.1, 
R54, R57.9, R64, R96, R98, R99, T99, Y83. 
Statistical analysis 
Due to non-normal distributions, total PA, walking and domestic work were categorized into 
three equal sized groups (i.e. tertiles). Since cycling, gardening and sports were not practiced by 
more than 60% of the population, the reference category for PA levels was no participation and 
the remaining two categories were divided by using the median.8 Consequently, the categories of 
total PA, walking and domestic work were coded as low, medium and high and the categories of 
cycling, gardening and sports were coded as never, medium and high.  
We investigated the associations of total PA and every PA type with all-cause mortality and 
the association of total PA with cause-specific mortality with Cox proportional hazard analysis, 
after confirming that the assumption for proportional hazards was met on the basis of Schoenfeld 
residuals. We adjusted our models for age, sex, smoking, alcohol consumption, education, diet 
quality (Dutch healthy diet index), marital status and prevalent diseases (i.e. diabetes, CVDs, 
cancer and chronic obstructive pulmonary disease (COPD)). In the analyses between PA types 
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and all-cause mortality, we additionally adjusted for the other PA types, operationalized as 
[MET∙hours∙week-1 in total PA] minus [MET∙hours∙week-1 from PA type under investigation]. 
The decision to include confounders in the multivariable regression models was based on 
previous literature or a >10%-change of the effect estimate in the crude model.4,5 PA variables 
were entered as categorical variables (lowest tertile/no participation as reference) in the separate 
models. Additionally, we analyzed total PA continuously per 50 MET∙hours∙week-1 increase. The 
underlying time-scale in all models was follow-up time, defined as the time between PA 
assessment and death, loss to follow-up or censoring at January 1, 2014.  
In sensitivity analyses, to examine the effect of body mass index (BMI) and other biological 
covariates, we repeated all our analyses in a model adjusted for BMI (model 2a) and a model 
additionally adjusted for total and high-density (HDL) lipoprotein cholesterol, glucose, systolic 
blood pressure (SBP) and anti-hypertensive medication (model 2b). We also performed sensitivity 
analyses with stratified models by age (below/above 65 years) and sex, including descriptive 
analyses comparing men and women. We investigated the possible effect of reverse causation, by 
excluding the first five and ten years of follow-up. We also excluded adults with prevalent CVDs, 
COPD, cancer or diabetes at baseline to examine the possibility that the results would be driven by 
adults in worse health. Moreover, 11,5% (n=828) was employed at baseline, but we did not collect 
information on occupational PA. Therefore, we repeated our analyses in participants not in the 
active labor force. Finally, we examined the association between PA and mortality from the 5 most 
frequently occurring cancers in the current study: lung cancer, colon cancer, pancreas cancer, 
breast cancer and prostate cancer. 
Data was missing for diet quality (27.0%), HDL cholesterol (14.3%), total cholesterol 
(13.3%), glucose (13.3%), BMI (10.7%), SBP (10.3%) and diabetes (9.5%). Other covariates had 
<5% missing data. We imputed missing data using Markov Chain Monte Carlo multiple 
imputation (n=5 imputations). All analyses were conducted using SPSS software version 20 (IBM 
SPSS Statistics for Windows, Armonk, NY: IBM Corp) and R (3.0.1).  
 
RESULTS 
Baseline characteristics of the study population are shown in Table 3.1.1 and the proportion of 
participants who engaged in the different PA types is shown in Supplement 3.1.1. During 15 years 
of follow-up (median: 13.1 years, interquartile range: 8.4-14.6 years), 3261 participants died. The 
number of participants and the number of events in each group of every PA type are presented in 
Supplement 3.1.2 A description and frequency of each cause of death in the total population are 
presented in Table 3.1.2.  
All-cause mortality 
In the categorical analysis, high compared to low total PA was associated with a 31% lower risk of 
all-cause mortality (95%CI:I 0.63, 0.75) (Figure 3.1.2). Additionally, all PA types were associated 
with a reduction in all-cause mortality (Table 3.1.3). Each 50 MET∙hours∙week-1 increment of total 
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PA, equivalent to an average 105 minutes/day of PA of 4 METs, was associated with a 19% lower 
mortality risk (95%CI: 0.78, 0.85) (Figure 3.1.2). 
 
Table 3.1.1. Baseline participant characteristics by tertile of total physical activity 
Tertiles of total PA 
 Low Medium High 
Total PA, MET∙hours∙week-1, median (range) 38.5 (<57.6) 74.3 (57.6-94.0) 123.1 (≥94.0) 
Participants, no (%) 2,401 (33.0) 2,421 (34.0) 2,403 (33.0) 
Female, no (%) 1,045 (43.5) 1,506 (62.2) 1,643 (68.4) 
Age, years 72.7 (9.8) 69.5 (7.9) 68.0 (7.2) 
Educational level, no (%) 
    Primary education 387 (16.1) 328 (13.5) 356 (14.8) 
    Lower education 901 (37.5) 1,109 (45.8) 1,118 (46.5) 
    Intermediate education 738 (30.7) 690 (28.5) 690 (28.7) 
    Higher education 375 (15.6) 294 (12.1) 239 (9.9) 
Living with partner, no (%) 1,409 (58.7) 1,525 (63) 1,590 (66.2) 
Employed, no (%) 399 (16.6) 252 (10.4) 177 (7.4) 
Smoking, no (%) 
    Never 991 (41.3) 1,150 (47.5) 1,137 (47.3) 
    Former 1,048 (43.6) 983 (40.6) 968 (40.3) 
    Current 362 (15.1) 288 (11.9) 298 (12.4) 
Dutch healthy diet index 47.0 (10.6) 48.9 (11.2) 49.3 (11.1) 
Alcohol, glasses/day 1.1 (1.5) 1.0 (1.5) 1.0 (1.3) 
BMI, kg/m2 27.3 (4.1) 27.2 (4.1) 26.8 (3.8) 
Disabled, no (%) 1,167 (48.6) 778 (32.1) 572 (23.8) 
Diabetes, no. (%) 482 (20.1) 365 (15.1) 377 (15.7) 
Prevalent cancer, no (%) 290 (12.1) 261 (10.8) 213 (8.9) 
Prevalent CVD, no (%) 561 (23.4) 308 (12.7) 252 (10.5) 
Prevalent COPD, no (%) 225 (9.4) 173 (7.1) 130 (5.4) 
Walking, MET∙hours∙week-1 12.3 (9.2) 22.9 (13.6) 46.9 (29.7) 
Cycling, MET∙hours∙week-1 2.6 (5.3) 7.7 (10.0) 15.1 (17.3) 
Domestic work, MET∙hours∙week-1 17.9 (12.4) 36.9 (16.6) 52.3 (24.9) 
Gardening, MET∙hours∙week-1 1.4 (3.6) 3.2 (7.0) 6.6 (13.3) 
Sports, MET∙hours∙week-1 2.0 (5.1) 4.2 (8.5) 9.9 (18.1) 
Systolic blood pressure, mmHg 145.6 (21.6) 144.1 (22.1) 142.0 (21.1) 
Cholesterol, mmol/L 5.7 (1.0) 5.8 (0.9) 5.9 (1.0) 
HDL-cholesterol, mmol/L 1.3 (0.4) 1.4 (0.4) 1.4 (0.4) 
Glucose, mmol/L 6.2 (1.7) 6.0 (1.6) 5.8 (1.2) 
Data are presented as mean (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); COPD, chronic 
obstructive pulmonary disease; CVD, cardiovascular disease; HDL, high-density lipoprotein; MET, metabolic equivalent of 
task; no, number; PA, physical activity. 
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Table 3.1.2. Description and frequencies of cause-specific mortality for participants in the 
rotterdam study 
    Cause Description Number (%) 
of deaths 
CVD           Cardio- and cerebrovascular pathology 981 (30.1) 
Cancer All cancer-related mortality 843 (25.9) 
Chronic lung disease   COPD, respiratory failure 124 (3.8) 
Dementia Dementia as final cause of death 339 (10.4) 
Other causes    
Unspecified, unattended and sudden death, 
nontumoral renal, gastrointestinal, hematological, and 
cerebral diseases, cachexia and senility 
662 (20.3) 
Infectious All infection-related mortality 187 (5.7) 
External causes Fractures, accidents and suicides 117 (3.6) 
Missing Cases without ICD-10 codes 8 (0.2) 
Abbreviation: COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; ICD-10, International 
Classification of Diseases, Tenth Revision  
 
Table 3.1.3. Association of physical activity types with all-cause mortality  
  Walking Cycling 
Domestic 
work Gardening Sports 
Tertile of 
activity 
HR  
(95%CI) 
HR  
(95%CI) 
HR  
(95%CI) 
HR  
(95%CI) 
HR  
(95%CI) 
Low* 1.00 [ref] 1.00 [ref] 1.00 [ref] 1.00 [ref] 1.00 [ref] 
Medium 
0.82 
(0.75, 0.89) 
0.72 
(0.66, 0.79) 
0.86 
(0.79, 0.94) 
0.75 
(0.68, 0.83) 
0.84 
(0.76, 0.93) 
High 
0.89 
(0.81, 0.97) 
0.65 
(0.58, 0.72) 
0.77 
(0.70, 0.86) 
0.86 
(0.77, 0.96) 
0.81 
(0.73, 0.91) 
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazards ratio; ref, referent 
The models were adjusted for age, sex, smoking, alcohol consumption, education, marital status, diet quality, prevalent CVD, 
prevalent cancer, prevalent diabetes, chronic obstructive pulmonary disease and the other physical activity types.  
* For cycling, gardening and sports, the low category refers to not doing that particular activity. 
Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 24, 60 and 141 
minutes per day of walking. 
Average domestic work is equivalent to 3.5 METs.18 The median levels of domestic work across categories are therefore 
equivalent to 28, 83 and 142 minutes per day of domestic work. 
Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
Average sports is equivalent to 5.5 METs. The median levels of sports across categories are therefore equivalent to 0, 8 and 30 
minutes per day of sports. 
 
 
Chapter 3.1 
134 
PA, equivalent to an average 105 minutes/day of PA of 4 METs, was associated with a 19% lower 
mortality risk (95%CI: 0.78, 0.85) (Figure 3.1.2). 
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Table 3.1.2. Description and frequencies of cause-specific mortality for participants in the 
rotterdam study 
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nontumoral renal, gastrointestinal, hematological, and 
cerebral diseases, cachexia and senility 
662 (20.3) 
Infectious All infection-related mortality 187 (5.7) 
External causes Fractures, accidents and suicides 117 (3.6) 
Missing Cases without ICD-10 codes 8 (0.2) 
Abbreviation: COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; ICD-10, International 
Classification of Diseases, Tenth Revision  
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Figure 3.1.2. Association of total physical activity with overall and cause-specific mortality among 
participants in the Rotterdam Study, 1997–2014.  
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.  
For every medium and high group, the reference is the low category.  
The models were adjusted for age, sex, smoking, alcohol consumption, education, prevalent cardiovascular disease, prevalent 
cancer, prevalent diabetes and prevalent chronic obstructive pulmonary disease.  
Total physical activity is composed of all physical activity types and thus of different METs. In this regard, the median levels of 
total PA across categories are equivalent to 1.4, 2.7 and 4.4 hours per day of moderate physical activity equivalent of 4 METs.  
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Cause-specific mortality 
Higher levels of total PA were associated with lower risk of mortality from CVDs, chronic lung 
diseases, infections and death from other causes. Each 50 MET∙hours∙week-1 more of total PA was 
associated with up to 39% lower risk of mortality from CVDs, chronic lung diseases, other causes 
and infections (Figure 3.1.2). 
 
Sensitivity analyses 
Supplement 3.1.3 and Supplement 3.1.4 show the results from all sensitivity analyses of PA types 
with all-cause mortality and total PA with cause-specific mortality, respectively. Additional 
adjustment for BMI in model 2a and for other biological risk factors in model 2b slightly 
attenuated the associations. In the descriptive analyses stratified by sex, we observed that the mean 
level of total PA was higher in women than in men, and that domestic work was on average higher 
in women (46.2 (SD: 21.3) MET∙hours∙week-1) compared to men (21.2 (SD: 17.7) 
MET∙hours∙week-1) (Supplement 3.1.5). The association between domestic work and all-cause 
mortality seems to be driven by women. After excluding the first 5 years of follow-up our results 
did not materially change. After excluding the first 10 years, the associations were attenuated. 
Noteworthy, we observed a reduction in the strength of the association between total PA and 
cause-specific mortality with longer exclusion times (Supplement 3.1.6). The association in 
participants without prevalent chronic disease were similar to the main results. Excluding 
participants in active labor force did not materially change the effect estimates. In our sensitivity 
analysis stratified by age, we observed that the associations were stronger in adults aged >65 years. 
The analyses in cancer-specific mortality did not show any associations (Supplement 3.1.7). 
 
DISCUSSION 
In this population-based study of older adults aged 55 and over, total PA was associated with a 
lower risk of mortality due to all-causes, CVDs, chronic lung diseases, infections and other causes. 
In contrast, we did not observe an association of total PA with mortality from cancer, dementia 
and external causes. All five PA types were associated with a lower risk of all-cause mortality. Our 
findings underline that engagement in any PA type may be conducive to reduce mortality risk in 
older adults. 
Existing literature on cause-specific mortality mostly focused on CVD and cancer mortality.4-
6,30,31 Our finding that higher levels of total PA are associated with lower risk of CVD mortality is 
in agreement with these studies. However, the fact that we did not observe an association with 
cancer mortality is in contrast to most previous evidence indicating a protective effect from higher 
PA levels.5,26,30,32,33 The association between PA and cancer might depend on the cancer site34,35 and 
it has been suggested that the association between PA and cancer occurs at least 10 years after the 
activity has been undertaken.6 However, in additional analyses stratifying by the 5 most occurring 
cancers in the current study and in analyses excluding the first 10 years of follow-up, we still 
Chapter 3.1 
136 
 
 
 
Figure 3.1.2. Association of total physical activity with overall and cause-specific mortality among 
participants in the Rotterdam Study, 1997–2014.  
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.  
For every medium and high group, the reference is the low category.  
The models were adjusted for age, sex, smoking, alcohol consumption, education, prevalent cardiovascular disease, prevalent 
cancer, prevalent diabetes and prevalent chronic obstructive pulmonary disease.  
Total physical activity is composed of all physical activity types and thus of different METs. In this regard, the median levels of 
total PA across categories are equivalent to 1.4, 2.7 and 4.4 hours per day of moderate physical activity equivalent of 4 METs.  
All-causes    
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
CVD 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
Cancer 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1  
 
Chronic lung disease 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
Dementia 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
Infections 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
External causes 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
Other causes 
   Medium 
   High 
 
Per 50 MET∙hours∙week-1 
 
 
0.76 (0.70, 0.83) 
0.69 (0.63, 0.75) 
 
0.81 (0.78, 0.85) 
 
 
0.78 (0.67, 0.90) 
0.69 (0.58, 0.81) 
 
0.81 (0.74, 0.88) 
 
 
0.90 (0.76, 1.06) 
0.84 (0.70, 1.00) 
 
0.93 (0.85, 1.01)  
 
 
0.53 (0.35, 0.81) 
0.44 (0.27, 0.71) 
 
0.61 (0.47, 0.79) 
 
 
0.99 (0.76, 1.29) 
0.90 (0.68, 1.19) 
 
0.94 (0.82, 1.08) 
 
 
0.53 (0.37, 1.04) 
0.47 (0.32, 0.71) 
 
0.62 (0.50, 0.77) 
 
 
0.65 (0.41, 1.04) 
0.81 (0.51, 1.29) 
 
0.78 (0.61, 1.01) 
 
 
0.68 (0.57, 0.82) 
0.56 (0.46, 0.69) 
 
0.73 (0.65, 0.81) 
 
0.35                   0.50                    0.71                    1.00                   1.40 
Hazard ratio (95%CI) 
Physical activity and cause-specific mortality 
137 
Cause-specific mortality 
Higher levels of total PA were associated with lower risk of mortality from CVDs, chronic lung 
diseases, infections and death from other causes. Each 50 MET∙hours∙week-1 more of total PA was 
associated with up to 39% lower risk of mortality from CVDs, chronic lung diseases, other causes 
and infections (Figure 3.1.2). 
 
Sensitivity analyses 
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with all-cause mortality and total PA with cause-specific mortality, respectively. Additional 
adjustment for BMI in model 2a and for other biological risk factors in model 2b slightly 
attenuated the associations. In the descriptive analyses stratified by sex, we observed that the mean 
level of total PA was higher in women than in men, and that domestic work was on average higher 
in women (46.2 (SD: 21.3) MET∙hours∙week-1) compared to men (21.2 (SD: 17.7) 
MET∙hours∙week-1) (Supplement 3.1.5). The association between domestic work and all-cause 
mortality seems to be driven by women. After excluding the first 5 years of follow-up our results 
did not materially change. After excluding the first 10 years, the associations were attenuated. 
Noteworthy, we observed a reduction in the strength of the association between total PA and 
cause-specific mortality with longer exclusion times (Supplement 3.1.6). The association in 
participants without prevalent chronic disease were similar to the main results. Excluding 
participants in active labor force did not materially change the effect estimates. In our sensitivity 
analysis stratified by age, we observed that the associations were stronger in adults aged >65 years. 
The analyses in cancer-specific mortality did not show any associations (Supplement 3.1.7). 
 
DISCUSSION 
In this population-based study of older adults aged 55 and over, total PA was associated with a 
lower risk of mortality due to all-causes, CVDs, chronic lung diseases, infections and other causes. 
In contrast, we did not observe an association of total PA with mortality from cancer, dementia 
and external causes. All five PA types were associated with a lower risk of all-cause mortality. Our 
findings underline that engagement in any PA type may be conducive to reduce mortality risk in 
older adults. 
Existing literature on cause-specific mortality mostly focused on CVD and cancer mortality.4-
6,30,31 Our finding that higher levels of total PA are associated with lower risk of CVD mortality is 
in agreement with these studies. However, the fact that we did not observe an association with 
cancer mortality is in contrast to most previous evidence indicating a protective effect from higher 
PA levels.5,26,30,32,33 The association between PA and cancer might depend on the cancer site34,35 and 
it has been suggested that the association between PA and cancer occurs at least 10 years after the 
activity has been undertaken.6 However, in additional analyses stratifying by the 5 most occurring 
cancers in the current study and in analyses excluding the first 10 years of follow-up, we still 
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observed no association between PA and cancer mortality. The small number of events in the 
cancer-specific analyses might have led to limited power to detect an association, and the results 
do suggest a positive association between PA and cancer, which is similar across cancer site. 
Future studies with larger sample sizes should further evaluate these associations.  
There is a paucity on studies regarding mortality related to external causes, dementia, 
infections and chronic lung diseases. Our finding that PA is associated with reduced mortality 
related to chronic lung diseases is in agreement with some studies on respiratory disease.12,13,36 The 
mechanism for the potential beneficial effects of regular PA are unknown, although improved 
muscle function, exercise capacity and reduced inflammation can be on the causal pathway.12 
Whereas we adjusted for prevalent COPD, our finding might still be related to reversed causality, 
as participants with undiagnosed lung disease might not be capable of engaging in high levels of 
PA to begin with. Future studies with careful adjustments should be performed to examine 
whether higher levels of PA truly decrease the risk for lung disease mortality.  
In our population, engaging in a median of 13 minutes/day of cycling (the medium category) 
was associated with a 28% lower all-cause mortality risk, which is in line with recent evidence that 
any PA is better than none.37 The mortality risk associated with cycling has been studied before, 
but conflicting results have been found. Several studies found that cycling to work,4 cycling for 
commuting30 or cycling for sports31 was associated with lower risk of mortality. In contrast, no 
association between cycling or walking for transportation and all-cause mortality6 was found 
among British adults. The way in which cycling was operationalized (commuting to work, any 
commuting, cycling for sports or all cycling) might contribute to the different findings. Moreover, 
the age of the participants and the cycling prevalence differed between studies. In studies 
including younger participants, the lower number of cases might have led to insufficient power to 
detect an association and in contrast to the United Kingdom, cycling is a common way of 
transportation in the Netherlands, where our study was performed. 
Domestic work is an important contributor of daily PA, especially in the elderly 10, and was 
associated with a lower all-cause mortality risk. The associations seemed to be driven by the 
women in our study, who engaged in domestic work more often than men. Our results are in line 
with previous studies, observing a lower all-cause mortality risk related to light household activity 
(<3 METS)5 and activities around the house, including gardening and do-it-yourself activities.6 
However, in another study, housework was not associated with all-cause mortality in 50-64 year 
old individuals.38 The differences between the studies might be related to the age group studied. 
This is supported by our analyses in adults <65 years, in whom we found weaker associations 
between domestic work and mortality. The inverse relation between domestic work and mortality 
independent of other PA types is consistent with the recommendations emphasizing the 
importance of moderate to vigorous-intensity PA performed as part of daily living.  
We acknowledge that our study has several limitations. It may be hypothesized that people in 
poor health participate in PA less than others, creating the possibility for reverse causation. After 
repeating our analyses in participants without prevalent chronic disease we observed comparable 
estimates, suggesting that underlying disease did not affect our associations. In contrast, in the 
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analyses excluding the first 5 and 10 years of follow-up, the strength of the association between 
total PA and cause-specific mortality was attenuated with longer exclusion times. This indicates 
that we cannot rule out the possibility of reverse causation affecting our results. Additionally, the 
attenuation of the association observed with increasing exclusion times might be the result of 
increasing exposure misclassification, as the time span between exposure and outcome 
classification increases. In the current study, we only measured PA at baseline, which can cause 
misclassification of PA over time, since levels of adults tend to decline with age.39 Due to the 
prospective design, this misclassification is likely to be non-differential. However, future studies 
with repeated PA measurements are needed to investigate the effect of exposure misclassification 
on the association between PA and mortality. Furthermore, we collected no information about 
occupational PA, so we could not adjust for this in our main analyses. However, excluding 
participants in active labor force (n=828, 11.5%) in our sensitivity analyses revealed comparable 
estimates. Additionally, our results are based on self-reported PA. Although our questionnaire has 
shown to be valid and reliable,16 potential recall bias and social desirability cannot be excluded. 
This limitation could have resulted in bias either towards or away from the null hypothesis. 
Finally, our questionnaire did not distinguish between walking and cycling for sports or for means 
of transportation. Since the intensity might differ between sports and transportation,18 future 
studies are needed to examine the association of the two distinct forms with mortality. 
Major strengths of the current study are its prospective population-based design, large 
sample size of adults aged over 55, relatively long follow-up period and the inclusion of seven 
different causes of death. Furthermore, we adjusted for several factors, thereby minimizing the 
possibility of the observed associations being explained by confounding. In addition, we included 
a number of different activities while adjusting for the remaining activities, which enabled us to 
examine their independent associations with all-cause mortality.  
Conclusions 
In summary, in this population of older and elderly adults, we found that PA was associated with 
a lower risk of mortality from all-causes, CVDs, chronic lung diseases, infections and other causes. 
All the five PA types under investigation contributed to the reduction in the all-cause mortality 
risk. For public health recommendations, our findings underline that engagement in any type of 
PA may successfully reduce mortality risk in older adults. Adults incapable of engaging in sports 
or exercise can engage in any activity that they enjoy and that their health allows them to, 
including cycling, walking and in- and around-the-house activities. 
 
REFERENCES 
1. Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Report, 2008. 
Washington, DC: U.S: Department of Health and Human Services;2008. 
2. Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-
response relationship. JAMA Intern Med. 2015;175(6):959-967. 
Chapter 3.1 
138 
observed no association between PA and cancer mortality. The small number of events in the 
cancer-specific analyses might have led to limited power to detect an association, and the results 
do suggest a positive association between PA and cancer, which is similar across cancer site. 
Future studies with larger sample sizes should further evaluate these associations.  
There is a paucity on studies regarding mortality related to external causes, dementia, 
infections and chronic lung diseases. Our finding that PA is associated with reduced mortality 
related to chronic lung diseases is in agreement with some studies on respiratory disease.12,13,36 The 
mechanism for the potential beneficial effects of regular PA are unknown, although improved 
muscle function, exercise capacity and reduced inflammation can be on the causal pathway.12 
Whereas we adjusted for prevalent COPD, our finding might still be related to reversed causality, 
as participants with undiagnosed lung disease might not be capable of engaging in high levels of 
PA to begin with. Future studies with careful adjustments should be performed to examine 
whether higher levels of PA truly decrease the risk for lung disease mortality.  
In our population, engaging in a median of 13 minutes/day of cycling (the medium category) 
was associated with a 28% lower all-cause mortality risk, which is in line with recent evidence that 
any PA is better than none.37 The mortality risk associated with cycling has been studied before, 
but conflicting results have been found. Several studies found that cycling to work,4 cycling for 
commuting30 or cycling for sports31 was associated with lower risk of mortality. In contrast, no 
association between cycling or walking for transportation and all-cause mortality6 was found 
among British adults. The way in which cycling was operationalized (commuting to work, any 
commuting, cycling for sports or all cycling) might contribute to the different findings. Moreover, 
the age of the participants and the cycling prevalence differed between studies. In studies 
including younger participants, the lower number of cases might have led to insufficient power to 
detect an association and in contrast to the United Kingdom, cycling is a common way of 
transportation in the Netherlands, where our study was performed. 
Domestic work is an important contributor of daily PA, especially in the elderly 10, and was 
associated with a lower all-cause mortality risk. The associations seemed to be driven by the 
women in our study, who engaged in domestic work more often than men. Our results are in line 
with previous studies, observing a lower all-cause mortality risk related to light household activity 
(<3 METS)5 and activities around the house, including gardening and do-it-yourself activities.6 
However, in another study, housework was not associated with all-cause mortality in 50-64 year 
old individuals.38 The differences between the studies might be related to the age group studied. 
This is supported by our analyses in adults <65 years, in whom we found weaker associations 
between domestic work and mortality. The inverse relation between domestic work and mortality 
independent of other PA types is consistent with the recommendations emphasizing the 
importance of moderate to vigorous-intensity PA performed as part of daily living.  
We acknowledge that our study has several limitations. It may be hypothesized that people in 
poor health participate in PA less than others, creating the possibility for reverse causation. After 
repeating our analyses in participants without prevalent chronic disease we observed comparable 
estimates, suggesting that underlying disease did not affect our associations. In contrast, in the 
Physical activity and cause-specific mortality 
139 
analyses excluding the first 5 and 10 years of follow-up, the strength of the association between 
total PA and cause-specific mortality was attenuated with longer exclusion times. This indicates 
that we cannot rule out the possibility of reverse causation affecting our results. Additionally, the 
attenuation of the association observed with increasing exclusion times might be the result of 
increasing exposure misclassification, as the time span between exposure and outcome 
classification increases. In the current study, we only measured PA at baseline, which can cause 
misclassification of PA over time, since levels of adults tend to decline with age.39 Due to the 
prospective design, this misclassification is likely to be non-differential. However, future studies 
with repeated PA measurements are needed to investigate the effect of exposure misclassification 
on the association between PA and mortality. Furthermore, we collected no information about 
occupational PA, so we could not adjust for this in our main analyses. However, excluding 
participants in active labor force (n=828, 11.5%) in our sensitivity analyses revealed comparable 
estimates. Additionally, our results are based on self-reported PA. Although our questionnaire has 
shown to be valid and reliable,16 potential recall bias and social desirability cannot be excluded. 
This limitation could have resulted in bias either towards or away from the null hypothesis. 
Finally, our questionnaire did not distinguish between walking and cycling for sports or for means 
of transportation. Since the intensity might differ between sports and transportation,18 future 
studies are needed to examine the association of the two distinct forms with mortality. 
Major strengths of the current study are its prospective population-based design, large 
sample size of adults aged over 55, relatively long follow-up period and the inclusion of seven 
different causes of death. Furthermore, we adjusted for several factors, thereby minimizing the 
possibility of the observed associations being explained by confounding. In addition, we included 
a number of different activities while adjusting for the remaining activities, which enabled us to 
examine their independent associations with all-cause mortality.  
Conclusions 
In summary, in this population of older and elderly adults, we found that PA was associated with 
a lower risk of mortality from all-causes, CVDs, chronic lung diseases, infections and other causes. 
All the five PA types under investigation contributed to the reduction in the all-cause mortality 
risk. For public health recommendations, our findings underline that engagement in any type of 
PA may successfully reduce mortality risk in older adults. Adults incapable of engaging in sports 
or exercise can engage in any activity that they enjoy and that their health allows them to, 
including cycling, walking and in- and around-the-house activities. 
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Supplement 3.1.5. Baseline participant characteristics, stratified by sex  
Men Women 
Participants, no (%) 3,031 (0.4) 4,194 (0.6) 
Age, years 69.3 (8.1) 70.7 (8.9) 
Educational level, no (%) 
    Primary education 293 (9.7) 778 (18.6) 
    Lower education 926 (30.6) 2,202 (52.5) 
    Intermediate education 1,177 (38.9) 941 (22.4) 
    Higher education 635 (20.9) 273 (6.5) 
Living with partner 2,391 (78.9) 2,133 (50.9) 
Employed, no (%) 532 (17.6) 296 (7.1) 
Smoking, no (%) 
    Never 736 (24.3) 2,542 (60.6) 
    Former 1,772 (58.5) 1,227 (29.3) 
    Current 523 (17.3) 425 (10.1) 
Dutch healthy diet index 46.1 (11.2) 50.1 (10.7) 
Alcohol, glasses/day 1.6 (1.8) 0.7 (1) 
BMI, kg/m2 26.5 (3.3) 27.4 (4.4) 
Disabled, no (%) 706 (23.3) 1,811 (43.2) 
Diabetes, no. (%) 512 (16.9) 612 (14.6) 
Prevalent cancer, no (%) 366 (12.1) 398 (9.5) 
Prevalent CVD, no (%) 665 (21.9) 456 (10.9) 
Prevalent COPD, no (%) 288 (0.095) 240 (0.057) 
Total PA, MET∙hours∙week-1 70.9 (43.1) 87.7 (43.3) 
Walking, MET∙hours∙week-1 26.9 (23.3) 27.7 (25) 
Cycling, MET∙hours∙week-1 10.6 (14.5) 7.0 (11.5) 
Domestic work, MET∙hours∙week-1 21.2 (17.7) 46.2 (21.3) 
Gardening, MET∙hours∙week-1 5.1 (11.7) 2.8 (6.6) 
Sports, MET∙hours∙week-1 7.2 (15.2) 4.0 (9.5) 
Systolic blood pressure, mmHg 144.1 (21) 143.7 (21.9) 
Cholesterol, mmol/L 5.5 (1) 6.0 (1) 
HDL-cholesterol, mmol/L 1.2 (0.3) 1.5 (0.4) 
Glucose, mmol/L 6.1 (1.7) 6.0 (1.5) 
Numbers are mean (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); COPD, chronic 
obstructive pulmonary disease; CVD, cardiovascular disease; HDL, high-density lipoprotein; MET, metabolic equivalent of 
task; no, number; PA, physical activity. 
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Supplement 3.1.5. Baseline participant characteristics, stratified by sex  
Men Women 
Participants, no (%) 3,031 (0.4) 4,194 (0.6) 
Age, years 69.3 (8.1) 70.7 (8.9) 
Educational level, no (%) 
    Primary education 293 (9.7) 778 (18.6) 
    Lower education 926 (30.6) 2,202 (52.5) 
    Intermediate education 1,177 (38.9) 941 (22.4) 
    Higher education 635 (20.9) 273 (6.5) 
Living with partner 2,391 (78.9) 2,133 (50.9) 
Employed, no (%) 532 (17.6) 296 (7.1) 
Smoking, no (%) 
    Never 736 (24.3) 2,542 (60.6) 
    Former 1,772 (58.5) 1,227 (29.3) 
    Current 523 (17.3) 425 (10.1) 
Dutch healthy diet index 46.1 (11.2) 50.1 (10.7) 
Alcohol, glasses/day 1.6 (1.8) 0.7 (1) 
BMI, kg/m2 26.5 (3.3) 27.4 (4.4) 
Disabled, no (%) 706 (23.3) 1,811 (43.2) 
Diabetes, no. (%) 512 (16.9) 612 (14.6) 
Prevalent cancer, no (%) 366 (12.1) 398 (9.5) 
Prevalent CVD, no (%) 665 (21.9) 456 (10.9) 
Prevalent COPD, no (%) 288 (0.095) 240 (0.057) 
Total PA, MET∙hours∙week-1 70.9 (43.1) 87.7 (43.3) 
Walking, MET∙hours∙week-1 26.9 (23.3) 27.7 (25) 
Cycling, MET∙hours∙week-1 10.6 (14.5) 7.0 (11.5) 
Domestic work, MET∙hours∙week-1 21.2 (17.7) 46.2 (21.3) 
Gardening, MET∙hours∙week-1 5.1 (11.7) 2.8 (6.6) 
Sports, MET∙hours∙week-1 7.2 (15.2) 4.0 (9.5) 
Systolic blood pressure, mmHg 144.1 (21) 143.7 (21.9) 
Cholesterol, mmol/L 5.5 (1) 6.0 (1) 
HDL-cholesterol, mmol/L 1.2 (0.3) 1.5 (0.4) 
Glucose, mmol/L 6.1 (1.7) 6.0 (1.5) 
Numbers are mean (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); COPD, chronic 
obstructive pulmonary disease; CVD, cardiovascular disease; HDL, high-density lipoprotein; MET, metabolic equivalent of 
task; no, number; PA, physical activity. 
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Supplement 3.1.7. Association of total physical activity and physical activity types with site-
specific cancer mortality (n=7,225) 
  Tertile of total PA HR (95%CI) 
Bronchus and lung cancer 
N= 177 cases 
Low 1.00 [ref] 
Medium 0.87 (0.60, 1.25) 
High 0.65 (0.43, 0.97) 
  
Colon cancer 
N=72 cases 
Low 1.00 [ref] 
Medium 0.62 (0.35, 1.11) 
High 0.65 (0.35, 1.20) 
  
Pancreas cancer 
N= 66 cases 
Low 1.00 [ref] 
Medium 0.82 (0.44, 1.51) 
High 0.69 (0.35, 1.36) 
  
Breast cancer 
N=61 cases† 
Low 1.00 [ref] 
Medium 0.87 (0.44, 1.73) 
High 0.75 (0.35, 1.59) 
  
Prostate cancer 
N=50 cases‡ 
Low 1.00 [ref] 
Medium 1.01 (0.50, 2.04) 
High 0.87 (0.41, 1.86) 
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; PA, physical activity; ref, referent. 
Analyses were adjusted for age, sex, smoking, alcohol consumption, education, marital status, diet quality, prevalent CVD, 
prevalent cancer, prevalent diabetes, prevalent chronic obstructive pulmonary disease and the other physical activity types. 
† The analyses for breast cancer were only run in women (n=4194) 
‡ The analyses for prostate cancer were only run in men (n=3031)
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Supplement 3.1.7. Association of total physical activity and physical activity types with site-
specific cancer mortality (n=7,225) 
  Tertile of total PA HR (95%CI) 
Bronchus and lung cancer 
N= 177 cases 
Low 1.00 [ref] 
Medium 0.87 (0.60, 1.25) 
High 0.65 (0.43, 0.97) 
  
Colon cancer 
N=72 cases 
Low 1.00 [ref] 
Medium 0.62 (0.35, 1.11) 
High 0.65 (0.35, 1.20) 
  
Pancreas cancer 
N= 66 cases 
Low 1.00 [ref] 
Medium 0.82 (0.44, 1.51) 
High 0.69 (0.35, 1.36) 
  
Breast cancer 
N=61 cases† 
Low 1.00 [ref] 
Medium 0.87 (0.44, 1.73) 
High 0.75 (0.35, 1.59) 
  
Prostate cancer 
N=50 cases‡ 
Low 1.00 [ref] 
Medium 1.01 (0.50, 2.04) 
High 0.87 (0.41, 1.86) 
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; PA, physical activity; ref, referent. 
Analyses were adjusted for age, sex, smoking, alcohol consumption, education, marital status, diet quality, prevalent CVD, 
prevalent cancer, prevalent diabetes, prevalent chronic obstructive pulmonary disease and the other physical activity types. 
† The analyses for breast cancer were only run in women (n=4194) 
‡ The analyses for prostate cancer were only run in men (n=3031)
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ABSTRACT 
 
Background: Research suggests that sedentary behavior is a risk factor for mortality. 
However, most studies rely on questionnaires, which are prone to reporting error.  
Methods: We examined the association between sedentary time assessed by actigraphy and 
mortality among 1,839 participants, aged 45-98 years, from the prospective population-based 
Rotterdam Study, enrolled between 2004 and 2007. Participants wore an actigraph around the 
wrist for seven days. Sedentary time was evaluated continuously, per one hour/day increase, 
and categorically in three groups (<8, 8–11, ≥11 hours/day). The lowest category was used as 
reference. Mortality risks were examined using Cox proportional hazard models, adjusted for 
confounders and biological risk factors. We examined the association between sedentary 
behavior and mortality over and beyond other activity measures (including physical activity 
(PA) and the disability score in a final model.  
Results: During 11 years of follow-up (median:7.5 years, interquartile range: 6.6-8.3 years), 
212 participants (11.5%) died. In the multivariable model, the hazard ratio (HR) and 95% 
confidence interval (95%CI) per 1 more hour/day sedentary time was 1.09 (1.00, 1.18). The 
HR (95%CI) after adjustment for PA and the disability score was 1.04 (0.96, 1.13). Participants 
sedentary for ≥11 hours/day had a higher mortality risk (HR:1.80, 95%CI: 1.14, 2.84) than 
those sedentary <8 hours/day, in the multivariable model. After adjusting for PA and the 
disability score, this association was clearly attenuated (HR:1.50, 95%CI: 0.93, 2.41).  
Conclusion: Our study suggests that sedentary behavior is a risk factor for mortality. Further 
investigation is needed to examine whether this association is distinct from the effect of other 
measures of activity. 
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INTRODUCTION 
Over the last decades, the benefits of physical activity (PA) have been well documented. Several 
studies have shown that people who do not engage in regular moderate physical activity are at 
increased risk of mortality.1-3 Other studies documented that sedentary behavior is a risk factor for 
mortality.4 Sedentary behavior is defined as engaging in sitting or reclining behaviors during the 
waking day, which result in little energy expenditure above rest.5,6 Recent meta-analyses have 
shown self-reported sedentary behavior to be associated with all-cause mortality, cardiovascular 
disease mortality and cancer mortality, independent of self-reported PA.4,7 However, self-reported 
data is known to be prone to reporting errors and recall bias, especially for low intensity 
behaviors.8,9 
To date, few studies examined the association between objectively measured sedentary 
behavior and mortality.10-12 Two studies in middle-aged adults, with an average follow up of 2.8 
and 2.9 years, showed that objectively measured sedentary time was associated with mortality 
independent of PA.10,12 This observation is supported by a study in men aged 71 years and older, 
followed for an average of 4.5 years.11 Due to the relatively short follow-up, there is a high chance 
for reverse causation in all of these studies. In this regard, adults could have higher levels of 
sedentary behavior because of their reduced health status (or underlying disease), and this 
reduced health could also increase their mortality risk. To minimize the effect of reverse causality, 
it is warranted to examine the association between sedentary behavior and mortality with longer 
follow-up and to evaluate the association after excluding the first years of follow-up. 
To address the long-term effects of sedentary behavior, we used data from the Rotterdam 
Study, of adults aged 45 years and older with 11 years of follow-up, and examined the association 
between sedentary behavior assessed by actigraphy and all-cause mortality.  
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study, a prospective population-based cohort in the 
Netherlands which started in 1990. The aim of the study was to examine the incidence of risk 
factors for neurological, cardiovascular, psychiatric, and other chronic diseases. Details of the 
study have been published previously.13 
From December 2004 to April 2007 2,632 consecutive participants of the Rotterdam Study 
were invited to participate in the actigraphy study. The current study was conducted in the 2,063 
participants that agreed to participate (78%). There were no exclusion criteria besides being able 
to understand the instructions for this study. In accordance with previous studies, 133 days with 
three or more continuous hours missing were excluded to prevent a time-of-day effect.14 
Subsequently, we excluded 168 recordings that failed because of technical problems or that 
contained fewer than 4 days (see Supplement 3.2.1). Additionally, data of 54 participants (2.8%) 
with unusually low (<20% per day) or high (>90% per day) sedentary time was considered 
unreliable after visual inspection and therefore these participants were excluded. Following, 2 
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participants were excluded that withdrew consent for the collection of follow-up data. Finally, 
1,839 subjects were included in the analyses.  
All subjects gave written informed consent, and the study protocol was approved by the 
medical ethics committee according to the Wet Bevolkingsonderzoek ERGO (Population Study 
Act Rotterdam Study), executed by the Ministry of Health, Welfare and Sport of The Netherlands.  
 
Measurement of sedentary time 
All participants were asked to wear an actigraph around the nondominant wrist (Actiwatch model 
AW4; Cambridge Technology, Cambridge, UK) for seven consecutive days and nights and to 
complete a 7-day sleep diary to report overnight sleep periods. The device had to be removed 
from the wrist for water-based activities only. Recordings were obtained in 30-second intervals 
during 24-hour periods.15 
The actigraph devices were initially designed to measure sleep in free-living settings. Since 
this was also the main interest of the original actigraphy study, the devices were not calibrated to 
measure the level of PA and thus do not allow comparison across individuals for PA. However, 
the actigraphy data can be used to estimate sedentary behavior, i.e., to validly measure active 
versus non-active periods in a person and test across person differences.16 In this regard, activity 
refers to all PA that is not sedentary behavior and can include light, moderate and vigorous 
intensity activity. To quantify sedentary time, only the waking hours were used. Waking hours 
were defined based on bed time and get up time. These times were derived from the event marker 
buttons on the device, and if these data were not present for a certain night, we derived them from 
the sleep diary, to determine sleep start and sleep end.15 In the current study, 10,852 valid days 
were recorded. Of these, bed time and get up time were based on the event marker for 11,725 days 
(88.1%) and on the diary for 1,686 days (11.6%). For 57 days (0.2%), we estimated bed time and 
get up time based on previous days and actigraphy pattern. The number of minutes per day spent 
in sedentary behavior was determined using the standard count-based intensity threshold value of 
<199 counts per minute (cpm).17 
 
Clinical outcome 
Information on vital status was collected through an automated follow-up system with a digital 
linkage of the study database to all medical records maintained by general practitioners. 
Additional information on vital status was obtained from the registry of the municipality of 
Rotterdam. Follow-up was complete until March 4, 2015. 
 
Covariates 
Information on covariates was collected through home interviews or measured at the study 
center, as described previously.18,19 Briefly, alcohol use was defined as the amount of glasses per 
day. Education was assessed in line with the international standard classification of education.20 
Smoking was divided in three categories: current, former and never. Employment status was used 
as a binary variable (employed/unemployed). Disability was assessed by activities of daily living, 
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from the Stanford Health Assessment Questionnaire, used to indicate general health and 
expressed as the disability score.21 The questionnaire included questions on being able to walk 
outdoors, being able to climb stairs and being able to dress oneself. Height and weight were 
measured to calculate body mass index (BMI). Serum total cholesterol and high-density 
lipoprotein (HDL) cholesterol were determined using an automated enzymatic procedure (Cobas, 
Roche Hitachi 917). Two seated blood pressure measurements were obtained at the right brachial 
artery using a random zero sphygmomanometer, the mean of two consecutive measurements was 
used in analyses. The presence of coronary heart disease, diabetes, stroke and cancer were 
determined using medical records, to define the number of comorbidities. 
For part of the study (n=868), PA was assessed at baseline with the validated LASA Physical 
Activity Questionnaire (LAPAQ).22 In the remainder (n = 971) the LAPAQ was assessed at follow-
up. The LAPAQ included questions on housekeeping activities, walking, cycling, sports and 
gardening. Time spent in these activities was combined and expressed in MET·hours·week-1. 
Furthermore, previous research in this cohort revealed that low stability and high fragmentation 
of the 24-hour activity rhythm, as measured by the actigraph data are associated with higher risk 
of all-cause mortality.23 To evaluate whether the association between sedentary behavior and 
mortality was independent of the 24-hour activity rhythm, we included the following variables in 
our analyses: interday stability (IS) and intraday variability (IV). Both variables are measures of 
the 24-hour activity rhythm. Specifically, IS is a measure of how similar the individual 24-hour 
activity patterns are over time and IV is a variable quantifying the fragmentation of the 24-hour 
activity profile into brief periods of rest and activity.24 
 
Statistical analysis 
Sedentary time was analyzed continuously per one hour increase (per day) and categorically. For 
categories, we created three cut-offs based on the existing literature 1) < 8 hours/day; 2) 8 - 11 
hours/day; 3) ≥ 11 hours/day 25-27. In some studies, <4 hours/day was the reference category.25-27 
Since only 6 participants were sedentary for less than 4 hours per day in our study, we chose not 
to include them in a separate category. Characteristics of participants were compared according to 
the three categories of sedentary behavior. 
To examine the independent associations between sedentary time and all-cause mortality, 
we used Cox proportional hazard models. The assumption for proportional hazards was tested 
using Schoenfeld residuals and found to be met for all models. To visualize the survival 
distribution of the three categories of sedentary behavior, we built Kaplan Meier plots, up to the 
follow-up time that corresponds to 90-95% of the participants at risk. Furthermore, we applied 
natural cubic splines to test for non-linearity of the survival models,28 but we found no evidence 
for a non-linear association between sedentary behavior and mortality risk. 
Covariates were included in the model based on previous research.4 We created four 
different models. Model 1 was the crude model, adjusted for age, sex, cohort and time awake. In 
model 2, we additionally adjusted for smoking, number of comorbidities, alcohol intake and 
education. To evaluate the independent association between sedentary behavior and mortality, 
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beyond intermediates and proxies of sedentary behavior, we built model 3 and 4. In model 3, we 
additionally adjusted for biological risk factors, including BMI, total and HDL cholesterol and 
systolic blood pressure. Disability, PA, IS and IV were considered as proxies of sedentary 
behavior, and not as pure confounders.29 Therefore, we additionally adjusted for the disability 
score, PA, IS and IV in model 4, to evaluate the specificity of the association between sedentary 
behavior and all-cause mortality. 
Statistical interactions of sedentary time with both gender and age on the risk of mortality 
were tested. None of these interactions reached statistical significance (all p>.05). Therefore 
results are primarily shown for men and women of all ages combined. Given prior work,25,30,31 we 
also present analyses using stratified models by sex. In sensitivity analyses, we investigated the 
possible effect of reverse causation, by excluding deaths in the first two years. Moreover, we 
repeated our analyses in non-workers, since 33.8% (n=622) was employed at baseline and we did 
not collect information on occupational PA. Finally, in literature, sedentary behavior has also 
been defined as the number of minutes per day spent <100 cpm.32 Therefore, we repeated our 
analyses using this cut-off.  
Some data was missing for PA (25.6%), the disability score (11.6%), IV (7.9%) and IS (7.9%). 
Other covariates had <2% missing data only. We used multiple imputation (n=5 imputations) by 
the Expectation Maximization method to account for uncertainty of missing data. All analyses 
were conducted using SPSS software version 20 (IBM SPSS Statistics for Windows, Armonk, NY: 
IBM Corp) and R (3.0.1).  
 
RESULTS 
From the 1,839 participants in the study, 10852 valid days were recorded, for an average of 5.8 
(SD: 0.5) days per participant. Baseline characteristics of the study population according to 
categories of sedentary behavior are shown in Table 3.2.1. Participants sedentary for ≥11 hours 
were older, more often male and more often had prevalent diabetes or coronary heart disease, 
compared to participants sedentary <8 hours per day. The average time spent in sedentary 
behavior was 8.8 hours (SD: 2.0) per day, which corresponds to 55.7% of the time awake. During 
11 years of follow-up (median: 7.5 years, interquartile range (IQR): 6.6-8.3 years), 212 participants 
(11.5%) died.  
The Kaplan-Meier survival curves, by categories of sedentary behavior, are presented in 
Figure 3.2.1. Additional adjustment for biological risk factors in model 3 did not materially affect 
the associations (see Table 3.2.2). Thus, we focus our discussion on the results presented in model 
3.  
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Table 3.2.1. Baseline participant characteristics by categories of sedentary time, The Rotterdam 
Study, 2004-2015 
 Categories of sedentary behavior, hours/day 
Between group 
differences (p value)a 
< 8 hours 8-11 hours ≥ 11 hours  
Participants, n (%) 637 (34.6) 956 (52.0) 246 (13.4)  
Age  60.1 (8.0) 63.7 (9.5) 65.2 (10.6) <0.001 
Female, n (%) 419 (65.8) 478 (50.0) 104 (42.3) <0.001 
Educational level, n (%) 0.06 
     Primary education 56 (8.8) 71 (7.4) 27 (11.0)  
     Lower education 282 (44.3) 387 (40.5) 84 (34.1)  
     Intermediate education 183 (28.7) 289 (30.2) 82 (33.3)  
     Higher education 116 (18.2) 209 (21.9) 53 (21.5)  
Employed, n (%) 261 (41.0) 293 (30.6) 68 (27.6) <0.001 
Sedentary time (hours/day) 6.7 (1.0) 9.3 (0.8) 12.2 (1.0) <0.001 
Not sedentary time (hours/day) 8.9 (1.3) 6.5 (1.1) 3.9 (1.3) <0.001 
Intraday variability 0.4 (0.1) 0.4 (0.1) 0.5 (0.2) <0.001 
Interday stability 0.8 (0.1) 0.8 (0.1) 0.8 (0.1) <0.001 
Smoking, n (%)  
    Never 225 (35.3) 294 (30.8) 61 (24.8)  
    Former 325 (51.0) 487 (50.9) 127 (51.6)  
    Current 87 (13.7) 175 (18.3) 58 (23.6)  
BMI (kg/m2) 27.3 (4.0) 27.9 (4.1) 29.0 (4.7) <0.001 
Disability score 0.2 (0.3) 0.3 (0.4) 0.4 (0.5) <0.001 
Dutch healthy diet score 57.1 (9.4) 56.2 (9.7) 56.1 (9.7) 0.01 
Alcohol (glasses/day) 0.9 (1.1) 1.1 (1.3) 1.1 (1.4) 0.08 
Physical activity 
(METhours/week) 
79.7 (54.4) 71.6 (46.7) 66.6 (43.8) 
<0.001 
Prevalent diabetes, n (%) 65 (10.2) 141 (14.7) 52 (21.1) <0.001 
Cholesterol (mg/dl) 219.7 (39.6) 216.5 (40.3) 210.0 (40.7) 0.002 
HDL-cholesterol (mg/dl 58.5 (16.9) 54.4 (15.8) 52.0 (16.2) <0.001 
Glucose (mg/dl) 99.3 (20.4) 102.4 (25.6) 107.4 (28.2) <0.001 
Systolic blood pressure (mm 
HG) 
136.6 (20.2) 139.5 (19.7) 142.7 (23.3) 
<0.001 
Prevalent CHD, n (%) 25 (3.9) 50 (5.2) 27 (11.0) <0.001 
Prevalent stroke, n (%) 10 (1.6) 31 (3.2) 6 (2.4) 0.12 
Prevalent cancer, n (%) 74 (11.6) 105 (11.0) 35 (14.2) 0.37 
Deaths, n (%) 39 (6.1) 120 (12.6) 53 (21.5) <0.001 
Data are presented as mean (SD), unless otherwise noted. 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CHD, coronary 
heartdisease; HDL, high-density lipoprotein; M, mean; N, number; SD, standard deviation. 
a Differences in characteristics across categories were compared using analysis of variance for normally distributed continuous 
variables, Kruskal–Wallis tests for skewed continuous variables, and chi-square tests for categorical variables. 
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beyond intermediates and proxies of sedentary behavior, we built model 3 and 4. In model 3, we 
additionally adjusted for biological risk factors, including BMI, total and HDL cholesterol and 
systolic blood pressure. Disability, PA, IS and IV were considered as proxies of sedentary 
behavior, and not as pure confounders.29 Therefore, we additionally adjusted for the disability 
score, PA, IS and IV in model 4, to evaluate the specificity of the association between sedentary 
behavior and all-cause mortality. 
Statistical interactions of sedentary time with both gender and age on the risk of mortality 
were tested. None of these interactions reached statistical significance (all p>.05). Therefore 
results are primarily shown for men and women of all ages combined. Given prior work,25,30,31 we 
also present analyses using stratified models by sex. In sensitivity analyses, we investigated the 
possible effect of reverse causation, by excluding deaths in the first two years. Moreover, we 
repeated our analyses in non-workers, since 33.8% (n=622) was employed at baseline and we did 
not collect information on occupational PA. Finally, in literature, sedentary behavior has also 
been defined as the number of minutes per day spent <100 cpm.32 Therefore, we repeated our 
analyses using this cut-off.  
Some data was missing for PA (25.6%), the disability score (11.6%), IV (7.9%) and IS (7.9%). 
Other covariates had <2% missing data only. We used multiple imputation (n=5 imputations) by 
the Expectation Maximization method to account for uncertainty of missing data. All analyses 
were conducted using SPSS software version 20 (IBM SPSS Statistics for Windows, Armonk, NY: 
IBM Corp) and R (3.0.1).  
 
RESULTS 
From the 1,839 participants in the study, 10852 valid days were recorded, for an average of 5.8 
(SD: 0.5) days per participant. Baseline characteristics of the study population according to 
categories of sedentary behavior are shown in Table 3.2.1. Participants sedentary for ≥11 hours 
were older, more often male and more often had prevalent diabetes or coronary heart disease, 
compared to participants sedentary <8 hours per day. The average time spent in sedentary 
behavior was 8.8 hours (SD: 2.0) per day, which corresponds to 55.7% of the time awake. During 
11 years of follow-up (median: 7.5 years, interquartile range (IQR): 6.6-8.3 years), 212 participants 
(11.5%) died.  
The Kaplan-Meier survival curves, by categories of sedentary behavior, are presented in 
Figure 3.2.1. Additional adjustment for biological risk factors in model 3 did not materially affect 
the associations (see Table 3.2.2). Thus, we focus our discussion on the results presented in model 
3.  
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Table 3.2.1. Baseline participant characteristics by categories of sedentary time, The Rotterdam 
Study, 2004-2015 
 Categories of sedentary behavior, hours/day 
Between group 
differences (p value)a 
< 8 hours 8-11 hours ≥ 11 hours  
Participants, n (%) 637 (34.6) 956 (52.0) 246 (13.4)  
Age  60.1 (8.0) 63.7 (9.5) 65.2 (10.6) <0.001 
Female, n (%) 419 (65.8) 478 (50.0) 104 (42.3) <0.001 
Educational level, n (%) 0.06 
     Primary education 56 (8.8) 71 (7.4) 27 (11.0)  
     Lower education 282 (44.3) 387 (40.5) 84 (34.1)  
     Intermediate education 183 (28.7) 289 (30.2) 82 (33.3)  
     Higher education 116 (18.2) 209 (21.9) 53 (21.5)  
Employed, n (%) 261 (41.0) 293 (30.6) 68 (27.6) <0.001 
Sedentary time (hours/day) 6.7 (1.0) 9.3 (0.8) 12.2 (1.0) <0.001 
Not sedentary time (hours/day) 8.9 (1.3) 6.5 (1.1) 3.9 (1.3) <0.001 
Intraday variability 0.4 (0.1) 0.4 (0.1) 0.5 (0.2) <0.001 
Interday stability 0.8 (0.1) 0.8 (0.1) 0.8 (0.1) <0.001 
Smoking, n (%)  
    Never 225 (35.3) 294 (30.8) 61 (24.8)  
    Former 325 (51.0) 487 (50.9) 127 (51.6)  
    Current 87 (13.7) 175 (18.3) 58 (23.6)  
BMI (kg/m2) 27.3 (4.0) 27.9 (4.1) 29.0 (4.7) <0.001 
Disability score 0.2 (0.3) 0.3 (0.4) 0.4 (0.5) <0.001 
Dutch healthy diet score 57.1 (9.4) 56.2 (9.7) 56.1 (9.7) 0.01 
Alcohol (glasses/day) 0.9 (1.1) 1.1 (1.3) 1.1 (1.4) 0.08 
Physical activity 
(METhours/week) 
79.7 (54.4) 71.6 (46.7) 66.6 (43.8) 
<0.001 
Prevalent diabetes, n (%) 65 (10.2) 141 (14.7) 52 (21.1) <0.001 
Cholesterol (mg/dl) 219.7 (39.6) 216.5 (40.3) 210.0 (40.7) 0.002 
HDL-cholesterol (mg/dl 58.5 (16.9) 54.4 (15.8) 52.0 (16.2) <0.001 
Glucose (mg/dl) 99.3 (20.4) 102.4 (25.6) 107.4 (28.2) <0.001 
Systolic blood pressure (mm 
HG) 
136.6 (20.2) 139.5 (19.7) 142.7 (23.3) 
<0.001 
Prevalent CHD, n (%) 25 (3.9) 50 (5.2) 27 (11.0) <0.001 
Prevalent stroke, n (%) 10 (1.6) 31 (3.2) 6 (2.4) 0.12 
Prevalent cancer, n (%) 74 (11.6) 105 (11.0) 35 (14.2) 0.37 
Deaths, n (%) 39 (6.1) 120 (12.6) 53 (21.5) <0.001 
Data are presented as mean (SD), unless otherwise noted. 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CHD, coronary 
heartdisease; HDL, high-density lipoprotein; M, mean; N, number; SD, standard deviation. 
a Differences in characteristics across categories were compared using analysis of variance for normally distributed continuous 
variables, Kruskal–Wallis tests for skewed continuous variables, and chi-square tests for categorical variables. 
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Results from analyses with continuous sedentary time 
In the analysis with continuous sedentary time, every one hour more sedentary time was 
associated with a higher mortality risk. The hazard ratio (HR) and 95% confidence interval 
(95%CI) per 1 hour more sedentary time was 1.09 (1.00, 1.18). About half of the observed effect 
could also be explained by other indicators of activity, that is, PA, the 24-hour activity rhythm (i.e. 
IS, IV) and the disability score (Table 3.2.2). In particular the disability score and the 24-hour 
activity rhythm explained half of the observed effect (data not shown). 
 
Results from analyses with categorical sedentary time 
Next, we analyzed sedentary time categorically and found that participants sedentary for 8-11 
hours/day (median: 9.2 hours, IQR: 8.6-10.0) were not at significantly higher risk of mortality, 
compared to those sedentary <8 hours/day (median: 6.9 hours/day, IQR: 6.2-7.5). The 
corresponding HR was 1.24 (0.85, 1.81). However, participants sedentary ≥11 hours/day (median: 
12.0 hours/day, IQR: 11.4-12.9) had a 1.80 higher mortality risk (95%CI: 1.14, 2.84). Again, part of 
the observed effect could be explained with other measures of activity, (see Table 3.2.2, model 4). 
In Table 3.2.3 we show the associations between sedentary behavior and mortality, stratified 
by gender (interaction p-value: 0.77 for model 3 in continuous analysis). Men sedentary for ≥11 
hours/day had a higher mortality risk than those sedentary <8 hours/day. The HR (95%CI) was 
2.31 (1.19, 4.45), P for trend 0.006, for men and 1.32 (0.66, 2.66), P for trend 0.40, for women. 
After additional adjustments for indicators of activity, the association in men was attenuated (HR: 
1.98, 95%CI: 0.99 ,3.96).  
 
Table 3.2.2. Association between sedentary time and mortality, The Rotterdam Study, 2004-2015 
  
Continuous 
analysis Categorical analysis 
  
Per 1 hour 
more 
Low 
sedentary 
Medium 
sedentary 
High 
 sedentary 
P for 
trend 
Hours/day 
sedentary, median 
(range) 
  6.9 (<8.0) 9.2 (8.0-11.0) 12.0 (≥11.0)   
No. Participants   637 956 246   
No. deaths   39 120 53   
Confounder adjusted models 
Model 1  1.13 (1.05, 1.23) 1.00 [ref] 1.33 (0.92, 1.94) 2.22 (1.43, 3.45) <0.001 
Model 2  1.08 (1.00, 1.17) 1.00 [ref] 1.23 (0.84, 1.80) 1.74 (1.11, 2.74) 0.01 
Model 3 1.09 (1.00, 1.18) 1.00 [ref] 1.24 (0.85, 1.81) 1.80 (1.14, 2.84) 0.01 
Additional adjustment for activity scores 
Model 4 1.04 (0.96, 1.13) 1.00 [ref] 1.21 (0.81, 1.81) 1.50 (0.93, 2.41) 0.09 
Abbreviations: no, number; ref, reference. 
Model 1 is adjusted for age, sex, cohort and time awake.  
Model 2 is additionally adjusted for smoking, number of comorbidities, alcohol intake and education 
Model 3 is additionally adjusted for body mass index, cholesterol, high-density lipoprotein cholesterol and systolic blood 
pressure.  
Model 4 is model 2 and additionally adjusted for physical activity, the 24h activity rhythm (i.e. interday stability, intraday 
variability) and the disability score. 
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In sensitivity analyses excluding events in the first two years, our findings did not materially 
change, although the associations remained significant in model 1 only (Supplement 3.2.2). 
Additionally, when we repeated our analyses in non-workers, we found similar results 
(Supplement 3.2.3). When we repeated the analyses using 100 counts per minute as cut-off for 
sedentary behavior, the mean time spent in sedentary behavior was 6.8 hour (SD: 2.0), 
corresponding to 43.0% of the time awake. The distribution of participants across the sedentary 
behavior categories changed (see Supplement 3.2.4). In these analyses, we found larger HRs in the 
high category of sedentary behavior, compared to our main analyses (HR: 2.53; 95%CI: 1.31, 4.88 
in model 3). However, the HRs in the continuous analyses were very similar to the original 
analyses (HR: 1.07; 95%CI: 0.99, 1.15 in model 3). 
 
 
 
 
Figure 3.2.1. Kaplan-Meier curve of mortality as a function of follow-up time according to the 
three categories of sedentary behavior 
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Results from analyses with continuous sedentary time 
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hours/day (median: 9.2 hours, IQR: 8.6-10.0) were not at significantly higher risk of mortality, 
compared to those sedentary <8 hours/day (median: 6.9 hours/day, IQR: 6.2-7.5). The 
corresponding HR was 1.24 (0.85, 1.81). However, participants sedentary ≥11 hours/day (median: 
12.0 hours/day, IQR: 11.4-12.9) had a 1.80 higher mortality risk (95%CI: 1.14, 2.84). Again, part of 
the observed effect could be explained with other measures of activity, (see Table 3.2.2, model 4). 
In Table 3.2.3 we show the associations between sedentary behavior and mortality, stratified 
by gender (interaction p-value: 0.77 for model 3 in continuous analysis). Men sedentary for ≥11 
hours/day had a higher mortality risk than those sedentary <8 hours/day. The HR (95%CI) was 
2.31 (1.19, 4.45), P for trend 0.006, for men and 1.32 (0.66, 2.66), P for trend 0.40, for women. 
After additional adjustments for indicators of activity, the association in men was attenuated (HR: 
1.98, 95%CI: 0.99 ,3.96).  
 
Table 3.2.2. Association between sedentary time and mortality, The Rotterdam Study, 2004-2015 
  
Continuous 
analysis Categorical analysis 
  
Per 1 hour 
more 
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sedentary 
Medium 
sedentary 
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 sedentary 
P for 
trend 
Hours/day 
sedentary, median 
(range) 
  6.9 (<8.0) 9.2 (8.0-11.0) 12.0 (≥11.0)   
No. Participants   637 956 246   
No. deaths   39 120 53   
Confounder adjusted models 
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Abbreviations: no, number; ref, reference. 
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Model 3 is additionally adjusted for body mass index, cholesterol, high-density lipoprotein cholesterol and systolic blood 
pressure.  
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Table 3.2.3. Association between sedentary time and mortality, stratified by gender, The 
Rotterdam Study, 2004-2015 
  
Continuous 
analysis Categorical analysis 
  
Per 1 hour 
more 
Low 
sedentary 
Medium 
sedentary 
High P for 
trend  sedentary 
Men           
Hours/day sedentary, median 
(range) 
7.0 (<8.0) 9.3 (8.0-11.0) 12.0 (≥11.0)   
No. Participants 218 478 142   
No. deaths   15 66 35   
Confounder adjusted models 
Model 1  1.15 (1.03, 1.29) 1.00 [ref] 1.38 (0.78, 2.46) 2.89 (1.53, 5.46) <0.001 
Model 2  1.09 (0.98, 1.22) 1.00 [ref] 1.21 (0.68, 2.16) 2.20 (1.15, 4.19) 0.007 
Model 3 1.10 (0.98, 1.23) 1.00 [ref] 1.26 (0.70, 2.26) 2.31 (1.19, 4.45) 0.006 
Additional adjustment for activity scores 
Model 4 1.06 (0.94, 1.20) 1.00 [ref] 1.19 (0.64, 2.21) 1.98 (0.99, 3.96) 0.03 
            
Women           
Hours/day sedentary, median 
(range) 6.9 (<8.0) 9.1 (8.0-11.0) 12.1 (≥11.0)   
No. Participants 419 478 104   
No. deaths   24 54 18   
Confounder adjusted models 
Model 1  1.12 (1.00, 1.25) 1.00 [ref] 1.34 (0.81, 2.22) 1.59 (0.83, 3.05) 0.15 
Model 2  1.08 (0.96, 1.21) 1.00 [ref] 1.25 (0.75, 2.09) 1.27 (0.64, 2.52) 0.44 
Model 3 1.08 (0.97, 1.21) 1.00 [ref] 1.23 (0.74, 2.06) 1.32 (0.66, 2.66) 0.34 
Additional adjustment for activity scores 
Model 4 1.04 (0.92, 1.17) 1.00 [ref] 1.25 (0.74, 2.11) 1.03 (0.49, 2.16) 0.82 
Abbreviations: no, number; ref, reference. 
Model 1 is adjusted for age, cohort and time awake.  
Model 2 is additionally adjusted for smoking, number of comorbidities, alcohol intake and education. 
Model 3 is additionally adjusted for body mass index, cholesterol, high-density lipoprotein cholesterol and systolic blood 
pressure.  
Model 4 is model 2 and additionally adjusted for physical activity, the 24h activity rhythm (i.e. interday stability, intraday 
variability) and the disability score. 
 
DISCUSSION 
In this population-based cohort study, we found that time spent in sedentary behavior, assessed 
by actigraphy, was associated with a higher mortality risk in middle-aged and elderly adults. 
Participants sedentary for more than 11 hours a day had a significantly higher mortality risk than 
participants sedentary for less than 8 hours per day. These associations remained after 
adjustments for health behaviors and risk factors and after excluding the first two years of follow-
up. However, after adjusting for other measures of activity, the association between sedentary 
behavior and mortality was clearly attenuated.  
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We found a 1.80 fold increased mortality risk for participants sedentary ≥11 hours per day 
compared to those sedentary <8 hours per day. This corresponds to a 9% higher mortality risk per 
every one hour more sedentary time in continuous analyses. A few other studies tested the 
association between objectively measured sedentary behavior and mortality.10-12 Schmid et al. 
found in a study of 1,677 adults aged 50 years and older, that participants sedentary ≥8.6 hours 
per day had a two times higher risk of mortality than those sedentary less than 8.6 hours per day.12 
In the study of Ensrud et al., in 2918 men aged 71 years and older, sedentary time of more than 15 
hours per day was associated with 80% higher mortality risk than being sedentary for less than 
12.9 hours per day.11  
In addition, in a study of 1,906 adults aged 50 years and over, Koster et al. found that adults 
who were sedentary for more than 10 hours per day, had a 3 times higher relative risk of mortality 
than those sedentary for 7.6 hours a day.10 These studies used different ways to categorize 
sedentary time, included participants from different age ranges and adjustment for potential 
confounding factors was limited. However, our results are in line with these studies, indicating 
that sedentary behavior is a risk factor for mortality, independent of the study population. An 
important limitation of the mentioned studies is that the average follow-up time was less than 5 
years. In studies with a relatively short follow-up time, the risk for reversed causation is high. 
There is a greater probability that sedentary time and mortality risk are both influenced by 
underlying diseases. Our study has a longer follow-up time of 11 years and is therefore less prone 
of reverse causation.  
To evaluate whether the association between sedentary behavior and mortality could be 
explained by other measures of activity, we adjusted our analyses for PA and disability as 
measured by questionnaire and indicators of the 24-hour activity rhythm as measured by 
actigraphy in our final model. Low PA levels can be the cause of sedentary behavior and may 
conceptually overlap with sedentary behavior. Our results indicate that the association between 
sedentary behavior and mortality risk was not independent of PA, which is in contrast to studies 
with shorter follow-up time.10,12,25 In contrast to these studies, a study in 5132 adults from the 
Whitehall II cohort, with over 16 years of follow-up, found no association between self-reported 
sitting time and mortality, after adjustment for PA.33 Moreover, a recent meta-analysis concluded 
that being active at moderate intensity for 60-75 minutes/day can attenuate the risk of death 
associated with sedentary behavior.34 One possible explanation for the inconsistent findings 
between studies might be related to the follow-up, with stronger associations found with shorter 
follow-up periods. Furthermore, in our analyses, in addition to adjusting for PA, we additionally 
adjusted for disability, as indicator for health. Importantly, the disability score attenuated the 
observed association more than PA. The disability score is computed by combining scores from 
the activities of daily living questionnaire. Activities of daily living reflect physical capabilities, by 
providing information on being able to walk outdoors, being able to climb stairs and being able to 
dress oneself.21 Participants with difficulties in any of the domains of activities of daily living, will 
not engage in those activities and as a consequence, are more likely to be inactive or sedentary. 
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Table 3.2.3. Association between sedentary time and mortality, stratified by gender, The 
Rotterdam Study, 2004-2015 
  
Continuous 
analysis Categorical analysis 
  
Per 1 hour 
more 
Low 
sedentary 
Medium 
sedentary 
High P for 
trend  sedentary 
Men           
Hours/day sedentary, median 
(range) 
7.0 (<8.0) 9.3 (8.0-11.0) 12.0 (≥11.0)   
No. Participants 218 478 142   
No. deaths   15 66 35   
Confounder adjusted models 
Model 1  1.15 (1.03, 1.29) 1.00 [ref] 1.38 (0.78, 2.46) 2.89 (1.53, 5.46) <0.001 
Model 2  1.09 (0.98, 1.22) 1.00 [ref] 1.21 (0.68, 2.16) 2.20 (1.15, 4.19) 0.007 
Model 3 1.10 (0.98, 1.23) 1.00 [ref] 1.26 (0.70, 2.26) 2.31 (1.19, 4.45) 0.006 
Additional adjustment for activity scores 
Model 4 1.06 (0.94, 1.20) 1.00 [ref] 1.19 (0.64, 2.21) 1.98 (0.99, 3.96) 0.03 
            
Women           
Hours/day sedentary, median 
(range) 6.9 (<8.0) 9.1 (8.0-11.0) 12.1 (≥11.0)   
No. Participants 419 478 104   
No. deaths   24 54 18   
Confounder adjusted models 
Model 1  1.12 (1.00, 1.25) 1.00 [ref] 1.34 (0.81, 2.22) 1.59 (0.83, 3.05) 0.15 
Model 2  1.08 (0.96, 1.21) 1.00 [ref] 1.25 (0.75, 2.09) 1.27 (0.64, 2.52) 0.44 
Model 3 1.08 (0.97, 1.21) 1.00 [ref] 1.23 (0.74, 2.06) 1.32 (0.66, 2.66) 0.34 
Additional adjustment for activity scores 
Model 4 1.04 (0.92, 1.17) 1.00 [ref] 1.25 (0.74, 2.11) 1.03 (0.49, 2.16) 0.82 
Abbreviations: no, number; ref, reference. 
Model 1 is adjusted for age, cohort and time awake.  
Model 2 is additionally adjusted for smoking, number of comorbidities, alcohol intake and education. 
Model 3 is additionally adjusted for body mass index, cholesterol, high-density lipoprotein cholesterol and systolic blood 
pressure.  
Model 4 is model 2 and additionally adjusted for physical activity, the 24h activity rhythm (i.e. interday stability, intraday 
variability) and the disability score. 
 
DISCUSSION 
In this population-based cohort study, we found that time spent in sedentary behavior, assessed 
by actigraphy, was associated with a higher mortality risk in middle-aged and elderly adults. 
Participants sedentary for more than 11 hours a day had a significantly higher mortality risk than 
participants sedentary for less than 8 hours per day. These associations remained after 
adjustments for health behaviors and risk factors and after excluding the first two years of follow-
up. However, after adjusting for other measures of activity, the association between sedentary 
behavior and mortality was clearly attenuated.  
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association between objectively measured sedentary behavior and mortality.10-12 Schmid et al. 
found in a study of 1,677 adults aged 50 years and older, that participants sedentary ≥8.6 hours 
per day had a two times higher risk of mortality than those sedentary less than 8.6 hours per day.12 
In the study of Ensrud et al., in 2918 men aged 71 years and older, sedentary time of more than 15 
hours per day was associated with 80% higher mortality risk than being sedentary for less than 
12.9 hours per day.11  
In addition, in a study of 1,906 adults aged 50 years and over, Koster et al. found that adults 
who were sedentary for more than 10 hours per day, had a 3 times higher relative risk of mortality 
than those sedentary for 7.6 hours a day.10 These studies used different ways to categorize 
sedentary time, included participants from different age ranges and adjustment for potential 
confounding factors was limited. However, our results are in line with these studies, indicating 
that sedentary behavior is a risk factor for mortality, independent of the study population. An 
important limitation of the mentioned studies is that the average follow-up time was less than 5 
years. In studies with a relatively short follow-up time, the risk for reversed causation is high. 
There is a greater probability that sedentary time and mortality risk are both influenced by 
underlying diseases. Our study has a longer follow-up time of 11 years and is therefore less prone 
of reverse causation.  
To evaluate whether the association between sedentary behavior and mortality could be 
explained by other measures of activity, we adjusted our analyses for PA and disability as 
measured by questionnaire and indicators of the 24-hour activity rhythm as measured by 
actigraphy in our final model. Low PA levels can be the cause of sedentary behavior and may 
conceptually overlap with sedentary behavior. Our results indicate that the association between 
sedentary behavior and mortality risk was not independent of PA, which is in contrast to studies 
with shorter follow-up time.10,12,25 In contrast to these studies, a study in 5132 adults from the 
Whitehall II cohort, with over 16 years of follow-up, found no association between self-reported 
sitting time and mortality, after adjustment for PA.33 Moreover, a recent meta-analysis concluded 
that being active at moderate intensity for 60-75 minutes/day can attenuate the risk of death 
associated with sedentary behavior.34 One possible explanation for the inconsistent findings 
between studies might be related to the follow-up, with stronger associations found with shorter 
follow-up periods. Furthermore, in our analyses, in addition to adjusting for PA, we additionally 
adjusted for disability, as indicator for health. Importantly, the disability score attenuated the 
observed association more than PA. The disability score is computed by combining scores from 
the activities of daily living questionnaire. Activities of daily living reflect physical capabilities, by 
providing information on being able to walk outdoors, being able to climb stairs and being able to 
dress oneself.21 Participants with difficulties in any of the domains of activities of daily living, will 
not engage in those activities and as a consequence, are more likely to be inactive or sedentary. 
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Arguably, the information on activities of daily living conceptually overlaps with sedentary 
behavior and partially provides the same information.  
The importance of evaluating the complete 24-hour period in the association with health 
outcomes has been mentioned recently.35 In another study with the actigraph data in this cohort, 
low stability and high fragmentation of the 24-hour activity rhythm predicted all-cause 
mortality.23 Therefore, we adjusted for these two measures of the 24-hour activity rhythm (i.e. IV 
and IS). Our results indicate that the association between sedentary behavior and mortality is not 
independent of these measures. 
Whereas our associations were clearly attenuated after adjustment for other activity 
measures, our results do not indicate that adults can safely engage in high amounts of sedentary 
behavior when they meet the PA guidelines. Other activity measures, including activities of daily 
living or disability, partially provide similar information as sedentary behavior. As a consequence, 
measuring activities of daily living might be a convenient and accessible tool to evaluate the health 
status and mortality risk of adults. For  public health programs, it remains important to not just 
focus on increasing population PA levels, but to concomitantly stress reducing sedentary time and 
improve activities of daily living levels. Encouraging high-risk groups such as individuals with 
cardiovascular disease, diabetes, overweight or obesity to sit less and to improve their ability to 
perform activities of daily living should be a public health priority. 
In literature, there is no consensus regarding the cut-off to use to define sedentary 
behavior.32 Whereas 199 cpm has been used in older adults,17,36,37 100 cpm has also been 
reported.38 In light of this debate, we have performed our analysis using the cut-off of 199 cpm in 
our main analyses, and have used the cut-off of 100 cpm in a sensitivity analysis. The results for 
the analysis using continuous sedentary time were similar, showing the robustness of this 
association.  
Different mechanisms have been proposed to link high sedentariness to an increased 
mortality risk. The impact of sedentary behavior on survival could reflect changes in metabolic 
risk factors, including fasting glucose, triglycerides and HDL cholesterol, that accompany 
sedentary behavior.39,40 Previous studies documented that metabolic changes in metabolic risk 
factors appear to be at least partially mediated by changes in lipoprotein lipase activity, a protein 
important for controlling such metabolic factors.39 However, when we adjusted for BMI, total 
cholesterol, HDL cholesterol and systolic blood pressure, the associations did not materially 
change, indicating only a minor effect of these variables. Other efforts have investigated more 
distal indicators of potential mechanisms, such as cardiovascular fitness. High sedentariness has 
been associated with lower cardiovascular fitness,41 which in turn is associated with increased 
mortality risk.42 Low levels of cardiovascular fitness might thus reflect the above pathological 
processes. However, more research is needed to understand the underlying physiological 
pathways through which sedentary behavior influences health.  
We found no evidence for a statistical interaction between sedentary behavior and gender in 
our analysis. When we stratified our analysis by gender, the associations between sedentary 
behavior and mortality risk in men was observed more clearly than in women. One reason for this 
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finding might be that there were more deaths in men (13.8%) than in women (9.6%), resulting in 
more power to find an association. Additionally, we observed that men spent on average slightly 
more time in sedentary behavior (9.2, SD 2.0) than women (8.5, SD 2.0), which might have 
influenced the results. 
The strengths of this study are the prospective population-based design, large sample size 
and a long follow-up period (11 years compared to the average 2.8 and 4.8 in previous 
publications).10-12 However, several potential limitations must be discussed. First, persons in poor 
health engage in sedentary behavior more than others, which could introduce reverse causation 
and confounding. However, the associations remained after adjusting for comorbidities. 
Moreover, repeating our analysis after exclusion of the first two years of follow-up showed similar 
results. Second, a limitation of the actigraph is that it does not allow differentiation between the 
postural allocations of sitting, standing and lying down and that it cannot distinguishing different 
types of sedentary behavior. For example, we were unable to distinguish socializing from driving. 
Moreover, we measured sedentary behavior during one week, which might not represent yearly 
exposure. Additionally, we did not analyze the length of the sedentary bouts. Therefore, we cannot 
provide information on the effects of specific patterns of sedentary behavior. Furthermore, we 
used questionnaire data to estimate PA levels. Although our questionnaire has been shown to be 
valid and reliable,22 potential recall bias and socially desired answers cannot be excluded. Another 
limitation is that for many participants, PA was measured after the actigraph study was 
conducted. We acknowledge this limitation and used these PA measures as a proxy of prior 
activities. These last two limitations could have resulted in bias towards the null hypothesis, which 
means that our findings could be an underestimation of the true effect of sedentary behavior on 
mortality. Finally, the PA questionnaires did not capture the occupational domain. However, only 
33.8% of our population was employed at baseline and only 31 of the 212 events (14.6%) events 
occurred in this group. 
 
Conclusions 
In conclusion, in this population of middle-aged and elderly adults, high levels of sedentary time 
were associated with mortality risk. After adjustment for other measures of activity, the 
association was clearly attenuated. Further investigation is needed to examine whether sedentary 
behavior is a risk factor for mortality, distinct from the effect of other measures of activity. 
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Supplement 3.2.2. Association between sedentary time and mortality, excluding deaths in the 
first two years (n=1,808), the Rotterdam Study, 2004-2015 
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Hours/day 
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  6.9 (<8.0) 9.2 (8.0-11.0) 12.0 (≥11.0)   
No. Participants   633 942 233   
No. deaths   36 107 40   
Confounder adjusted models 
Model 1  1.11 (1.02, 1.20) 1.00 [ref] 1.30 (0.87, 1.93) 1.86 (1.15, 3.01) 0.01 
Model 2  1.05 (0.97, 1.15) 1.00 [ref] 1.19 (0.80, 1.77) 1.43 (0.88, 2.34) 0.15 
Model 3 1.05 (0.97, 1.15) 1.00 [ref] 1.18 (0.80, 1.76) 1.46 (0.89, 2.39) 0.14 
Additional adjustment for activity scores 
Model 4 1.05 (0.97, 1.15) 1.00 [ref] 1.17 (0.77, 1.77) 1.26 (0.75, 2.12) 0.37 
Abbreviations: no, number; ref, reference. 
Model 1 is adjusted for age, sex, cohort and time awake.  
Model 2 is additionally adjusted for smoking, number of comorbidities, alcohol intake and education. 
Model 3 is additionally adjusted for body mass index, cholesterol, high-density lipoprotein cholesterol and systolic blood 
pressure.  
Model 4 is model 2 and additionally adjusted for physical activity, the 24h activity rhythm (i.e. interday stability, intraday 
variability) and the disability score. 
 
 
Supplement 3.2.3. Association between sedentary time and mortality in non-workers (n=1,217), 
the Rotterdam Study, 2004-2015 
  
Continuous 
analysis 
Categorical analysis 
  
Per 1 hour 
more 
Low 
sedentary 
Medium 
sedentary 
High 
 sedentary 
P for 
trend 
Hours/day 
sedentary, median 
(range) 
  7.0 (<8.0) 9.3 (8.0-11.0) 11.9 (≥11.0)   
No. Participants   376 663 178   
No. deaths   33 98 50   
Confounder adjusted models 
Model 1  1.14 (1.04, 1.25) 1.00 [ref] 1.09 (0.72, 1.65) 2.06 (1.29, 3.29) 0.001 
Model 2  1.10 (1.01, 1.20) 1.00 [ref] 1.06 (0.70, 1.61) 1.74 (1.08, 2.81) 0.01 
Model 3 1.11 (1.01, 1.21) 1.00 [ref] 1.08 (0.71, 1.64) 1.86 (1.15, 3.03) 0.01 
Additional adjustment for activity scores 
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Supplement 3.2.4. Association between sedentary time and mortality, using 100 counts per 
minute as cut off point for sedentary behavior, the Rotterdam Study, 2004-2015 
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pressure.  
Model 4 is model 2 and additionally adjusted for physical activity, the 24h activity rhythm (i.e. interday stability, intraday 
variability) and the disability score. 
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ABSTRACT 
Background: Physical activity (PA) is associated with decreased risk of coronary heart 
disease (CHD). The specific PA types that provide beneficial effects in an older population 
remain unclear.  
Methods: We assessed the association of total PA, walking, cycling, domestic work, sports 
and gardening with CHD by using Cox proportional hazard models among 5,901 
participants aged >55 (median age: 67 years) from the prospective population-based 
Rotterdam Study, enrolled between 1997 and 2001. Activities were categorized into tertiles 
and the lowest tertiles were used as reference. In the multivariable model we adjusted for, 
age, gender, smoking, alcohol consumption, education, diet and other PA types.  
Results: During 15 years of follow-up (median:10.3 years, interquartile range: 8.0-11.8 years), 
642 participants (10.9%) experienced a CHD event. In the multivariable model, the 
respective hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the medium and 
high category compared to the low category were: 0.79 (0.66, 0.96) and 0.71 (0.58, 0.87) for 
total PA, 0.76 (0.63, 0.92) and 0.70 (0.57, 0.88) for cycling, and 0.81 (0.66, 0.98) and 0.71 
(0.56, 0.90) for domestic work. Walking, sports and gardening were not associated with 
CHD.  
Conclusion: In this long-term follow-up study of older adults domestic work and cycling 
were associated with reduced CHD risk. PA should be promoted in this population with the 
aim to prevent CHD. 
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INTRODUCTION 
Over the last decades, numerous observational epidemiologic studies have demonstrated that 
physical activity (PA) is inversely related to cardiovascular morbidity and mortality.1, 2 According 
to recent meta-analyses, regular PA of moderate to vigorous intensity may contribute to up to 
27% reduced risk of coronary heart disease (CHD).3, 4 Previous studies have mainly focused on the 
effect of overall leisure time PA , whereas it remains unclear what specific PA types contribute 
most to the beneficial effects of PA. Only a few studies have addressed the impact of different 
types of PA on CHD.5-7 Moreover, several studies documented a beneficial association between 
walking and CHD risk,8, 9 but evidence of the influence of cycling and domestic work remains 
scarce.6, 10-12 
Recently, one study12 investigated the association between different PA types and 
cardiovascular disease (CVD) in young and middle-aged adults and found a beneficial association 
with sports and cycling. However, PA levels tend to decrease with age13 and PA types in which 
older adults engage differ markedly from the activities performed by younger and middle-aged 
adults.14 For example, domestic work contributes to approximately 35% to the PA energy 
expenditure of elderly adults and only around 27% and 19% in middle-aged and younger adults, 
respectively.14 This raises the question what kind of activities are beneficially associated with CHD 
in an older population. The few studies in older adults showed a beneficial association between 
walking and CHD risk,1, 15 but did not focus on other PA. Therefore, we aim to examine the 
association between PA and CHD incidence in an older population, aged 55 years and over. More 
specifically, we will assess independent and combined associations between walking, cycling, 
sports, domestic work and gardening and CHD.  
 
METHODS 
Study population 
This study was embedded within the Rotterdam Study (RS), a prospective population-based 
cohort study among subjects aged 55 years or older in the municipality of Rotterdam, the 
Netherlands. The baseline examination was completed between 1990 and 1993. In 2000-2001, the 
Rotterdam Study was extended with 3,011 participants who had become ≥ 55 years old or had 
moved into the study district. For the current study, we used data from the participants attending 
the third examination of the original cohort (RS-I-3, between 1997 and 1999; n = 4,796) and the 
participants attending the first examination of the extended cohort (RS-II-1, between 2000 and 
2001; n=3,011).16 Of this combined total, 7,310 participants completed PA collection (see Figure 
4.1.1). Following, 52 subjects were excluded due to not provided, or withdrawn, informed consent 
for collection of follow-up data and 8 were excluded due to missing follow-up data. Subjects with 
previous CHD (n=622), stroke (n=230), heart failure (n=187) and atrial fibrillation (n=291) were 
also excluded. Finally, 19 cases were deleted due to unreliable completion of PA data collection. 
Eventually, 5,901 subjects were included in the analyses. To collect the baseline information, 
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trained research assistants interviewed the participants at home. All subjects gave written 
informed consent, and the study protocol was approved by the medical ethics committee of 
Erasmus University, Rotterdam. Detailed information on the design of the Rotterdam Study can 
be found elsewhere.16 
 
 
Figure 4.1.1. Flow chart of participant inclusion for the Rotterdam Study, 1997-2012. 
497 Participants Excluded Due to No 
Physical Activity Data Collection 
      60 Participants Excluded 
            52 Participants did not   
            provide or withdrew informed    
            consent for collection of     
            follow-up data 
            8 Participants excluded due   
            to missing follow-up data 
      1,330 Participants Excluded 
          622 Coronary heart disease 
          230 Stroke 
          187 Heart failure 
          291 Atrial fibrillation 
19 Participants Excluded Due to 
Unreliable Completion of Physical 
Activity Data Collection 
7,807 Total Participants 
4,796 at RS-I visit 3 (1997–1999) 
3,011 at RS-II visit 1 (2000–2001) 
7,310 Participants 
7,250 Participants 
5,920 Participants 
5,901 Participants Included in 
Analyses 
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Physical activity assessment  
PA levels were assessed with an adapted version of the Zutphen Physical Activity Questionnaire.17 
This questionnaire has been validated in which the test-retest reliability was 0.93 and the 
correlation with doubly labelled water was 0.61.18 The original Zutphen questionnaire contains 
questions regarding walking, cycling, sports, gardening and hobbies. In the current study 
questions on housekeeping activities were added to attain a more complete assessment of PA 
levels. 
Participants were asked how many hours per week they spent in each activity in the past 
year. To address seasonal variability in PA, participants were asked whether they only participated 
in a particular activity during summer or winter (e.g. sports, gardening). When answered 
confirmative, we calculated a weighted estimate by dividing the reported time by two. 
Furthermore, the questionnaire provided one question in which participants could mention all 
sports they participated in that were not captured by previous questions. If multiple sports were 
mentioned, we assumed that time spent in these sports was equally distributed. 
To quantify activity intensity, we used metabolic equivalent of task (MET). We assigned 
MET-values to all activities mentioned in the questionnaire, according to the 2011 updated 
version of the Compendium of Physical Activities.19 Sports that were not in this compendium and 
to which no MET-value could be assigned (e.g. under water hockey, roller skiing) were not used in 
the analyses (n=33; 2.8%).  
Finally, we multiplied MET-values of specific activities with time (in hours) per week spent 
in that activity to calculate MET∙hours∙week-1 in total PA, defined as the sum of cycling, walking, 
sports, domestic work and gardening, and in every type of PA (cycling, walking, sports, domestic 
work, gardening).  
Cardiovascular risk factors (covariates) 
Information on cardiovascular risk factors was collected through home interviews or was 
measured at the study centre visit as described previously.20, 21 Briefly, alcohol use was defined as 
the amount of glasses per day. Education was divided in primary, junior vocational/academic 
education and higher vocational/academic education. Smoking was divided into two categories: 
current and other (former and never). Height and weight were measured, with which body mass 
index was calculated (kg/m2). Diabetes mellitus was defined as the use of blood glucose-lowering 
medication, a random or postload serum glucose level of 11.1 mmol/L or higher22 or a fasting 
serum glucose level of 7.0 mmol/L or higher22 and used as a binary variable (yes/no). 
Concentration of serum total cholesterol and high-density lipoprotein cholesterol was determined 
using an automated enzymatic procedure (Boehringer Mannheid System, Mannheim, Germany) 
and expressed in mg/dl. Two seated blood pressure measurements were obtained at the right 
brachial artery using a random zero sphygmomanometer and the mean of two consecutive 
measurements expressed in mmHg was used in analyses as a continuous variable. Hypertension 
was defined as a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg or 
use of blood pressure–lowering drugs with the indication of hypertension. Medication use was 
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informed consent, and the study protocol was approved by the medical ethics committee of 
Erasmus University, Rotterdam. Detailed information on the design of the Rotterdam Study can 
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medication, a random or postload serum glucose level of 11.1 mmol/L or higher22 or a fasting 
serum glucose level of 7.0 mmol/L or higher22 and used as a binary variable (yes/no). 
Concentration of serum total cholesterol and high-density lipoprotein cholesterol was determined 
using an automated enzymatic procedure (Boehringer Mannheid System, Mannheim, Germany) 
and expressed in mg/dl. Two seated blood pressure measurements were obtained at the right 
brachial artery using a random zero sphygmomanometer and the mean of two consecutive 
measurements expressed in mmHg was used in analyses as a continuous variable. Hypertension 
was defined as a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg or 
use of blood pressure–lowering drugs with the indication of hypertension. Medication use was 
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assessed during the home interview. Dietary information was not collected at the same time as PA 
data collection, therefore we used diet information measured in the first wave (1989-1993) of the 
original cohort (RS-I) and in the third wave (2011-2012) of the extended cohort (RS-II). 
Information on diet were obtained through a 170-item validated semi quantitative food frequency 
questionnaire.23 From the questionnaire an overall healthy diet score representing adherence to 
the Dutch dietary guidelines was calculated, as described previously.24 
 
Clinical outcome 
The main outcome measure under study was CHD, defined as fatal or non-fatal myocardial 
infarction, surgical or percutaneous coronary revascularization procedure (as a proxy for unstable 
or incapacitating angina), or death due to CHD.25 Data on clinical outcomes including CHD were 
collected through an automated follow-up system involving digital linkage of the study database 
to medical records maintained by general practitioners working in the research area. Trained 
research assistants collected notes, outpatient clinic reports, hospital discharge letters, 
electrocardiograms, and imaging results from general practitioner records and hospital records. 
Subsequently, research physicians independently adjudicated all data on potential events. 
Afterwards, medical specialists whose judgments are considered decisive reviewed the potential 
cases. Information on vital status was additionally obtained from the central registry of the 
municipality of the city of Rotterdam. Follow-up was complete until January 1, 2012. 
Statistical analysis 
Total PA and PA types were categorized into tertiles. For activities not practiced by more than 
60% of the population (cycling, gardening, sports), the bottom category for PA levels was no 
participation and the remaining two categories were divided by using the median value.26 PA 
types that were significantly associated with CHD were combined to assess the combined 
association with CHD risk. In this procedure, each tertile of a certain PA type was combined with 
every tertile of the other PA type, creating 9 groups in total. We investigated the associations 
between the PA variables and CHD with Cox proportional hazards in three serially adjusted 
models, after confirming that the assumption for proportional hazards was met on the basis of 
Schoenfeld residuals. Model 1 was adjusted for age and sex. In model 2 we additionally adjusted 
for behavioral risk factors, including smoking, alcohol consumption, education, diet and the other 
PA types. Model 3 was additionally adjusted for biological risk factors, including body mass index, 
total and high-density lipoprotein high-density lipoprotein cholesterol, diabetes, lipid reducing 
agents, systolic blood pressure and anti-hypertensive medication. The decision to include 
confounders in the multivariable regression models was based on previous literature or >10%-
change of the effect estimate in the crude model.6, 7, 12 
Total PA and PA types were entered as categorical variables (tertiles) in the separate models. 
Additionally, PA variables in which participation was over 60% (i.e. total PA, walking and 
domestic work) were analyzed continuously per 10 MET∙hours∙week-1 increase. The underlying 
time-scale in these models was follow-up time, defined as the time between PA assessment and 
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the first fatal or non-fatal CHD event, death, emigration, or censoring at January 1, 2012. There 
was no interaction for any PA variable with gender or age (p >.05 for all). However, we conducted 
several sensitivity analyses using stratified models by sex and age (below/above median of 67 
years). We investigated the possible effect of reverse causation, by excluding the events in the first 
two years. Also, we repeated analyses by excluding domestic work, to make sure our results were 
not driven by that variable. Moreover, 12.9% (n=759) was employed at baseline, but we did not 
collect information on occupational PA. Therefore, we repeated our analyses in non-workers. 
Additionally, we repeated the analyses in the original dataset without imputation (n= 4,232). 
Finally, we stratified our models by fatal and non-fatal outcomes. 
Our data contained missing data for diet (26.5%), high-density lipoprotein cholesterol 
(13.1%), total cholesterol (12.1%) and diabetes (11.4%). Other covariates had <10% missing data. 
We used multiple imputation (n=5 imputations) by the Expectation Maximization method. All 
analyses were conducted using SPSS software version 20 (IBM SPSS Statistics for Windows, 
Armonk, NY: IBM Corp) and R (3.0.1).  
 
RESULTS 
Baseline characteristics of the study population are shown in Table 4.1.1 and the proportion of 
participants who reported engaging in the considered PA types is shown in Figure 4.1.2. The five 
most mentioned sports per gender are displayed in Supplement 4.1.1. During 15 years of follow 
up (median: 10.3 years, interquartile range: 8.0-11.8 years), there were 642 (10.9%) CHD events, 
of which 284 (44.2%) were fatal.  
 
 
Figure 4.1.2. Proportion of participants by physical activity type for the Rotterdam Study, 1997-
2012. 
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Table 4.1.1. Baseline participant characteristics by tertile of total PA, Rotterdam Study, 1997-2012 
Tertiles of total PA, MET∙hours∙week-1 
Median (range), MET∙hours∙week-1 
42.0 
(<61.4) 
77.5 
(61.5-96.9) 
126.7 
(≥97.0) 
Participants, n (%) 1,967 (33.3) 1,968 (33.3) 1,966 (33.3) 
Demographic factors 
Age, years 70.7 (9.7) 68.0 (7.7) 66.9 (7.0) 
Female, n (%) 916 (46.6) 1,298 (66) 1,413 (71.9) 
Primary education, n (%) 754 (38.3) 852 (43.3) 914 (46.5) 
Physical activity 
Cycling, hours/week 0.8 (1.5) 2.0 (2.5) 3.9 (4.5) 
Gardening, hours/week 0.4 (0.9) 0.8 (1.9) 1.7 (3.3) 
Walking, hours/week 4.4 (3.1) 7.8 (4.5) 15.8 (10.2) 
Sports, hours/week 0.5 (1.5) 1.1 (2.1) 2.1 (3.7) 
Domestic work, hours/week 6.7 (4.6) 12.6 (5.6) 17.6 (8.2) 
Lifestyle factors 
Alcohol, glasses/day 1.1 (1.6) 1.0 (1.6) 1.0 (1.2) 
Currently smoking 473 (24) 382 (19.4) 374 (19) 
Biological risk factors 
BMIa 27.2 (4.2) 27.1 (4.1) 26.7 (3.9) 
Cholesterol level, mg/dl 222.8 (37.8) 227.0 (35.8) 231.0 (36.8) 
HDL-cholesterol level, mg/dl 51.9 (15.1) 55.0 (15.2) 56.1 (15.0) 
Systolic blood pressure, mmHg 146.2 (21.0) 143.8 (22,0) 141.9 (20.7) 
Having diabetes, n (%) 353 (17.9) 248 (12.6) 201 (10.2) 
Using serum lipid reducing agents, n (%) 154 (7.8) 215 (10.9) 180 (9.2) 
Using anti-hypertensive medication with the 
indication of hypertension, n (%) 477 (24.3) 492 (25) 403 (20.5) 
Cardiovascular cases 
CHD event, n (%) 272 (13.8) 195 (9.9) 175 (8.9) 
Fatal CHD event, no., n (%) 140 (7.1) 73 (3.7) 71 (3.6) 
Time to event, years 8.5 (3.7) 9.6 (3.1) 10.2 (3.0) 
Abbreviations: BMI, body mass index ; CHD, coronary heart disease; HDL, high-density lipoprotein; MET, metabolic 
equivalent of task; no, number; PA, physical activity 
Data are presented as mean (SD), unless otherwise stated. 
a Weight (kg)/height (m)2 
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Table 4.1.2 presents multivariable-adjusted hazard ratios (HRs) with their 95% confidence interval 
(CI) for total PA and every PA type. In model 2, total PA, cycling and domestic work were 
strongly associated with reduced CHD risk. Walking, gardening and sports were not associated 
with CHD risk in any model. Additional adjustment for biological risk factors in model 3 only 
slightly attenuated the associations and therefore we will present the results of the second model.  
For total PA, the median (interquartile range) levels across categories were 42.0 (29.5-52.5), 
77.5 (69.5-86.1) and 126.7 (108.8-150.9) MET∙hours∙week-1, corresponding to 1.5, 2.8 and 4.5 
hours a day of moderate activity of 4 METs. In model 2, compared to the lowest category, the 
respective HR (95% CI) of the moderate and high category were 0.79 (0.66, 0.96) and 0.71 (0.58, 
0.87), with P for trend, <0.001. Each 10 MET∙hours∙week-1 increment of total PA, which is 
equivalent to an average 21 minutes per day of PA of 4 METs, reduced CHD risk with 4% (HR = 
0.96; 95% CI: 0.94, 0.98). 
We considered cycling equivalent to 4.0 METs. The median (interquartile range) levels of 
cycling across categories were 0, 6.0 (3.0-9.0) and 24.0 (16.0-32.0) MET∙hours∙week-1, which 
corresponds to 0, 13 and 51 minutes per day. In model 2, compared to the low category, the 
respective HR (95% CI) of the medium and high category were 0.76 (0.63, 0.92) and 0.70 (0.57, 
0.88) respectively (P for trend, <0.001).  
For domestic work, we calculated the average intensity to be 3.5 METs.19,21 The median 
(interquartile range) levels of domestic work across categories were 12.9 (6.5-19.0), 36.0 (31.0-
41.3) and 59.5 (52.6-69.6) MET∙hours∙week-1, equivalent to 32, 88 and 146 minutes per day. In 
model 2, compared to the low category, the HR (95% CI) of the medium and high category were 
0.81 (0.66, 0.98) and 0.71 (0.56, 0.90), respectively, with P for trend 0.004. Each 10 
MET∙hours∙week-1 increment of domestic work, equivalent to an average 25 minutes per day of 
domestic work, reduced CHD risk with 6% (HR = 0.94; 95% CI: 0.90, 0.99). 
In model 2, engaging in both cycling and domestic work revealed a stronger association 
with CHD risk than these separate activity types (Figure 4.1.3). Compared to the lowest category 
of combined domestic work and cycling (i.e. low category of domestic work and low category of 
cycling), the strongest protective association was seen for the combination of the medium 
category of cycling and the high category of domestic work, reflecting median 146 minutes of 
domestic work and 13 minutes of cycling a day [HR = 0.46 (95% CI: 0.31, 0.67)].  
In our sensitivity analysis split by age, our findings did not materially change (Supplement 
4.1.2). Analyses split by gender revealed slightly stronger associations for women than for men, 
for total PA, cycling and domestic work (Supplement 4.1.3). Excluding events in the first 2 years, 
excluding domestic work or workers or repeating our analyses in the original dataset without 
imputation, did not change the results significantly, although some associations were no longer 
significant (Supplement 4.1.4 – Supplement 4.1.7). Stratifying our analyses by fatal and non-fatal 
CHD events indicated that the associations were stronger for fatal events (Supplement 4.1.8). 
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DISCUSSION 
In this population-based study of adults aged 55 and over, domestic work and cycling were 
specific PA types strongly associated with decreased CHD risk. Total PA was also inversely 
associated with CHD incidence. These associations remained after adjustment for behavioral and 
biological risk factors and in several sensitivity analyses. The results of our study also suggest that 
engaging in both cycling and domestic work was strongly related to a reduction in CHD 
incidence.  
We found a linear, inverse association between total PA and CHD risk, which is in 
agreement with previous studies.3, 4 Moreover, we found the association to be stronger for fatal 
events than for non-fatal events, a finding that has been reported before.27 The plausible biological 
mechanisms via which PA may reduce CHD risk include reducing blood pressure and body 
weight, increasing high-density lipoprotein cholesterol and maintaining normal glucose 
tolerance.28 However, adjusting for these factors in model 3 did not change our results 
significantly and it has been reported that only ~35% of the risk reduction can be attributed to this 
pathway.28  
 
 
 
Figure 4.1.3. Hazard ratios and 95% confidence intervals of coronary heart disease for the 
combined domestic work and cycling variable in multivariable model 2, Rotterdam Study, 1997-
2012.  
In every combination, the tertile of domestic work is mentioned first and cycling second. Model 2 is adjusted for age, sex, all 
other physical activity types, smoking, alcohol consumption, diet and education. Circles indicate hazard ratios; horizontal 
lines indicate 95% confidence interval. 
Abbreviations: HR, hazard ratio. 
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DISCUSSION 
In this population-based study of adults aged 55 and over, domestic work and cycling were 
specific PA types strongly associated with decreased CHD risk. Total PA was also inversely 
associated with CHD incidence. These associations remained after adjustment for behavioral and 
biological risk factors and in several sensitivity analyses. The results of our study also suggest that 
engaging in both cycling and domestic work was strongly related to a reduction in CHD 
incidence.  
We found a linear, inverse association between total PA and CHD risk, which is in 
agreement with previous studies.3, 4 Moreover, we found the association to be stronger for fatal 
events than for non-fatal events, a finding that has been reported before.27 The plausible biological 
mechanisms via which PA may reduce CHD risk include reducing blood pressure and body 
weight, increasing high-density lipoprotein cholesterol and maintaining normal glucose 
tolerance.28 However, adjusting for these factors in model 3 did not change our results 
significantly and it has been reported that only ~35% of the risk reduction can be attributed to this 
pathway.28  
 
 
 
Figure 4.1.3. Hazard ratios and 95% confidence intervals of coronary heart disease for the 
combined domestic work and cycling variable in multivariable model 2, Rotterdam Study, 1997-
2012.  
In every combination, the tertile of domestic work is mentioned first and cycling second. Model 2 is adjusted for age, sex, all 
other physical activity types, smoking, alcohol consumption, diet and education. Circles indicate hazard ratios; horizontal 
lines indicate 95% confidence interval. 
Abbreviations: HR, hazard ratio. 
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Other plausible mechanisms for decreased CHD risk are improved endothelial function, 
stabilization of vulnerable plaques preventing plaque rupture and reduced myocardial oxygen 
demand.29 Possibly, these adaptations over the years might protect against more severe 
manifestations of CHD. Since most of the research in this field has been conducted in middle-
aged adults,30 further research is needed to gain more insight in the mechanisms behind the 
association between PA and CHD risk in older adults. 
For cycling, we found a linear decrease of CHD risk for participants in the medium to high 
category compared with the lowest. The difference in CHD risk between the medium (cycling 13 
min/day) and high category (cycling 51 min/day) was 6%, indicating that the largest benefits are 
achieved by going from no cycling to any level of cycling, a trend that is common for other PA 
types as well.4 We found one study in agreement with our findings, reporting an inverse 
association between cycling and risk of CHD death.31 Another study6 did not find an independent 
association between cycling and CHD risk in 40 to 75-year-old men, which might be because only 
7% of their study population spent more than 1 hour per week in cycling. Another possible 
explanation is that individuals started integrating cycling in their everyday life in an effort to 
counteract existing disease. In contrast, cycling is a common way of commuting in the 
Netherlands, and a large proportion of participants in our study participated in cycling on a 
weekly basis (57.8%).  
Domestic work is an important contributor of daily PA, especially in the elderly.14 For this 
activity we found a 6% reduced risk for every 2.8 hours per week increment and we found a linear 
decrease of CHD risk for participants in the medium to high category, compared to the lowest. 
Increasing from 32 to 88 minutes a day of domestic work decreased CHD risk with 19%. Our 
results resemble one study in a similar study population,10 reporting that men and women doing 
demanding household work had a 22% and 45% reduced risk of having a fatal or non-fatal 
myocardial infarction, respectively. Another study11 found no association between intense 
domestic PA and CVD, which might be explained by the younger age group (mean age 52 years) 
and the use of only intense domestic PA, whereas domestic work was assessed in a broad sense in 
the current study.  
We did not find an association between walking and CHD, whereas several large prospective 
investigations1 and recent meta-analyses8,32 found inverse associations between walking and CHD. 
Differences in the findings can be attributed to the different study populations, different methods 
used to measure walking and the different definitions of walking.8, 32 Some studies used only 
walking for transport, whereas other studies assessed walking in a broad sense, as was also done in 
our study. For example, not only taking a walk, but also walking for transportation and shopping 
were taken into account.1, 6 In two studies with walking patterns comparable with the current 
population,12, 33 no association with CVD was observed, suggesting that beneficial influence of 
walking may be limited to relatively inactive populations.12 Additionally, the fact that we used 
walking duration instead of walking pace might have influenced our results, since walking pace is 
a stronger predictor of CHD than walking volume and walking volume does not adequately cover 
the intensity used during walking.6, 8  
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Other plausible mechanisms for decreased CHD risk are improved endothelial function, 
stabilization of vulnerable plaques preventing plaque rupture and reduced myocardial oxygen 
demand.29 Possibly, these adaptations over the years might protect against more severe 
manifestations of CHD. Since most of the research in this field has been conducted in middle-
aged adults,30 further research is needed to gain more insight in the mechanisms behind the 
association between PA and CHD risk in older adults. 
For cycling, we found a linear decrease of CHD risk for participants in the medium to high 
category compared with the lowest. The difference in CHD risk between the medium (cycling 13 
min/day) and high category (cycling 51 min/day) was 6%, indicating that the largest benefits are 
achieved by going from no cycling to any level of cycling, a trend that is common for other PA 
types as well.4 We found one study in agreement with our findings, reporting an inverse 
association between cycling and risk of CHD death.31 Another study6 did not find an independent 
association between cycling and CHD risk in 40 to 75-year-old men, which might be because only 
7% of their study population spent more than 1 hour per week in cycling. Another possible 
explanation is that individuals started integrating cycling in their everyday life in an effort to 
counteract existing disease. In contrast, cycling is a common way of commuting in the 
Netherlands, and a large proportion of participants in our study participated in cycling on a 
weekly basis (57.8%).  
Domestic work is an important contributor of daily PA, especially in the elderly.14 For this 
activity we found a 6% reduced risk for every 2.8 hours per week increment and we found a linear 
decrease of CHD risk for participants in the medium to high category, compared to the lowest. 
Increasing from 32 to 88 minutes a day of domestic work decreased CHD risk with 19%. Our 
results resemble one study in a similar study population,10 reporting that men and women doing 
demanding household work had a 22% and 45% reduced risk of having a fatal or non-fatal 
myocardial infarction, respectively. Another study11 found no association between intense 
domestic PA and CVD, which might be explained by the younger age group (mean age 52 years) 
and the use of only intense domestic PA, whereas domestic work was assessed in a broad sense in 
the current study.  
We did not find an association between walking and CHD, whereas several large prospective 
investigations1 and recent meta-analyses8,32 found inverse associations between walking and CHD. 
Differences in the findings can be attributed to the different study populations, different methods 
used to measure walking and the different definitions of walking.8, 32 Some studies used only 
walking for transport, whereas other studies assessed walking in a broad sense, as was also done in 
our study. For example, not only taking a walk, but also walking for transportation and shopping 
were taken into account.1, 6 In two studies with walking patterns comparable with the current 
population,12, 33 no association with CVD was observed, suggesting that beneficial influence of 
walking may be limited to relatively inactive populations.12 Additionally, the fact that we used 
walking duration instead of walking pace might have influenced our results, since walking pace is 
a stronger predictor of CHD than walking volume and walking volume does not adequately cover 
the intensity used during walking.6, 8  
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In the current study, we did not find an association between CHD and gardening or sports. 
Two studies investigating the independent association between gardening and all-cause 
mortality26 or CVD risk,12 did not report a substantial protective association either. The non-
significant association between sports and CHD observed in this study is not in agreement with 
previous literature.9, 33-35 Our finding might be explained by the low number of participants 
engaging in any sport activities and the low duration, leading to insufficient power to detect an 
association. This low percentage of sports engagement is directly related with the age distribution 
of our population. In our study, 36.2% of participants engaged in any sporting activities, with a 
mean duration of 3.5 hours (SD=3.7) per week. This proportion of participants engaging in sports 
is similar as found in other studies,36-38 however, a lower rate has also been reported.14 
When we stratified our analyses by gender, we found the associations for total PA, cycling 
and domestic work to be stronger in women than in men. This gender difference has been 
reported before4, 35 however the specific mechanism remains unclear. Previous evidence does not 
support more favorable effects of PA on CHD risk factors (including lipid levels, blood pressure, 
cardiorespiratory fitness, vascular indicators and metabolic syndrome) among women compared 
with men.39 The differences may partly be due to differences in PA intensity and PA types in 
which the men and women engage in35 and in potential gender differences in ethipathogenesis of 
cardiovascular disorders. Another explanation might be the difference in perception of the 
intensity of PA, and therefore a difference in answering the questions between men and women. 
For example, a recent study has shown men to over-report moderate to vigorous PA more than 
women.40 
We acknowledge that our study has limitations. First, it may be hypothesized that people in 
poor health participate in PA less than others, creating the opportunity for reverse causation. 
However, repeating our analyses after exclusion of cases that occurred within the first two years of 
follow up revealed comparable results. Second, we collected no information about occupational 
PA, so we could not adjust for this in our main analyses. However, excluding these participants 
(n=759, 12.9%) in our sensitivity analyses also revealed comparable results. Despite this, we 
cannot rule out the possibility of residual confounding from lifetime exposure to physical 
activities at work, which can influence CVD risk.41 Third, we only measured PA at baseline, which 
can cause misclassification of PA over time, since research showed PA levels of adults to change 
and decline with age.42 Moreover, our results are based on self-reported PA. Although our 
questionnaire has shown to be valid and reliable18 potential recall bias and social desirability 
cannot be excluded. These last two limitations could have resulted in bias towards the null 
hypothesis. Furthermore, diet was measured in the first wave (1989-1993) for the original cohort 
(RS-I) and in the third wave (2011-2012) of the extended cohort (RS-II). Therefore, we cannot 
fully exclude the possibility of residual confounding by diet. Finally, we estimated the PA intensity 
according to the Compendium of Physical Activities,19 which has a few drawbacks. First, it might 
not capture the energy expenditure of older adults accurately.19 However, we carefully took into 
consideration the age of the participants while assigning METs to activities. Second, there 
probably was some heterogeneity in the intensity in which participants engaged in the different 
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activity types. This might have led to misclassification of participants with either higher or lower 
intensity levels than our assigned values. Since this misclassification was non-differential, this 
could have biased our estimates towards the null hypothesis. Additionally, this heterogeneity 
might be directly linked to the age and physical fitness of the participants. Therefore, using 
relative intensity might be more accurate.43 
Major strengths of the current study are its prospective population-based design, large 
sample size of adults aged over 55 and relatively long follow-up period. Furthermore, we had an 
accurate method of outcome ascertainment and were able to adjust for several factors, thereby 
minimizing the possibility of the observed associations being explained by confounding. In 
addition, we included a number of different activities while adjusting for the remaining activities, 
which enabled us to examine their independent associations with CHD.  
 
Conclusions 
In summary, in this population of older adults, we found that total PA, and more specifically 
cycling and domestic work, were associated with lower CHD risk. Engaging in both cycling and 
domestic work resulted in greater risk reduction than performing either activity alone. Therefore, 
public health efforts should focus on promoting PA with the aim to prevent CHD. 
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SUPPLEMENT CHAPTER 4.1 
Supplement 4.1.1. Five most frequent reported sports for men and women in the Rotterdam 
Study, 1997-2012 
  Sport Ainsworth 
codea 
Intensity 
(MET)a 
Ainsworth 
descriptiona 
No. (%)  of men 
or women 
Men Billiards 15080 2,5 billiards 236 (10.4) 
  Swimming 18240 5,8 swimming laps, 
freestyle, front crawl, 
slow, light or 
moderate effort 
208 (9.1) 
  Tennis 15675 7,3 tennis, general 158 (6.9) 
  Fishing 4001 3,5 fishing, general 136 (6.0) 
  Gymnastics 15300 3,8 gymnastics, general 121 (5.3) 
              
Women Gymnastics 15300 3,8 gymnastics, general 445 (12.3) 
  Swimming 18240 5,8 swimming laps, 
freestyle, slow, light 
or moderate effort 
385 (10.6) 
  Yoga 2150 2,5 yoga, hatha 142 (3.9) 
  Stretching 2101 2,3 stretching, mild 178 (4.9) 
  Tennis 15675 7,3 tennis, general 130 (3.6) 
Abbreviations: MET, metabolic equivalent of task; no, number 
a This information was derived from the Compendium of Physical Activities 2011.1  
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SUPPLEMENT CHAPTER 4.1 
Supplement 4.1.1. Five most frequent reported sports for men and women in the Rotterdam 
Study, 1997-2012 
  Sport Ainsworth 
codea 
Intensity 
(MET)a 
Ainsworth 
descriptiona 
No. (%)  of men 
or women 
Men Billiards 15080 2,5 billiards 236 (10.4) 
  Swimming 18240 5,8 swimming laps, 
freestyle, front crawl, 
slow, light or 
moderate effort 
208 (9.1) 
  Tennis 15675 7,3 tennis, general 158 (6.9) 
  Fishing 4001 3,5 fishing, general 136 (6.0) 
  Gymnastics 15300 3,8 gymnastics, general 121 (5.3) 
              
Women Gymnastics 15300 3,8 gymnastics, general 445 (12.3) 
  Swimming 18240 5,8 swimming laps, 
freestyle, slow, light 
or moderate effort 
385 (10.6) 
  Yoga 2150 2,5 yoga, hatha 142 (3.9) 
  Stretching 2101 2,3 stretching, mild 178 (4.9) 
  Tennis 15675 7,3 tennis, general 130 (3.6) 
Abbreviations: MET, metabolic equivalent of task; no, number 
a This information was derived from the Compendium of Physical Activities 2011.1  
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Supplement 4.1.4. Association between total PA and different types of PA and CHD, without 
domestic work, in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of Physical 
Activity 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 13.0  <21.0 1,967/272 1.00 Referent 
2 31.5  21.1-43.5 1,968/195 0.82  0.74, 0.90 
3 68.9  ≥43.6 1,966/175 0.75  0.62, 0.91 
Per 10 MET·hours·week-1 0.96  0.94, 0.98 
P for trend 0.004 
Walkingc 
1 9.0   <15.0 2,102/223 1.00 Referent 
2 21.0   15.1-30.0 2,009/235 1.13  0.94, 1.36 
3 49.5   ≥30.1 1,790/184 0.93  0.76, 1.13 
Per 10 MET·hours·week-1 0.98  0.95, 1.01 
P for trend 0.50 
Cyclingd 
1 0.0   0.0 2,488/324 1.00 Referent 
2 6.0   0.0-12.0 1,871/182 0.75  0.61, 0.92 
3 24.0   ≥12.1 1,542/136 0.69  0.56, 0.86 
P for trend <.001 
Gardeninge 
1 0.0   0.0 3,448/401 1.00 Referent 
2 4.0   0.0-6.0 1,514/138 0.87  0.71, 1.06 
3 14.0   ≥6.1 939/103 0.97  0.77, 1.21 
P for trend 0.50 
Sportsf 
1 0.0   0.0 3,768/439 1.00 Referent 
2 5.5  0.0-7.6 1,073/96 0.82  0.65, 1.02 
3 19.9  ≥7.7 1,060/107 0.92  0.74, 1.14 
P for trend 0.23 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education.  
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 0.5, 1.1 and 2.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
e Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
f Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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Supplement 4.1.5. Association between total PA and different types of PA and CHD in non-
workers, in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 45.5  <64.3 1,715/238 1.00 Referent 
2 80.0  64.4-99.8 1,714/174 0.82  0.67, 1.00 
3 128.9  ≥99.9 1,713/154 0.72  0.58, 0.90 
Per 10 MET·hours·week-1   0.95, 0.99 
P for trend   0.003 
Walkingc   
1 9.0  <15.8 1,712/185 1.00 Referent 
2 21.0  15.9-30.0 1,782/205 1.23  1.00, 1.51 
3 51.0  ≥30.1 1,648/176 1.06  0.86, 1.31 
Per 10 MET·hours·week-1   0.96, 1.03 
P for trend   0.55 
Domestic workd   
1 14.1  <28.0 1,520/224 1.00 Referent 
2 36.3  28.1-48.2 1,784/192 0.83  0.67, 1.03 
3 59.5  ≥48.3 1,838/150 0.70  0.55, 0.90 
Per 10 MET·hours·week-1   0.89, 0.98 
P for trend   0.01 
Cyclinge   
1 0.0  0.0 2,256/294 1.00 Referent 
2 6.0  <12.0 1,543/144 0.73  0.66, 0.82 
3 24.0  ≥12.1 1,343/128 0.76  0.61, 0.96 
P for trend   0.01 
Gardeningf   
1 0.0  0.0 3,108/371 1.00 Referent 
2 4.0  <6.0 1,211/104 0.80  0.64, 1.00 
3 14.0  ≥6.1 823/91 0.97  0.77, 1.24 
P for trend   0.43 
Sportsg   
1 0.0  0.0 3,334/394 1.00 Referent 
2 5.3  <8.4 905/80 0.81  0.64, 1.03 
3 18.0  ≥8.5 903/92 0.92  0.73, 1.16 
P for trend 0.25 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.6, 2.9 and 4.6 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 146 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 34, 89 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 8 and 28 
minutes per day of sports. 
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Supplement 4.1.4. Association between total PA and different types of PA and CHD, without 
domestic work, in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of Physical 
Activity 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 13.0  <21.0 1,967/272 1.00 Referent 
2 31.5  21.1-43.5 1,968/195 0.82  0.74, 0.90 
3 68.9  ≥43.6 1,966/175 0.75  0.62, 0.91 
Per 10 MET·hours·week-1 0.96  0.94, 0.98 
P for trend 0.004 
Walkingc 
1 9.0   <15.0 2,102/223 1.00 Referent 
2 21.0   15.1-30.0 2,009/235 1.13  0.94, 1.36 
3 49.5   ≥30.1 1,790/184 0.93  0.76, 1.13 
Per 10 MET·hours·week-1 0.98  0.95, 1.01 
P for trend 0.50 
Cyclingd 
1 0.0   0.0 2,488/324 1.00 Referent 
2 6.0   0.0-12.0 1,871/182 0.75  0.61, 0.92 
3 24.0   ≥12.1 1,542/136 0.69  0.56, 0.86 
P for trend <.001 
Gardeninge 
1 0.0   0.0 3,448/401 1.00 Referent 
2 4.0   0.0-6.0 1,514/138 0.87  0.71, 1.06 
3 14.0   ≥6.1 939/103 0.97  0.77, 1.21 
P for trend 0.50 
Sportsf 
1 0.0   0.0 3,768/439 1.00 Referent 
2 5.5  0.0-7.6 1,073/96 0.82  0.65, 1.02 
3 19.9  ≥7.7 1,060/107 0.92  0.74, 1.14 
P for trend 0.23 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education.  
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 0.5, 1.1 and 2.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
e Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
f Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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Supplement 4.1.5. Association between total PA and different types of PA and CHD in non-
workers, in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 45.5  <64.3 1,715/238 1.00 Referent 
2 80.0  64.4-99.8 1,714/174 0.82  0.67, 1.00 
3 128.9  ≥99.9 1,713/154 0.72  0.58, 0.90 
Per 10 MET·hours·week-1   0.95, 0.99 
P for trend   0.003 
Walkingc   
1 9.0  <15.8 1,712/185 1.00 Referent 
2 21.0  15.9-30.0 1,782/205 1.23  1.00, 1.51 
3 51.0  ≥30.1 1,648/176 1.06  0.86, 1.31 
Per 10 MET·hours·week-1   0.96, 1.03 
P for trend   0.55 
Domestic workd   
1 14.1  <28.0 1,520/224 1.00 Referent 
2 36.3  28.1-48.2 1,784/192 0.83  0.67, 1.03 
3 59.5  ≥48.3 1,838/150 0.70  0.55, 0.90 
Per 10 MET·hours·week-1   0.89, 0.98 
P for trend   0.01 
Cyclinge   
1 0.0  0.0 2,256/294 1.00 Referent 
2 6.0  <12.0 1,543/144 0.73  0.66, 0.82 
3 24.0  ≥12.1 1,343/128 0.76  0.61, 0.96 
P for trend   0.01 
Gardeningf   
1 0.0  0.0 3,108/371 1.00 Referent 
2 4.0  <6.0 1,211/104 0.80  0.64, 1.00 
3 14.0  ≥6.1 823/91 0.97  0.77, 1.24 
P for trend   0.43 
Sportsg   
1 0.0  0.0 3,334/394 1.00 Referent 
2 5.3  <8.4 905/80 0.81  0.64, 1.03 
3 18.0  ≥8.5 903/92 0.92  0.73, 1.16 
P for trend 0.25 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.6, 2.9 and 4.6 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 146 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 34, 89 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 8 and 28 
minutes per day of sports. 
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Supplement 4.1.6. Association between total PA and different types of PA and CHD, without 
cases in first two years in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 42.4  <61.7 1,932/217 1.00 Referent 
2 77.8  61.8-97.3 1,932/169 0.85  0.69, 1.04 
3 126.9  ≥97.4 1,932/151 0.74  0.60, 0.92 
Per 10 MET·hours·week-1     0.97  
P for trend    0.007 
Walkingc      
1 9.0  <15.0 2,070/191 1.00 Referent 
2 21.0  15.1- 30.0 1,967/193 1.10  0.99, 1.22 
3 49.5  ≥30.1 1,759/153 0.91  0.73, 1.14 
Per 10 MET·hours·week-1     0.99  
P for trend    0.45 
Domestic workd      
1 13.0  <25.3 1,935/227 1.00 Referent 
2 36.4  25.4-46.6 1,929/171 0.82  0.71, 0.94 
3 59.5  ≥46.7 1,932/139 0.72  0.56, 0.93 
Per 10 MET·hours·week-1     0.94  
P for trend    0.01 
Cyclinge      
1 0.0  0.0 2,434/270 1.00 Referent 
2 6.0  <12.0 1,841/152 0.75  0.61, 0.93 
3 24.0  ≥12.1 1,521/115 0.71  0.56, 0.90 
P for trend    0.003 
Gardeningf      
1 0.0  0.0 3,385/338 1.00 Referent 
2 4.0  <6.0 1,494/118 0.87  0.70, 1.09 
3 14.0  ≥6.1 917/81 0.90  0.70, 1.16 
P for trend    0.29 
Sportsg      
1 0.0  0.0 3,687/358 1.00 Referent 
2 5.5  <9.3 1,062/85 0.88  0.69, 1.12 
3 20.0  ≥9.4 1,047/94 1.01  0.79, 1.27 
P for trend    0.79 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.5, 2.8 and 4.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 32, 89 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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Supplement 4.1.7. Association between total PA and different types of PA and CHD in the original 
dataset without imputation (n=4232), in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 45.7  <64.5 1,411/195 1.00 Referent 
2 80.7  64.6-101.0 1,411/128 0.71  0.56, 0.89 
3 131.1  ≥101.1 1,410/125 0.69  0.55, 0.87 
Per 10 MET·hours·week-1     0.97  
P for trend    0.004 
Walkingc      
1 9.0  <15.0 1,422/148 1.00 Referent 
2 21.0  15.1-30.0 1,429/162 1.10  0.88, 1.38 
3 52.5  ≥30.1 1,381/138 0.94  0.74, 1.19 
Per 10 MET·hours·week-1     0.99  
P for trend    0.61 
Domestic workd      
1 14.2  <26.6 1,410/193 1.00 Referent 
2 37.6  26.7-47.4 1,412/138 0.84  0.66, 1.08 
3 59.8  ≥47.5 1,410/117 0.81  0.61, 1.08 
Per 10 MET·hours·week-1     0.98  
P for trend    0.14 
Cyclinge      
1 0.0  0.0 1,654/211 1.00 Referent 
2 6.0  <12.0 1,392/131 0.74  0.58, 0.93 
3 22.0  ≥12.1 1,186/106 0.70  0.54, 0.90 
P for trend    0.004 
Gardeningf      
1 0.0  0.0 2,389/270 1.00 Referent 
2 4.0  <6.0 1,133/102 0.88  0.70, 1.12 
3 14.0  ≥6.1 710/76 0.97  0.74, 1.26 
P for trend    0.61 
Sportsg      
1 0.0  0.0 2,683/314 1.00 Referent 
2 5.4  <9.1 775/60 0.70  0.53, 0.93 
3 19.5  ≥9.2 774/74 0.85  0.65, 1.10 
P for trend    0.07 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.6, 2.9 and 4.7 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 150 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 35, 92 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 47 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 8 and 30 
minutes per day of sports. 
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Supplement 4.1.6. Association between total PA and different types of PA and CHD, without 
cases in first two years in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 42.4  <61.7 1,932/217 1.00 Referent 
2 77.8  61.8-97.3 1,932/169 0.85  0.69, 1.04 
3 126.9  ≥97.4 1,932/151 0.74  0.60, 0.92 
Per 10 MET·hours·week-1     0.97  
P for trend    0.007 
Walkingc      
1 9.0  <15.0 2,070/191 1.00 Referent 
2 21.0  15.1- 30.0 1,967/193 1.10  0.99, 1.22 
3 49.5  ≥30.1 1,759/153 0.91  0.73, 1.14 
Per 10 MET·hours·week-1     0.99  
P for trend    0.45 
Domestic workd      
1 13.0  <25.3 1,935/227 1.00 Referent 
2 36.4  25.4-46.6 1,929/171 0.82  0.71, 0.94 
3 59.5  ≥46.7 1,932/139 0.72  0.56, 0.93 
Per 10 MET·hours·week-1     0.94  
P for trend    0.01 
Cyclinge      
1 0.0  0.0 2,434/270 1.00 Referent 
2 6.0  <12.0 1,841/152 0.75  0.61, 0.93 
3 24.0  ≥12.1 1,521/115 0.71  0.56, 0.90 
P for trend    0.003 
Gardeningf      
1 0.0  0.0 3,385/338 1.00 Referent 
2 4.0  <6.0 1,494/118 0.87  0.70, 1.09 
3 14.0  ≥6.1 917/81 0.90  0.70, 1.16 
P for trend    0.29 
Sportsg      
1 0.0  0.0 3,687/358 1.00 Referent 
2 5.5  <9.3 1,062/85 0.88  0.69, 1.12 
3 20.0  ≥9.4 1,047/94 1.01  0.79, 1.27 
P for trend    0.79 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.5, 2.8 and 4.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 32, 89 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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Supplement 4.1.7. Association between total PA and different types of PA and CHD in the original 
dataset without imputation (n=4232), in the Rotterdam Study, 1997-2012, presented for model 2 
Activity Type and 
Tertile of PA 
Median MET-
hours per week Range 
No. Ps/CHD 
events Model 2a 
HR 95%CI 
Total Physical Activityb 
1 45.7  <64.5 1,411/195 1.00 Referent 
2 80.7  64.6-101.0 1,411/128 0.71  0.56, 0.89 
3 131.1  ≥101.1 1,410/125 0.69  0.55, 0.87 
Per 10 MET·hours·week-1     0.97  
P for trend    0.004 
Walkingc      
1 9.0  <15.0 1,422/148 1.00 Referent 
2 21.0  15.1-30.0 1,429/162 1.10  0.88, 1.38 
3 52.5  ≥30.1 1,381/138 0.94  0.74, 1.19 
Per 10 MET·hours·week-1     0.99  
P for trend    0.61 
Domestic workd      
1 14.2  <26.6 1,410/193 1.00 Referent 
2 37.6  26.7-47.4 1,412/138 0.84  0.66, 1.08 
3 59.8  ≥47.5 1,410/117 0.81  0.61, 1.08 
Per 10 MET·hours·week-1     0.98  
P for trend    0.14 
Cyclinge      
1 0.0  0.0 1,654/211 1.00 Referent 
2 6.0  <12.0 1,392/131 0.74  0.58, 0.93 
3 22.0  ≥12.1 1,186/106 0.70  0.54, 0.90 
P for trend    0.004 
Gardeningf      
1 0.0  0.0 2,389/270 1.00 Referent 
2 4.0  <6.0 1,133/102 0.88  0.70, 1.12 
3 14.0  ≥6.1 710/76 0.97  0.74, 1.26 
P for trend    0.61 
Sportsg      
1 0.0  0.0 2,683/314 1.00 Referent 
2 5.4  <9.1 775/60 0.70  0.53, 0.93 
3 19.5  ≥9.2 774/74 0.85  0.65, 1.10 
P for trend    0.07 
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; 
n/a, not applicable; PA, physical activity; Ps, participants; Ref, referent; T, tertile. 
a Model 2 was adjusted for age, sex, all other PA types, smoking, alcohol consumption, diet and education. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.6, 2.9 and 4.7 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 150 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 35, 92 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 47 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5. The median levels of sports across categories are therefore equivalent to 0, 8 and 30 
minutes per day of sports. 
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ABSTRACT 
Background: The association between physical activity (PA) and atrial fibrillation(AF) 
remains controversial. PA has been associated with a higher and lower AF risk. These 
inconsistent results might be related to the type of PA. We aimed to investigate the 
association of total and types of PA including walking, cycling, domestic work, gardening and 
sports, with AF. 
Methods: Our study was performed in the Rotterdam Study, a prospective population-based 
cohort. We included 7,018 participants aged 55 years and older with information on PA 
between 1997-2001. Cox proportional hazards models were used to examine the association 
of PA with AF risk. Models were adjusted for biological and behavioural risk factors and the 
remaining PA types. PA was categorised in tertiles and the low group was used as reference. 
Results: During 16.8 years of follow-up (median: 12.3 years, interquartile range: 8.7-15.9 
years), 800 AF events occurred (11.4% of the study population). We observed no association 
between total PA and AF risk in any model. After adjustment for confounders, the hazard 
ratio and 95%confidence interval for the high PA category compared to the low PA category 
was: 0.71(0.80,1.14) for total PA. We did not observe a significant association between any of 
the PA types with AF risk.  
Conclusion: Our results suggest no association between PA and a higher or lower risk of 
incident AF. Neither total PA nor any of the included PA types was associated with AF risk. 
However, considering the beneficial effect of PA on other health outcomes, PA should still be 
encouraged for overall health promotion. 
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INTRODUCTION 
Physical activity (PA) has been extensively proven to reduce the risk of cardiovascular disease 
(CVD) and all-cause mortality.1,2 However, it remains unclear whether all cardiovascular 
conditions, including atrial fibrillation (AF), may benefit from PA. AF is the most common 
chronic cardiac arrhythmia with significant morbidity and mortality.3 Known risk factors of AF, 
such as heart failure (HF) and myocardial infarction (MI), are directly influenced by the level of 
PA.1,2 Therefore, since increasing PA levels decrease the risk of HF and MI, it might also reduce 
the risk of AF.  
Results regarding the relation between PA an AF remain controversial.4-6 Meta-analyses of 
mostly prospective cohort studies with ages of participants ranging from 40 up to 75 years found 
no significant association between leisure time PA and AF risk in pooled analyses.4,5 However, it 
has been hypothesized that the relation between PA and AF is U-shaped, with lower risk when 
exercising moderately in terms of intensity as well as duration but not when exercising 
vigorously.7,8 As intensity is related to the type of PA, this implies that the association between PA 
and AF risk might be related to the type of PA in which adults engage in. In a study among 5,446 
older adults with a mean age of 73 years, higher levels of walking and running were associated 
with lower AF risk.7 Furthermore, Drca et al. found cycling and walking among older men (mean 
age 60 years) to be inversely related to AF risk.9 In addition to walking and cycling, older people 
engage in several other PA types, including gardening, domestic work or sports in general. These 
different PA types vary in intensity, frequency and duration, and might be associated with AF risk 
in different ways. Furthermore, for older people who cannot engage in certain leisure-time 
activities or other exercise and perform activities differently from younger and middle-aged 
adults, health effects of other PA types performed by elderly might by informative and crucial in 
lowering their AF risk. Since overall PA levels tend to decrease with age this is especially 
important.10 
Therefore, we aim to examine the association between total PA and AF incidence in a 
population of older adults, aged 55 years and over. Furthermore, we will assess the independent 
association of different types of PA including walking, gardening, domestic work, sports and 
cycling with AF incidence. 
 
METHODS 
Study population 
This study was embedded within the Rotterdam Study (RS), a prospective population-based 
cohort study among subjects aged 55 years or older in the municipality of Rotterdam, the 
Netherlands. Between 1990 and 1993 the baseline examination of the original cohort was 
performed (RS-I). The RS was extended in 2000-2001 with 3,011 participants who had either 
become 55 years old or had moved into the study district (RS-II). For this study, we used data 
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from the participants attending the third examination of the original cohort (RS-I-3, between 
1997 and 1999; n = 4,797) and the participants attending the first examination of the extended 
cohort (RS-II-1, between 2000 and 2001; n = 3,011).11 7,310 participants completed PA data 
collection. Subjects with prevalent AF were excluded (n=205) (See Figure 4.2.1). Following, 54 
subjects were excluded due to not provided, or withdrawn, informed consent for collection of 
follow-up data. 33 cases were removed because of unreliable PA values or missing follow-up data. 
A total of 7,018 subjects were included in the analyses. Baseline information was collected by 
trained research assistants who interviewed the participants at home. All subject gave written 
consent, and the study protocol was approved by the medical ethics committee according to the 
Wet Bevolkingsonderzoek ERGO (Population Study Act Rotterdam Study), executed by the 
Ministry of Health, Welfare and Sport of The Netherlands. Detailed information on the design of 
the Rotterdam Study can be found elsewhere.11  
Physical activity assessment 
PA levels were assessed with an adapted version of the Zutphen Physical Activity Questionnaire.12 
The original questionnaire has been validated with a test-retest reliability of 0.93 and a correlation 
with doubly labelled water of 0.61.13 The questionnaire contains questions on walking, cycling, 
sports, gardening and hobbies. Questions on domestic work were added to obtain a more reliable 
estimate of the PA level in this age group. Detailed information on the collection of PA can be 
found elsewhere.14  
We used metabolic equivalent of task (MET) to quantify the intensity of an activity 
according to the 2011 updated version of the Compendium of Physical.15 Sports that were 
mentioned in the questionnaire that were not in this compendium were not used in the analyses 
(n=33). Finally, we calculated MET hours per week in total PA (i.e. the sum of cycling, walking, 
sports, domestic work and gardening) and in every type of PA (cycling, walking, sports, domestic 
work, gardening). 
Assessment of covariates 
Covariates were assessed when participants visited the study centre or collected through home 
interviews as described previously.14,16,17 Prevalent cardiovascular disease and diabetes was 
determined using medical records and used as binary variable (present/not present). Alcohol 
consumption was measured by interview and defined as glasses per day. Smoking was categorized 
as current, former or never. Height and weight were measured during the centre visit, and body 
mass index (BMI) was calculated as weight divided by height squared (kg/m2). Blood pressure was 
measured twice with the participant seated, measuring the right brachial artery using a random 
zero sphygmomanometer. The mean of the two consecutive measurements in mmHg was used as 
a continuous variable in our analyses. Hypertension was defined as either a diastolic blood 
pressure 90 mmHg and above, a systolic blood pressure of 140 mmHg and above or the use of 
anti-hypertensive medication. Medication use was determined during the home interviews for 
anti-thrombotic agents and angiotensin converting enzyme (ACE)-inhibitors. With an automated 
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enzymatic procedure (Boehringer Mannheid System, Mannheim, Germany) the serum total 
cholesterol and high-density lipoprotein (HDL) cholesterol was measured and expressed in 
mg/dL. As an indication of socio-economic status, educational level was used and divided in 
primary, junior vocational/academic education and higher vocational/academic education. 
Dietary information was obtained by a semi-quantitative food frequency questionnaire consisting 
of 170 items.18 For part of the study sample (n=4,374 from RS-I-3), 
 
Figure 4.2.1. Flow chart of participant inclusion for the Rotterdam Study, 1997-2012. 
497 subjects excluded due to no PA 
collection 
205 subjects with prevalent AF 
54 subjects were excluded due to not 
provided, or withdrawn, informed 
consent for collection of follow-up 
data and due to missing follow-up 
data 
33 cases were deleted due to unreliable 
completion of PA data collection 
RS-I visit 3, between 1997 and 1999; n=4,796 
RS-II visit 1, between 2000 and 2001; n=3,011 
Total: 7,807 
7,310 
7,105 
7,051 
7,018 Participants Included in Analyses 
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Dietary information was not obtained at the same time as the PA data. Therefore, dietary 
information from the first wave (1989-1993) of the original cohort (RS-I) was used to calculate an 
overall healthy diet score, based on Dutch dietary guidelines.19  
Clinical outcome 
The main outcome measure under study was AF. Data on clinical outcomes were collected 
through an automated follow-up system involving digital linkage of the study database to medical 
records maintained by general practitioners working in the research area. Trained research 
assistants collected notes, outpatient clinic reports, hospital discharge letters and 
electrocardiograms (ECG). AF was coded as an event when it had been diagnosed with a 12 lead 
ECG. Research physicians independently adjudicated all data on potential events. Medical 
specialists reviewed potential cases as a final decision. Follow-up was complete until January 1, 
2014. 
Statistical analysis 
Due to their non-normal distribution, all five PA types and total PA were categorized into tertiles. 
Total PA, walking domestic work were divided into three categories of equal size by the 33rd and 
66th percentiles of MET·hours·week-1. Since a large proportion of the participants did not 
participate in sports, gardening and cycling, the bottom category for these types was no 
participation and the remaining two categories were created by using the median.14 We assessed 
the association of total PA and all types of PA with incident AF with Cox proportional hazards, 
after confirming that the assumption for proportional hazards was met. The underlying timescale 
in these models was follow-up time, defined as the time between PA assessment and the first fatal 
or nonfatal AF event, death, or censoring at January 1, 2014.  
To minimize confounding, covariates were added separately in different models. Model 1 
was adjusted for age and sex. Model 2 was the model additionally adjusted for behavioural risk 
factors, including smoking, prevalent CVD, alcohol consumption, diet quality and education. For 
the PA types, model 2 was also adjusted for the MET·hours·week-1 in all other PA types. In Model 
3 we additionally adjusted for biological risk factors, including BMI, total and HDL-cholesterol, 
diabetes, lipid reducing agents, systolic and diastolic blood pressure, anti-thrombotic agents and 
ACE-inhibitor use. The decision to include confounders in the multivariable regression models 
was based on previous literature or >10% change of the effect estimate in the crude model.4,5 PA 
variables were entered as categorical variables (tertiles) in the separate models.  
We performed stratified analyses by sex and age (below 65 years and 65 years and above). 
Furthermore, to see whether our results would be driven by underlying CVD, we performed an 
additional analysis by excluding participants with prevalent CVD (n=5997). Finally, since we did 
not obtain occupational PA data, we analysed our data in non-workers (n=6197).  
Our data contained missing values for diet (28.7%), systolic and diastolic blood pressure 
(10.2%), BMI (10.6%), total cholesterol (13.2%) and HDL- cholesterol (14.2%). Other covariates 
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had <10% missing data. Missing variables were calculated by IBM statistics with the multiple 
imputation (n=5 imputations) function based on the distribution of existing data.  
 
RESULTS 
Baseline characteristics of the study population are shown in Table 4.2.1. During 16.8 years of 
follow up (median: 12.6 years) 800 AF events occurred (11.4% of the study population). Of the 
7018 included participants, 4083 (58.2%) were female and the mean (standard deviation (SD)) age 
among men and women was 69.4 (8.3) years at enrolment. The mean (SD) level of physical 
activity was 80.9 (44.0) MET·hours·week-1, corresponding to 2.9 hours/day of moderate intensity 
PA of 4 METs.  
Table 4.2.2 shows the multivariable-adjusted hazard ratios (HRs) with their 95% confidence 
interval (95%CI) for total PA and every PA type. For total PA, the median levels of 
MET·hours·week-1 across the three tertiles were 38.7 MET·hours·week-1 in the low group, 74.7 
MET·hours·week-1 in the medium group and 123.2 MET·hours·week-1 in the high group. This 
corresponds to 1.4 hours/day of moderate intensity PA of 4 METs for the low group, 2.7 
hours/day for the medium group and 4.4 hours/day for the high group.   
In the model adjusted for behavioural risk factors (model 2) the HR (95% CI) of the 
medium and high groups, compared to the low group, were 1.05 (0.89-1.24) and 0.71 (0.80-1.14), 
respectively, with P for trend 0.58.  
For all five PA types, we did not observe a significant association with AF risk in the crude 
model, the model adjusted for behavioural risk factors (model 2), or in the model after adjustment 
for biological risk factors (model 3). Furthermore, we did not observe a significant trend across 
categories in any of the analyses. For example, the HR (95% CI) for the high category of walking 
and cycling were 1.00 (0.84-1.20) and 0.92 (0.76-1.12), respectively, compared to the low 
categories, with P for trend 0.98 and 0.43, respectively.  
Our sensitivity analysis split by age and sex showed some differences in HRs between the 
groups, but the results remained non-significant (Supplement 4.2.1 – Supplement 4.2.2). 
Moreover, excluding working people or excluding participants who previously were diagnosed 
with a CVD did not change the results (Supplement 4.2.3 – Supplement 4.2.4).  
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Table 4.2.1. Baseline participant characteristics by tertile of total PA, Rotterdam Study, 1997-2012 
  Tertiles of total PA, MET∙hours∙week-1 
Median (range), MET∙hours∙week-1 
40.6  
(<58.1) 
74.9  
(58.1-94.2) 
124.8 
(≥94.2) 
Participants, n (%) 2,340 (33.3) 2,340 (33.3) 2,338 (33.3) 
Demographic factors 
Age, years 71.4 (9.6) 68.9 (7.7) 67.6 (7.0) 
Female, n (%) 1,016 (43.4) 1,462 (62.4) 1,605 (68.6) 
Primary education, n (%) 371 (15.9) 316 (13.5) 336 (14.3) 
Physical activity 
Sports, hours/week 2.0 (5.1) 4.3 (8.5) 10.1 (18.3) 
Walking, hours/week 12.3 (9.1) 23.0 (13.6) 47.0 (30.0) 
Cycling, hours/week 2.7 (5.3) 7.8 (10.1) 15.2 (17.3) 
Gardening, hours/week 1.5 (3.6) 3.2 (6.9) 6.6 (13.2) 
Domestic work, hours/week 18.0 (12.5) 37.0 (16.6) 52.4 (24.8) 
Lifestyle factors 
Alcohol, glasses/day 1.1 (1.6) 1.0 (1.5) 1.0 (1.3) 
Currently smoking, n (%) 450 (19.2) 415 (17.7) 401 (17.2) 
Diet score 54.7 (10.5) 55.9 (11.0) 56.5 (10.5) 
Biological risk factors 
Body mass indexa 27.1 (4.1) 27.1 (4.1) 26.7 (3.8) 
Cholesterol level, mg/dl 219.4 (39.7) 225.1 (36.6) 229.2 (37.4) 
HDL-cholesterol level, mg/dl 50.9 (14.5) 54.0 (15.1) 55.7 (15.1) 
Systolic blood pressure, mmHg 145.8 (21.3) 144.0 (21.8) 142.1 (20.8) 
Having diabetes, n (%) 514 (22) 361 (15.4) 276 (11.8) 
Using serum lipid reducing agents, n (%) 300 (12.8) 316 (13.5) 286 (12.2) 
Using ACE-inhibitors, n (%) 337 (14.4) 312 (13.3) 238 (10.2) 
Using anti-trombotic agents, n (%) 661 (28.2) 456 (19.5) 355 (15.2) 
Using anti-hypertensive medication with 
the indication of hypertension, n (%) 
646 (28) 620 (26.5) 500 (21.3) 
AF cases 
AF event, n (%) 259 (11.1) 285 (12.2) 256 (10.9) 
Time to event, years, n (%) 9.2 (4.8) 11.2 (4.0) 11.9 (3.8) 
Abbreviations: AF, atrial fibrillation; HDL, high density lipoprotein; MET, metabolic equivalent of task; SD, standard 
deviation. 
a Weight (kg)/height (m)2 
Results are presented as mean (SD) unless otherwise stated.  
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Table 4.2.1. Baseline participant characteristics by tertile of total PA, Rotterdam Study, 1997-2012 
  Tertiles of total PA, MET∙hours∙week-1 
Median (range), MET∙hours∙week-1 
40.6  
(<58.1) 
74.9  
(58.1-94.2) 
124.8 
(≥94.2) 
Participants, n (%) 2,340 (33.3) 2,340 (33.3) 2,338 (33.3) 
Demographic factors 
Age, years 71.4 (9.6) 68.9 (7.7) 67.6 (7.0) 
Female, n (%) 1,016 (43.4) 1,462 (62.4) 1,605 (68.6) 
Primary education, n (%) 371 (15.9) 316 (13.5) 336 (14.3) 
Physical activity 
Sports, hours/week 2.0 (5.1) 4.3 (8.5) 10.1 (18.3) 
Walking, hours/week 12.3 (9.1) 23.0 (13.6) 47.0 (30.0) 
Cycling, hours/week 2.7 (5.3) 7.8 (10.1) 15.2 (17.3) 
Gardening, hours/week 1.5 (3.6) 3.2 (6.9) 6.6 (13.2) 
Domestic work, hours/week 18.0 (12.5) 37.0 (16.6) 52.4 (24.8) 
Lifestyle factors 
Alcohol, glasses/day 1.1 (1.6) 1.0 (1.5) 1.0 (1.3) 
Currently smoking, n (%) 450 (19.2) 415 (17.7) 401 (17.2) 
Diet score 54.7 (10.5) 55.9 (11.0) 56.5 (10.5) 
Biological risk factors 
Body mass indexa 27.1 (4.1) 27.1 (4.1) 26.7 (3.8) 
Cholesterol level, mg/dl 219.4 (39.7) 225.1 (36.6) 229.2 (37.4) 
HDL-cholesterol level, mg/dl 50.9 (14.5) 54.0 (15.1) 55.7 (15.1) 
Systolic blood pressure, mmHg 145.8 (21.3) 144.0 (21.8) 142.1 (20.8) 
Having diabetes, n (%) 514 (22) 361 (15.4) 276 (11.8) 
Using serum lipid reducing agents, n (%) 300 (12.8) 316 (13.5) 286 (12.2) 
Using ACE-inhibitors, n (%) 337 (14.4) 312 (13.3) 238 (10.2) 
Using anti-trombotic agents, n (%) 661 (28.2) 456 (19.5) 355 (15.2) 
Using anti-hypertensive medication with 
the indication of hypertension, n (%) 
646 (28) 620 (26.5) 500 (21.3) 
AF cases 
AF event, n (%) 259 (11.1) 285 (12.2) 256 (10.9) 
Time to event, years, n (%) 9.2 (4.8) 11.2 (4.0) 11.9 (3.8) 
Abbreviations: AF, atrial fibrillation; HDL, high density lipoprotein; MET, metabolic equivalent of task; SD, standard 
deviation. 
a Weight (kg)/height (m)2 
Results are presented as mean (SD) unless otherwise stated.  
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DISCUSSION 
In this population-based study of adults aged 55 years and over, we found no evidence for an 
association between PA and AF risk over 16.8 years of follow-up. Total PA was not associated 
with an in- or decreased AF risk and we did not observe an association for any of the PA types 
with AF.  
Our findings are in concordance with two meta-analyses, which do not support an 
association between leisure-time PA and incidence of AF.4,5 In these meta-analyses, no association 
was found for moderate or vigorous PA compared to a sedentary life style. However analysed 
studies were heterogeneous whether PA was assessed for duration, intensity or life-time exposure 
or a combination of those three. More recently, a meta-analysis of 13 prospective studies found no 
association between total life-time PA exposure and AF risk, nor between vigorous intensity PA 
and risk of AF.6 However when sex-stratified total physical activity exposure was associated with 
an increased risk of AF in men. 6 
Our results contradict a number of recent cohort studies, reporting that moderate intensity 
PA or leisure-time PA is associated with a lower risk of AF.7,9,20 Between these studies, the shape of 
the association varies. One study found a J-shaped association with initially lower risk of AF for 
moderate PA levels of at least 4 hours of exercise per week. The risk of AF however steeply rises 
when exercising vigorously in terms of intensity and duration.20 Others observed a U-shaped 
association, with the lowest risk for participants that exercised at moderate intensity,21 for 
example walking at 6.5 kilometers per hour (km/h) or cycling at 16-19 km/h.7-9 The widely 
varying categorizing of PA and different cultural patterns of sport seem to limit the comparisons 
between existing studies.22 Moreover, only three studies examined the association between PA and 
AF risk among elderly participants.7,9,23 One study found that older men (mean age of 60 years) 
participating in walking and cycling at baseline were at lower risk of AF, compared to individuals 
almost never engaging in these activities.9 Additionally, in a study of the same research group in 
older women, higher levels of leisure time PA were associated with lower risk of AF.23 In another 
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walking were associated with progressively lower AF risk.7 In this study, both walking distance 
and walking pace was assessed, whereas only information on walking duration was obtained in the 
current study. The different results between this study and our study might be explained by this 
methodological difference. For example, in our study it’s possible that two persons both reported 
1 hour of walking per week, but that one person walked 4 km within this time frame, whereas 
another walked 6 km. In this case, the discriminative power of our walking estimate might be too 
low to find an association with AF. Future studies on the association between walking and AF 
should therefore collect information on walking duration, walking pace and walking distance, to 
get a more complete overview of the PA pattern. 
The fact that we did not find an association between any PA variable and AF might also be 
explained by the relatively high PA levels of our population. In the low group of total PA, 
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DISCUSSION 
In this population-based study of adults aged 55 years and over, we found no evidence for an 
association between PA and AF risk over 16.8 years of follow-up. Total PA was not associated 
with an in- or decreased AF risk and we did not observe an association for any of the PA types 
with AF.  
Our findings are in concordance with two meta-analyses, which do not support an 
association between leisure-time PA and incidence of AF.4,5 In these meta-analyses, no association 
was found for moderate or vigorous PA compared to a sedentary life style. However analysed 
studies were heterogeneous whether PA was assessed for duration, intensity or life-time exposure 
or a combination of those three. More recently, a meta-analysis of 13 prospective studies found no 
association between total life-time PA exposure and AF risk, nor between vigorous intensity PA 
and risk of AF.6 However when sex-stratified total physical activity exposure was associated with 
an increased risk of AF in men. 6 
Our results contradict a number of recent cohort studies, reporting that moderate intensity 
PA or leisure-time PA is associated with a lower risk of AF.7,9,20 Between these studies, the shape of 
the association varies. One study found a J-shaped association with initially lower risk of AF for 
moderate PA levels of at least 4 hours of exercise per week. The risk of AF however steeply rises 
when exercising vigorously in terms of intensity and duration.20 Others observed a U-shaped 
association, with the lowest risk for participants that exercised at moderate intensity,21 for 
example walking at 6.5 kilometers per hour (km/h) or cycling at 16-19 km/h.7-9 The widely 
varying categorizing of PA and different cultural patterns of sport seem to limit the comparisons 
between existing studies.22 Moreover, only three studies examined the association between PA and 
AF risk among elderly participants.7,9,23 One study found that older men (mean age of 60 years) 
participating in walking and cycling at baseline were at lower risk of AF, compared to individuals 
almost never engaging in these activities.9 Additionally, in a study of the same research group in 
older women, higher levels of leisure time PA were associated with lower risk of AF.23 In another 
study among elderly men, Mozaffarian et al. found that higher levels of leisure-time PA and 
walking were associated with progressively lower AF risk.7 In this study, both walking distance 
and walking pace was assessed, whereas only information on walking duration was obtained in the 
current study. The different results between this study and our study might be explained by this 
methodological difference. For example, in our study it’s possible that two persons both reported 
1 hour of walking per week, but that one person walked 4 km within this time frame, whereas 
another walked 6 km. In this case, the discriminative power of our walking estimate might be too 
low to find an association with AF. Future studies on the association between walking and AF 
should therefore collect information on walking duration, walking pace and walking distance, to 
get a more complete overview of the PA pattern. 
The fact that we did not find an association between any PA variable and AF might also be 
explained by the relatively high PA levels of our population. In the low group of total PA, 
individuals engaged in a median level of 38.7 MET·hours·week-1of PA, corresponding to 1.4 
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hours/day of moderate intensity PA of 4 METs. Additionally, more than 98.5% of our study 
population had higher total PA levels than the recommended 7.5 MET·hours·week-1.24 
Considering the fact that the greatest health effects are usually gained at low levels of PA,9,25 it is 
possible that the participants in the low group of PA in the current study were already sufficiently 
active and where therefore not at increased AF risk. This hypothesis is supported by the relatively 
low percentage of AF cases in the current study (11.4%), compared to the 19% of AF incidence in 
a similar study population of the study of Mozaffarian at al.7 The participants in the current study 
might also have a relatively high cardiorespiratory fitness, which has been demonstrated to be 
associated with lower AF risk.26 Moreover, Kwok et al. hypothesized that a health-consciousness 
attitude might contribute to non-significant association between PA and AF risk.5 Athletes or 
active individuals participating in sports, might be more health conscious and therefore more 
often evaluated for cardiac arrhythmias.5 In comparison to individuals who perform less exercise, 
this subgroup might thus have higher rates of AF diagnoses. Subsequently, this could bias the 
association between PA and AF. 
There have been several proposed mechanisms for the association between PA and either 
higher or lower AF risk. The proposed mechanism behind the association between PA and lower 
AF risk is that PA can have a beneficial effect on several AF risk factors, including improving the 
management of hypertension and diabetes mellitus,27 assist in weight management28 and improve 
cardiac structure and function.29,30 Hypertension and obesity are linked to interstitial fibrosis, 
conduction slowing and low atrial voltages due to atrial remodeling.30 Therefore, PA or exercise 
could protect against AF. Protection of AF through exercise could lead to harm when PA is done 
frequently and with high intensity, resulting in an increased risk of AF when exercising 5-7 times 
a week.31 Pathophysiological pathways for increased AF risk following vigorous exercise are left 
atrial enlargement, left ventricular hypertrophy left ventricular dilation, inflammatory changes 
and an increase in parasympathetic tone.9,32,33 To add to the complexity, a 12-week physician-led 
program for increasing exercise activity led to a lower AF recurrence independent of weight 
changes among AF patients.34 This shows that PA might have a short-term effect on recurrent AF 
risk. Only a very limited number of individuals with prevalent AF at baseline in the current study 
had a second event (Data not shown) and therefore we could not test this effect of PA on the 
recurrence of AF in the current study. It has also been shown that life-time PA exposure and the 
intensity of PA that was performed both are related to AF risk.31 It might be that some 
participants have been very active in their young-adult and middle-aged life and this might have 
contributed to a higher AF risk in later life.31,35 In this case, our associations might be affected by 
residual confounding by previous PA levels. 
Importantly, whereas our study does not show evidence for that higher PA levels are 
associated with lower AF risk in older age, we do not refute the effect that PA can have on other 
health outcomes. In no case is the risk of exercising higher than an inactive or sedentary life 
style.25 However, with high levels of endurance training especially adults should be made aware of 
the modest increase in the risk of AF.31 But most importantly, any type of PA should be 
encouraged as it reduces risk of mortality and promotes well-being.25   
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Our study contains several strengths, including the large sample size of elderly adults a long 
follow-up period of almost 17 years and the prospective population-based design. Furthermore, 
our method of confirming the AF diagnosis by ECG was very accurate. By adding different types 
of PA, we were able to independently study their association with AF. Moreover, in studying this 
association, we adjusted for several factors which minimized the chance of finding a confounded 
result.  
However, we also need to acknowledge some limitations. We measured PA with a self-
reported questionnaire. Our questionnaire has shown to be valid and reliable,13 but recall bias and 
social desirable answers cannot be excluded. However, the use of questionnaire data on PA is 
essential when examining types of PA. Further, in the current study we used The Compendium of 
Physical Activities to assign MET-values to activities in the questionnaire.15 While assigning these 
values, we carefully considered the age of our study population. However, it might not have 
captured the energy expenditure of older adults accurately. Furthermore, since only duration of 
performed PA was obtained, this might also have given rise to heterogeneity with regard to the 
intensity in which participants engaged in the different PA types. This might have led to 
misclassification of participants with either higher or lower intensity levels than our assigned 
values. Since this misclassification was non-differential, this could have biased our estimates 
towards the null hypothesis. Also, PA was assessed only once in our study, which could have 
resulted in missing PA changes in participants, which could have altered their AF risk during 
follow-up as compared to their baseline activity profile. Further, AF has a tendency to be 
asymptomatic. We cannot rule out that some of our non-cases were in fact ‘silent’ AF cases 
leading to an underestimation of total AF cases.  
Conclusions 
In conclusion, our results suggest that there is no association between PA and risk of increased or 
decreased incident AF. Neither total PA nor any of the included PA types was associated with AF 
risk in any of the analyses. However, considering the beneficial effect of PA on other health 
outcomes, PA should still be promoted. 
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hours/day of moderate intensity PA of 4 METs. Additionally, more than 98.5% of our study 
population had higher total PA levels than the recommended 7.5 MET·hours·week-1.24 
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Supplement 4.2.3. Association between total PA and different types of PA and AF, Rotterdam 
Study, 1997-2012, in participants without paid employment 
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Type and Tertile 
Median MET-hours per week Range 
No. Ps/AF events 
Model 2a 
        HR 95% CI 
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1 39.3 <58.1 1,940/223 1.00 Reference 
2 75.1 58.1-94.2 2,092/270 1.08 0.90-1.30 
3 123.4 ≥94.2 2,165/239 0.94 0.77-1.14 
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Abbreviations: AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; PA, 
physical activity; Ps, participants. 
a Model 2 was adjusted for all other PA types, smoking, previous cardiovascular disease, alcohol consumption, diet and 
education.  
*Sensitivity analysis with model 2 stratified for Previous CVD.  
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.5, 2.8 and 4.5 hours per day of moderate PA equivalent of 4 METs. 
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Supplement 4.2.3. Association between total PA and different types of PA and AF, Rotterdam 
Study, 1997-2012, in participants without paid employment 
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No. Ps/AF events 
Model 2a 
        HR 95% CI 
Total Physical Activityb         
1 39.3 <58.1 1,940/223 1.00 Reference 
2 75.1 58.1-94.2 2,092/270 1.08 0.90-1.30 
3 123.4 ≥94.2 2,165/239 0.94 0.77-1.14 
Walkingc 
1 8.3 <13.5 1,980/231 1.00 Reference 
2 21.0 13.9-30.0 2,291/261 0.92 0.78-1.08 
3 51.0 ≥30.8 1,926/240 0.97 0.81-1.17 
Domestic workd 
1 12.5 <22.6 1,870/224 1.00 Reference 
2 34.2 22.6-44.7 2,133/263 1.10 0.91-1.33 
3 57.7 ≥44.7 2,194/245 1.11 0.89-1.39 
Cyclinge 
1 0.0 0.0 2,863/336 1.00 Reference 
2 6.0 0.33-12.0 1,805/221 0.94 0.78-1.13 
3 24.0 ≥12.5 1,529/175 0.87 0.71-1.07 
Gardeningf 
1 0.0 0.0 3,868/444 1.00 Reference 
2 4.0 2.0-6.0 1,368/161 1.04 0.86-1.25 
3 14.0 ≥8.0 961/127 1.06 0.87-1.31 
Sportsg 
1 0.0 0.0 4,071/477 1.00 Reference 
2 5.5 1.3-9.3 1,108/133 1.00 0.82-1.21 
3 18.6 ≥9.4 1,018/122 0.98 0.80-1.20 
Abbreviations: AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; PA, 
physical activity; Ps, participants. 
a Model 2 was adjusted for all other PA types, smoking, previous cardiovascular disease, alcohol consumption, diet and 
education.  
*Sensitivity analysis with model 2 stratified for Previous CVD.  
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.5, 2.8 and 4.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 32, 88 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5 METs. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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        HR 95% CI 
Total Physical Activityb         
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1 0.0 0.0 3,831/416 1.00 Reference 
2 5.5 1.3-9.3 1,095/119 0.99 0.80-1.21 
3 20.0 ≥9.4 1,071/108 0.94 0.76-1.17 
Abbreviations: AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent of task; PA, 
physical activity; CVD, cardiovascular disease; Ps, participants. 
a Model 2 was adjusted for all other PA types, smoking, previous cardiovascular disease, alcohol consumption, diet and 
education.  
*Sensitivity analysis with model 2 stratified for Previous CVD.  
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.5, 2.8 and 4.5 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 26, 60 and 141 
minutes per day of walking. 
d Average domestic work is equivalent to 3.5 METs.1 The median levels of domestic work across categories are therefore 
equivalent to 32, 88 and 146 minutes per day of domestic work. 
e Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
f Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
g Average sports is equivalent to 5.5 METs. The median levels of sports across categories are therefore equivalent to 0, 9 and 31 
minutes per day of sports. 
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ABSTRACT 
Background: We aimed to determine the contribution of specific physical activity (PA) types 
(i.e. walking, cycling, domestic work, sports and gardening) on total life expectancy (LE) and 
LE with and without cardiovascular disease (CVD). 
Methods: We constructed multistate life tables to calculate the effects of total PA and PA 
types on LE, among individuals older than 55 years from the Rotterdam Study. For the life 
table calculations, we used sex-specific prevalences, incident rates and hazard ratios for 3-
transitions (healthy-to-CVD, healthy-to-death, and CVD-to-death) by levels of PA and 
adjusted for confounders. 
Results: High total PA was associated with gains in total and CVD-free LE. High cycling 
contributed to higher total LE in men (3.7 years) and women (2.1 years) and higher LE 
without CVD in men (3.1 years) and women (2.4 years). Total and CVD-free LE were 
increased by high domestic work in women (2.6 and 2.4 years, respectively) and high 
gardening in men (2.7 and 2.0 years, respectively).  
Conclusions: Higher PA levels are associated with increased LE and more years lived without 
CVD. Of the different PA types, cycling provided high effects in both men and women. 
Cycling could be more strongly encouraged in activity guidelines to maximize the population 
benefits of PA. 
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INTRODUCTION 
The association between physical activity (PA) and reduced risk of mortality and cardiovascular 
disease (CVD) has been well documented.1,2 According to a recent meta-analysis, regular PA of 
moderate to vigorous intensity may contribute to up to 27% reduced risk of CVD and mortality.3 
However, to provide comprehensive information for public and individual health care planning, it 
could be informative to look beyond hazard ratios and to provide measures of the lifetime 
consequences of PA. Additionally, since individuals with CVD have a reduced quality of life,4,5 
information on the life years with and without CVD is of relevance. 
Previous studies evaluating the association between PA and LE have shown that compared 
to individuals with low levels of PA, high levels of PA in adulthood are associated with an increase 
in LE of 1.8-4.2 years.6-8 Two studies within the Framingham Heart Study both showed that at the 
age of 50 years, high levels of PA not only increased total LE, but also increased the number of 
years lived without CVD.9,10 However, these studies started data collection in the end of the 20th 
century, whereas treatment for cardiovascular risk factors has improved after 1990, resulting in 
the reduction of cardiovascular incidence and mortality rates.11 Additionally, previous studies 
have evaluated the effect of total or leisure time PA, whereas it remains unclear whether specific 
PA types contribute most to the beneficial effects of PA in middle-aged and elderly adults. It is 
important to distinguish and to measure the independent effect of different types of PA (e.g. 
cycling, walking, domestic work) on LE, to be able to make clear and effective public health 
recommendations.  
Therefore, we aimed to evaluate the impact of total PA and PA types on the average years 
lived with and without CVD at age 55 years or older. Using data from the Rotterdam study, we 
constructed multistate life tables from data collected starting in the year 2000 and with over 10 
years of follow-up. 
 
METHODS 
Study population 
This study was embedded within the Rotterdam Study, a prospective population-based cohort 
study among subjects aged ≥55 years in Rotterdam, the Netherlands. Baseline examinations were 
completed between 1990 and 1993. In 2000-2001, the Rotterdam Study was extended with 3,011 
participants who had become ≥55 years old or had moved into the study district. The objectives 
and design of the Rotterdam Study have been described in detail elsewhere.12 
For the current study, we used data from 7,808 participants attending the third 
examination of the original cohort (RS-I-3, between 1997 and 1999; n =4,797) and the participants 
attending the first examination of the extended cohort (RS-II-1, between 2000 and 2001; n=3,011). 
Of this combined total, 7,310 participants completed PA collection (see Supplement 4.3.1). 
Subsequently, we excluded participants without informed consent (n=52) or without information 
regarding CVD (n=4). After exclusion, 7,254 participants (4,207 women) were available for the 
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INTRODUCTION 
The association between physical activity (PA) and reduced risk of mortality and cardiovascular 
disease (CVD) has been well documented.1,2 According to a recent meta-analysis, regular PA of 
moderate to vigorous intensity may contribute to up to 27% reduced risk of CVD and mortality.3 
However, to provide comprehensive information for public and individual health care planning, it 
could be informative to look beyond hazard ratios and to provide measures of the lifetime 
consequences of PA. Additionally, since individuals with CVD have a reduced quality of life,4,5 
information on the life years with and without CVD is of relevance. 
Previous studies evaluating the association between PA and LE have shown that compared 
to individuals with low levels of PA, high levels of PA in adulthood are associated with an increase 
in LE of 1.8-4.2 years.6-8 Two studies within the Framingham Heart Study both showed that at the 
age of 50 years, high levels of PA not only increased total LE, but also increased the number of 
years lived without CVD.9,10 However, these studies started data collection in the end of the 20th 
century, whereas treatment for cardiovascular risk factors has improved after 1990, resulting in 
the reduction of cardiovascular incidence and mortality rates.11 Additionally, previous studies 
have evaluated the effect of total or leisure time PA, whereas it remains unclear whether specific 
PA types contribute most to the beneficial effects of PA in middle-aged and elderly adults. It is 
important to distinguish and to measure the independent effect of different types of PA (e.g. 
cycling, walking, domestic work) on LE, to be able to make clear and effective public health 
recommendations.  
Therefore, we aimed to evaluate the impact of total PA and PA types on the average years 
lived with and without CVD at age 55 years or older. Using data from the Rotterdam study, we 
constructed multistate life tables from data collected starting in the year 2000 and with over 10 
years of follow-up. 
 
METHODS 
Study population 
This study was embedded within the Rotterdam Study, a prospective population-based cohort 
study among subjects aged ≥55 years in Rotterdam, the Netherlands. Baseline examinations were 
completed between 1990 and 1993. In 2000-2001, the Rotterdam Study was extended with 3,011 
participants who had become ≥55 years old or had moved into the study district. The objectives 
and design of the Rotterdam Study have been described in detail elsewhere.12 
For the current study, we used data from 7,808 participants attending the third 
examination of the original cohort (RS-I-3, between 1997 and 1999; n =4,797) and the participants 
attending the first examination of the extended cohort (RS-II-1, between 2000 and 2001; n=3,011). 
Of this combined total, 7,310 participants completed PA collection (see Supplement 4.3.1). 
Subsequently, we excluded participants without informed consent (n=52) or without information 
regarding CVD (n=4). After exclusion, 7,254 participants (4,207 women) were available for the 
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current analysis. Baseline information was collected through home interviews or was measured at 
the study center visit as described previously.13,14  
Physical activity assessment  
Participants were asked how many hours per week they spent in walking, cycling, sports, 
gardening and domestic work in the past year, using an adapted version of the Zutphen Physical 
Activity Questionnaire.15,16 We used metabolic equivalent of task (MET) to quantify the intensity 
of activity. MET-values were assigned to every activity, according to the 2011 updated version of 
the Compendium of Physical Activities.17 Sports that were not in this compendium and to which 
we could not assign a MET-value (e.g. under water hockey, “revalidation sports”) were not used in 
the analyses (n=33; 2.8%). MET-values of physical activities were multiplied with time (in hours) 
per week spent in that specific activity to calculate MET∙hours∙week-1 in total PA and in every type 
of PA (cycling, walking, sports, domestic work, gardening). Further detail on the assessment of PA 
can be found elsewhere.18 
Finally, all PA variables were categorized into tertiles. For activities not practiced by more 
than 60% of the population (cycling, gardening, sports), the bottom category for PA levels was no 
participation and the remaining two categories were divided by using the median value.  
Assessment of outcome 
The main outcome measure under study was incident non-fatal or fatal CVD and overall 
mortality. CVD is defined as the presence of one or more definite manifestation of coronary heart 
disease (coronary revascularization or non-fatal or fatal myocardial infarction or death due to 
coronary heart disease), stroke and heart failure.19-21 Information about cause and circumstances 
of death was obtained from general practitioner medical records and from municipal records. The 
follow-up was complete until January 1, 2010.  
Confounding variables 
The confounding variables included smoking, education, living situation and alcohol use, which 
were assessed by questionnaire. Smoking status was accounted for through the states ‘current 
smoker’, ‘former smoker’ and ‘never smoker’. Height and weight were measured, with which body 
mass index (BMI) was calculated (kg/m2). Education was assessed according to the standard 
classification of education comparable to the international standard classification of education 
and was grouped into four categories “elementary education”, “lower secondary education”, 
“higher secondary education” and “tertiary education”.22 We assessed living situation as a 
dichotomous variable describing whether the participant lived alone or not. Based on daily intake 
of alcohol consumption in glasses per day we created 3 equal groups and added alcohol in the 
model as categorical variable. Concentration of serum total cholesterol and high-density 
lipoprotein (HDL) cholesterol was determined using an automated enzymatic procedure 
(Boehringer Mannheid System, Mannheim, Germany) and expressed in mg/dl. Blood pressure 
was measured at the right brachial artery with a random-zero sphygmomanometer with the 
participant in sitting position, and the mean of 2 consecutive measurements was used. Treatment 
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for hypertension was assessed through interview. We classified participants by the presence of 
hypertension; as defined by systolic and diastolic blood pressure higher than 140/90 mmHg or the 
use of treatment for hypertension. Diabetes was defined as a fasting serum blood glucose ≥ 7.0 
mmol/L, a non-fasting blood glucose ≥ 11.1 mmol/L (when fasting samples were not available), or 
the use of blood glucose lowering medication.  
Data analysis 
To calculate LE with and without CVD, we built multistate life tables for participants with low, 
medium and high levels of total PA and every PA type. We included three health states: “free of 
CVD”, “history of CVD” and “death”. The possible transitions were from free of CVD to CVD, 
from free of CVD to death and from history of CVD to death. Backflows were not allowed, and 
only the first entry into a state was considered.9,23 
In order to assess the differences in risk of mortality and CVD among individuals 55 years 
and older by different categories of PA at baseline, we first calculated the overall sex- and age-
specific rates for each transition. Following, we calculated the prevalence of low, medium and high 
PA, for every PA variable, by sex, 10-year age groups, and for individuals with and without CVD 
separately. Subsequently, gender-specific hazard ratios (HRs) comparing high and medium PA 
categories to low PA for each PA variable were calculated using Poisson regression (“Gompertz” 
distribution) in 3 models.9,19 Model 1 was adjusted for age; model 2 was additionally adjusted for 
smoking status, alcohol consumption in tertiles, education, marital status, cancer prevalence and 
the other PA types; model 3 was additionally adjusted for body mass index, total and high-density 
lipoprotein cholesterol, diabetes, lipid reducing agents and anti-hypertensive medication. 
Additionally, we repeated the analyses in the total population, in which we adjusted for sex in 
model 1-3. 
Finally, we calculated three sets of transitions rates for each PA variable separately using the 
(1) overall sex-specific transition rates, the (2) adjusted HRs (model 2) for CVD and mortality, 
and the (3) prevalence of PA by gender and absence or presence of CVD. Comparable calculations 
have been previously described.9,19 The multistate life table was started at age 55 years and was 
closed at age 100 years.  
Confidence intervals for all life expectancies and differences in LE were calculated using 
@RISK software (Anonymous 2000; MathSoft Inc, Cambridge, Mass), by Monte Carlo simulation 
(parametric bootstrapping) 10 000 runs.23,24 
In a sensitivity analysis, to exclude potential bias caused by disease, we estimated the life 
expectancy among participants without diabetes, hypertension and dyslipidemia at baseline (n = 
4,049) for the three categories of total PA. 
Missing values for covariates (less than 15%) were imputed using single imputation with the 
Expectation Maximization method in SPSS (IBM SPSS Statistical for Windows, Armonk, New 
York: IBM Corp). We used STATA version 13 for Windows (StataCorp, College Station) and R 
statistical software (A language and environment for statistical computing. R Foundation for 
Statistical Computing, Vienna, Austria) for our analysis.  
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CVD”, “history of CVD” and “death”. The possible transitions were from free of CVD to CVD, 
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only the first entry into a state was considered.9,23 
In order to assess the differences in risk of mortality and CVD among individuals 55 years 
and older by different categories of PA at baseline, we first calculated the overall sex- and age-
specific rates for each transition. Following, we calculated the prevalence of low, medium and high 
PA, for every PA variable, by sex, 10-year age groups, and for individuals with and without CVD 
separately. Subsequently, gender-specific hazard ratios (HRs) comparing high and medium PA 
categories to low PA for each PA variable were calculated using Poisson regression (“Gompertz” 
distribution) in 3 models.9,19 Model 1 was adjusted for age; model 2 was additionally adjusted for 
smoking status, alcohol consumption in tertiles, education, marital status, cancer prevalence and 
the other PA types; model 3 was additionally adjusted for body mass index, total and high-density 
lipoprotein cholesterol, diabetes, lipid reducing agents and anti-hypertensive medication. 
Additionally, we repeated the analyses in the total population, in which we adjusted for sex in 
model 1-3. 
Finally, we calculated three sets of transitions rates for each PA variable separately using the 
(1) overall sex-specific transition rates, the (2) adjusted HRs (model 2) for CVD and mortality, 
and the (3) prevalence of PA by gender and absence or presence of CVD. Comparable calculations 
have been previously described.9,19 The multistate life table was started at age 55 years and was 
closed at age 100 years.  
Confidence intervals for all life expectancies and differences in LE were calculated using 
@RISK software (Anonymous 2000; MathSoft Inc, Cambridge, Mass), by Monte Carlo simulation 
(parametric bootstrapping) 10 000 runs.23,24 
In a sensitivity analysis, to exclude potential bias caused by disease, we estimated the life 
expectancy among participants without diabetes, hypertension and dyslipidemia at baseline (n = 
4,049) for the three categories of total PA. 
Missing values for covariates (less than 15%) were imputed using single imputation with the 
Expectation Maximization method in SPSS (IBM SPSS Statistical for Windows, Armonk, New 
York: IBM Corp). We used STATA version 13 for Windows (StataCorp, College Station) and R 
statistical software (A language and environment for statistical computing. R Foundation for 
Statistical Computing, Vienna, Austria) for our analysis.  
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RESULTS 
We observed 1,156 (19.3%) incident CVD events and 2,363 (32.6%) overall deaths over 10 years of 
follow-up. Compared to women, men were slightly younger, smoked more and showed lower 
levels of BMI and total PA levels (Table 4.3.1). Individuals not completing PA data collection were 
slightly older and more often female, compared to individuals included in the study. 
HRs of men and women were very similar. Therefore, Table 4.3.2 presents the HRs and 95% 
confidence interval (95%CI) for the total population, for model 2. Additional adjustment for 
biological risk factors in model 3 only slightly attenuated the associations. Therefore, the results 
for model 1 and 3 are presented in Supplement 4.3.2. Sex-specific HRs used for the analyses are 
presented in Supplement 4.3.3 and Supplement 4.3.4. High total PA was associated with a lower 
risk of incident CVD (HR:0.73, 95%CI: 0.63, 0.85), compared to low PA, in model 2. Regarding 
PA types, compared to the low category, the high level of cycling (HR:0.77, 95%CI: 0.65, 0.91) and 
the medium category of sports (HR:0.80, 95%CI: 0.68, 0.95) were associated with a lower risk of 
incident CVD.  
Among participants without CVD, high total PA was associated with a lower mortality risk 
(HR:0.66, 95%CI: 0.58, 0.75), compared to low PA. Regarding types, walking, cycling, domestic 
work, sports and gardening were each associated with 12-35% reduced mortality risk (Table 
4.3.2). Compared to the low categories, the largest risk reductions were observed for the high 
categories of cycling, domestic work and gardening (Table 4.3.2).  
Among participants with CVD, high total PA was associated with a lower mortality risk 
(HR:0.73, 95%CI: 0.62, 0.86), compared to the low category. Regarding types, the medium 
category of walking (HR:0.85, 95%CI: 0.73, 0.98) and sports (HR:0.76, 95%CI: 0.63, 0.93) and the 
high category of cycling (HR:0.76, 95%CI: 0.63, 0.93) were associated with reduced mortality risk, 
compared to the low categories.  
The association between total PA and every PA type with the risk of each transition was 
translated into number of years lived with and without CVD (Table 4.3.3 (men), Table 4.3.4 
(women)  and Figure 4.3.1).  
Compared to men with low total PA, total LE was increased with 2.2 (95%CI: 1.5, 2.9) years in the 
medium category and 3.5 (95%CI: 2.8, 4.2) years in the high category. For women, these 
differences were 1.5 (95%CI: 0.8, 2.1) and 3.0 (95%CI: 2.3, 3.5) years, respectively (Table 4.3.3). 
The LE without CVD associated with total PA was up to 3.3 (95%CI: 2.5, 4.2) years in men and up 
to 2.8 (95%CI: 2.2, 3.6) years in women. In men, the amount of years lived with CVD was higher 
in the medium category of total PA. 
Regarding types of PA, men and women in the medium and high category of walking, 
cycling, domestic work, sports and gardening had higher total LE and LE without CVD than 
participants in the low categories of these PA types, although the magnitude of the effect differed 
per PA type (Table 4.3.3).  
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Table 4.3.1. Baseline characteristics of study population (n=7,254) 
Men Women 
Participants 3,047 (42.0) 4,207 (58.0) 
Demographic factors   
Age 69.3 (8.1) 70.7 (8.9) 
Educational level, n (%) 
  Elementary 297 (9.7) 782 (18.6) 
  Lower secondary 933 (30.6) 2,212 (52.6) 
  Higher secondary 1,175 (38.6) 938 (22.3) 
  Tertiary 642 (21.1) 275 (6.5) 
Marital status, n (%) 
  Single 87 (2.9) 294 (7.0) 
  Married 2,404 (78.9) 2,142 (50.9) 
  Widowed 347 (11.4) 1,363 (32.4) 
  Divorced/separated 209 (6.9) 408 (9.7) 
Physical activity   
Total PA, METhours/week 71.0 (43.2) 88.0 (43.8) 
Walking, METhours/week 26.9 (23.4) 27.8 (25.3) 
Cycling, METhours/week 10.5 (14.5) 7.0 (12.0) 
Domestic work, METhours/week 21.2 (17.8) 46.4 (21.7) 
Sports, METhours/week 7.2 (15.4) 4.0 (9.5) 
Gardening, METhours/week 5.2 (11.9) 2.8 (6.6) 
Lifestyle factors   
Smoking, n (%)   
  Never 909 (29.8) 2,558 (60.8) 
  Former 1,569 (51.5) 927 (22.0) 
  Current 569 (18.7) 722 (17.2) 
BMI, kg/m2 26.5 (3.2) 27.4 (4.2) 
Alcohol, n (%)   
  Low 618 (20.3) 1,827 (43.4) 
  Medium 974 (32.0) 1,487 (35.3) 
  High 1,455 (47.8) 893 (21.2) 
Biological risk factors   
Using blood pressure medication, n (%) 707 (23.2) 1,143 (27.2) 
Using lipid reducing agents, n (%) 412 (13.5) 486 (11.6) 
Cholesterol, mg/dl 5.5 (1.0) 6.0 (1.0) 
HDL-cholesterol, mg/dl 1.2 (0.3) 1.5 (0.4) 
Glucose, mg/dl 6.2 (1.7) 6.0 (1.6) 
Systolic blood pressure, mm HG 144.4 (21.2) 143.8 (21.7) 
Prevalent diabetes, n (%) 534 (17.5) 661 (15.7) 
Values are mean (SD) or number (percentage).  
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Table 4.3.2. Hazard ratios for the different transitions for men and women, based on the 
Rotterdam Study 
    No CVD to CVD No CVD to death CVD to death 
No. events 1156 1569 1136 
Person-years   45219 54715 13641 
  Median (Range) (MET·hours·week-1) 
Model 2a Model 2a Model 2a 
HR (95% CI) HR (95% CI) HR (95% CI) 
Total PAb 
  Low  38.5 (≤57.6) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  74.3 (57.7-94.0) 0.93 (0.81,1.07) 0.76 (0.68,0.86) 0.86 (0.75,0.99) 
  High  123.2 (≥94.1) 0.73 (0.63,0.85) 0.66 (0.58,0.75) 0.73 (0.62,0.86) 
P for trend <0.001 <0.001 <0.001 
Walkingc 
  Low  8.3 (≤13.5) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  21.0 (13.6-30.0) 0.89 (0.77,1.02) 0.88 (0.79,1.00) 0.85 (0.73,0.98) 
  High  49.5 (≥30.1) 0.86 (0.74,1.00) 0.90 (0.79,1.02) 0.87 (0.75,1.01) 
P for trend 0.05     0.09 0.05  
Cyclingd 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  6.0 (≤12.0) 0.85 (0.74,0.99) 0.71 (0.62,0.81) 0.85 (0.73,1.00) 
  High  24.0 (≥12.1) 0.77 (0.65,0.91) 0.65 (0.56,0.76) 0.76 (0.63,0.93) 
P for trend 0.002      <0.001 0.004      
Domestic worke 
  Low  11.6 (≤22.5) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  34.1 (22.6-44.7) 0.93 (0.80,1.09) 0.83 (0.73,0.94) 0.94 (0.82,1.09) 
  High  57.8 (≥44.8) 0.85 (0.71,1.01) 0.73 (0.63,0.85) 0.88 (0.74,1.05) 
P for trend 0.06       <0.001 0.15      
Sportsf 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  5.4 (≤6.0) 0.80 (0.68,0.95) 0.79 (0.68,0.91) 0.81 (0.67,0.97) 
  High  19.2 (≥6.1) 1.06 (0.90,1.26) 0.86 (0.73,1.00) 0.85 (0.70,1.03) 
P for trend 0.87       0.005      0.02      
Gardeningg 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  4.0 (≤9.2) 0.89 (0.76,1.04) 0.75 (0.65,0.87) 0.87 (0.72,1.05) 
  High  14.0 (≥9.3) 0.98 (0.82,1.18) 0.73 (0.62,0.87) 0.94 (0.77,1.15) 
 P for trend   0.53 <0.001 0.28 
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio, PA, physical activity; ref, referent. 
a Model 2 was adjusted for age, sex smoking status, alcohol consumption in tertiles, education, marital status and cancer 
prevalence. For PA types, model 2 was also adjusted for all other PA types. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.4, 2.7 and 4.4 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 24, 60 and 141 
minutes per day of walking. 
d Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
e Average domestic work is equivalent to 3.5 METs.17 The median levels of domestic work across categories are therefore 
equivalent to 28, 83 and 142 minutes per day of domestic work. 
f Average sports is equivalent to 5.5 METs. The median levels of sports across categories are therefore equivalent to 0, 8 and 30 
minutes per day of sports. 
g Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
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In men and women, high cycling increased LE with 3.7 (95%CI: 3.0, 4.4) years and 2.1 (95%CI: 
1.1, 3.0) years, respectively. In women, domestic work was also associated with large gains in LE, 
with up to 2.6 (95%CI: 1.9, 3.3) years for the high category. In men, both sports and gardening 
were associated with higher LE. The medium category of sports increased LE with 3.1 (95%CI: 2.3, 
4.0) years, and the high category of gardening had 2.7 (95%CI: 1.9, 3.5) years higher LE, compared 
to the low category. 
 
 
 
 
Figure 4.3.1. Effect of physical activity on life expectancy with and without CVD at age 55 years. 
All life expectancies have been calculated with sex-specific hazard ratios adjusted for age, smoking status, alcohol 
consumption in tertiles, education, marital status and cancer prevalence. Models with PA types were additionally 
adjusted for the other PA types. Abbreviations: CVD, cardiovascular disease; LE, life expectancy; PA, physical activity. 
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Table 4.3.2. Hazard ratios for the different transitions for men and women, based on the 
Rotterdam Study 
    No CVD to CVD No CVD to death CVD to death 
No. events 1156 1569 1136 
Person-years   45219 54715 13641 
  Median (Range) (MET·hours·week-1) 
Model 2a Model 2a Model 2a 
HR (95% CI) HR (95% CI) HR (95% CI) 
Total PAb 
  Low  38.5 (≤57.6) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  74.3 (57.7-94.0) 0.93 (0.81,1.07) 0.76 (0.68,0.86) 0.86 (0.75,0.99) 
  High  123.2 (≥94.1) 0.73 (0.63,0.85) 0.66 (0.58,0.75) 0.73 (0.62,0.86) 
P for trend <0.001 <0.001 <0.001 
Walkingc 
  Low  8.3 (≤13.5) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  21.0 (13.6-30.0) 0.89 (0.77,1.02) 0.88 (0.79,1.00) 0.85 (0.73,0.98) 
  High  49.5 (≥30.1) 0.86 (0.74,1.00) 0.90 (0.79,1.02) 0.87 (0.75,1.01) 
P for trend 0.05     0.09 0.05  
Cyclingd 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  6.0 (≤12.0) 0.85 (0.74,0.99) 0.71 (0.62,0.81) 0.85 (0.73,1.00) 
  High  24.0 (≥12.1) 0.77 (0.65,0.91) 0.65 (0.56,0.76) 0.76 (0.63,0.93) 
P for trend 0.002      <0.001 0.004      
Domestic worke 
  Low  11.6 (≤22.5) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  34.1 (22.6-44.7) 0.93 (0.80,1.09) 0.83 (0.73,0.94) 0.94 (0.82,1.09) 
  High  57.8 (≥44.8) 0.85 (0.71,1.01) 0.73 (0.63,0.85) 0.88 (0.74,1.05) 
P for trend 0.06       <0.001 0.15      
Sportsf 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  5.4 (≤6.0) 0.80 (0.68,0.95) 0.79 (0.68,0.91) 0.81 (0.67,0.97) 
  High  19.2 (≥6.1) 1.06 (0.90,1.26) 0.86 (0.73,1.00) 0.85 (0.70,1.03) 
P for trend 0.87       0.005      0.02      
Gardeningg 
  Low  0.0 (0.0) 1 [ref] 1 [ref] 1 [ref] 
  Moderate  4.0 (≤9.2) 0.89 (0.76,1.04) 0.75 (0.65,0.87) 0.87 (0.72,1.05) 
  High  14.0 (≥9.3) 0.98 (0.82,1.18) 0.73 (0.62,0.87) 0.94 (0.77,1.15) 
 P for trend   0.53 <0.001 0.28 
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio, PA, physical activity; ref, referent. 
a Model 2 was adjusted for age, sex smoking status, alcohol consumption in tertiles, education, marital status and cancer 
prevalence. For PA types, model 2 was also adjusted for all other PA types. 
b Total PA is composed of all PA types and thus of different METs. In this regard, the median levels of total PA across 
categories are equivalent to 1.4, 2.7 and 4.4 hours per day of moderate PA equivalent of 4 METs. 
c Walking is equivalent to 3.0 METs. The median levels of walking across categories are therefore equivalent to 24, 60 and 141 
minutes per day of walking. 
d Cycling is equivalent to 4.0 METs. The median levels of cycling across categories are therefore equivalent to 0, 13 and 51 
minutes per day of cycling. 
e Average domestic work is equivalent to 3.5 METs.17 The median levels of domestic work across categories are therefore 
equivalent to 28, 83 and 142 minutes per day of domestic work. 
f Average sports is equivalent to 5.5 METs. The median levels of sports across categories are therefore equivalent to 0, 8 and 30 
minutes per day of sports. 
g Gardening is equivalent to 4.0 METs. The median levels of gardening across categories are therefore equivalent to 0, 9 and 30 
minutes per day of gardening. 
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In men and women, high cycling increased LE with 3.7 (95%CI: 3.0, 4.4) years and 2.1 (95%CI: 
1.1, 3.0) years, respectively. In women, domestic work was also associated with large gains in LE, 
with up to 2.6 (95%CI: 1.9, 3.3) years for the high category. In men, both sports and gardening 
were associated with higher LE. The medium category of sports increased LE with 3.1 (95%CI: 2.3, 
4.0) years, and the high category of gardening had 2.7 (95%CI: 1.9, 3.5) years higher LE, compared 
to the low category. 
 
 
 
 
Figure 4.3.1. Effect of physical activity on life expectancy with and without CVD at age 55 years. 
All life expectancies have been calculated with sex-specific hazard ratios adjusted for age, smoking status, alcohol 
consumption in tertiles, education, marital status and cancer prevalence. Models with PA types were additionally 
adjusted for the other PA types. Abbreviations: CVD, cardiovascular disease; LE, life expectancy; PA, physical activity. 
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The largest gains in LE without CVD were found for cycling, with up to 3.3 (95%CI: 2.5, 4.2) years 
in men and 2.7 (95%CI: 1.9, 3.5) years in women. In men, the medium category of sports also 
increased LE without CVD with 2.9 (95%CI: 1.8, 4.0) years and the medium and high category of 
gardening increased LE with 2.4 (95%CI: 1.5, 3.4) and 2.0 (95%CI: 0.8, 3.1) years, respectively. In 
women, domestic work was associated with increases in LE in the medium and high category of 
1.1 (95%CI: 0.1, 2.0) and 2.4 (95%CI: 1.5, 3.3) years, respectively. 
Total LE and the number of years lived with and without CVD for participants without 
hypertension, diabetes and dyslipidemia are presented in Supplement 4.3.5 for total PA. 
Compared to the population included in the main analyses, total LE was up to 1.2 year higher for 
individuals without hypertension, diabetes and dyslipidemia. Moreover, in this population, LE 
free from CVD was up to 1.6 year higher, whereas LE with CVD was lower. 
 
DISCUSSION 
In this prospective cohort study, we found that high total PA at age 55 and over was associated 
with an increase in total LE and with a greater number of years lived without CVD. Cycling was 
associated with gains in total LE in both men and women. Additionally, domestic work in women 
and sports and gardening in men were independently associated with large increases in total LE. 
Cycling also had a beneficial effect on extending LE without CVD in both men and women. Total 
PA and types of PA had a small impact on years lived with CVD. 
The higher LE free from CVD in individuals with higher PA levels was the result of a lower 
risk of CVD and mortality. Due to the lower CVD risk, the first CVD event occurs later in the 
lifespan and consequently, LE without CVD is increased. Furthermore, being free from CVD 
reduces the mortality risk and therefore increases the number of years lived and consequently the 
number of years free of CVD. We also found that men with higher levels of total PA, sports and 
cycling spent slightly more years with CVD, compared  to men with low PA. The years lived with 
CVD are a consequence of the CVD risk in individuals without history of CVD, influencing the 
age of the first event, and mortality risk in those with CVD, determining the years lived after the 
CVD event. In our study, men with high PA and a history of CVD had a lower mortality risk and 
therefore they lived slightly longer with CVD. 
The HRs we found in our study support existing evidence that PA reduces the incidence of 
CVD.3,25 Moreover the reduction in mortality risk among persons without history of CVD 
associated with total PA, is in line with previous studies.26,27 Our results also confirm that total PA 
reduces mortality in persons with a history of CVD.26,28,29 The effects of specific types of PA, 
however, are less well documented in literature. We found one study reporting the association 
between gardening, sports, walking and cycling with incident CVD, which reported similar HRs 
as we found.30 Additionally, a study within the Whitehall population reported similar HRs for all-
cause mortality for cycling, sports and gardening.31 In this study, domestic work did not reduce 
mortality risk, which might be related to the slightly younger participants (mean age 56 years).  
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The largest gains in LE without CVD were found for cycling, with up to 3.3 (95%CI: 2.5, 4.2) years 
in men and 2.7 (95%CI: 1.9, 3.5) years in women. In men, the medium category of sports also 
increased LE without CVD with 2.9 (95%CI: 1.8, 4.0) years and the medium and high category of 
gardening increased LE with 2.4 (95%CI: 1.5, 3.4) and 2.0 (95%CI: 0.8, 3.1) years, respectively. In 
women, domestic work was associated with increases in LE in the medium and high category of 
1.1 (95%CI: 0.1, 2.0) and 2.4 (95%CI: 1.5, 3.3) years, respectively. 
Total LE and the number of years lived with and without CVD for participants without 
hypertension, diabetes and dyslipidemia are presented in Supplement 4.3.5 for total PA. 
Compared to the population included in the main analyses, total LE was up to 1.2 year higher for 
individuals without hypertension, diabetes and dyslipidemia. Moreover, in this population, LE 
free from CVD was up to 1.6 year higher, whereas LE with CVD was lower. 
 
DISCUSSION 
In this prospective cohort study, we found that high total PA at age 55 and over was associated 
with an increase in total LE and with a greater number of years lived without CVD. Cycling was 
associated with gains in total LE in both men and women. Additionally, domestic work in women 
and sports and gardening in men were independently associated with large increases in total LE. 
Cycling also had a beneficial effect on extending LE without CVD in both men and women. Total 
PA and types of PA had a small impact on years lived with CVD. 
The higher LE free from CVD in individuals with higher PA levels was the result of a lower 
risk of CVD and mortality. Due to the lower CVD risk, the first CVD event occurs later in the 
lifespan and consequently, LE without CVD is increased. Furthermore, being free from CVD 
reduces the mortality risk and therefore increases the number of years lived and consequently the 
number of years free of CVD. We also found that men with higher levels of total PA, sports and 
cycling spent slightly more years with CVD, compared  to men with low PA. The years lived with 
CVD are a consequence of the CVD risk in individuals without history of CVD, influencing the 
age of the first event, and mortality risk in those with CVD, determining the years lived after the 
CVD event. In our study, men with high PA and a history of CVD had a lower mortality risk and 
therefore they lived slightly longer with CVD. 
The HRs we found in our study support existing evidence that PA reduces the incidence of 
CVD.3,25 Moreover the reduction in mortality risk among persons without history of CVD 
associated with total PA, is in line with previous studies.26,27 Our results also confirm that total PA 
reduces mortality in persons with a history of CVD.26,28,29 The effects of specific types of PA, 
however, are less well documented in literature. We found one study reporting the association 
between gardening, sports, walking and cycling with incident CVD, which reported similar HRs 
as we found.30 Additionally, a study within the Whitehall population reported similar HRs for all-
cause mortality for cycling, sports and gardening.31 In this study, domestic work did not reduce 
mortality risk, which might be related to the slightly younger participants (mean age 56 years).  
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Our study is the first to report mortality risk for several PA types among participants with 
and without prevalent CVD. Moreover, we revealed that cycling, sports and walking not only 
prevented the first cardiovascular event in those without CVD, but also improved the prognosis of 
CVD in participants with CVD. In our study, compared to low PA, we found increases in LE for 
high PA which are similar to findings from other studies.6-10 One study found a slightly higher 
LE,7 which could be explained by the fact that they only looked at leisure time PA, whereas we 
evaluated leisure time, housework and transportation combined. Additionally, compared to low 
PA, we found increases in LE without CVD for high total PA of 3.3 in men and 2.8 in women, 
comparable to previous studies.9,10 In earlier studies comprising participants from the 
Framingham Heart Study, at age 50, high PA was associated with increases in LE without CVD of 
3.0-3.2 years for men and 3.1-3.3 years for women, compared to low PA.9,10 This study included 
participants aged 50 years, between 1948 and 1950, and followed them up until the end of the 20th 
century, whereas we included participants starting from 1999 and followed them until 2010. After 
1990, the treatment for cardiovascular risk factors has improved, which resulted in the reduction 
of cardiovascular incidence and mortality rates.11 Additionally, it might be expected that our 
population was less physically active, due to population changes in PA over the years. In spite of 
these population differences, the relative contribution of high PA compared to low PA has 
remained stable, indicating that being physically active can protect against CVD, independent of 
differences in the population. 
In our analyses, cycling was an important contributor to the effect of total PA. Furthermore, 
domestic work was important for women, whereas gardening and sports were important for men. 
The beneficial effect of several different PA types on LE has not been studied before and we are 
the first to show that these PA types have independent effects on total LE and LE without CVD. 
However, previous studies have shown beneficial effects of cycling, domestic work and sports on 
CVD and mortality risk.30,32-36 Moreover, whereas the World Health Organization recommends to 
engage in 30 minutes of PA, 5 days a week, to gain health benefits,37 our results suggest that 13 
minutes of cycling per day (the medium category) can already increase LE with 2.1 years in men 
and 2.4 years in women. This has also been shown in another study,38 in which an increase in total 
LE of 3 years was reported for 15 minutes of leisure time PA per day. Regarding other specific PA 
types, we only found one study reporting on walking, with increases in LE similar to ours.39 
This study has some limitations. First, we did not collect information on occupational PA, 
so we could not adjust for this in our analyses. However, since only 11.5% was employed at 
baseline, we do not believe this would have significantly influenced our results. Second, although 
our questionnaire has been validated,15 some error in self-report is inevitable. Moreover, since PA 
was measured at baseline only, this could have led to misclassification of PA over time. These last 
two limitations could have resulted in bias towards the null. Furthermore, people in poor health 
might participate in PA less than others, creating the opportunity for reverse causation. However, 
we adjusted for diabetes and hypertension in our third model and observed no major changes in 
the HRs. Finally, we excluded individuals that did not complete PA data collection. These 
individuals were slightly older and more often female. 
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Our study is the first to report mortality risk for several PA types among participants with 
and without prevalent CVD. Moreover, we revealed that cycling, sports and walking not only 
prevented the first cardiovascular event in those without CVD, but also improved the prognosis of 
CVD in participants with CVD. In our study, compared to low PA, we found increases in LE for 
high PA which are similar to findings from other studies.6-10 One study found a slightly higher 
LE,7 which could be explained by the fact that they only looked at leisure time PA, whereas we 
evaluated leisure time, housework and transportation combined. Additionally, compared to low 
PA, we found increases in LE without CVD for high total PA of 3.3 in men and 2.8 in women, 
comparable to previous studies.9,10 In earlier studies comprising participants from the 
Framingham Heart Study, at age 50, high PA was associated with increases in LE without CVD of 
3.0-3.2 years for men and 3.1-3.3 years for women, compared to low PA.9,10 This study included 
participants aged 50 years, between 1948 and 1950, and followed them up until the end of the 20th 
century, whereas we included participants starting from 1999 and followed them until 2010. After 
1990, the treatment for cardiovascular risk factors has improved, which resulted in the reduction 
of cardiovascular incidence and mortality rates.11 Additionally, it might be expected that our 
population was less physically active, due to population changes in PA over the years. In spite of 
these population differences, the relative contribution of high PA compared to low PA has 
remained stable, indicating that being physically active can protect against CVD, independent of 
differences in the population. 
In our analyses, cycling was an important contributor to the effect of total PA. Furthermore, 
domestic work was important for women, whereas gardening and sports were important for men. 
The beneficial effect of several different PA types on LE has not been studied before and we are 
the first to show that these PA types have independent effects on total LE and LE without CVD. 
However, previous studies have shown beneficial effects of cycling, domestic work and sports on 
CVD and mortality risk.30,32-36 Moreover, whereas the World Health Organization recommends to 
engage in 30 minutes of PA, 5 days a week, to gain health benefits,37 our results suggest that 13 
minutes of cycling per day (the medium category) can already increase LE with 2.1 years in men 
and 2.4 years in women. This has also been shown in another study,38 in which an increase in total 
LE of 3 years was reported for 15 minutes of leisure time PA per day. Regarding other specific PA 
types, we only found one study reporting on walking, with increases in LE similar to ours.39 
This study has some limitations. First, we did not collect information on occupational PA, 
so we could not adjust for this in our analyses. However, since only 11.5% was employed at 
baseline, we do not believe this would have significantly influenced our results. Second, although 
our questionnaire has been validated,15 some error in self-report is inevitable. Moreover, since PA 
was measured at baseline only, this could have led to misclassification of PA over time. These last 
two limitations could have resulted in bias towards the null. Furthermore, people in poor health 
might participate in PA less than others, creating the opportunity for reverse causation. However, 
we adjusted for diabetes and hypertension in our third model and observed no major changes in 
the HRs. Finally, we excluded individuals that did not complete PA data collection. These 
individuals were slightly older and more often female. 
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Major strengths of the current study are our relatively long follow-up period in a well-
defined prospective population-based cohort study. Furthermore, we had a very accurate method 
of outcome ascertainment and we were able to adjust for several factors, thereby minimizing the 
possibility of the observed associations being explained by confounding. Additionally, by 
including a number of different physical activities, while adjusting for the remaining activities, we 
could examine their independent associations with CVD and mortality.  
Conclusions 
We conclude that high levels of PA are associated with a higher LE and prolonged years lived 
without CVD. Cycling contributed most to the most health benefits in both men and women, 
whereas domestic work contributed in women and sports and gardening contributed in men. 
Such activities could be more strongly encouraged in activity guidelines to maximize the 
population benefits of physical activity. 
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Major strengths of the current study are our relatively long follow-up period in a well-
defined prospective population-based cohort study. Furthermore, we had a very accurate method 
of outcome ascertainment and we were able to adjust for several factors, thereby minimizing the 
possibility of the observed associations being explained by confounding. Additionally, by 
including a number of different physical activities, while adjusting for the remaining activities, we 
could examine their independent associations with CVD and mortality.  
Conclusions 
We conclude that high levels of PA are associated with a higher LE and prolonged years lived 
without CVD. Cycling contributed most to the most health benefits in both men and women, 
whereas domestic work contributed in women and sports and gardening contributed in men. 
Such activities could be more strongly encouraged in activity guidelines to maximize the 
population benefits of physical activity. 
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Supplement 4.3.5. Effect of total physical activity on life expectancy with and without 
cardiovascular disease (CVD) at age 55 years, for participants without hypertension, diabetes and 
dyslipidemia. 
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Supplement 4.3.5. Effect of total physical activity on life expectancy with and without 
cardiovascular disease (CVD) at age 55 years, for participants without hypertension, diabetes and 
dyslipidemia. 
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ABSTRACT 
Background: Being overweight or obese is associated with increased risk of cardiovascular 
disease (CVD). Physical activity (PA) might reduce the risk associated with overweight and 
obesity. We examined the association between overweight and obesity and CVD risk as a 
function of PA levels in a middle aged and elderly population. 
Methods: This study included 5,344 participants aged 55 years or older from the population-
based Rotterdam Study. Participants were classified as having high or low PA, based on the 
median of the population. Subsequently, normal weight (18.5-24.9 kg/m2), overweight (25-
29.9 kg/m2), and obese participants (≥30 kg/m2) were categorized as having high or low PA, 
forming 6 categories. We assessed the association of the six categories with CVD risk using 
Cox proportional hazard models, adjusted for confounders. High PA and normal weight was 
used as the reference group.  
Results: During 15 years of follow-up (median:10.3 years, interquartile range: 8.2-11.7 years), 
866 participants (16.2%) experienced a CVD event. Overweight and obese participants with 
low PA had a higher CVD risk, compared to normal weight individuals with high PA. The 
hazard ratio (HR) and 95% confidence interval (95%CI) were 1.33 (1.07-1.66) and 1.35 (1.04-
1.75), respectively. Overweight and obese individuals with high PA did not show a higher 
CVD risk: HRs (95%CIs) 1.03 (0.82-1.29) and 1.12 (0.83-1.52), respectively.  
Conclusions: Our findings suggest that the beneficial impact of PA on CVD might outweigh 
the negative impact of BMI among middle-aged and elderly people. This emphasizes the 
importance of PA for all individuals and across all BMI strata, while highlighting the risk 
associated with inactivity even among normal-weight persons. 
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INTRODUCTION 
While overweight and obesity are associated with increased risk of cardiovascular disease (CVD),1-
3 higher levels of physical activity are associated with a decreased risk of CVD.4-6 However, to what 
extent physical activity can counterbalance the risk associated with overweight and obesity 
remains unclear.  
In recent years, several studies have investigated the combined association of physical 
activity and body mass index (BMI) with CVD risk in middle-aged adults, but the results are 
inconsistent.7-12 A review combining studies that evaluated the risk associated with obesity and 
physical activity, reported that four out of eight studies favored the hypothesis that the risk for 
cardiovascular mortality was lower in obese individuals with high physical activity than in normal 
weight individuals with low levels of physical activity.13 A study by Weinstein et al. that assessed 
the joint effect of physical activity and BMI on coronary heart disease in women reported that the 
risk of coronary heart disease associated with elevated BMI was considerably reduced by higher 
levels of physical activity8 These results indicate that the CVD risk associated with high BMI 
might be partly negated by physical activity. However, previous studies included middle-aged 
participants and information among the elderly remains to be scarce. In older adults, it has been 
suggested that the risk of myocardial infarction and stroke associated with overweight and obesity 
are attenuated.14 This might be because in older adults, BMI is a poor indicator of body fat and 
distribution and BMI alone might not be a good indicator of CVD risk.15 Moreover, lean mass and 
fat mass might act as nutritional preserves during illness. Furthermore, physical activity levels 
tend to decrease with age.16 Therefore, the role of physical activity on the association between BMI 
and CVD could differ between younger, middle-aged and elderly adults.  
In the current study, using data from the large population-based Rotterdam Study, we 
aimed to study the role of physical activity in the association between BMI and CVD among 
middle-aged and elderly individuals.  
 
METHODS 
Study population 
This study was embedded within the Rotterdam Study (RS), a prospective population-based 
cohort study among persons aged 55 years or older in the municipality of Rotterdam, the 
Netherlands. The baseline examination of the original cohort (RS-1) was completed between 1990 
and 1993. In 2000-2001, the Rotterdam Study was extended with 3,011 participants who had 
become ≥ 55 years old or had moved into the study district (RS-II). For the current study, we used 
data from participants attending the third examination of the original cohort (RS-I-3, between 
1997 and 1999; n = 4,797) and the participants attending the first examination of the extended 
cohort (RS-II-1, between 2000 and 2001; n=3,011). Of this combined total (n=7,808), 6,510 
participants completed data collection for both physical activity and BMI. Furthermore, 1,122 
persons with prevalent CVD were excluded and 6 were excluded due to missing follow-up data. 
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Subjects who were considered being underweight (BMI < 18.5 kg/m2) were also excluded (n=38). 
Eventually, 5,344 subjects were included in the current analyses. To collect the baseline 
information, trained research assistants interviewed the participants at home. 
All subjects gave written informed consent, and the study protocol was approved by the 
medical ethics committee of Erasmus University, Rotterdam. Detailed information on the design 
of the Rotterdam Study can be found elsewhere.17 
Assessment of anthropometrics and physical activity 
Height and weight were measured with the participants standing without shoes and heavy outer 
garments. Subsequently, BMI was calculated as weight divided by height squared (kg/m2). physical 
activity levels were assessed with an adapted version of the Zutphen Physical Activity 
Questionnaire,18 including questions regarding walking, cycling, sports, gardening and 
housekeeping activities. To quantify activity intensity, we assigned metabolic equivalent of task 
(MET)-scores to all activities, according to the 2011 updated version of the Compendium of 
Physical Activities.19 Finally, we multiplied MET-values of specific activities with time (in hours) 
per week spent in that activity to calculate MET∙hours∙week-1 in total physical activity. Further 
detail on the assessment of physical activity can be found elsewhere.20  
Assessment of confounders 
Alcohol use was defined as the amount of glasses per day. Education was assessed according to the 
standard classification of education comparable to the international standard classification of 
education and was grouped into four categories “elementary education”, “lower secondary 
education”, “higher secondary education” and “tertiary education”.21 Smoking was divided into 2 
categories: current and other (former and never). Dietary information was not collected at the 
same time as physical activity data were collected; therefore, we used the diet information 
measured in the first examination of the original cohort (RS-I-1, between 1989 and 1993) and in 
the third examination of the extended cohort (RS-II-3, between 2011 and 2012). Information on 
diet were obtained through a 170-item validated semiquantitative food frequency questionnaire.22 
From the questionnaire, an overall healthy diet score representing adherence to the Dutch dietary 
guidelines was calculated, as described previously.23 A family history of premature myocardial 
infarction was defined as having a parent, sibling, or child who experienced a myocardial 
infarction at the age of ≤65 years and used as a binary variable (yes/no). Since 97.6 % of our 
participants were Caucasian, adjustment for ethnicity was not required 
Clinical outcome 
The main outcome measure under study was incident hard atherosclerotic CVD, composed of 
fatal and non-fatal myocardial infarction, other coronary heart disease mortality, and fatal and 
non-fatal stroke.24 Data on clinical outcomes including CVD were collected through an automated 
follow-up system involving digital linkage of the study database to medical records managed by 
general practitioners working in the research area. Trained research assistants collected notes, 
outpatient clinic reports, hospital discharge letters, electrocardiograms, and imaging results from 
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general practitioners and hospital records. Subsequently, research physicians adjudicated all data 
on potential events independently. Following, medical specialists whose judgments are considered 
decisive reviewed the potential cases. Information on vital status was additionally obtained from 
the central registry of the municipality of the city of Rotterdam. Follow-up was complete until 
January 1, 2012. 
Statistical analysis 
Participants were classified as having a high or low level of total physical activity by using the 
median. Following, normal weight (<25 kg/m2), overweight (25-29.9 kg/m2), and obese 
participants (≥30 kg/m2) were categorized as being high or low physically active, forming 6 
categories. Baseline characteristics of the study population are presented as mean ± SD (or 
frequency and percentage when appropriate) for the 6 phenotypes formed by the physical activity 
levels (lower and higher) across different BMI categories.  
In our analysis, we first estimated the CVD risk associated with the BMI categories and with 
physical activity, using Cox proportional hazard regression analysis. Second, in our main analysis, 
we used Cox proportional hazard regression analysis to estimate the hazard ratio (HR) and 95% 
confidence interval (95%CI) for the 6 phenotypes described above in association with CVD, using 
normal weight with high levels of physical activity as the reference category. Proportional hazards 
assumptions were confirmed in all Cox models by visually comparing Kaplan-Meier curves of the 
different groups. The models were adjusted for age, gender, smoking, alcohol use, education, diet 
quality and family history of premature myocardial infarction. We decided a priori not to adjust 
for systolic blood pressure, total or high density lipoprotein cholesterol or plasma glucose, as they 
are all intermediators in the association between BMI and CVD.  
Physical activity, BMI and the joint BMI and physical activity phenotypes were entered as 
categorical variables in the model. Additionally, we assessed whether there was a trend across 
categories of BMI, by entering the categorical BMI variable as continuous in the model.  
We did not observe a significant interaction of gender or age with BMI, physical activity 
or the joint BMI and physical activity phenotypes. Moreover, no multiplicative or additive 
interaction between BMI and physical activity was observed. 
Sensitivity analyses  
Due to high competing risk of non-CVD death among the elderly, we performed a competing risk 
analysis using the method proposed by Fine and Gray.25 Additionally, we repeated the main 
analysis in participants older than 65, to specifically examine the associations in the elderly. We 
further investigated the possible effect of reverse causation by excluding the events in the first two 
years. Finally, we repeated the analysis in participants without missing information on diet. 
We had 24.6% missing data on the diet quality. For other covariates, we had less than 5% 
missing data. We used the single imputation by the Expectation Maximization method in SPSS. 
The analyses were performed using IBM SPSS Statistics for Windows (IBM SPSS Statistics for 
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further investigated the possible effect of reverse causation by excluding the events in the first two 
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missing data. We used the single imputation by the Expectation Maximization method in SPSS. 
The analyses were performed using IBM SPSS Statistics for Windows (IBM SPSS Statistics for 
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Windows, Armonk, NY: IBM Corp) and R version 3.2.1 (R Foundation for Statistical Computing, 
Vienna, Austria). Statistical significance was accepted at p <0.05. 
 
RESULTS 
The median level of physical activity by which the two physical activity categories were created 
was 79.4 MET·hours·week-1. The median and interquartile range (IQR) were 111.3 (93.7-139.6) 
and 54.6 (39.0-67.5) for the high and low category, respectively. These numbers correspond to 4 
hours and 2 hours per day of moderate intensity physical activity (4 METs). Table 4.4.1 shows the 
characteristics of the participants by the level of physical activity and BMI categories. The 
participants with low levels of physical activity were more often male, older and more often 
current smokers compared with participants with a high level of physical activity. The mean age of 
the population was 68.5 years (standard deviation: 7.9; range: 55-97 years) and 60.1% was female. 
During a median follow-up of 10.3 years, there were 866 (16.2%) incident CVD events. 
Table 4.4.2 presents the association of BMI categories and level of physical activity with 
incident CVD separately. Compared with normal weight individuals, overweight (HR 1.13, 95%CI 
0.97-1.57) and obese (HR 1.20, 95%CI 0.99-1.46) individuals were not at significantly increased 
CVD risk. In addition, we observed no significant trend across categories of BMI (P for trend 
0.05). Compared with the higher level of physical activity (irrespective of obesity), individuals 
with a low level of physical activity were at higher risk of CVD (HR 1.22, 95%CI 1.06-1.41). 
Figure 4.4.1 shows the association between the joint physical activity and BMI phenotypes 
with incident CVD. Compared to normal weight participants with high levels of physical activity, 
the risk of CVD was not significantly different in overweight (HR: 1.03, 95%CI: 0.82-1.29) and 
obese (HR: 1.12, 95%CI: 0.83-1.52) participants with a high level of physical activity. In contrast, 
overweight and obese participants with a low level of physical activity were at increased risk of 
CVD, compared to normal weight individuals with high physical activity. The corresponding HRs 
(95%CIs) were 1.33 (1.07-1.66) and 1.35 (1.04-1.75), respectively.  
 
Sensitivity analyses 
Supplement 4.4.1 shows that the HRs (95%CIs) from the competing risk approach were not 
substantially different from our original analysis. Additionally, when we repeated the main 
analysis in adults 65 and older, or when we excluded first 2 years of follow-up, we found similar 
results (Supplement 4.4.2 and Supplement 4.4.3) as in the total population. Finally, the results in 
the participants with information on diet quality were similar to the main analysis (Supplement 
4.4.4).  
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DISCUSSION
In this population-based study of adults aged 55 and over, overweight and obese individuals with 
high levels of physical activity were not at increased risk of CVD, compared with their normal 
weight counterparts. In contrast, among individuals with lower levels of physical activity, being 
overweight and obese was associated with a higher risk of CVD. Moreover, low physical activity 
levels increased the risk of CVD in the total population. These findings suggest that the impact of 
physical activity on CVD might outweigh that of BMI among middle-aged and elderly individuals. 
Similar studies regarding the joint association of BMI and physical activity with CVD are 
consistent with our findings.7-12 A study comprised of 18,892 Finish men and women aged 25-74 
years concluded that physical inactivity has an independent association with CVD risk, whereas 
obesity increases the risk through modification of other risk factors.11 In addition, the Women’s 
Health Study found that the risk of coronary heart disease associated with elevated BMI is 
considerable reduced by higher physical activity levels.8  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1. The association between joint physical activity and body mass index categories with 
cardiovascular disease 
Analyses adjusted for age, gender, education, diet quality, alcohol, smoking and family history of premature myocardial 
infarction 
*p < 0.05 vs. reference group. 
* 
* 
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Windows, Armonk, NY: IBM Corp) and R version 3.2.1 (R Foundation for Statistical Computing, 
Vienna, Austria). Statistical significance was accepted at p <0.05. 
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Table 4.4.2. The association of body mass index, and physical activity levels with cardiovascular 
disease 
    n/N HR (95%CI) 
Body mass index Normal weight 270/1,765 1.00 (reference) 
Overweight 428/2,535 1.13 (0.97-1.32) 
Obese 168/1,044 1.20 (0.99-1.46) 
Physical activity High physical activity 367/2,671 1.00 (reference) 
  Low physical activity 499/2,673 1.22 (1.06-1.40)* 
Abbreviations: n, number of events; N, number at risk; HR, hazard ratio; CI, confidence interval. 
Analyses adjusted for age, gender, education, diet quality, alcohol and smoking.  
*p < 0.05 vs. reference group. 
 
However, the risk was not completely eliminated, which reinforces the importance of being 
lean and physically active.8 Similarly, the analysis from the Nurse’s Health Study of 88,393 women 
aged 34 to 59 older showed that being moderately physically active attenuated, but did not 
eliminate, the adverse effect of obesity on coronary heart disease risk.7 Furthermore, they also 
showed that being lean did not counteract the increased risk associated with physical inactivity.7 
In the current study, we extended the evidence to the middle-aged and elderly individuals. We 
showed that once analyzed separately, the magnitude of the association between reduced physical 
activity with CVD was roughly similar to the one between obesity and CVD, although the latter 
did not reach statistical significance. However, once analyzed jointly, overweight and obese 
individuals with high levels of physical activity were not at significantly increased risk of CVD, 
whereas being overweight and obese was associated with increased risk of CVD among physically 
inactive individuals. Our results, while not refuting the cardiovascular risk associated with 
overweight and obesity, suggest that the impact of physical activity on CVD might outweigh that 
of BMI among middle-age and elderly adults.  
In addition to leisure time physical activity, we included transportation and housework in 
the assessment of total physical activity in the current study. Therefore, our results extend the 
previous findings and indicate that overall higher levels of physical activity (irrespective and 
beyond leisure time) can be beneficial to reduce CVD risk. Moreover, our study has been 
conducted in an older population. Elderly individuals might have more difficulties in engaging in 
sports or exercise (leisure time physical activity) and spend a relatively large proportion of their 
time on housework, compared to younger individuals.26 Our study emphasizes the importance of 
the beneficial effects of physical activity as part of our daily life, as supported in the recent 
recommendations.27 
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had a 1.33 and 1.35 times higher risk of CVD, compared to normal weight individuals with a high 
level of physical activity. Other studies,7,8,11,12 reported a up to 3 times higher CHD risk7,8 and up to 
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Table 4.4.2. The association of body mass index, and physical activity levels with cardiovascular 
disease 
    n/N HR (95%CI) 
Body mass index Normal weight 270/1,765 1.00 (reference) 
Overweight 428/2,535 1.13 (0.97-1.32) 
Obese 168/1,044 1.20 (0.99-1.46) 
Physical activity High physical activity 367/2,671 1.00 (reference) 
  Low physical activity 499/2,673 1.22 (1.06-1.40)* 
Abbreviations: n, number of events; N, number at risk; HR, hazard ratio; CI, confidence interval. 
Analyses adjusted for age, gender, education, diet quality, alcohol and smoking.  
*p < 0.05 vs. reference group. 
 
However, the risk was not completely eliminated, which reinforces the importance of being 
lean and physically active.8 Similarly, the analysis from the Nurse’s Health Study of 88,393 women 
aged 34 to 59 older showed that being moderately physically active attenuated, but did not 
eliminate, the adverse effect of obesity on coronary heart disease risk.7 Furthermore, they also 
showed that being lean did not counteract the increased risk associated with physical inactivity.7 
In the current study, we extended the evidence to the middle-aged and elderly individuals. We 
showed that once analyzed separately, the magnitude of the association between reduced physical 
activity with CVD was roughly similar to the one between obesity and CVD, although the latter 
did not reach statistical significance. However, once analyzed jointly, overweight and obese 
individuals with high levels of physical activity were not at significantly increased risk of CVD, 
whereas being overweight and obese was associated with increased risk of CVD among physically 
inactive individuals. Our results, while not refuting the cardiovascular risk associated with 
overweight and obesity, suggest that the impact of physical activity on CVD might outweigh that 
of BMI among middle-age and elderly adults.  
In addition to leisure time physical activity, we included transportation and housework in 
the assessment of total physical activity in the current study. Therefore, our results extend the 
previous findings and indicate that overall higher levels of physical activity (irrespective and 
beyond leisure time) can be beneficial to reduce CVD risk. Moreover, our study has been 
conducted in an older population. Elderly individuals might have more difficulties in engaging in 
sports or exercise (leisure time physical activity) and spend a relatively large proportion of their 
time on housework, compared to younger individuals.26 Our study emphasizes the importance of 
the beneficial effects of physical activity as part of our daily life, as supported in the recent 
recommendations.27 
In the current study, overweight and obese individuals with a low level of physical activity 
had a 1.33 and 1.35 times higher risk of CVD, compared to normal weight individuals with a high 
level of physical activity. Other studies,7,8,11,12 reported a up to 3 times higher CHD risk7,8 and up to 
2.36 times higher CVD risk11,12 for obese individuals with low physical activity, compared to 
normal weight individuals with high activity. The lower risk in the current study might be 
explained by the relatively high levels of physical activity in the low physical activity group. The 
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median level of physical activity for the low group was 54.6 MET∙hours∙week-1, corresponding to 2 
hours per day of moderate intensity physical activity. This is a higher physical activity level than 
reported in the low group of other studies.7,8,11,12 Whereas our risk estimates were relatively low, 
our results do not indicate that the risk associated with inactivity should be neglected. For public 
health programs, it remains important to focus on increasing population physical activity levels, 
and to concomitantly stress body weight management. The mechanism underlying the harmful 
effect of overweight and obesity on CVD risk has been well investigated. Adipose tissue releases 
free fatty acids, interleukins, and cytokines that influence cardiac function by acceleration of 
atherosclerosis processes, inflammation, endothelial and coagulation dysfunction.28,29 The 
plausible mechanisms through which physical activity has been suggested to improve CVD risk 
are improved endothelial function, stabilization of vulnerable plaques preventing plaque rupture 
and reduced myocardial oxygen demand.30 This indicates that physical activity directly reduces 
and combats the harmful effect of the prothrombotic factors released by adipose tissue.8,31 
In our study, obese individuals with high levels of physical activity conferred a similar risk 
of CVD as normal weight individuals with low level of physical activity when we compared both 
groups to normal weight individuals with a high level of physical activity. Notably, both groups 
were at high risk of CVD, although the associations did not reach the significance threshold. 
These findings suggest that being lean does not counteract the increased risk associated with 
physical inactivity, but also being physically active does not offset the increased risk of being 
obese. Therefore, our study confirms previous findings that physically active and lean individuals 
are at low risk of CVD7,11 and extends these findings to middle-aged and elderly individuals.  
Major strengths of the current study are its prospective population-based design, large 
sample size of adults aged 55 years and older and relatively long follow-up period. Furthermore, 
we had a reliable assessment of CVD events and were able to adjust for several lifestyle factors, 
thereby minimizing the possibility of the observed associations being explained by confounding. 
However, several limitations should be considered. First, our conclusions are drawn from baseline 
measurements. Therefore some misclassification, due to the changes in BMI or physical activity 
levels during follow-up, could have occurred. However, weight gain tends to be linear over time 
and therefore the difference between the groups is likely to remain constant, even with weight 
change.8 Additionally, our results are based on self-reported physical activity. Although our 
questionnaire has shown to be valid and reliable32 potential recall bias and social desirability 
cannot be excluded. These last two limitations could have resulted in bias towards the null 
hypothesis. Furthermore, information on diet quality was not collected at the same time as BMI 
and physical activity. We acknowledge this limitation and used this information as a proxy of diet 
quality. Additionally, information on diet quality was missing for 24.6% of participants and was 
therefore imputed. Although we cannot fully exclude the possibility of residual confounding by 
diet quality, restricting the analysis to participants with diet information revealed comparable 
results. Finally, it may be hypothesized that participants with poor health engage in physical 
activity less than others, thereby creating the opportunity for reverse causation. However, in our 
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analyses exclusion events that occurred within the first two years of follow up revealed 
comparable results.  
Conclusions 
In summary, in this long-term follow-up study of older adults the risk associated with overweight 
and obesity was attenuated in individuals with high physical activity levels. This suggests that 
regular physical activity reduces the CVD risk in older adults and that further benefits can be 
gained from maintaining a healthy weight. 
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These findings suggest that being lean does not counteract the increased risk associated with 
physical inactivity, but also being physically active does not offset the increased risk of being 
obese. Therefore, our study confirms previous findings that physically active and lean individuals 
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Major strengths of the current study are its prospective population-based design, large 
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we had a reliable assessment of CVD events and were able to adjust for several lifestyle factors, 
thereby minimizing the possibility of the observed associations being explained by confounding. 
However, several limitations should be considered. First, our conclusions are drawn from baseline 
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and therefore the difference between the groups is likely to remain constant, even with weight 
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questionnaire has shown to be valid and reliable32 potential recall bias and social desirability 
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comparable results.  
Conclusions 
In summary, in this long-term follow-up study of older adults the risk associated with overweight 
and obesity was attenuated in individuals with high physical activity levels. This suggests that 
regular physical activity reduces the CVD risk in older adults and that further benefits can be 
gained from maintaining a healthy weight. 
 
REFERENCES 
1. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J 
Am Coll Cardiol. 2009;53(21):1925-1932. 
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr. Body-mass index and mortality in a prospective cohort of 
U.S. adults. N Engl J Med. 1999;341(15):1097-1105. 
3. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from 
Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; 
the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr. 2007;85(5):1197-1202. 
4. Williams PT. Dose-response relationship of physical activity to premature and total all-cause and cardiovascular disease 
mortality in walkers. PLoS One. 2013;8(11):e78777. 
5. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of 
cardiovascular events in women. N Engl J Med. 2002;347(10):716-725. 
6. Armstrong ME, Green J, Reeves GK, Beral V, Cairns BJ, Million Women Study C. Frequent physical activity may not 
reduce vascular disease risk as much as moderate activity: large prospective study of women in the United Kingdom. 
Circulation. 2015;131(8):721-729. 
7. Li TY, Rana JS, Manson JE, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease 
in women. Circulation. 2006;113(4):499-506. 
8. Weinstein AR, Sesso HD, Lee IM, et al. The joint effects of physical activity and body mass index on coronary heart 
disease risk in women. Arch Intern Med. 2008;168(8):884-890. 
9. Kenchaiah S, Sesso HD, Gaziano JM. Body mass index and vigorous physical activity and the risk of heart failure among 
men. Circulation. 2009;119(1):44-52. 
10. Dankel SJ, Loenneke JP, Loprinzi PD. The impact of overweight/obesity duration on the association between physical 
activity and cardiovascular disease risk: an application of the "fat but fit" paradigm. Int J Cardiol. 2015;201:88-89. 
11. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist 
circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and 
women. Eur Heart J. 2004;25(24):2212-2219. 
12. Carlsson AC, Arnlov J, Sundstrom J, Michaelsson K, Byberg L, Lind L. Physical activity, obesity and risk of 
cardiovascular disease in middle-aged men during a median of 30 years of follow-up. Eur J Prev Cardiol. 
2016;23(4):359-365. 
13. Fogelholm M. Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A 
systematic review. Obes Rev. 2010;11(3):202-221. 
14. Janssen I. Morbidity and mortality risk associated with an overweight BMI in older men and women. Obesity (Silver 
Spring). 2007;15(7):1827-1840. 
15. Dhana K, van Rosmalen J, Vistisen D, et al. Trajectories of body mass index before the diagnosis of cardiovascular 
disease: a latent class trajectory analysis. European Journal of Epidemiology. 2016;31(6):583-592. 
16. Sun F, Norman IJ, While AE. Physical activity in older people: a systematic review. BMC Public Health. 2013;13:449. 
17. Hofman A, Brusselle GG, Darwish Murad S, et al. The Rotterdam Study: 2016 objectives and design update. Eur J 
Epidemiol. 2015;30(8):661-708. 
18. Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and 
their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 
1991;133(11):1078-1092. 
19. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes 
and MET values. Med Sci Sports Exerc. 2011;43(8):1575-1581. 
Chapter 4.4 
262 
20. Koolhaas CM, Dhana K, Golubic R, et al. Physical Activity Types and Coronary Heart Disease Risk in Middle-Aged and 
Elderly Persons: The Rotterdam Study. Am J Epidemiol. 2016;183(8):729-738. 
21. United Nations Educational SaCOUISCoEI. 1976. 
22. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a 
semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8):588-596. 
23. van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van't Veer P, Feskens EJ. The Dutch Healthy Diet index (DHD-
index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J. 2012;11:49. 
24. Goff DC, Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a 
report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am 
Coll Cardiol. 2014;63(25 Pt B):2935-2959. 
25. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American 
statistical association. 1999;94(446):496-509. 
26. Dong L, Block G, Mandel S. Activities Contributing to Total Energy Expenditure in the United States: Results from the 
NHAPS Study. Int J Behav Nutr Phys Act. 2004;1(1):4. 
27. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the 
American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081-1093. 
28. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115 Suppl 8A:37S-41S. 
29. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595-2600. 
30. Bowles DK, Laughlin MH. Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart 
disease. J Appl Physiol (1985). 2011;111(1):308-310. 
31. Powers SK, Lennon SL, Quindry J, Mehta JL. Exercise and cardioprotection. Curr Opin Cardiol. 2002;17(5):495-502. 
32. Westerterp K, Saris W, Bloemberg B, Kempen K, Caspersen C, Kromhout D. Validation of the Zutphen physical 
activity questionnaire for the elderly with doubly labeled water [abstract]. Med Sci Sports Exerc. 1992;24(5):S68. 
The impact of physical activity on the association of overweight and obesity with CVD 
263 
SUPPLEMENT CHAPTER 4.4 
Supplement 4.4.1. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease after taking in account competing risk 
  n/N HR (95%CI) 
High physical activity Normal weight 125/924 1.00 (reference) 
 Overweight 179/1,279 1.05 (0.84, 1.32) 
 Obese 63/468 1.12 (0.83, 1.51) 
Low physical activity Normal weight 145/841 1.02 (0.79, 1.30) 
 Overweight 249/1,256 1.27 (1.02, 1.58)* 
 Obese 105/576 1.30 (1.01,  1.69)* 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
 
Supplement 4.4.2. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease in elderly, aged 65+ (n=3,238) 
  n/N HR (95%CI) 
High physical activity Normal weight 96/524 1.00 (reference) 
 Overweight 142/737 1.05 (0.81,  1.36) 
 Obese 54/259 1.24 (0.89,  1.74) 
Low physical activity Normal weight 115/545 1.08 (0.82,  1.42) 
 Overweight 201/800 1.34 (1.05,  1.72)* 
 Obese 88/373 1.36 (1.02,  1.83)* 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
Supplement 4.4.3. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease, excluding events in the first 2 years (n=5,150) 
  n/N HR (95%CI) 
High physical activity Normal weight 101/900 1.00 (reference) 
 Overweight 136/1,236 0.96 (0.74, 1.25) 
 Obese 52/457 1.12 (0.80, 1.57) 
Low physical activity Normal weight 114/810 1.13 (0.86, 1.49) 
 Overweight 187/1,194 1.30 (1.02, 1.67)* 
 Obese 82/553 1.33 (0.99, 1.79) 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
 
 
  
Chapter 4.4 
262 
20. Koolhaas CM, Dhana K, Golubic R, et al. Physical Activity Types and Coronary Heart Disease Risk in Middle-Aged and 
Elderly Persons: The Rotterdam Study. Am J Epidemiol. 2016;183(8):729-738. 
21. United Nations Educational SaCOUISCoEI. 1976. 
22. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a 
semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8):588-596. 
23. van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van't Veer P, Feskens EJ. The Dutch Healthy Diet index (DHD-
index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J. 2012;11:49. 
24. Goff DC, Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a 
report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am 
Coll Cardiol. 2014;63(25 Pt B):2935-2959. 
25. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American 
statistical association. 1999;94(446):496-509. 
26. Dong L, Block G, Mandel S. Activities Contributing to Total Energy Expenditure in the United States: Results from the 
NHAPS Study. Int J Behav Nutr Phys Act. 2004;1(1):4. 
27. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the 
American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081-1093. 
28. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115 Suppl 8A:37S-41S. 
29. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595-2600. 
30. Bowles DK, Laughlin MH. Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart 
disease. J Appl Physiol (1985). 2011;111(1):308-310. 
31. Powers SK, Lennon SL, Quindry J, Mehta JL. Exercise and cardioprotection. Curr Opin Cardiol. 2002;17(5):495-502. 
32. Westerterp K, Saris W, Bloemberg B, Kempen K, Caspersen C, Kromhout D. Validation of the Zutphen physical 
activity questionnaire for the elderly with doubly labeled water [abstract]. Med Sci Sports Exerc. 1992;24(5):S68. 
The impact of physical activity on the association of overweight and obesity with CVD 
263 
SUPPLEMENT CHAPTER 4.4 
Supplement 4.4.1. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease after taking in account competing risk 
  n/N HR (95%CI) 
High physical activity Normal weight 125/924 1.00 (reference) 
 Overweight 179/1,279 1.05 (0.84, 1.32) 
 Obese 63/468 1.12 (0.83, 1.51) 
Low physical activity Normal weight 145/841 1.02 (0.79, 1.30) 
 Overweight 249/1,256 1.27 (1.02, 1.58)* 
 Obese 105/576 1.30 (1.01,  1.69)* 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
 
Supplement 4.4.2. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease in elderly, aged 65+ (n=3,238) 
  n/N HR (95%CI) 
High physical activity Normal weight 96/524 1.00 (reference) 
 Overweight 142/737 1.05 (0.81,  1.36) 
 Obese 54/259 1.24 (0.89,  1.74) 
Low physical activity Normal weight 115/545 1.08 (0.82,  1.42) 
 Overweight 201/800 1.34 (1.05,  1.72)* 
 Obese 88/373 1.36 (1.02,  1.83)* 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
Supplement 4.4.3. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease, excluding events in the first 2 years (n=5,150) 
  n/N HR (95%CI) 
High physical activity Normal weight 101/900 1.00 (reference) 
 Overweight 136/1,236 0.96 (0.74, 1.25) 
 Obese 52/457 1.12 (0.80, 1.57) 
Low physical activity Normal weight 114/810 1.13 (0.86, 1.49) 
 Overweight 187/1,194 1.30 (1.02, 1.67)* 
 Obese 82/553 1.33 (0.99, 1.79) 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
 
 
  
Chapter 4.4 
264 
Supplement 4.4.4. The association between joint physical activity and body mass index 
phenotypes with cardiovascular disease, in those without missing dietary quality information 
(n=4,030) 
  n/N HR (95%CI) 
High physical activity Normal weight 102/752 1.00 (reference) 
 Overweight 133/991 0.99 (0.76, 1.28) 
 Obese 43/372 0.94 (0.66, 1.35) 
Low physical activity Normal weight 103/612 1.11 (0.84, 1.47) 
 Overweight 176/903 1.37 (1.07, 1.76)* 
 Obese 68/400 1.31 (0.96, 1.79) 
Analyses adjusted for age, gender, education, diet, alcohol, smoking and family history of premature myocardial infarction.  
Abbreviations: CI, confidence interval; HR, hazard ratio; n, number of events; N, number at risk. 
*p < 0.05 vs. reference group. 
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ABSTRACT 
Background: Physical activity (PA) is associated with health-related quality of life (HRQL). 
The specific PA types that provide beneficial effects in an older population remain unclear. 
We assessed the association of total PA, walking, cycling, domestic work, sports and 
gardening with HRQL in middle-aged and elderly adults. 
Methods: Our cross-sectional study included 5,554 individuals from the population-based 
Rotterdam Study. Total PA was categorized in five groups to evaluate the dose-response effect 
of PA and specific PA types were categorized in tertiles. HRQL was measured with the 
EuroQoL 5-dimension. The outcome of every HRQL domain (i.e. mobility, self-care, daily 
activities, pain and mood) was expressed as having any problems versus not having problems. 
Logistic and linear regression analyses were used, adjusting for confounders, to examine 
associations of total PA and PA types with HRQL domains. 
Results: In both middle-aged (<65 years) and elderly adults (>65 years), we found a dose-
response association between total PA and better HRQL (i.e. lower odds of having problems 
in HRQL domains). In the middle-aged, sports was the only PA type associated with lower 
odds of having problems with all HRQL domains. In the elderly, all PA types were associated 
with less problems with HRQL domains, but cycling contributed most to the beneficial effect.  
Conclusion: Total PA was associated with better HRQL. Sports and cycling were the activity 
types that contributed most to this association in the middle-aged and elderly, respectively. 
Since PA levels tend to decline with aging, cycling and sports should be promoted with the 
aim to improve HRQL. 
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INTRODUCTION 
Recent studies have shown a consistent association between physical activity (PA) and health-
related quality of life (HRQL).1,2 HRQL is defined as an individuals’ perspective of well-being in 
physical, mental and social domains of life.3 Previous studies have mainly focused on the effect of 
overall PA,1,2 whereas it remains unclear how specific PA types affect quality of life. To be able to 
make clear and effective public health recommendations, It is important to distinguish between 
different types of PA (e.g. cycling, walking) and HRQL.  
In young adults, performing sports was reported to be associated with better HRQL in 20-70 
year old adults4 and domestic work was positively associated to general health in male university 
students.5 In men aged 18-55 years old, cycling frequency was associated with higher physical and 
psychological quality of life.6 However, information among older adults remains scarce. With 
increasing age, PA levels tend to decrease7 and PA types in which older adults engage differ 
markedly from the activities performed by younger adults.8 This raises the question what kind of 
activities are beneficially associated with HRQL in the middle-aged and elderly. Additionally, 
because 65 years of age is considered the retirement age in many countries, it is interesting to 
explore whether different PA types are associated with HRQL before and after retirement age. 
Moreover, only a few studies have investigated the nature of the dose-response relation between 
PA and HRQL, with conflicting results and limited information among the elderly.2,9-11 The 
Rotterdam study includes adults aged 45 years and older and has previously shown to be a 
relatively active population,12 which makes it an interesting population to study. 
Therefore, we aimed to examine the association between PA, PA types (walking, cycling, 
sports, domestic work, and gardening) and HRQL in a middle-aged and elderly population. In 
addition, we aimed to describe the dose-response relationship between PA and HRQL. 
  
METHODS 
Study population 
This study was embedded within the Rotterdam Study, a prospective population-based cohort in 
the Netherlands.13 The cohort was initially defined in 1990 (RS-I) and expanded in 2000 (RS-II) 
and 2005 (RS-III). In 1990 and 2000, all inhabitants aged 55 years and older of Ommoord, a 
suburb of Rotterdam, were invited to participate. In 2005, all inhabitants aged 45 years and older 
were invited. For the current study, we used data from participants attending the fifth 
examination of the original cohort (RS-I-5, between 2009 and 2011; n =2,147; aged 72 to 97 years), 
participants attending the third examination of the extended cohort (RS-II-3, between 2011 and 
2012; n=1,893; aged 64 to 97 years) and participants attending the second examination of the third 
cohort (RS-III-2, between 2012 and 2014; n=3,122; aged 51 to 92 years).13,14 Of this combined 
total, 5,573 completed both PA and HRQL collection (See Supplement 5.1.1). We did not exclude 
any participants based on their health status. However, 19 cases were excluded because their PA 
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data was considered unreliable. After exclusion, 5,554 participants were available for the current 
analysis.  
All subjects gave written informed consent, and the study protocol was approved by the 
medical ethics committee according to the Wet Bevolkingsonderzoek ERGO (Population Study 
Act Rotterdam Study), executed by the Ministry of Health, Welfare and Sport of The Netherlands. 
Detailed information on the design of the Rotterdam Study can be found elsewhere.13,14 
Physical activity assessment  
PA levels were assessed with the self-administered LASA Physical Activity Questionnaire 
(LAPAQ). This questionnaire has been validated in 439 participants from the Longitudinal Aging 
Study Amsterdam (LASA), in which the LAPAQ was completed twice and participants completed 
a 7-day activity diary and wore a pedometer for 7 days. The test-retest reliability was reasonably 
good (0.65–0.75) and the correlations with the pedometer and 7-day diary were 0.56 and 0.68, 
respectively.15 The LAPAQ contains questions regarding the frequency and duration of walking, 
cycling, sports, gardening, and housework. Participants were asked how many hours per week 
they spent in each activity in the past two weeks. Furthermore, the questionnaire provided two 
questions in which participants could mention other sports they participated in that were not 
captured by previous questions. Missing values for specific PA questions were imputed using age- 
and sex-specific means. For example, if participants indicated they participated in walking two 
times per week, but they did not fill in the walking duration, the age- and sex-specific mean was 
imputed. 
To quantify activity intensity, we used metabolic equivalent of task (MET). MET-values 
were assigned to all activities in the questionnaire, according to the 2011 updated version of the 
Compendium of Physical Activities.16 Of all mentioned other activities,  14 (3.8%) were not sports 
and 16 (4,4%) were not in the compendium (e.g. ‘treadmill’, ‘indoor sports’, ‘power plate’). For 
these activities, no MET-values were assigned and they were not used in the analyses. 
Finally, we multiplied MET-values of specific activities with time (in hours) per week 
spent in that activity to calculate MET∙hours∙week-1 in total PA, defined as the sum of cycling, 
walking, sports, domestic work and gardening, and in every type of PA.  
Covariates 
Information on covariates was collected through home interviews, using an extensive 
questionnaire, or obtained at the study center visit, as described previously.17,18 Briefly, alcohol use 
was defined as alcohol intake in grams per day. Smoking was divided in three categories: current, 
former and never. Education was assessed according to the standard classification of education, 
comparable to the international standard classification of education.19 We assessed living situation 
as a dichotomous variable describing whether the participant lived alone or not. Information on 
job status was categorized in employed/unemployed. Height and weight were measured and body 
mass index (BMI) was calculated (kg/m2). Finally, comorbidity was defined as the presence of 
cancer, diabetes, stroke, or coronary heart disease in 2012 and used as a binary variable (yes/no). 
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Health-related quality of life (HRQL) assessment (Outcome) 
HRQL was evaluated using the Dutch version of the EuroQoL, during the home interview. This 
questionnaire has been validated in 90 participants who completed the questionnaire at baseline 
and after six months,20 in which the Spearman retest correlation was 0.67. The EuroQoL consists 
of five dimensions: mobility, self-care, daily activities, pain/discomfort, and mood (i.e. 
anxiety/depression)21,22 and each of the dimensions is assessed based on a single question with 
three response levels (no problem, some or moderate problems, and extreme problems). For the 
current study, each dimension was recoded in two levels: no problems versus any problems. 
Furthermore, the EuroQoL includes a standard vertical 20 cm visual analogue scale (VAS), for 
recording an individual’s rating for their current HRQL. 
Statistical analysis 
For all PA types, we categorized participants into tertiles based on MET∙hours∙week-1, because of 
the non-normal distribution of all PA types. For activities not practiced by more than 60% of the 
population (cycling, gardening, sports, domestic work), the bottom category for PA levels was no 
participation and the remaining two categories were divided by using the median.23 The median 
levels were 6.0, 26.9, 8.0 and 14.9 MET∙hours∙week-1 for cycling, domestic work, gardening and 
sports, respectively. For total PA, we created five categories, based on percentiles, to examine the 
dose-response association between total PA and HRQL. The values on which the categories were 
based are 12.0, 27.5, 53.0 and 88.8  MET∙hours∙week-1.  
Logistic regression models were used to analyze associations between PA (total and per 
type) with binary HRQL outcomes and linear regression models were used to evaluate the 
association with the VAS. A lower odds ratio (OR) indicates lower odds of having problems in a 
particular HRQL domain. We performed separate analyses for middle-aged (≤65 years) and 
elderly adults (>65 years) because PA might have a different association with HRQL in both age 
groups.9 Analyses were adjusted for age, sex, living situation, smoking, alcohol consumption, 
education, job status and comorbidity. For PA types,  models were additionally adjusted for the 
other PA types. The decision to include confounders in the multivariable regression models was 
based on previous literature or >10%-change of the effect estimate in the crude model.9,10 Total PA 
and PA types were entered as categorical variables in the separate models.  
Given prior work, we conducted a sensitivity analysis using stratified models by sex.11 
Moreover, 24.6% (n=1,364) was employed at baseline, but we did not collect information on 
occupational PA. Therefore, we repeated our analyses in non-workers. Finally, we repeated the 
analysis in participants with and without comorbidity to evaluate whether the association is 
driven by individuals who are less healthy. 
Our data contained 15.2% missing data for alcohol consumption and all other covariates 
had less than 5% missing data. We used multiple imputation (n=5 imputations) by the 
Expectation Maximization method. All analyses were conducted using SPSS software version 20 
(IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp) and R (3.0.1).  
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anxiety/depression)21,22 and each of the dimensions is assessed based on a single question with 
three response levels (no problem, some or moderate problems, and extreme problems). For the 
current study, each dimension was recoded in two levels: no problems versus any problems. 
Furthermore, the EuroQoL includes a standard vertical 20 cm visual analogue scale (VAS), for 
recording an individual’s rating for their current HRQL. 
Statistical analysis 
For all PA types, we categorized participants into tertiles based on MET∙hours∙week-1, because of 
the non-normal distribution of all PA types. For activities not practiced by more than 60% of the 
population (cycling, gardening, sports, domestic work), the bottom category for PA levels was no 
participation and the remaining two categories were divided by using the median.23 The median 
levels were 6.0, 26.9, 8.0 and 14.9 MET∙hours∙week-1 for cycling, domestic work, gardening and 
sports, respectively. For total PA, we created five categories, based on percentiles, to examine the 
dose-response association between total PA and HRQL. The values on which the categories were 
based are 12.0, 27.5, 53.0 and 88.8  MET∙hours∙week-1.  
Logistic regression models were used to analyze associations between PA (total and per 
type) with binary HRQL outcomes and linear regression models were used to evaluate the 
association with the VAS. A lower odds ratio (OR) indicates lower odds of having problems in a 
particular HRQL domain. We performed separate analyses for middle-aged (≤65 years) and 
elderly adults (>65 years) because PA might have a different association with HRQL in both age 
groups.9 Analyses were adjusted for age, sex, living situation, smoking, alcohol consumption, 
education, job status and comorbidity. For PA types,  models were additionally adjusted for the 
other PA types. The decision to include confounders in the multivariable regression models was 
based on previous literature or >10%-change of the effect estimate in the crude model.9,10 Total PA 
and PA types were entered as categorical variables in the separate models.  
Given prior work, we conducted a sensitivity analysis using stratified models by sex.11 
Moreover, 24.6% (n=1,364) was employed at baseline, but we did not collect information on 
occupational PA. Therefore, we repeated our analyses in non-workers. Finally, we repeated the 
analysis in participants with and without comorbidity to evaluate whether the association is 
driven by individuals who are less healthy. 
Our data contained 15.2% missing data for alcohol consumption and all other covariates 
had less than 5% missing data. We used multiple imputation (n=5 imputations) by the 
Expectation Maximization method. All analyses were conducted using SPSS software version 20 
(IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp) and R (3.0.1).  
 
Chapter 5.1 
274 
RESULTS 
Middle-aged adults participated more often in cycling, domestic work, gardening and sports than 
elderly adults (Figure 5.1.1). Additionally, middle-aged adults reported fewer problems with 
mobility, self-care and daily activities (Table 5.1.1). The number of participants in each group of 
every PA type is presented in Supplement 5.1.2. The median (range) of the 5 categories of total PA 
are 1) 6.0 (<12.0) MET·hours·week-1; 2) 18.8 (12.1-27.5) MET·hours·week-1; 3) 39.3 (27.6-53.0) 
MET·hours·week-1; 4) 68.2 (53.1-88.8) MET·hours·week-1; 5) 119.9 (>88.8) MET·hours·week-1. The 
median levels of total PA across categories are therefore equivalent to 13, 40, 84, 146 and 257 
minutes per day of total physical activity of 4 METs. There were no associations found with the 
VAS for any PA variable (Supplement 5.1.3). 
In both middle-aged and elderly adults, higher total PA was associated with lower odds of 
having problems with mobility, daily activities and mood (i.e. being anxious or depressed) and 
with lower odds of having pain (Figure 5.1.2). Additionally, total PA was associated with lower 
odds of having problems with self-care in the elderly. The ORs (95%CI) of the associations 
between the highest level of total PA, compared to the lowest level of total PA, and having 
mobility problems were 0.54 (0.35, 0.83) and 0.33 (0.26, 0.43) in middle-aged and elderly adults, 
respectively. For problems with mood the ORs (95%CI) for the highest level of total PA were 0.59 
(0.36, 0.96) and 0.57 (0.41, 0.8) for the middle-aged and elderly, respectively. 
 
 
Figure 5.1.1. Proportion of participants by physical activity type for the Rotterdam Study. 
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Table 5.1.1. Baseline participant characteristics per age group (n=5,554) 
 Middle-aged (≤ 65 years) Elderly (>65 years) 
Participants, no. 1,819 3,735 
Female, no. (%) 1,055 (58.0) 2,143 (57.4) 
Age 59.2 (3.7) 74.0 (6.4) 
Educational level, no. (%) 
   Primary education 122 (6.7) 323 (8.6) 
   Lower education 573 (31.5) 1,635 (43.8) 
   Intermediate education, 553 (30.4) 1,112 (29.8) 
   Higher education, 571 (31.4) 665 (17.8) 
Living with partner, no. (%) 1,455 (80.0) 2,489 (66.6) 
Employed, no. (%) 1,134 (62.3) 232 (6.2) 
Smoking, no. (%) 
   Never 637 (35.0) 1,297 (34.7) 
   Former 886 (48.7) 2,095 (56.1) 
   Current 296 (16.3) 343 (9.2) 
Alcohol, grams/day 13.3 (14.7) 11.1 (14.1) 
BMI, no. (%)   
   Underweight (<18.5 kg/m2) 49 (2.7) 60 (1.6) 
   Normal weight (18.5 – 25.0 kg/m2) 539 (29.6) 980 (26.2) 
   Overweight (25 – 30 kg/m2) 822 (45.2) 1,825 (48.9) 
   Obese (≥30 kg/m2) 409 (22.5) 870 (23.3) 
Diabetes, no. (%) 166 (9.1) 649 (17.4) 
Cancer, no. (%) 166 (9.1) 818 (21.9) 
CHD, no. (%) 65 (3.6) 400 (10.7) 
Stroke, no. (%) 17 (0.9) 148 (4.0) 
Groups of physical activity, no. (%) 
   Very low 305 (16.8) 822 (22.0) 
   Low 350 (19.2) 740 (19.8) 
   Medium 417 (22.9) 698 (18.7) 
   High 393 (21.6) 719 (19.3) 
   Very high 354 (19.5) 756 (20.2) 
Total PA, MET·hours·week-1 55.9 (52.1) 54.1 (55.0) 
Walking, MET·hours·week-1 11.3 (15.0) 12.2 (14.1) 
Cycling, MET·hours·week-1 5.5 (10.5) 4.2 (9.0) 
Domestic work, MET·hours·week-1 20.8 (31.3) 20.0 (28.9) 
Gardening, MET·hours·week-1 3.7 (10.7) 3.8 (11.5) 
Sports, MET·hours·week-1 14.6 (23.8) 14.0 (28.9) 
Any problems with mobility, no. (%) 278 (15.3) 967 (25.9) 
Any problems with self-care, no. (%) 33 (1.8) 196 (5.2) 
Any problems with daily activities, no. (%) 174 (9.6) 526 (14.1) 
Any problems with pain, no. (%) 825 (45.4) 1,657 (44.4) 
Any problems with mood, no. (%) 223 (12.3) 424 (11.4) 
Visual analogue scale 82.1 (53.1) 80.4 (40.1) 
Abbreviations: BMI, body mass index; CHD, coronary heart disease; no, number; PA, physical activity 
Numbers are mean (SD), unless otherwise stated. 
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Alcohol, grams/day 13.3 (14.7) 11.1 (14.1) 
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Cycling, MET·hours·week-1 5.5 (10.5) 4.2 (9.0) 
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Regarding PA types, walking was not associated with any HRQL domain in middle-aged adults 
(Table 5.1.2), but with mobility, self-care, daily activities and pain in the elderly (Table 5.1.3). For 
example, in the elderly, the high walking category was associated with 43% lower odds of having 
problems with mobility (95%CI: 0.47, 0.69), compared to the low category. 
Cycling was associated with HRQL in the elderly only (Table 5.1.3). Moreover, cycling was the PA 
type associated with the lowest ORs overall in elderly adults. Compared to low cycling, high 
cycling was associated with 37% (95%CI: 0.50, 0.78), 57% (95%CI: 0.24, 0.77), 58% (95%CI: 0.30, 
0.59) and 33% (95%CI: 0.56, 0.80) lower odds of having problems with mobility, self-care, daily 
activities and pain, respectively. 
 
 
Figure 5.1.2. Associations between total physical activity groups with quality of life measures in 
middle aged (≤65 years) and elderly adults (age >65 years).  
Abbreviations: OR, odds ratio; VAS, visual analogue scale. 
Association between five total PA categories and six measures of health-related quality of life. The x-axis represents the 5 
levels of total physical activity The median (range) are 1) 6.0 (<12.0) MET·hours·week-1; 2) 18.8 (12.1-27.5) MET·hours·week-1; 
3) 39.3 (27.6-53.0) MET·hours·week-1; 4) 68.2 (53.1-88.8) MET·hours·week-1; 5) 119.9 (>88.8) MET·hours·week-1. The median 
levels of total physical activity across categories are therefore equivalent to 13, 40, 84, 146 and 257minutes per day of total 
physical activity of 4 metabolic equivalents. The y-axis represents odds ratios (OR) and 95% confidence intervals (95%CIs) of 
having problems with a quality of life domain, and beta coefficients and their 95%CI for the visual analogue scale. The first 
total physical activity category is the reference category (i.e. OR = 1 and β=0). Models are adjusted for age, sex, marital status, 
smoking, alcohol consumption, education, job status, and comorbidity. 
0
1
2
3
0 1 2 3 4 5
D
ai
ly
 ac
tiv
iti
es
 (O
R)
 
0
0.5
1
1.5
2
0 1 2 3 4 5
M
ob
ili
ty
 (O
R)
 
age <= 65
age > 65
0
0.5
1
1.5
2
0 1 2 3 4 5
M
oo
d 
(O
R)
 
-1
1
3
5
7
0 1 2 3 4 5
Se
lf 
ca
re
 (O
R)
 
0
0.5
1
1.5
0 1 2 3 4 5
Pa
in
 (O
R)
 
-10
-5
0
5
10
15
0 1 2 3 4 5
V
A
S 
(β
) 
Physical activity types and health-related quality of life 
277 
We found domestic work to be associated with pain in middle-aged adults (Table 5.1.2) and with 
mobility, self-care, daily activities and pain in the elderly (Table 5.1.3). For example, in the 
middle-aged, medium domestic work was associated with 27% lower odds of having pain (95%CI: 
0.57, 0.93), compared to the low category.  
For gardening we found significant associations with HRQL domains in both middle-aged 
and elderly adults (Table 5.1.2-5.1.3). For example, high gardening was associated with 57% 
(95%CI: 0.21, 0.88) and 38% (95%CI: 0.41-0.92) lower odds of having problems with daily 
activities in middle-aged and elderly adults, respectively. 
We found sports to be associated with better mobility and less pain in both age groups and 
with better self-care, daily activities and mood in middle-aged adults (Table 5.1.2). Moreover, it 
was the PA type with the most associations with HRQL domains in the middle-aged. In this age 
group, compared to low sports, high sports was associated with 41% (95%CI: 0.41, 0.85), 82% 
(95%CI: 0.04, 0.84), 60% (95%CI: 0.24, 0.66), 44% (95%CI: 0.43, 0.72) and 34% (95%CI: 0.45, 0.99) 
lower odds of having problems with mobility, self-care, daily activities, pain and mood, 
respectively (Table 5.1.2). 
In our sensitivity analyses by gender, employment status and presence of comorbidity, our 
findings did not materially change (Supplement 5.1.4 – Supplement 5.1.13).  
 
DISCUSSION 
In this population-based cohort of middle-aged and elderly adults, we found a dose-response 
relation between total PA and better HRQL. Additionally, we found that sport was associated with 
better mobility, self-care, daily activities, mood and less pain in middle-aged adults, whereas 
cycling was associated strongest with these HRQL domains in the elderly.  
Only a few studies have investigated the nature of the dose-response relation between PA 
and HRQL, and have reported conflicting results.2,9-11 A systematic review among adults aged <65 
years suggested that there might be optimal levels of PA, and any PA below or above this 
threshold might not have additional benefits on HRQL.2 In contrast, two studies in middle-aged 
adults found a linear trend between PA and HRQL.10,11 Finally, a study from the Australian 
Longitudinal Study on Women’s Health, in middle-aged and elderly women (aged 50-81 years), 
found that improvements in HRQL were observed at very low levels of PA and continued up to 
higher levels, after which increases were less marked for some outcomes, like the physical 
component summary and physical functioning.9 In agreement with this study, we found that the 
odds of having problems with HRQL domains decreased with increasing total PA levels in both 
middle-aged and elderly adults. In the elderly, the decreases were observed at the lowest PA levels 
and continued up to the highest level, but were less marked. In middle-aged participants, the odds 
of having problems with HRQL domains declined less rapidly with increasing total PA levels.  
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Due to the cross-sectional nature of the studies, we cannot comment on the direction of the 
association between PA and HRQL. It is unclear whether physically active individuals experience 
a better HRQL or that people with a better HRQL are more likely to be physically active. In this 
regard, it is plausible that lower odds of having pain lead to higher levels of sports participation, 
but it could also be that higher sports participation leads to lower odds of having pain problems.  
Data from randomized controlled trials indicate that exercise has a positive effect on quality 
of life in older adults with insomnia24 and minor depression25 and can reduce pain among 
individuals with osteoarthritis.26,27 In addition, a recent randomized controlled trial in frail elderly 
adults indicated that an activity oriented intervention program (e.g. training of functions and 
skills) could aid in improving physical functioning and vitality, although these results did not 
reach significance.28 Moreover,  longitudinal studies suggest that increases in PA levels are 
associated with improvements in physical functioning and vitality scores,9,29 indicating that PA 
patterns are an important determinant of HRQL. 
Our study included both middle-aged (≤65 years) and elderly adults (>65 years). In the 
Netherlands, 65 years is considered retirement age, and different PA patterns for these groups are 
therefore expected We found that walking was associated with lower odds of having problems 
with mobility, self-care, daily activities and pain in elderly participants, but not in the middle-
aged. This resembles results from a recent study, that found stronger associations of walking with 
the mental component summary, physical functioning, mental health and vitality in older 
compared to middle-aged women.9 Another study in adults aged 75 years and older reported that 
older persons who attained recommended levels of walking had better results in most aspects of 
HRQL.30 Moreover, a walking intervention among older individuals has shown beneficial effects 
on physical and mental HRQL.31 The fact that in the current study walking was only associated 
with HRQL in the elderly participants might be explained by the relative importance of this 
activity type among the elderly, whereas they participate less in other PA types.32 
We found that a high level of cycling was associated with fewer problems with daily 
activities, mobility, self-care and pain in the elderly, but we not in middle-aged adults. We are not 
aware of another study evaluating the association between cycling and HRQL in elderly adults. 
Even so, a study in Australian men, aged 18-55 years, found a beneficial association between 
cycling frequency and psychological well-being.6 The fact that we found no association between 
cycling and HRQL in middle-aged adults might be explained by the fact that in contrast to 
Australia, cycling is a common way of commuting in the Netherlands, instead of a solely a form of 
sports. Indeed, a large proportion of participants in our study participated in cycling on a weekly 
basis (57.5% of middle-aged and 39.8% of elderly).  
We found an association between gardening and HRQL that has not been reported before. 
Since gardening can be considered a relaxing activity, this might explain the positive association. 
Moreover, being outside might contribute to the effect as well. It is possible that sunlight exposure 
during gardening increased vitamin D levels, which consequently improved quality of life.33 
Furthermore, in literature, the association between domestic work and HRQL remains unclear. A 
study in younger adults reported an inverse association,34 whereas domestic work was positively 
Physical activity types and health-related quality of life 
281 
related to HRQL in university students.5 Our study indicates that domestic work is associated with 
better HRQL in middle-aged and elderly adults. 
Sports is an activity type that has been reported to be associated with HRQL in middle-aged 
adults.4 In our study, we found that it was associated with lower odds of having problems with all 
HRQL-aspects in middle-aged adults, whereas it was only associated with better mobility and less 
pain in elderly adults. Probably, elderly adults engage in different kinds of sports than their 
middle-aged counterparts. Indeed, we found that younger adults engage more in high intensity 
activities like tennis and jogging, whereas elderly participated more in gymnastics, bowls and 
billiards (data not shown). Additionally, sports made up 20% of the total MET∙hours∙week-1 in 
middle-aged adults and 15% of the MET∙hours∙week-1 in the elderly.  
Major strengths of our study were the use of a large community-based cohort and the 
categorization of participants into broad range of PA categories, to facilitate the examination of 
dose-response relationships. Furthermore,  we included a number of different activities while 
adjusting for the remaining activities, which enabled us to examine their independent associations 
with HRQL. However, our study has some limitations worth mentioning: because of the cross-
sectional design, the influence of PA on HRQL could not be determined. It is possible that PA 
influenced HRQL, but it is also possible that people with lower HRQL are less likely to engage in 
PA. Second, it may be hypothesized that people in poor health participate in PA less than others, 
creating the opportunity for reverse causation. Although we did not find that results were 
influenced by comorbidity. Furthermore, we had data on cancer, cardiovascular disease and 
diabetes up to 2012, whereas we collected data on PA and HRQL for RS-III (n=1,893) between 
2012 and 2014. It is possible that part of the observed associations might be explained presence of 
comorbidities that presented after 2012. Therefore, we cannot fully exclude the possibility of 
residual confounding by comorbidities. Another limitation is that our results are based on self-
reported PA and HRQL. Although our questionnaires have shown to be valid and reliable15,35 
potential recall bias and social desirability cannot be excluded. 
Conclusions 
In summary, sport was the PA type with most associations with HRQL in middle-aged adults, 
whereas activities with lower intensity, like walking, cycling and domestic work, were more 
important in elderly adults. These results suggest that different activities could be promoted to 
different age groups, to improve HRQL. Future research, involving trials or studies with 
longitudinal designs, could provide more insight about the characteristics of specific PA types 
beneficially related with HRQL in different populations. 
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Supplement 5.1.1. Flow chart of participant inclusion for the Rotterdam Study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
5,573 Participants 
1,589 Participants Excluded Due to 
No Physical Activity Data or Health 
Related Quality of Life Data 
Collection 
19 Participants Excluded Due to 
Unreliable Completion of Physical 
Activity Data Collection 
7,162 Total Participants 
2,147 at RS-I visit 5 (2009-2011) 
1,893 at RS-II visit 3 (2011-2012) 
3,122 at RS-III visit 2 (2012-2014) 
5,554 Participants Included in Analyses: 
x 3,735 aged >65 years 
x 1,819 aged ≤65 years 
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Supplement 5.1.2. Number of middle-aged (≤65 years) and elderly adults (>65 years) in each 
physical activity group 
Activity Type and Tertile of 
Physical Activity Number of participants 
Middle-aged participants 
(age ≤65 years) 
Elderly participants 
(age > 65 years) 
Total Physical Activity  
1 520 1,335 
2 690 1,159 
3 609 1,241 
Walking   
1 704 1,201 
2 605 1,242 
3 510 1,292 
Domestic work   
1 762 2,103 
2 576 846 
3 481 786 
Cycling   
1 687 1,658 
2 610 997 
3 522 1,080 
Sports   
1 1,150 2,775 
2 468 498 
3 201 462 
Gardening   
1 683 1,649 
2 559 1,054 
3 577 1,032 
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Supplement 5.1.3. Beta coefficients and their 95% confidence intervals for the visual analogue 
scale in middle-aged (≤65 years) and elderly adults (> 65 years) for all physical activity types, the 
Rotterdam Study, 2009-2014.  
  Middle-aged adults Elderly adults 
  
Median 
METhours/ 
week 
(range) 
β 95% CI 
Median 
METhours 
/week 
(range) 
β 95% CI 
Walking 
  Low 2.3 (<4.5) Ref 2.3 <4.5 Ref 
  Moderate 7.9 (4.5-12.0) -5.69 -11.46, 0.08 7.9 4.5-12.0 -0.64 -3.83, 2.55 
  High 21.0 (≥12.1) -3.08 -9.28, 3.11 21.0 ≥12.1 2.10 1.06, 5.27 
Cycling 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 3.0 (0-6.0) 1.66 -4.18, 7.49 3.0 0-6.0 1.73 -1.61, 5.08 
  High 12.0 (≥6.1) 7.63 1.47, 13.78 12.0 ≥6.1 -0.06 -3.52, 3.40 
Domestic work 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 12.3 (0-26.9) -1.88 -7.98, 4.23 14.5 0-26.9 -1.16 -4.5, 2.19 
  High 45.9 (≥27.0) -4.53 -11.15, 2.09 47.2 ≥27.0 -1.24 -4.57, 2.09 
Gardening 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 4.0 (0-8.0) 0.64 -5.19, 6.47 4.0 0-8.0 -1.56 -5.51, 2.39 
  High 16.0 (≥8.1) 2.66 -5.36, 10.68 17.8 ≥8.1 1.76 -2.31, 5.82 
Sports 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 7.6 (0-14.9) -4.21 -10.57, 2.16 6.8 0-14.9 -0.81 -4.19, 2.58 
  High 29.0 (≥15.0) -0.72 -7.11, 5.68 30.5 ≥15.0 0.05 -3.59, 3.69 
Abbreviations: Ref, referent; VAS, visual analogue scale. 
Models are adjusted for age, sex, marital status, smoking, alcohol consumption, education, job status, comorbidity and the 
other physical activity types 
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Supplement 5.1.3. Beta coefficients and their 95% confidence intervals for the visual analogue 
scale in middle-aged (≤65 years) and elderly adults (> 65 years) for all physical activity types, the 
Rotterdam Study, 2009-2014.  
  Middle-aged adults Elderly adults 
  
Median 
METhours/ 
week 
(range) 
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  Moderate 7.9 (4.5-12.0) -5.69 -11.46, 0.08 7.9 4.5-12.0 -0.64 -3.83, 2.55 
  High 21.0 (≥12.1) -3.08 -9.28, 3.11 21.0 ≥12.1 2.10 1.06, 5.27 
Cycling 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 3.0 (0-6.0) 1.66 -4.18, 7.49 3.0 0-6.0 1.73 -1.61, 5.08 
  High 12.0 (≥6.1) 7.63 1.47, 13.78 12.0 ≥6.1 -0.06 -3.52, 3.40 
Domestic work 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 12.3 (0-26.9) -1.88 -7.98, 4.23 14.5 0-26.9 -1.16 -4.5, 2.19 
  High 45.9 (≥27.0) -4.53 -11.15, 2.09 47.2 ≥27.0 -1.24 -4.57, 2.09 
Gardening 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 4.0 (0-8.0) 0.64 -5.19, 6.47 4.0 0-8.0 -1.56 -5.51, 2.39 
  High 16.0 (≥8.1) 2.66 -5.36, 10.68 17.8 ≥8.1 1.76 -2.31, 5.82 
Sports 
  Low 0 (0) Ref 0 0 Ref 
  Moderate 7.6 (0-14.9) -4.21 -10.57, 2.16 6.8 0-14.9 -0.81 -4.19, 2.58 
  High 29.0 (≥15.0) -0.72 -7.11, 5.68 30.5 ≥15.0 0.05 -3.59, 3.69 
Abbreviations: Ref, referent; VAS, visual analogue scale. 
Models are adjusted for age, sex, marital status, smoking, alcohol consumption, education, job status, comorbidity and the 
other physical activity types 
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ABSTRACT 
Introduction Based on studies using self-reported sitting time, sedentary behavior has been 
suggested as a risk factor for poor mental health and cognition. However, it remains unclear 
whether objectively measured sedentary behavior is longitudinally associated with depression, 
anxiety disorders or cognition. 
Methods In the population-based Rotterdam Study, cross-sectional and longitudinal 
associations of objectively assessed sedentary time with depressive symptoms, anxiety 
disorders and cognition were assessed among 1,841 participants (mean follow-up: 5.7 years). 
Participants wore a wrist actigraph for seven days between 2004 and 2007 to assess sedentary 
time (hours/day). Depression, anxiety disorders and cognition were assessed twice between 
2004 and 2014. Depressive symptoms were continuously measured with the Centre for 
Epidemiologic Studies-Depression scale (CES-D) and diagnoses of anxiety disorders (n=147) 
were obtained by interviews. Cognition was assessed using a test battery. Analyses were 
adjusted for age, sex, smoking, education, body mass index, occupational status, marital 
status, functional disability score, and physical activity. 
Results One hour/day more sedentary time was cross-sectionally associated with 0.25 (95% 
confidence interval (95%CI): 0.08, 0.41) higher CES-D score, 1.11 (95%CI: 1.01, 1.21) higher 
odds of anxiety disorder, and 0.03 (95%CI: -0.05, -0.01) lower global cognition score. After 
adjustment for confounders, these associations no longer remained. Sedentary time at 
baseline was not associated longitudinally with changes in depressive symptoms, anxiety 
disorders and cognition. 
Conclusions We found no support for an association between objectively measured sedentary 
behavior and impaired mental health or cognition. All observed associations were explained 
by confounders, in particular, disability, occupational status and smoking. The previously 
reported association between sitting time and mental health might reflect residual 
confounding, bias of subjective measures, or the social context of sedentary behavior.  
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INTRODUCTION 
Sedentary behavior has been suggested as a risk factor for several chronic diseases, including 
cardiovascular disease, diabetes, poor mental health and low cognitive performance.1 However, 
reviews of the effect of sedentary behavior on mental health and cognitive performance conclude 
this association is less conclusive, even though several studies have related higher levels of 
sedentary behavior to an increased likelihood of depression2-4 anxiety disorders,5,6 and worse 
cognition.7,8  
There are important limitations to the studies included in these reviews and meta-analyses. 
First, most studies were cross-sectional,3,4,6,8-10 making it impossible to determine whether high 
sedentary behavior leads to impaired mental health and cognition or the converse. Second, only a 
few studies adjusted for a measure of disability, which can be considered an important 
confounder in the association of sedentary behavior with mental health and cognition, certainly in 
a middle-aged or elderly population. Third, the majority of the studies included self-reported 
measures of sedentary behavior, which might be subject to the influence of perception, 
particularly in persons with problems related to depression, anxiety or cognition.11 Moreover, 
these subjective measures of sedentary behavior typically address television viewing, computer use 
or occupational sitting as proxies of sedentary behavior. This practice, however, can influence the 
results,12-15 as associations might be driven more by the social context than the sedentary behavior 
itself.16 In summary, it remains unclear whether objectively measured sedentary behavior is 
longitudinally associated with depression, anxiety, and cognition. 
In this population-based study, we examined the cross-sectional and longitudinal 
association of objectively measured sedentary behavior with depression, anxiety, and cognition, in 
older persons. Depression, anxiety and cognition were assessed twice over an average follow-up 
period of 5.7 years.  
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study, a prospective population-based cohort in the 
Netherlands, started in 1990. The aim of the study was to examine the incidence of psychiatric, 
neurological, cardiovascular, and other chronic diseases. Details of the study have been published 
elsewhere.17 
From December 2004 to April 2007, 2,632 successive participants of the Rotterdam Study 
were invited to participate in the actigraphy study. The current study was conducted in 2,063 
participants who agreed to participate (78%). The only requirement for participation was being 
able to understand the instructions for this study. To prevent missing data diluting our estimated 
hours of sedentary behavior per day, days with more than 3 hours of continuous missing data 
(133 days) were excluded.18,19 We excluded 168 recordings with technical problems or that 
contained fewer than 4 days (see Figure 5.2.1). Additionally, sedentary data of 54 participants 
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(2.8%) with unusually low (<20% per day) or high (>90% per day) sedentary time was considered 
unreliable after visual inspection and therefore excluded. The 1,841 participants with data on 
sedentary behavior all had information on at least one of the 5 outcomes relating to mental health 
or cognition (Figure 5.2.1). More specifically, 1,488 participants (80.8%) had information on all 5 
measures, 321 (17.4%) on 4 measures, 25 (1.4%) on 3 measures and 7 (0.4%) on 2 measures. The 
number (%) of individuals with an anxiety disorder at baseline was 147 (8.0%) and 22 (1.2%) were 
diagnosed with prevalent major depressive disorder (MDD). Since a diagnosis of MDD was 
conditional on information on depressive symptoms, MDD was not included in the flowchart.  
All subjects provided written informed consent, and the study protocol was approved by the 
institutional review board (Medical Ethics Committee) of the Erasmus Medical Center and by the 
review board of The Netherlands Ministry of Health, Welfare and Sports. 
Measurement of sedentary time 
Participants were asked to wear an actigraph around the non-dominant wrist (Actiwatch model 
AW4; Cambridge Technology, Cambridge, UK) for seven consecutive days and nights and to 
additionally complete a 7-day sleep diary to report overnight sleep periods. The actigraph had to 
be removed from the wrist for water-based activities only. Recordings were collected in 30-second 
intervals, during 24-hour periods.20 Initially, the actigraph devices were introduced to the 
Rotterdam study to measure sleep in everyday life. The devices were therefore not calibrated to 
measure the level of physical activity and do not allow for comparison across individuals 
regarding physical activity. However, the actigraph device can validly measure active versus non-
active intervals within a person. We can use these data as a proxy of sedentary behavior and test 
between person differences.21  
To quantify sedentary time, we only used waking hours, based on bedtime and get up time. 
Bedtime and get up time were obtained from the event marker button on the actigraph for 9575 
(88.1%) days. If these data were not present for a night, we obtained the information from the 
sleep diary (n=1265 days, 11.6%) or we estimated bedtime and get up time based on the previous 
days and the actigraphy pattern (n=24 days, 0.2%).20 The time (hours/day) spent in sedentary 
behavior was determined using the standard count-based intensity threshold value of <199 counts 
per minute (cpm).22 
Measurement of clinical outcomes  
Depressive symptoms 
At baseline (2004-2007) and the next follow-up measurement (2009-2014) depressive symptoms 
were assessed with the Dutch version of the Centre for Epidemiologic Studies Depression scale 
(CES-D),23 a scale designed to assess presence and severity of self-reported depressive symptoms.24 
During the home interview, participants were asked 20 questions that correspond with criterion-
based symptoms associated with depression and the summative scale ranges from score 0 to 60. A 
score of 16 or greater is traditionally accepted as cut-off to define clinical depression.25 
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(2.8%) with unusually low (<20% per day) or high (>90% per day) sedentary time was considered 
unreliable after visual inspection and therefore excluded. The 1,841 participants with data on 
sedentary behavior all had information on at least one of the 5 outcomes relating to mental health 
or cognition (Figure 5.2.1). More specifically, 1,488 participants (80.8%) had information on all 5 
measures, 321 (17.4%) on 4 measures, 25 (1.4%) on 3 measures and 7 (0.4%) on 2 measures. The 
number (%) of individuals with an anxiety disorder at baseline was 147 (8.0%) and 22 (1.2%) were 
diagnosed with prevalent major depressive disorder (MDD). Since a diagnosis of MDD was 
conditional on information on depressive symptoms, MDD was not included in the flowchart.  
All subjects provided written informed consent, and the study protocol was approved by the 
institutional review board (Medical Ethics Committee) of the Erasmus Medical Center and by the 
review board of The Netherlands Ministry of Health, Welfare and Sports. 
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AW4; Cambridge Technology, Cambridge, UK) for seven consecutive days and nights and to 
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be removed from the wrist for water-based activities only. Recordings were collected in 30-second 
intervals, during 24-hour periods.20 Initially, the actigraph devices were introduced to the 
Rotterdam study to measure sleep in everyday life. The devices were therefore not calibrated to 
measure the level of physical activity and do not allow for comparison across individuals 
regarding physical activity. However, the actigraph device can validly measure active versus non-
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between person differences.21  
To quantify sedentary time, we only used waking hours, based on bedtime and get up time. 
Bedtime and get up time were obtained from the event marker button on the actigraph for 9575 
(88.1%) days. If these data were not present for a night, we obtained the information from the 
sleep diary (n=1265 days, 11.6%) or we estimated bedtime and get up time based on the previous 
days and the actigraphy pattern (n=24 days, 0.2%).20 The time (hours/day) spent in sedentary 
behavior was determined using the standard count-based intensity threshold value of <199 counts 
per minute (cpm).22 
Measurement of clinical outcomes  
Depressive symptoms 
At baseline (2004-2007) and the next follow-up measurement (2009-2014) depressive symptoms 
were assessed with the Dutch version of the Centre for Epidemiologic Studies Depression scale 
(CES-D),23 a scale designed to assess presence and severity of self-reported depressive symptoms.24 
During the home interview, participants were asked 20 questions that correspond with criterion-
based symptoms associated with depression and the summative scale ranges from score 0 to 60. A 
score of 16 or greater is traditionally accepted as cut-off to define clinical depression.25 
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Depression diagnosis 
Participants with a CES-D score of 16 or higher were invited for a semi-structured clinical 
interview with the Schedules for Clinical Assessment of Neuropsychiatry (SCAN),26 an instrument 
commonly used to diagnose depression in older adults of the Dutch population.27 The SCAN 
interview was conducted by a trained clinician at the participant’s home. Using a digitalized 
algorithm of the DSM-IV, we considered a participant having an MDD when they met the 
condition for MDD according to the DSM-IV. 
Anxiety disorders 
The 12-month prevalence of 5 different anxiety disorders according to the DSM-IV-TR (Text 
Revision) Criteria28 was assessed during the home interview, using an adapted version of the 
Munich version of the Composite International Diagnostic Interview (M-CIDI). The anxiety 
disorders under consideration were generalized anxiety disorder, panic disorder, agoraphobia, 
social phobia, and specific phobia as described previously.29 Participants were classified as having 
an anxiety disorder if they had at least one of these anxiety disorders. The M-CIDI was designed 
specifically to obtain DSM-IV diagnoses of mental disorders. The test-retest reliability of using the 
M-CIDI for anxiety disorders is satisfactory.30 
Cognitive function 
A detailed assessment of cognitive function was obtained using a test battery during the research 
center visit. The tests included the mini mental state examination (MMSE), Stroop test (time in 
seconds taken for completing each of the following 3 tasks: word reading, color naming, and a 
reading/color naming interference task), the letter-digit substitution task (scored as the number of 
correct digits in 1 minute), the verbal fluency test (scored as the number of mentioned animal 
species within 1 minute), the 15-word learning test (recall and recognition of visually presented 
words), and the Purdue pegboard test for fine motor skills.31 For the Purdue pegboard test, the 
scores from the right hand, left hand, and both hands were summed.  
We calculated a general cognitive factor (g-factor) by performing principal component 
analyses incorporating the letter-digit substitution task, the verbal fluency test, 15-word learning 
delayed recall subtask, the inverse value of the Stroop color–word interference subtask and the 
sum of the Purdue pegboard scores. A higher g-factor indicates better performance. The g-factor 
explained 52.3% of all variance in cognitive tests at baseline and 51.6% at the follow-up 
measurement, which is in accordance with literature.31 
Measurement of covariates 
Information on covariates was collected through home interviews or measured at the study 
center, as described elsewhere.32,33 For the current study, alcohol consumption was defined as the 
amount of glasses per day. Education was assessed in line with the international standard 
classification of education and classified as primary, lower, intermediate and higher education.34 
Smoking was categorized in three groups: current, former and never. Marital status was defined as 
living with a partner or not. Occupational status was used as a binary variable 
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(employed/unemployed). Activities of daily living were measured with the Stanford Health 
Assessment Questionnaire and used to indicate the level of disability (i.e. disability score).35 
Height and weight were measured to calculate body mass index (BMI). The presence of coronary 
heart disease, diabetes, stroke and cancer were determined using medical records, to define the 
number of comorbidities. For part of the study population (n=870), physical activity was assessed 
at baseline with the validated LASA Physical Activity Questionnaire (LAPAQ).36 In the remainder 
(n = 971) the LAPAQ was assessed in the next round of measurements and this assessment was 
used as a proxy for current physical activity levels at baseline. The LAPAQ included questions on 
housekeeping activities, walking, cycling, sports and gardening. Time spent in these activities was 
combined and expressed in MET·hours·week-1.  
Statistical analysis 
Sedentary time was analyzed continuously (per one hour/day). Additionally, baseline 
characteristics were compared across three categories of sedentary behavior: 1) < 8 hours/day;  
2) 8 - 11 hours/day; 3) ≥ 11 hours/day.19 
To examine the cross-sectional and longitudinal associations of sedentary time with 
depressive symptoms, the g-factor and MMSE score, we used linear regression models. To 
examine the association of sedentary time with anxiety disorders and MDD, we used logistic 
regression models. We applied natural cubic splines to test for non-linearity of each of the 
models,37 but found no evidence for a non-linear association of sedentary behavior with any 
outcome in any model. Covariates were included in the models based on previous research2,5,7 or a 
10% change in the effect estimate.38 Based on these results, we did not include alcohol 
consumption and the number of comorbidities in our models.  
For our cross-sectional analyses, we first created a basic model for all the outcomes (i.e. 
depressive symptoms, MDD, anxiety disorders, g-factor, MMSE score), including age, sex, cohort 
and time awake. In model 2, we additionally included sociodemographic and lifestyle factors, i.e. 
education, occupational status, marital status, smoking and BMI. In model 3, to examine the effect 
of sedentary behavior beyond physical activity and disability measures, we additionally adjusted 
for physical activity and the disability score. We examined the effect of adding each of these 
factors in the models, by computing the percentage change in the effect estimate for sedentary 
behavior after including the specific factor. 
For the longitudinal analyses we also created 3 separate models in line with the cross-
sectional analyses. To account for the longitudinal design, we additionally adjusted model 1 for 
the time between the baseline and the follow-up measurement and the baseline value of the 
outcome (for the analyses of depressive symptoms, g-factor or MMSE score). For our longitudinal 
analyses of anxiety disorders, we excluded prevalent cases at baseline from our analyses. Because 
incidence of MDD in participants without MDD at baseline was limited (n=7), we did not 
conduct the longitudinal analyses of MDD. 
In sensitivity analyses, we examined the associations stratified by age (younger or older than 
65 years old) and sex. We also repeated the analyses for depressive symptoms, g-factor and 
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MMSE-score with change (e.g. depressive symptoms at time point 2 - depressive symptoms at 
time point 1) as the outcome variable while not adjusting for baseline scores of the outcome 
variable. Finally, we performed cross-sectional analyses of the cognitive tests included in the g-
factor. 
Substantial data was missing for physical activity (24.5%) and the disability score (25.5%), 
other covariates had <2% missing data. We performed multiple imputations (n=20 imputations) 
using a Markov Monte Carlo imputation method. All analyses were conducted using SPSS 
software version 21 (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp) and R (3.4.1).  
Non-response analysis 
When we compared participants who agreed to those who refused to wear an actigraph, we 
observed that the former were slightly older, more often men, had better scores for the g-factor 
and MMSE and had a lower disability score (Supplement 5.2.1).  
 
RESULTS 
Table 5.2.1 shows the baseline characteristics of the 1,841 participants included in the study 
according to categories of sedentary behavior. Mean age was 62.6 years (standard deviation (SD): 
9.3), 54.4% of the sample was female, and the mean daily sedentary time was 8.8 hours (SD: 2.0), 
corresponding to 55.7% of the waking time. The mean (SD) follow-up time was 5.7 (0.6) years. 
Sedentary behavior in association with depressive symptoms and MDD 
In our cross-sectional analyses adjusted for age, sex, cohort and time awake (model 1), one hour 
more sedentary time was associated with 0.25 point higher CES-D score (95%CI: 0.08, 0.41) 
(Table 5.2.2). After additional adjustment for confounders in model 2, the effect estimate was 
slightly reduced (β: 0.18; 95%CI: 0.006, 0.34). The association was clearly attenuated after 
additional adjustment for activity variables in model 3 (β: 0.08; 95%CI: -0.09, 0.24). The change in 
the effect estimate was particularly large (54%) after adding the disability score to the model 
(Supplement 5.2.2A). Additionally, occupational status, marital status, and smoking were 
associated with changes in the effect estimate of more than 10%. 
In our longitudinal analyses, we observed no association between sedentary time and the 
CES-D score in any model (Table 5.2.3). We also observed no cross-sectional association of 
sedentary behavior with MDD in any model (Table 5.2.2). 
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Table 5.2.1. Baseline participant characteristics by categories of sedentary time, the Rotterdam 
Study 
  Categories of sedentary behavior, hours/day 
< 8 hours 8-11 hours ≥ 11 hours 
Demographics 
Participants, n (%) 637 (34.6) 958 (52) 246 (13.4) 
Age  60.1 (8) 63.7 (9.5) 65.2 (10.6) 
Female 419 (65.8) 478 (49.9) 104 (42.3) 
Educational level, n (%) 
     Primary education 56 (8.7) 71 (7.4) 27 (11) 
     Lower education 282 (44.3) 387 (40.3) 84 (34.1) 
     Intermediate education 182 (28.6) 291 (30.3) 82 (33.3) 
     Higher education 117 (18.4) 210 (21.9) 53 (21.5) 
Employed, n (%) 262 (41.1) 293 (30.6) 68 (27.7) 
Living with partner, n (%) 513 (80.5) 753 (78.6) 170 (69.1) 
Lifestyle factors 
Smoking, n (%) 
    Never 224 (35.2) 294 (30.7) 61 (24.8) 
    Former 327 (51.3) 489 (51.0) 127 (51.5) 
    Current 86 (13.5) 176 (18.3) 58 (23.7) 
BMI (kg/m2) 27.3 (4.0) 27.9 (4.1) 29.0 (4.8) 
Disability score 0.3 (0.3) 0.3 (0.4) 0.4 (0.4) 
Alcohol (glasses/day) 0.9 (1.1) 1.1 (1.3) 1.1 (1.4) 
Physical activity (METhours/week) 68.8 (66.5) 57.3 (64.7) 50.2 (52.4) 
Mental Health 
Baseline CESD score 5.2 (6.8) 5.5 (6.9) 5.7 (7.2) 
Prevalent MDD, n (%) 6 (1.0) 13 (1.4) 3 (1.3) 
Prevalent anxiety disorder, n (%) 50 (8.1) 77 (8.2) 20 (8.5) 
Baseline g-factor 0.2 (0.9) -0.1 (1.0) -0.4 (1.1) 
MMSE score 28.0 (1.8) 27.9 (2.0) 27.9 (1.8) 
Prevalent diseases 
Prevalent diabetes, n (%) 65 (10.2) 142 (14.8) 52 (21.1) 
Prevalent CHD, n (%) 25 (3.9) 52 (5.4) 27 (11) 
Prevalent stroke, n (%) 10 (1.6) 31 (3.2) 6 (2.4) 
Prevalent cancer, n (%) 74 (11.6) 105 (11.0) 35 (14.2) 
Data are presented as means (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CHD, coronary heart disease; 
MET, metabolic equivalent of task; MDD, major depressive disorder; MMSE, mini mental state examination 
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Sedentary behavior in association with anxiety disorders 
Per one hour more sedentary time, the odds of having an anxiety disorder were 1.11 times higher 
(95%CI: 1.01, 1.21) when adjusted for age, sex, cohort and time awake only. However, after 
additional adjustment for lifestyle factors, the association did not remain (Table 5.2.2). Again, the 
change in the effect estimate was largest (26.9%) after inclusion of the disability score to the 
model. Additionally, physical activity, smoking, and BMI were associated with changes in the 
effect estimate of more than 10% (Supplement 5.2.2B).  
We observed no longitudinal association between sedentary time and anxiety disorders 
(Table 5.2.3). 
 
Table 5.2.2. Cross-sectional associations of objectively assessed sedentary time with depressive 
symptoms and anxiety disorders 
  Depressive symptoms score 
Major depressive 
disorder* Anxiety disorders* 
(n=1,826) (n=1,817) (n=1,788) 
  β (95%CI) p β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time 
Model 1 0.25 (0.08, 0.41) 0.004 1.17 (0.96, 1.44) 0.12 1.11 (1.01, 1.21) 0.03 
Model 2 0.18 (0.01, 0.34) 0.04 1.14 (0.92, 1.41) 0.23 1.07 (0.98, 1.17) 0.15 
Model 3 0.08 (-0.09, 0.24) 0.37 1.10 (0.88, 1.38) 0.41 1.04 (0.95, 1.14) 0.40 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
* There were 22 participants with a major depressive disorder and 147 participants with an anxiety disorder. 
Model 1 is adjusted for age, sex, cohort and time awake.   
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score. 
 
Table 5.2.3. Longitudinal associations of objectively assessed sedentary time with depressive 
symptoms and anxiety disorders  
  Depressive symptoms score  Anxiety disorders* 
(n=1,530)  (n=1,347) 
  β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time  
Model 1 0.13 (-0.04, 0.31) 0.13  1.13 (0.99, 1.28) 0.08 
Model 2 0.08 (-0.09, 0.26) 0.36  1.07 (0.93, 1.23) 0.33 
Model 3 0.05 (-0.13, 0.23) 0.57   1.06 (0.92, 1.22) 0.42 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
* There were 59 incident cases of anxiety disorders. 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of depression symptoms 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Sedentary behavior in association with cognition: g-factor and MMSE score 
In our cross-sectional analyses adjusted for age, sex, cohort and time awake, one hour more 
sedentary time was associated with 0.03 lower score for the g-factor (95%CI: -0.05, -0.01). Again, 
the association disappeared with additional adjustment for sociodemographic and lifestyle factors 
in model 2 and 3 (Table 5.2.4). Smoking, BMI and the disability score were all associated with 
large changes in the effect estimate (Supplement 5.2.2C).  
In longitudinal analyses, we observed no association between sedentary time and the g-
factor in any model (Table 5.2.5). We also observed no cross-sectional or longitudinal association 
between sedentary behavior and the MMSE-score (Table 5.2.4 – Table 5.2.5). 
The cross-sectional analyses with the separate components of the g-factor showed a similar 
trend as the overall g-factor (Supplement 5.2.3). 
 
Table 5.2.4. Cross-sectional associations of objectively assessed sedentary time with cognition 
  G-factor, Z-score  MMSE score 
 
(n=1,539)  (n=1,828) 
  β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time 
 
 
  
Model 1 -0.03 (-0.05, -0.01) 0.005  -0.01 (-0.06, 0.04) 0.66 
Model 2 -0.02 (-0.04, 0.004) 0.12  -0.0017 (-0.05, 0.04) 0.94 
Model 3 -0.01 (-0.03, 0.01) 0.23  -0.0004 (-0.05, 0.05) 0.98 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake.      
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
 
Table 5.2.5. Longitudinal associations of objectively assessed sedentary time with cognition 
  G-factor, Z-score  MMSE score 
 
(n=1,012)  (n=1,444) 
  β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time 
 
 
  
Model 1 -0.01 (-0.02, 0.01) 0.37  0.02 (-0.03, 0.06) 0.46 
Model 2 -0.01 (-0.02, 0.01) 0.44  0.02 (-0.03, 0.06) 0.46 
Model 3 -0.004 (-0.02, 0.01) 0.61  0.02 (-0.02, 0.07) 0.31 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of the g-factor or MSSE score. 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score.  
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Sedentary behavior in association with anxiety disorders 
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symptoms and anxiety disorders 
  Depressive symptoms score 
Major depressive 
disorder* Anxiety disorders* 
(n=1,826) (n=1,817) (n=1,788) 
  β (95%CI) p β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time 
Model 1 0.25 (0.08, 0.41) 0.004 1.17 (0.96, 1.44) 0.12 1.11 (1.01, 1.21) 0.03 
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Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
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Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
* There were 59 incident cases of anxiety disorders. 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
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Sedentary behavior in association with cognition: g-factor and MMSE score 
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Table 5.2.4. Cross-sectional associations of objectively assessed sedentary time with cognition 
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Model 3 -0.01 (-0.03, 0.01) 0.23  -0.0004 (-0.05, 0.05) 0.98 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake.      
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
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Model 2 -0.01 (-0.02, 0.01) 0.44  0.02 (-0.03, 0.06) 0.46 
Model 3 -0.004 (-0.02, 0.01) 0.61  0.02 (-0.02, 0.07) 0.31 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of the g-factor or MSSE score. 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score.  
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Sensitivity analyses  
In our sensitivity analyses stratified by age, we observed that the cross-sectional associations were 
driven by the oldest participants (> 65 years), but there were no apparent differences in the 
longitudinal analyses (Supplement 5.2.4 – Supplement 5.2.7). Furthermore, the sex-stratified 
analyses showed similar associations for men and women (Supplement 5.2.8 – Supplement 
5.2.11). The analyses of sedentary behavior with change in depressive symptoms, the g-factor and 
MMSE-score also did not provide any support to reject the null hypothesis (Data not shown).  
 
DISCUSSION  
In this population-based cohort study, we found no evidence for a cross-sectional or longitudinal 
association of actigraphically assessed sedentary time with depressive symptoms, anxiety disorders 
or cognition. The observed cross-sectional associations between sedentary behavior and the 
mental health or cognitive outcome measures were explained by external factors. and were not 
observed longitudinally. 
In several cross-sectional studies, associations of higher self-reported or objectively 
measured sedentary time with depression.3,4 and anxiety,6 and with impaired cognitive function8 
have been reported. In the current study, we also found that high levels of sedentary time were 
cross-sectionally associated with more depressive symptoms, worse cognitive performance, and 
higher odds for anxiety disorders. However, the associations were largely explained by other 
variables, including disability, smoking and occupational status.  
In the associations between sedentary behavior and mental and cognitive health, the effect 
estimate for sedentary behavior changed notably after inclusion of the disability score. Having a 
disability increases the risk of worse mental health and cognition,39-41 and higher levels of 
disability are associated with higher levels of sedentary behavior,42 making disability an important 
factor to consider. In the association between sedentary behavior and mental health and 
cognition, we considered disability as a confounder; an antecedent of the exposure and the 
outcome, and not on the causal pathway.43 However, it might be argued that prior sedentary 
behavior had led to disabilities, which in turn led to poor mental health and impaired cognition. 
Many scientists, such as Schisterman et al.,44 have warned for overadjustment bias when analyses 
are adjusted for an intermediate variable that is on a causal pathway from the exposure to the 
outcome. However, we argue that it is more likely that in the elderly having physical disabilities 
will lead to more sedentary behavior than the converse. It is certainly important to understand the 
effect of sedentary tome above the effect of disease, thus it is important to include a measure of 
disability or functional limitations. However, only a few other studies have adjusted for a measure 
of disability in the association between sedentary behavior and mental health and cognition. In 
the recent meta-analysis of Zhai et al., which summarizes the association between sedentary 
behavior and depression, only 4 out of 20 studies adjusted for physical disability or perceived 
physical health.2 In the meta-analysis of Falck et al.,7 only 2 out of 8 studies adjusted for disability 
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in the association between sedentary behavior and cognitive function. None of the studies in the 
meta-analyses of sedentary behavior and anxiety adjusted for disability.5 We can only speculate 
whether previous studies might have been affected by (residual) confounding, but future studies 
examining the association between sedentary behavior and mental health should be aware of the 
possibility of residual confounding if not adjusting for by disability. 
Other important confounders in the cross-sectional analyses were smoking and 
occupational status. Whereas most previous studies adjusted for these variables, others did not 
consider these factors in their analyses.2,5,7 Unhealthy behaviors tend to cluster together,45 and 
participants with higher levels of sedentary behavior were more often smokers in the current 
study. Since adults with poor mental health tend to smoke more than adults with better mental 
health status,46 this makes smoking an important confounding factor in the association between 
sedentary behavior and mental health and cognition. Regarding employment, adults with paid 
occupation had lower levels of sedentary behavior in the current study and having employment is 
generally associated with having better mental health and cognition.47 
In the longitudinal analyses, we observed no association between objectively measured 
sedentary behavior and depressive symptoms, anxiety or cognitive performance after a follow-up 
period of 5.7 years, whether disability and other confounders were accounted for or not. In 
contrast, previous longitudinal studies using self-reports provided support for effects of high 
sedentary time on poor mental health and cognitive performance,2,5,7 next to the detrimental 
effects of prolonged sitting on cardio-metabolic features.1 The follow-up time in previous studies 
ranged from 1 to 10 years, with most studies including 6 years of follow-up, similar to the current 
study.12,48-56 Furthermore, the age-range of participants in previous studies is similar to the 
population in the current study. Therefore, it seems unlikely that these factors contribute to the 
inconsistent findings between studies. Instead, the explanation for these inconsistencies might be 
related to the measure of sedentary behavior. For self-report, there is a possibility of shared 
method variance bias or reporter bias.57 In previous studies based on self-reported sedentary 
behavior, the information on the dependent and independent variable were both obtained from 
the same individual with subjective measures. Furthermore, with more objective methods, like 
actigraphy, all sedentary behavior during the day is captured, whereas questionnaires typically do 
not address sitting during breakfast, lunch or dinner.  
Possibly, overall sedentary behavior does not underlie the observed association between self-
reported sedentary behavior and mental health and cognition, rather the context of sedentary 
behavior. All of the studies observing a longitudinal association between sedentary behavior and 
mental health or cognition included watching television in their measure, whereas the studies 
using computer or internet use as a proxy for sitting time more often observed no association with 
mental health.2,5,58,59 This suggests that not all types of sedentary behaviors are related to poor 
mental health and cognition. In contrast to the (socially) interactive character of 
computer/internet use, television viewing is a passive form of sedentary behavior. We cannot rule 
out that viewing television is an independent risk factor for poor mental health over and above 
sitting. 
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In our sensitivity analyses stratified by age, we observed that the cross-sectional associations were 
driven by the oldest participants (> 65 years), but there were no apparent differences in the 
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higher odds for anxiety disorders. However, the associations were largely explained by other 
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disability increases the risk of worse mental health and cognition,39-41 and higher levels of 
disability are associated with higher levels of sedentary behavior,42 making disability an important 
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cognition, we considered disability as a confounder; an antecedent of the exposure and the 
outcome, and not on the causal pathway.43 However, it might be argued that prior sedentary 
behavior had led to disabilities, which in turn led to poor mental health and impaired cognition. 
Many scientists, such as Schisterman et al.,44 have warned for overadjustment bias when analyses 
are adjusted for an intermediate variable that is on a causal pathway from the exposure to the 
outcome. However, we argue that it is more likely that in the elderly having physical disabilities 
will lead to more sedentary behavior than the converse. It is certainly important to understand the 
effect of sedentary tome above the effect of disease, thus it is important to include a measure of 
disability or functional limitations. However, only a few other studies have adjusted for a measure 
of disability in the association between sedentary behavior and mental health and cognition. In 
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in the association between sedentary behavior and cognitive function. None of the studies in the 
meta-analyses of sedentary behavior and anxiety adjusted for disability.5 We can only speculate 
whether previous studies might have been affected by (residual) confounding, but future studies 
examining the association between sedentary behavior and mental health should be aware of the 
possibility of residual confounding if not adjusting for by disability. 
Other important confounders in the cross-sectional analyses were smoking and 
occupational status. Whereas most previous studies adjusted for these variables, others did not 
consider these factors in their analyses.2,5,7 Unhealthy behaviors tend to cluster together,45 and 
participants with higher levels of sedentary behavior were more often smokers in the current 
study. Since adults with poor mental health tend to smoke more than adults with better mental 
health status,46 this makes smoking an important confounding factor in the association between 
sedentary behavior and mental health and cognition. Regarding employment, adults with paid 
occupation had lower levels of sedentary behavior in the current study and having employment is 
generally associated with having better mental health and cognition.47 
In the longitudinal analyses, we observed no association between objectively measured 
sedentary behavior and depressive symptoms, anxiety or cognitive performance after a follow-up 
period of 5.7 years, whether disability and other confounders were accounted for or not. In 
contrast, previous longitudinal studies using self-reports provided support for effects of high 
sedentary time on poor mental health and cognitive performance,2,5,7 next to the detrimental 
effects of prolonged sitting on cardio-metabolic features.1 The follow-up time in previous studies 
ranged from 1 to 10 years, with most studies including 6 years of follow-up, similar to the current 
study.12,48-56 Furthermore, the age-range of participants in previous studies is similar to the 
population in the current study. Therefore, it seems unlikely that these factors contribute to the 
inconsistent findings between studies. Instead, the explanation for these inconsistencies might be 
related to the measure of sedentary behavior. For self-report, there is a possibility of shared 
method variance bias or reporter bias.57 In previous studies based on self-reported sedentary 
behavior, the information on the dependent and independent variable were both obtained from 
the same individual with subjective measures. Furthermore, with more objective methods, like 
actigraphy, all sedentary behavior during the day is captured, whereas questionnaires typically do 
not address sitting during breakfast, lunch or dinner.  
Possibly, overall sedentary behavior does not underlie the observed association between self-
reported sedentary behavior and mental health and cognition, rather the context of sedentary 
behavior. All of the studies observing a longitudinal association between sedentary behavior and 
mental health or cognition included watching television in their measure, whereas the studies 
using computer or internet use as a proxy for sitting time more often observed no association with 
mental health.2,5,58,59 This suggests that not all types of sedentary behaviors are related to poor 
mental health and cognition. In contrast to the (socially) interactive character of 
computer/internet use, television viewing is a passive form of sedentary behavior. We cannot rule 
out that viewing television is an independent risk factor for poor mental health over and above 
sitting. 
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Taken together, the results of the current study suggest that sedentary behavior per se might 
not be related to impaired mental health and cognition and we found no support for a pathway 
from sedentary behavior to depression, anxiety or cognitive performance. However, since there is 
evidence that high levels of sedentary behavior are associated with worse cardiometabolic health,1 
public health efforts should continue encouraging adults to be active. Future studies using 
comprehensive questionnaires in addition to objective measures to capture sedentary behavior are 
recommended to better understand the association of sedentary behavior with mental health and 
cognition.  
The strengths of this study are the objective measurement of sedentary behavior, the 
prospective population-based design and the relatively large sample size over a follow-up period 
of six years. However, several potential limitations must be acknowledged. Participants that 
agreed to wear an Actiwatch were more often men, showed a lower disability score and better 
cognitive performance than individuals not participating in the current study. This might affect 
the generalizability towards the total population of older adults. Furthermore, we did not analyze 
the length of the sitting bouts in the current study. Therefore, we were unable to provide 
information on the association of specific patterns of sedentary behavior with mental health. 
Moreover, in our longitudinal analyses, there might be some survival effect, since only those alive 
at follow-up could complete the next measurements of the mental health factors. Finally, other 
selection biases may have occurred, since participants with missing information on any of the 
outcome measures might be in worse health than those with complete information. For example, 
we could only compute the g-factor if all the cognitive tests were completed. Those with missing 
test scores for the cognitive test battery might be cognitively more compromised than those who 
completed all tests. However similar associations were seen when the respective cognitive tests 
were analyzed individually. 
In conclusion, in this population of middle-aged and elderly adults, high levels of sedentary 
time were not associated with depressive symptoms, anxiety or cognition. Previously observed 
longitudinal associations might be driven by specific types of sedentary behavior or the subjective 
assessment of sedentary behavior.  
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evidence that high levels of sedentary behavior are associated with worse cardiometabolic health,1 
public health efforts should continue encouraging adults to be active. Future studies using 
comprehensive questionnaires in addition to objective measures to capture sedentary behavior are 
recommended to better understand the association of sedentary behavior with mental health and 
cognition.  
The strengths of this study are the objective measurement of sedentary behavior, the 
prospective population-based design and the relatively large sample size over a follow-up period 
of six years. However, several potential limitations must be acknowledged. Participants that 
agreed to wear an Actiwatch were more often men, showed a lower disability score and better 
cognitive performance than individuals not participating in the current study. This might affect 
the generalizability towards the total population of older adults. Furthermore, we did not analyze 
the length of the sitting bouts in the current study. Therefore, we were unable to provide 
information on the association of specific patterns of sedentary behavior with mental health. 
Moreover, in our longitudinal analyses, there might be some survival effect, since only those alive 
at follow-up could complete the next measurements of the mental health factors. Finally, other 
selection biases may have occurred, since participants with missing information on any of the 
outcome measures might be in worse health than those with complete information. For example, 
we could only compute the g-factor if all the cognitive tests were completed. Those with missing 
test scores for the cognitive test battery might be cognitively more compromised than those who 
completed all tests. However similar associations were seen when the respective cognitive tests 
were analyzed individually. 
In conclusion, in this population of middle-aged and elderly adults, high levels of sedentary 
time were not associated with depressive symptoms, anxiety or cognition. Previously observed 
longitudinal associations might be driven by specific types of sedentary behavior or the subjective 
assessment of sedentary behavior.  
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Supplement 5.2.1. Characteristics of participants who agreed to participate in the study compared 
to those who rejected participation 
  Participants 
agreeing to 
participate 
Participants 
not agreeing to 
participate 
 
  P value 
Demographics 
Participants, n (%) 2,086 546 
Age  61.9 (9.4) 53.6 (4.4) 0.049 
Female 1,146 (54.9) 328 (60.1) 0.04 
Educational level, n (%) 0.07 
     Primary education 174 (8.4) 63 (11.6) 
     Lower education 843 (40.7) 229 (42.2) 
     Intermediate education 622 (30) 153 (28.2) 
     Higher education 431 (20.8) 98 (18) 
Employed, n (%) 719 (34.8) 123 (23) <0.001 
Marital status, n (%) 1,598 (77.3) 346 (64.7) <0.001 
Lifestyle factors 
Smoking, n (%) 0.90 
    Never 649 (31.4) 170 (31.8) 
    Former 1,037 (50.2) 263 (49.2) 
    Current 380 (18.4) 102 (19.1) 
BMI (kg/m2) 27.9 (4.3) 27.6 (4.2) 0.16 
Disability score 0.35 (0.43) 0.49 (0.53) <0.001 
Alcohol (glasses/day) 1.1 (1.3) 1.2 (1.5) 0.14 
Physical activity (METhours/week) 60.3 (61.7) 49.5 (45.7) 0.004 
Mental Health 
Baseline CESD score 5.6 (7.1) 6.1 (7.5) 0.11 
Prevalent MDD, n (%) 29 (1.4) 9 (1.7) 0.76 
Prevalent anxiety disorder, n (%) 173 (8.6) 44 (8.5) 1.00 
Baseline g-factor 0.06 (0.98) -0.25 (1.05) <0.001 
MMSE score 27.9 (2.0) 27.4 (2.5) <0.001 
Prevalent diseases 
Prevalent diabetes, n (%) 285 (13.8) 89 (16.9) 0.09 
Prevalent CHD, n (%) 112 (5.4) 47 (8.7) 0.005 
Prevalent stroke, n (%) 54 (2.6) 30 (5.5) 0.001 
Prevalent cancer, n (%) 245 (11.7) 90 (16.5) 0.004 
Data are presented as mean (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CHD, coronary heart disease; 
MET, metabolic equivalent of task; MDD, major depressive disorder; MMSE, mini mental state examination 
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Supplement 5.2.2A. The effect of adding covariates to the cross-sectional model between 
sedentary time and the CESD score 
Factor added to the 
model* 
β per 1 
hour/day more 
sedentary time (95%CI) p 
% Change from 
former to current 
β 
NA (Model 1) 0.25 (0.08, 0.41) 0.004 na 
+ Education 0.24 (0.08, 0.41) 0.004 1.0 
+ Occupational status 0.22 (0.05, 0.38) 0.011 10.3 
+ Marital status 0.19 (0.03, 0.36) 0.023 11.2 
+ Smoking 0.17 (0.01, 0.34) 0.043 10.7 
+ BMI 0.18 (0.01, 0.34) 0.043 -1.5 
+ Physical activity 0.16 (-0.01, 0.33) 0.06 6.4 
+ Disability score 0.08 (-0.09, 0.24) 0.37 53.6 
Abbreviations: BMI, body mass index; CESD, Center for Epidemiologic Studies Depression; CI, confidence interval; na, not 
applicable 
Model 1 is adjusted for age, sex, cohort and time awake. 
* Each of the factors is added to the models in addition to the previous factors, so that the final model includes age, cohort, 
time awake, education, occupational status, marital status, smoking, BMI, physical activity and the disability score. 
 
Supplement 5.2.2B. The effect of adding covariates to the cross-sectional model between 
sedentary time and anxiety disorders 
Factor added to the 
model* 
β per 1 
hour/day more 
sedentary time (95%CI) p 
% Change from 
former to current 
β 
NA (Model 1) 0.10 (0.01, 0.19) 0.026 na 
+ Education 0.10 (0.01, 0.19) 0.025 -0.3 
+ Occupational status 0.09 (0.01, 0.18) 0.038 6.3 
+ Marital status 0.09 (-0.002, 0.18) 0.06 7.8 
+ Smoking 0.07 (-0.02, 0.16) 0.11 14.5 
+ BMI 0.07 (-0.02, 0.16) 0.15 10.2 
+ Physical activity 0.05 (-0.04, 0.15) 0.24 17.8 
+ Disability score 0.04 (-0.05, 0.13) 0.40 26.9 
Abbreviations: BMI, body mass index; CI, confidence interval; na, not applicable; OR, odds ratio 
Model 1 is adjusted for age, sex, cohort and time awake. 
* Each of the factors is added to the models in addition to the previous factors, so that the final model includes age, cohort, 
time awake, education, occupational status, marital status, smoking, BMI, physical activity and the disability score. 
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Supplement 5.2.2C. The effect of adding covariates to the cross-sectional model between 
sedentary time and the g-factor 
Factor added to the 
model 
β per 1 hour/day 
more sedentary 
time (95%CI) p 
% Change from 
former to current 
β 
NA (Model 1) -0.031 (-0.05, -0.01) 0.005 na 
+ Education -0.034 (-0.05, -0.01) 0.002 -7.7 
+ Occupational status -0.03 (-0.05, -0.01) 0.005 10.3 
+ Marital status -0.029 (-0.05, -0.01) 0.007 4.5 
+ Smoking -0.022 (-0.04, -0.001) 0.043 25.4 
+ BMI -0.017 (-0.04, 0.004) 0.12 22.5 
+ Physical activity -0.017 (-0.04, 0.004) 0.12 -0.4 
+ Disability score -0.013 (-0.03, 0.01) 0.23 22.3 
Abbreviations: BMI, body mass index; CI, confidence interval; na, not applicable 
Model 1 is adjusted for age, sex, cohort and time awake. 
* Each of the factors is added to the models in addition to the previous factors, so that the final model includes age, cohort, 
time awake, education, occupational status, marital status, smoking, BMI, physical activity and the disability score. 
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* Each of the factors is added to the models in addition to the previous factors, so that the final model includes age, cohort, 
time awake, education, occupational status, marital status, smoking, BMI, physical activity and the disability score. 
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Supplement 5.2.2C. The effect of adding covariates to the cross-sectional model between 
sedentary time and the g-factor 
Factor added to the 
model 
β per 1 hour/day 
more sedentary 
time (95%CI) p 
% Change from 
former to current 
β 
NA (Model 1) -0.031 (-0.05, -0.01) 0.005 na 
+ Education -0.034 (-0.05, -0.01) 0.002 -7.7 
+ Occupational status -0.03 (-0.05, -0.01) 0.005 10.3 
+ Marital status -0.029 (-0.05, -0.01) 0.007 4.5 
+ Smoking -0.022 (-0.04, -0.001) 0.043 25.4 
+ BMI -0.017 (-0.04, 0.004) 0.12 22.5 
+ Physical activity -0.017 (-0.04, 0.004) 0.12 -0.4 
+ Disability score -0.013 (-0.03, 0.01) 0.23 22.3 
Abbreviations: BMI, body mass index; CI, confidence interval; na, not applicable 
Model 1 is adjusted for age, sex, cohort and time awake. 
* Each of the factors is added to the models in addition to the previous factors, so that the final model includes age, cohort, 
time awake, education, occupational status, marital status, smoking, BMI, physical activity and the disability score. 
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Supplement 5.2.4. Cross-sectional associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by age 
 Adults < 65 years 
Depressive symptoms score 
(n=1,184)  
Anxiety disorders* 
(n=1,163) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.18 (-0.03, 0.40) 0.09 1.09 (0.98, 1.21) 0.10 
Model 2 0.10 (-0.12, 0.31) 0.37 1.04 (0.94, 1.16) 0.43 
Model 3 0.05 (-0.16, 0.26) 0.62 1.03 (0.92, 1.15) 0.62 
    
Adults ≥ 65 years 
Depressive symptoms score 
(n=642) 
 
Anxiety disorders* 
(n=625) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.35 (0.08, 0.62) 0.01 1.15 (0.97, 1.36) 0.12 
Model 2 0.27 (-0.004, 0.55) 0.05 1.13 (0.94, 1.35) 0.20 
Model 3 0.13 (-0.14, 0.40) 0.33 1.08 (0.90, 1.31) 0.40 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
There were 103 prevalent cases with an anxiety disorder in adults < 65 years and 44 in adults ≥ 65 years. 
Model 1 is adjusted for age, sex, cohort and time awake.   
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
 
Supplement 5.2.5. Longitudinal associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by age 
 Adults < 65 years 
Depressive symptoms score 
(n=1,044)  
Anxiety disorders* 
(n=923) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.12 (-0.08, 0.32) 0.24  1.12 (0.97, 1.29) 0.13 
Model 2 0.06 (-0.15, 0.27) 0.57  1.07 (0.92, 1.24) 0.37 
Model 3 0.04 (-0.17, 0.25) 0.68  1.07 (0.92, 1.24) 0.40 
    
Adults ≥ 65 years 
Depressive symptoms score 
(n=486) 
 Anxiety disorders* 
(n=424) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.09 (-0.23, 0.42) 0.57  NA   
Model 2 0.02 (-0.31, 0.36) 0.90  NA   
Model 3 -0.01 (-0.35, 0.32) 0.95  NA   
Abbreviations: CI, confidence interval; NA, not applicable due to limited number of cases; OR, odds ratio; ref, reference 
*There were 51 incident cases of anxiety disorders in adults <65 years and 8 cases in adults ≥ 65 years. 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of depression symptoms 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.4. Cross-sectional associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by age 
 Adults < 65 years 
Depressive symptoms score 
(n=1,184)  
Anxiety disorders* 
(n=1,163) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.18 (-0.03, 0.40) 0.09 1.09 (0.98, 1.21) 0.10 
Model 2 0.10 (-0.12, 0.31) 0.37 1.04 (0.94, 1.16) 0.43 
Model 3 0.05 (-0.16, 0.26) 0.62 1.03 (0.92, 1.15) 0.62 
    
Adults ≥ 65 years 
Depressive symptoms score 
(n=642) 
 
Anxiety disorders* 
(n=625) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.35 (0.08, 0.62) 0.01 1.15 (0.97, 1.36) 0.12 
Model 2 0.27 (-0.004, 0.55) 0.05 1.13 (0.94, 1.35) 0.20 
Model 3 0.13 (-0.14, 0.40) 0.33 1.08 (0.90, 1.31) 0.40 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
There were 103 prevalent cases with an anxiety disorder in adults < 65 years and 44 in adults ≥ 65 years. 
Model 1 is adjusted for age, sex, cohort and time awake.   
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
 
Supplement 5.2.5. Longitudinal associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by age 
 Adults < 65 years 
Depressive symptoms score 
(n=1,044)  
Anxiety disorders* 
(n=923) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.12 (-0.08, 0.32) 0.24  1.12 (0.97, 1.29) 0.13 
Model 2 0.06 (-0.15, 0.27) 0.57  1.07 (0.92, 1.24) 0.37 
Model 3 0.04 (-0.17, 0.25) 0.68  1.07 (0.92, 1.24) 0.40 
    
Adults ≥ 65 years 
Depressive symptoms score 
(n=486) 
 Anxiety disorders* 
(n=424) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.09 (-0.23, 0.42) 0.57  NA   
Model 2 0.02 (-0.31, 0.36) 0.90  NA   
Model 3 -0.01 (-0.35, 0.32) 0.95  NA   
Abbreviations: CI, confidence interval; NA, not applicable due to limited number of cases; OR, odds ratio; ref, reference 
*There were 51 incident cases of anxiety disorders in adults <65 years and 8 cases in adults ≥ 65 years. 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of depression symptoms 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.6. Cross-sectional associations of objectively assessed sedentary time with 
cognition, stratified by age 
 Adults < 65 years 
G-factor, Z-score 
(n=1,013)  
MMSE score 
(n=1,182) 
β (95%CI) p β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.02 (-0.04, 0.01) 0.21  0.002 (-0.05, 0.05) 0.94 
Model 2 -0.01 (-0.03, 0.02) 0.52  0.001 (-0.05, 0.05) 0.98 
Model 3 -0.01 (-0.03, 0.02) 0.57  -0.003 (-0.05, 0.05) 0.92 
    
Adults ≥ 65 years 
G-factor, Z-score 
(n=526)  
MMSE score 
(n=646) 
β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.06 (-0.10, -0.02) 0.001  -0.04 (-0.13, 0.05) 0.42 
Model 2 -0.03 (-0.07, 0.01) 0.11  0.004 (-0.09, 0.10) 0.94 
Model 3 -0.02 (-0.06, 0.01) 0.21  0.01 (-0.08, 0.11) 0.77 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake.     
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score. 
 
Supplement 5.2.7. Longitudinal associations of objectively assessed sedentary time with 
cognition, stratified by age 
 Adults < 65 years 
G-factor, Z-score 
(n=740)  
MMSE score 
(n=999) 
β (95%CI) p β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.01 (-0.03, 0.01) 0.33  0.01 (-0.03, 0.06) 0.52 
Model 2 -0.01 (-0.03, 0.01) 0.33  0.01 (-0.03, 0.06) 0.54 
Model 3 -0.01 (-0.03, 0.01) 0.48  0.02 (-0.03, 0.06) 0.47 
    
Adults ≥ 65 years 
G-factor, Z-score 
(n=272) 
 MMSE score 
(n=445) 
β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.01 (-0.03, 0.04) 0.63  0.06 (-0.05, 0.18) 0.28 
Model 2 0.01 (-0.02, 0.05) 0.50  0.08 (-0.04, 0.20) 0.18 
Model 3 0.01 (-0.02, 0.05) 0.50  0.09 (-0.03, 0.22) 0.13 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of the g-factor or MSSE score. 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.8. Cross-sectional associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by sex 
Men 
Depressive symptoms score 
(n=832)  
Anxiety disorders* 
(n=826) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.26 (0.05, 0.48) 0.02  1.01 (0.84, 1.22) 0.89 
Model 2 0.26 (0.04, 0.48) 0.02  0.98 (0.80, 1.19) 0.82 
Model 3 0.16 (-0.06, 0.39) 0.15  0.93 (0.76, 1.15) 0.52 
    
Women 
Depressive symptoms score 
(n=994)  
Anxiety disorders* 
(n=962) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.24 (-0.01, 0.48) 0.06  1.13 (1.02, 1.25) 0.02 
Model 2 0.12 (-0.13, 0.37) 0.34  1.09 (0.98, 1.21) 0.11 
Model 3 0.01 (-0.23, 0.26) 0.91  1.06 (0.96, 1.18) 0.26 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
There were 33 men with a prevalent anxiety disorder and 114 women with a prevalent anxiety disorder. 
Model 1 is adjusted for age, cohort and time awake.   
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
 
Supplement 5.2.9. Longitudinal associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by sex 
Men 
Depressive symptoms score 
(n=692)  
Anxiety disorders* 
(n=652) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.09 (-0.12, 0.30) 0.39  1.09 (0.80, 1.49) 0.58 
Model 2 0.06 (-0.16, 0.27) 0.60  1.07 (0.76, 1.51) 0.68 
Model 3 0.04 (-0.18, 0.26) 0.72  1.06 (0.75, 1.51) 0.73 
    
Women 
Depressive symptoms score 
(n=838) 
 Anxiety disorders* 
(n=696) 
β (95%CI) p   OR (95%CI) p 
Per 1 hour/day more sedentary time   
Model 1 0.17 (-0.09, 0.43) 0.21  1.14 (0.99, 1.32) 0.07 
Model 2 0.11 (-0.16, 0.38) 0.43  1.09 (0.94, 1.27) 0.25 
Model 3 0.07 (-0.20, 0.34) 0.61  1.08 (0.93, 1.26) 0.32 
Abbreviations: CI, confidence interval; NA, not applicable due to limited number of cases; OR, odds ratio; ref, reference 
There were 11 men with an incident anxiety disorder and 48 women with an incident anxiety disorder. 
Model 1 is adjusted for age, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of depression symptoms 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.6. Cross-sectional associations of objectively assessed sedentary time with 
cognition, stratified by age 
 Adults < 65 years 
G-factor, Z-score 
(n=1,013)  
MMSE score 
(n=1,182) 
β (95%CI) p β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.02 (-0.04, 0.01) 0.21  0.002 (-0.05, 0.05) 0.94 
Model 2 -0.01 (-0.03, 0.02) 0.52  0.001 (-0.05, 0.05) 0.98 
Model 3 -0.01 (-0.03, 0.02) 0.57  -0.003 (-0.05, 0.05) 0.92 
    
Adults ≥ 65 years 
G-factor, Z-score 
(n=526)  
MMSE score 
(n=646) 
β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.06 (-0.10, -0.02) 0.001  -0.04 (-0.13, 0.05) 0.42 
Model 2 -0.03 (-0.07, 0.01) 0.11  0.004 (-0.09, 0.10) 0.94 
Model 3 -0.02 (-0.06, 0.01) 0.21  0.01 (-0.08, 0.11) 0.77 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake.     
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score. 
 
Supplement 5.2.7. Longitudinal associations of objectively assessed sedentary time with 
cognition, stratified by age 
 Adults < 65 years 
G-factor, Z-score 
(n=740)  
MMSE score 
(n=999) 
β (95%CI) p β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.01 (-0.03, 0.01) 0.33  0.01 (-0.03, 0.06) 0.52 
Model 2 -0.01 (-0.03, 0.01) 0.33  0.01 (-0.03, 0.06) 0.54 
Model 3 -0.01 (-0.03, 0.01) 0.48  0.02 (-0.03, 0.06) 0.47 
    
Adults ≥ 65 years 
G-factor, Z-score 
(n=272) 
 MMSE score 
(n=445) 
β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.01 (-0.03, 0.04) 0.63  0.06 (-0.05, 0.18) 0.28 
Model 2 0.01 (-0.02, 0.05) 0.50  0.08 (-0.04, 0.20) 0.18 
Model 3 0.01 (-0.02, 0.05) 0.50  0.09 (-0.03, 0.22) 0.13 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, sex, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of the g-factor or MSSE score. 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.8. Cross-sectional associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by sex 
Men 
Depressive symptoms score 
(n=832)  
Anxiety disorders* 
(n=826) 
β (95%CI) p OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.26 (0.05, 0.48) 0.02  1.01 (0.84, 1.22) 0.89 
Model 2 0.26 (0.04, 0.48) 0.02  0.98 (0.80, 1.19) 0.82 
Model 3 0.16 (-0.06, 0.39) 0.15  0.93 (0.76, 1.15) 0.52 
    
Women 
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(n=994)  
Anxiety disorders* 
(n=962) 
β (95%CI) p  OR (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 0.24 (-0.01, 0.48) 0.06  1.13 (1.02, 1.25) 0.02 
Model 2 0.12 (-0.13, 0.37) 0.34  1.09 (0.98, 1.21) 0.11 
Model 3 0.01 (-0.23, 0.26) 0.91  1.06 (0.96, 1.18) 0.26 
Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference 
There were 33 men with a prevalent anxiety disorder and 114 women with a prevalent anxiety disorder. 
Model 1 is adjusted for age, cohort and time awake.   
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score.  
 
Supplement 5.2.9. Longitudinal associations of objectively assessed sedentary time with 
depressive symptoms and anxiety disorders, stratified by sex 
Men 
Depressive symptoms score 
(n=692)  
Anxiety disorders* 
(n=652) 
β (95%CI) p OR (95%CI) p 
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Model 2 0.06 (-0.16, 0.27) 0.60  1.07 (0.76, 1.51) 0.68 
Model 3 0.04 (-0.18, 0.26) 0.72  1.06 (0.75, 1.51) 0.73 
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Depressive symptoms score 
(n=838) 
 Anxiety disorders* 
(n=696) 
β (95%CI) p   OR (95%CI) p 
Per 1 hour/day more sedentary time   
Model 1 0.17 (-0.09, 0.43) 0.21  1.14 (0.99, 1.32) 0.07 
Model 2 0.11 (-0.16, 0.38) 0.43  1.09 (0.94, 1.27) 0.25 
Model 3 0.07 (-0.20, 0.34) 0.61  1.08 (0.93, 1.26) 0.32 
Abbreviations: CI, confidence interval; NA, not applicable due to limited number of cases; OR, odds ratio; ref, reference 
There were 11 men with an incident anxiety disorder and 48 women with an incident anxiety disorder. 
Model 1 is adjusted for age, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of depression symptoms 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.10. Cross-sectional associations of objectively assessed sedentary time with 
cognition, stratified by sex 
Men 
G-factor, Z-score 
(n=686)  
MMSE score 
(n=834) 
β 95%CI p β 95%CI p 
Per 1 hour/day more sedentary time           
Model 1 -0.03 (-0.06, 0.001) 0.06  -0.04 (-0.111, 0.03) 0.24 
Model 2 -0.02 (-0.05, 0.01) 0.25  -0.03 (-0.10, 0.03) 0.33 
Model 3 -0.02 (-0.05, 0.01) 0.23  -0.03 (-0.10, 0.04) 0.42 
    
Women 
G-factor, Z-score 
(n=853)  
MMSE score 
(n=994) 
β 95%CI p  β 95%CI p 
Per 1 hour/day more sedentary time           
Model 1 -0.03 (-0.06, -0.001) 0.045  0.01 (-0.05, 0.07) 0.65 
Model 2 -0.02 (-0.05, 0.01) 0.26  0.03 (-0.03, 0.09) 0.41 
Model 3 -0.01 (-0.04, 0.02) 0.49  0.03 (-0.04, 0.09) 0.41 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, cohort and time awake.      
Model 2 is additionally adjusted for education, occupational status, marital status, smoking and body mass index. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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Supplement 5.2.11. Longitudinal associations of objectively assessed sedentary time with 
cognition, stratified by sex 
Men 
G-factor, Z-score 
(n=451)  
MMSE score 
(n=658) 
β (95%CI) p β (95%CI) p 
Per 1 hour/day more sedentary time           
Model 1 -0.01 (-0.04, 0.01) 0.35  0.01 (-0.06, 0.09) 0.71 
Model 2 -0.01 (-0.04, 0.01) 0.32  0.01 (-0.07, 0.08) 0.81 
Model 3 -0.01 (-0.03, 0.02) 0.54  0.02 (-0.06, 0.09) 0.65 
    
Women 
G-factor, Z-score 
(n=561)  
MMSE score 
(n=786) 
β (95%CI) p  β (95%CI) p 
Per 1 hour/day more sedentary time 
Model 1 -0.003 (-0.02, 0.02) 0.80  0.02 (-0.04, 0.07) 0.56 
Model 2 -0.001 (-0.02, 0.02) 0.90  0.02 (-0.04, 0.07) 0.61 
Model 3 -0.001 (-0.02, 0.02) 0.96  0.02 (-0.04, 0.08) 0.46 
Abbreviations: CI, confidence interval; MMSE, mini mental state examination; OR, odds ratio; ref, reference 
Model 1 is adjusted for age, cohort and time awake, the time between the baseline and follow-up measurement and the 
baseline measurement of the g-factor or MSSE score. 
Model 2 is additionally adjusted for smoking, education, body mass index, occupational status and marital status. 
Model 3 is additionally adjusted for physical activity and the disability score. 
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ABSTRACT 
Background: Based on cross-sectional and longitudinal studies using self-reports , short sleep 
is considered a risk factor for obesity. It remains unknown whether the association is 
bidirectional. 
Methods: We studied the bidirectional association between sleep measured by a wrist-worn 
actigraph, and body size in the population-based Rotterdam Study. Body mass index (BMI), 
actigraphic total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE) and wake 
after sleep onset (WASO) were measured twice between 2004 and 2014 (n=1,031, age: 45-91 
years, median follow-up: 6 years). Cross-sectional associations of sleep with BMI were 
examined with linear regressions adjusted for lifestyle and health parameters. Longitudinal 
associations were explored with linear mixed models.  
Results: Cross-sectionally, each hour shorter TST was associated with approximately 
0.5kg/m2 higher BMI. Longitudinally, average longer sleep duration and higher sleep 
efficiency were associated with lower BMI, and a slower decrease in BMI across time. 
Conversely, one point higher average BMI was associated with a 0.02 hours (95% confidence 
interval: -0.03,-0.01) shorter TST, reduced the yearly increase in TST by 0.002 hours, and 
reduced the yearly increase in SE by 0.02%. A 1 kg/m2 increase in BMI across the follow-up 
was associated with 0.23 hours longer TST (95%CI: 0.04,0.41).  
Conclusion: In this population of older adults there was a clear bidirectional association 
between sleep and BMI over a follow-up of 6 years. Although sleep has been implied as an 
important determinant of body size, a healthy BMI also relates to better sleep indices in an age 
group with increasing sleep problems.  
The bidirectional association between objectively measured sleep and body mass index 
327 
INTRODUCTION 
Sleep has been identified as a potentially modifiable factor related to mental and physical health.1,2 
Short sleep duration has been associated with higher body weight and obesity.3 This has given rise 
to the idea that chronic sleep curtailment contributes to the developing obesity epidemic.4 
Systematic reviews of observational studies examining the association between sleep 
duration and adiposity3,5 concluded that short sleep is associated with an increased risk of obesity.3 
Based on these findings, the hypothesis that short and disturbed sleep has a direct influence on 
energy metabolism leading to weight gain has been postulated.6 However, studies assessing the 
association between sleep and obesity have important methodological limitations. First, studies 
have mostly been cross-sectional, thus the temporality of the relation cannot be explored.3,5 
Second, prospective studies have relied on self-reported measures, prone to information and recall 
bias.7 
Adiposity might also influence sleep. Few studies have examined the hypothesis that the 
association between sleep and adiposity is bidirectional.8-10 One study using self-reports concluded 
that higher a BMI predicts a decrease in sleep duration over time, but not vice versa.11 To 
overcome these limitations, prospective studies using objectively measured sleep and body 
composition are required. 
We evaluated the direction of the association of actigraphic sleep patterns with BMI, in a 
population-based prospective cohort of older persons. Objective measures of sleep and BMI were 
assessed twice over a follow-up of 6 years. 
 
METHODS 
Study population 
This study was embedded in the Rotterdam Study, an ongoing prospective population-based 
cohort in the Netherlands.12 Participants undergo extensive follow-up examinations 
approximately every 5 years.13,14 
For the baseline of our study (T1: December 2004 to April 2007), 2,632 participants were 
invited to participate in the actigraphy study, 2,063 (78%) agreed to participate.15,16 Due to 
technical issues (n=125), valid data was available for 1,938 participants at baseline. Of the 1,431 
participants invited for a follow-up measurement (T2: March 2009 to June 2014), valid sleep data 
on at least 4 consecutive days and BMI data in both waves was available for 1,031 individuals 
(details in Supplement 5.3.1). There were no exclusion criteria besides being able to understand 
the instructions for this study. All subjects gave written informed consent, and the study protocol 
was approved by the medical ethics committee according to the Wet Bevolkingsonderzoek ERGO 
(Population Study Act Rotterdam Study), executed by the Ministry of Health, Welfare and Sport 
of The Netherlands.  
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Measurement of sleep 
At baseline, all participants wore an actigraph around the non-dominant wrist (Actiwatch model 
AW4; Cambridge Technology, Cambridge, UK) for seven consecutive days and nights. The device 
had to be removed for water-based activities. At follow-up, participants wore either the Actiwatch 
(n=592), or a GeneActiv triaxial accelerometer (Activinsights Ltd, Kimbolton, Cambridgeshire, 
UK) (n= 439). Recordings were sampled at 32Hz (Actiwatch) and 50Hz (GeneActiv), and were 
averaged into a score for each 30-second interval, taking into account weighted values of previous 
and following epochs. To ensure comparability between the estimates of the two devices, we used 
a validated algorithm to convert the triaxial GeneActiv to one-dimensional 30s epoch data (using 
the z-axis), that was thereafter calibrated to Actiwatch counts using Passing-Bablok regression.17  
To estimate sleep, we used an algorithm validated against polysomnography at the highest 
sensitivity (sleep threshold <20 counts).7,18 Sleep diaries were used to determine sleep-wake 
schedules (bedtime, wake-time and get-up time), and were used as an event marker by the sleep 
algorithm. A night’s data was considered invalid if recording had failed due to technical issues, the 
participant had discontinued wearing the actigraph, or if the information on bedtime and get-up 
time from the sleep diary were invalid or missing. The assumed sleep period was defined as the 
time between sleep onset and final wake-time estimated by the algorithm,7,17,18 and the following 
sleep parameters were calculated: 1) Total sleep time (TST, hours): the sum of the number of 
epochs in the assumed sleep period scored as sleep, multiplied by the epoch length; 2) Sleep onset 
latency (SOL, minutes): time between bed time according to the sleep diary and the estimated 
sleep onset; 3) Sleep efficiency (SE, %): ratio of TST to time in bed (time between bedtime and 
wake-time) multiplied by 100; and 4) Wake after sleep onset (WASO, minutes), defined as the 
number of epochs within the assumed sleep period scored as wake multiplied by the epoch length. 
Anthropometric measurements 
Height and weight were measured by trained staff in the research center with the participants 
standing without shoes and heavy outer garments on a calibrated scale. BMI was calculated as 
weight divided by height squared (kg/m2).  
Measurement of covariates 
Education was assessed in line with the international standard classification of education 19 and 
grouped into primary education, lower education, intermediate education and higher education. 
Employment status was used as a binary variable (employed/unemployed). Smoking was 
categorized as: current, former and never. Physical activity was assessed with the validated LASA 
Physical Activity Questionnaire,20 including questions on housekeeping activities, walking, 
cycling, sports and gardening. Time spent in these activities was combined and expressed in 
MET·hours·week-1.21 The presence of cardiovascular disease, diabetes and cancer were determined 
using medical records. We defined a binary variable for the presence of any of these chronic 
diseases. Depressive symptoms were assessed with the Center for Epidemiologic Studies 
Depression (CES-D) scale,22 excluding the question on restless sleep in the score. Frequency of 
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napping was defined as the number of days the participant had napped during the actigraphy 
assessment, as reported in the sleep diary.15. As a proxy of sleep disordered breathing (SDB), one 
item of the Pittsburgh Sleep Quality Questionnaire23 was used to assess the frequency of 
respiratory pauses during sleep. 
Statistical Analyses 
Missing values on covariates were less than 10%, except for frequency of SDB at T1 (19%) and 
frequency of SDB at T2 (17.9%). We imputed missing data using fully conditional specification 
multiple imputation (m=20 imputations). Statistical analyses were performed on each imputed 
data set, and results were pooled.24 
Cross-sectional associations between sleep parameters (TST, SOL, SE and WASO) and BMI 
were tested using linear regression at baseline and at follow-up in a model correcting for several 
covariates (see tables). The decision to include covariates was based on previous literature16,25,26 or 
>10%-change of the effect estimate in the crude model.27  
We used linear mixed models to examine whether sleep parameters were associated with 
BMI across time, and vice versa, whether BMI was associated with sleep parameters across time, 
corrected for covariates. All models included the time between the baseline and follow-up 
measurement of the outcome variable in years, the average of the determinant across the two 
measurements (i.e., (TSTT2+TSTT1)/2 and (BMIT2+BMIT1)/2), the yearly change in the 
determinant (i.e., (TSTT2-TSTT1)/follow-up time and (BMIT2-BMIT1)/follow-up time), and 
interaction terms between the average and the change in the determinant and follow-up time (e.g. 
[average TST]*time and [ΔTST]*time or [average BMI]*time and [ΔBMI]*time). To account for 
the correlation between measurements of the same individual we included a random intercept 
based on (adapted) likelihood ratio tests. The final linear mixed model equations are presented in 
Supplement 5.3.2.  
In the linear mixed models, the effect estimate of the average captures how average levels of 
the determinant influence the trajectory of the outcome across time. The effect estimate of the 
change captures how changes in levels of the determinant influence the trajectory of the outcome 
across time. The interaction terms capture changes of the observed associations with time.  
Analyses were conducted using SPSS software version 21.0 (IBM SPSS Statistics for 
Windows, Armonk, NY: IBM Corp) and R (Version 3.4.1).28 
Sensitivity analyses.  
We repeated all longitudinal analyses stratified by sex.29,30 Since we included information from 
two different devices in our study, we stratified the analyses by device at follow-up (GeneActiv or 
Actiwatch). For nonresponse analyses, participants included in the analyses were compared to 
those who refused to participate or were lost to follow up (n=754), based on several demographic 
and health characteristics (i.e. age, sex, depressive symptom score, sleep parameters and BMI) 
using chi-squared, Mann-Whitney U tests, or independent sample t-tests.  
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Windows, Armonk, NY: IBM Corp) and R (Version 3.4.1).28 
Sensitivity analyses.  
We repeated all longitudinal analyses stratified by sex.29,30 Since we included information from 
two different devices in our study, we stratified the analyses by device at follow-up (GeneActiv or 
Actiwatch). For nonresponse analyses, participants included in the analyses were compared to 
those who refused to participate or were lost to follow up (n=754), based on several demographic 
and health characteristics (i.e. age, sex, depressive symptom score, sleep parameters and BMI) 
using chi-squared, Mann-Whitney U tests, or independent sample t-tests.  
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RESULTS 
Characteristics of the study population are shown in Table 5.3.1. At baseline, mean age was 60.6 
years (standard deviation (SD): 7.7) and 52.0% were women. Mean (SD) BMI was 27.9 (4.3) kg/m2 
at T1, and 27.6 (4.3) kg/m2 at T2. The median time difference between the two visits was 6 years 
(range 5 to 9 years).  
 
Table 5.3.1. Characteristics of the study population, Rotterdam Study, 2004-2014 
 
T1: December 2004 - 
April 2007  
T2: March 2009 –  
June 2014 
Participants, n (%) 1,031 1,031 
Age (years) 60.6 (7.7) 66.8 (7.9) 
Female, n (%) 535 (52.0) 555 (52.0) 
BMI (kg/m2) 27.9 (4.3) 27.6 (4.3) 
Total sleep time (hours) 6.0 (0.9) 6.2 (0.9) 
Sleep onset latency (minutes) 20.8 (17.7) 18.3 (16.8) 
Sleep efficiency (%) 74.8 (8.6) 75.5 (8.6) 
Education, n (%)* 
   Primary education 71 ( 6.9) NA 
   Lower education 403 (39.1) NA 
   Intermediate education 311 (30.2) NA 
   Higher education 246 (23.9) NA 
Employed, n (%) 385 (37.3) 284 (27.5) 
Prevalent chronic disease, n (%) 289 (28.0) 383 (37.2) 
Smoking, n (%) 
   Non smoker 328 (31.8) 345 (33.5) 
   Former smoker 538 (52.2) 564 (54.7) 
   Current smoker 165 (16.0) 121 (11.7) 
Physical activity (METhours/week)* NA 64.6 (65.4) 
CES-D score† 4.3 (6.2) 4.7 (6.6) 
Self-reported frequency of sleep 
disordered breathing , n (%)    
   Not in the past month 845 (82.0) 837 (81.2) 
   Less than once per week 63 (6.1) 76 (7.4) 
   Once or twice per week 67 (6.5) 56 (5.4) 
   More than twice per week 56 (5.4) 62 (6.0) 
Number of days with a nap, n (%) 1.5 (1.9)   1.6 (1.9) 
Data are presented as mean (SD), unless otherwise stated. 
Abbreviations: BMI, body mass index; CES-D, Center for Epidemiologic Studies Depression; MET, metabolic equivalent of 
task; NA, not applicable; T, time point; WC, waist circumference. 
*Education was only assessed at baseline and physical activity only at follow-up. 
† The CES-D score did not include the question on restless sleep. 
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Cross-sectional analyses 
In cross-sectional analyses, one hour longer TST was associated with approximately 0.5 kg/m2 
lower BMI at T1 and T2 (see Table 5.3.2). At T2, one percent higher SE was associated with 0.04 
kg/m2 (95%CI: -0.07, -0.01) lower BMI (Table 5.3.2). We observed no associations for SOL and 
WASO. 
Longitudinal analyses: sleep parameters predicting BMI across time 
In longitudinal analyses with sleep indices as the exposure variables, we found that on average 
longer sleep duration and higher sleep efficiency are associated with lower BMI (main effects for 
average sleep parameters in Table 5.3.3 and Figure 5.3.1a and 5.3.1b). We also observed that the 
average yearly decrease in BMI of 0.20 kg/m2 in the elderly (Figure 5.3.1; and effect of time in 
Table 5.3.3) is reduced by 0.02 kg/m2 (95%CI: 0.003, 0.05) with every hour longer average sleep 
duration, and by 0.002 kg/m2 (95% CI: 0.00002, 0.005) with every 1% higher sleep efficiency. In 
other words, habitually longer and more efficient sleep is associated with a slower decrease in BMI 
across time (less steep slopes of dotted lines compared to solid lines in Figure 5.3.1).  
In addition, a yearly 1% decrease in sleep efficiency was associated with 0.22 (95%CI: -0.40,  
-0.03) kg/m2 higher BMI across time (effect of ΔSE in Table 5.3.3). An increase in WASO over 
time reversed the slope of BMI, resulting in an increase in BMI across time (dotted lines versus 
solid lines in Figure 5.3.1d). Changes in TST and SOL across the follow up were not associated 
with BMI. 
 
Table 5.3.2. Cross-sectional associations of objective sleep with body mass index (kg/m2) at two 
time points, Rotterdam Study, 2004-2014 
N=1031 
Associations at T1  
(December 2004 - April 2007) 
  Associations at T2* 
(March 2009 - June 2014) 
B 95% CI P-value   B 95% CI P-value 
TST, hours 
 
-0.51 -0.81, -0.21 0.001  -0.58 -0.87, -0.29 <0.001 
SOL†, min 
 
0.01 -0.01, 0.02 0.25  0.01 -0.003, 0.03 0.11 
SE, %   -0.01 -0.04, 0.02 0.36   -0.04 -0.07, -0.01 0.008 
WASO, min   0.002 -0.008; 0.012 0.70  0.005 -0.005; 0.015 0.34 
Abbreviations: BMI, body mass index; SE, sleep efficiency; SOL, sleep onset latency; T, time point; TST, total sleep time, 
WASO, wake after sleep onset. 
Models are adjusted for sex, age, cohort, smoking, education, employment, prevalent chronic disease(s), CES-Depression score, 
self-reported frequency of sleep disordered breathing, and frequency of napping 
*Additionally adjusted for physical activity and actigraphy device (Actiwatch or GeneActiv) 
† SOL was log-transformed for analyses 
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kg/m2 (95%CI: -0.07, -0.01) lower BMI (Table 5.3.2). We observed no associations for SOL and 
WASO. 
Longitudinal analyses: sleep parameters predicting BMI across time 
In longitudinal analyses with sleep indices as the exposure variables, we found that on average 
longer sleep duration and higher sleep efficiency are associated with lower BMI (main effects for 
average sleep parameters in Table 5.3.3 and Figure 5.3.1a and 5.3.1b). We also observed that the 
average yearly decrease in BMI of 0.20 kg/m2 in the elderly (Figure 5.3.1; and effect of time in 
Table 5.3.3) is reduced by 0.02 kg/m2 (95%CI: 0.003, 0.05) with every hour longer average sleep 
duration, and by 0.002 kg/m2 (95% CI: 0.00002, 0.005) with every 1% higher sleep efficiency. In 
other words, habitually longer and more efficient sleep is associated with a slower decrease in BMI 
across time (less steep slopes of dotted lines compared to solid lines in Figure 5.3.1).  
In addition, a yearly 1% decrease in sleep efficiency was associated with 0.22 (95%CI: -0.40,  
-0.03) kg/m2 higher BMI across time (effect of ΔSE in Table 5.3.3). An increase in WASO over 
time reversed the slope of BMI, resulting in an increase in BMI across time (dotted lines versus 
solid lines in Figure 5.3.1d). Changes in TST and SOL across the follow up were not associated 
with BMI. 
 
Table 5.3.2. Cross-sectional associations of objective sleep with body mass index (kg/m2) at two 
time points, Rotterdam Study, 2004-2014 
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Associations at T1  
(December 2004 - April 2007) 
  Associations at T2* 
(March 2009 - June 2014) 
B 95% CI P-value   B 95% CI P-value 
TST, hours 
 
-0.51 -0.81, -0.21 0.001  -0.58 -0.87, -0.29 <0.001 
SOL†, min 
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WASO, min   0.002 -0.008; 0.012 0.70  0.005 -0.005; 0.015 0.34 
Abbreviations: BMI, body mass index; SE, sleep efficiency; SOL, sleep onset latency; T, time point; TST, total sleep time, 
WASO, wake after sleep onset. 
Models are adjusted for sex, age, cohort, smoking, education, employment, prevalent chronic disease(s), CES-Depression score, 
self-reported frequency of sleep disordered breathing, and frequency of napping 
*Additionally adjusted for physical activity and actigraphy device (Actiwatch or GeneActiv) 
† SOL was log-transformed for analyses 
  
Chapter 5.3 
332 
Longitudinal analyses: BMI predicting sleep parameters across time 
Longitudinal analyses with BMI as exposure variable are shown in Table 5.3.4. One point higher 
average BMI was associated with a 0.02 hours (95%CI: -0.03, -0.01) shorter TST. However, an 
increase in BMI across the follow-up was associated with 0.23 hours longer TST (95%CI: 0.04, 
0.41) per kg/m2, but was not related to the other sleep parameters. 
 
Table 5.3.3. Actigraphically measured sleep parameters predicting BMI  
    BMI (kg/m
2)Total Sleep Time 
(hours) 
    β 95% CI 
1. Total sleep time (TST), hours 
Average TST  -0.75 -1.08, -0.42 
ѐ TST  -1.63 -3.57, 0.30 
Time, years -0.20 -0.34, -0.07 
Average TST & Time Interaction 0.03 0.003, 0.05 
ѐ TST & Time Interaction -0.05 -0.18, 0.08 
2. Sleep efficiency (SE), % 
Average SE  -0.04 -0.08, -0.01 
ѐ SE -0.22 -0.41, -0.03 
Time, years -0.22 -0.40, -0.05 
Average SE & Time Interaction 0.002 0.00002, 0.005 
ѐ SE & Time Interaction -0.008 -0.02, 0.005 
3. Sleep onset latency (SOL), minutes 
Average SOL  0.40 -0.02, 0.82 
ѐ SOL 0.08 -1.81, 1.98 
Time, years -0.03 -0.12, 0.05 
Average SOL & Time Interaction -0.01 -0.03, 0.02 
ѐ SOL & Time Interaction -0.02 -0.15, 0.11 
4. Wake after sleep onset (WASO), minutes 
Average WASO  0.004 -0.01, 0.02 
ѐ WASO 0.01 -0.05, 0.08 
Time, years -0.03 -0.08, 0.02 
Average WASO & Time Interaction -0.0004 -0.001, 0.0004 
ѐ WASO & Time Interaction   0.005 0.00003, 0.01 
β's are derived from linear mixed models.  Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time.  
The interaction term estimates how the effects of the average of the sleep parameter and time depend on each other.  
Models are adjusted for sex, age, cohort, actigraphy device at follow-up, smoking, education, employment, prevalent chronic 
disease(s), depressive symptoms, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed in analyses. 
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Figure 5.3.1. Actigraphically measured sleep parameters predicting body mass index across time 
Abbreviations: BMI, body mass index; TST, total sleep time in hours; SE, sleep efficiency in %; WASO, wake after sleep onset 
in minutes; SOL, sleep after onset latency in minutes.  
Light grey indicates “poor sleep” (e.g. TST=6 hours, SE=60%, SOL=40minutes, WASO=90minutes), Dark grey indicates 
“good sleep” (e.g. TST=8 hours, SE=90%, SOL=10minutes, WASO=30minutes). Dotted lines indicate a worsening of sleep 
parameters relative to the respective color (e.g. Ļ1 hour TST, Ļ 10% SE, Ĺ10minutes SOL, Ĺ30minutes WASO). Estimates are 
representative for a non-smoking, high-educated male of 61 years old, with no sleep disordered breathing or other 
comorbidities, and average level of physical activity and depressive symptoms. 
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4. Wake after sleep onset (WASO), minutes 
Average WASO  0.004 -0.01, 0.02 
ѐ WASO 0.01 -0.05, 0.08 
Time, years -0.03 -0.08, 0.02 
Average WASO & Time Interaction -0.0004 -0.001, 0.0004 
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β's are derived from linear mixed models.  Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time.  
The interaction term estimates how the effects of the average of the sleep parameter and time depend on each other.  
Models are adjusted for sex, age, cohort, actigraphy device at follow-up, smoking, education, employment, prevalent chronic 
disease(s), depressive symptoms, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed in analyses. 
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Figure 5.3.1. Actigraphically measured sleep parameters predicting body mass index across time 
Abbreviations: BMI, body mass index; TST, total sleep time in hours; SE, sleep efficiency in %; WASO, wake after sleep onset 
in minutes; SOL, sleep after onset latency in minutes.  
Light grey indicates “poor sleep” (e.g. TST=6 hours, SE=60%, SOL=40minutes, WASO=90minutes), Dark grey indicates 
“good sleep” (e.g. TST=8 hours, SE=90%, SOL=10minutes, WASO=30minutes). Dotted lines indicate a worsening of sleep 
parameters relative to the respective color (e.g. Ļ1 hour TST, Ļ 10% SE, Ĺ10minutes SOL, Ĺ30minutes WASO). Estimates are 
representative for a non-smoking, high-educated male of 61 years old, with no sleep disordered breathing or other 
comorbidities, and average level of physical activity and depressive symptoms. 
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Figure 5.3.2. Body mass index predicting actigraphically measured sleep parameters across time 
Abbreviations: BMI, body mass index; TST, total sleep time in hours; SE, sleep efficiency in %; WASO, wake after sleep onset 
in minutes; SOL, sleep after onset latency in minutes.  
Light grey represents the estimates for a BMI of 30 kg/m2, dark grey represents the estimates of 20 kg/m2, and dotted lines 
indicate 3 points decrease from the respective color. Estimates are for a non-smoking, high-educated male of 61 years old, 
with no sleep disordered breathing or other comorbidities, average physical activity and depressive symptoms level.  
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In our elderly population, actigraphically assessed sleep duration and efficiency increased over the 
follow-up (effect of time; Table 5.3.4). However, a high average BMI had a negative effect on this 
relation. That is, a one point higher average BMI reduced the yearly increase in TST by 0.002 
hours, and SE by 0.02% (interaction between average BMI and time; Table 5.3.4). In other words, 
the negative effect that average BMI has on sleep parameters becomes more pronounced over time 
(βTST*TIME=-0.002, (95%CI: -0.004, -0.00002) and βSE*TIME=-0.02, (95%CI: -0.04, -0.004)). Sleep 
patterns across time for normal weight and obese person are visually presented in Figure 5.3.2. 
Interestingly, an increase in 3 points for a person with BMI of 30 kg/m2 (a shift from overweight to 
obese) resulted in a decrease in SE over time (Figure 5.3.2b). 
Sensitivity analyses 
Results were similar across the sexes (Supplement 5.3.3 – Supplement 5.3.4), and across the two 
actigraphy devices (Supplement 5.3.5 – Supplement 5.3.7). The nonresponse analysis indicated 
that participants included in the study were more likely to be highly educated (χ2=12.855, 
P=0.005), but did not differ from those lost to follow up regarding age, sex, depressive symptom 
score, any of the sleep parameters or baseline BMI.  
 
Table 5.3.4. BMI predicting actigraphically measured sleep parameters  
 
Total sleep time 
(TST), hours 
Sleep efficiency 
(SE), % 
Sleep onset latency 
(SOL), minutes 
Wake after sleep 
onset (WASO), 
minutes 
 β 95% CI β 95% CI β 95% CI β 95% CI 
Average BMI 
(kg/m2) 
-0.02 -0.03, -0.005 -0.04 -0.17, 0.08 0.01 -0.003, 0.02 0.02 
-0.36, 
0.40 
Δ BMI 
(kg/m2) 
0.23 0.04, 0.41 1.76 -0.05, 3.58 0.002 -0.15, 0.16 -4.01 -9.44, 1.41 
Time (years) 0.08 0.03, 0.14 0.74 0.20, 1.29 -0.02 -0.08, 0.03 -1.14 -2.70, 0.42 
Average BMI 
& Time 
Interaction 
-0.002 -0.004,  -0.0002 -0.02 
-0.04,  
-0.004 0.00002 
-0.002, 
0.002 0.03 
-0.03, 
0.08 
Δ BMI & 
Time 
Interaction 
-0.007 -0.03, 0.02 -0.13 -0.42, 0.15 -0.003 -0.03, 0.03 0.69 -0.12, 1.50 
β's are derived from linear mixed models. Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time. The interaction term estimates 
how the effects of average BMI and time depend on each other.  
Models are adjusted for sex, age, cohort, actigraphy device at follow-up, smoking, education, employment, prevalent chronic 
disease(s), depressive symptoms, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed in analyses. 
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Figure 5.3.2. Body mass index predicting actigraphically measured sleep parameters across time 
Abbreviations: BMI, body mass index; TST, total sleep time in hours; SE, sleep efficiency in %; WASO, wake after sleep onset 
in minutes; SOL, sleep after onset latency in minutes.  
Light grey represents the estimates for a BMI of 30 kg/m2, dark grey represents the estimates of 20 kg/m2, and dotted lines 
indicate 3 points decrease from the respective color. Estimates are for a non-smoking, high-educated male of 61 years old, 
with no sleep disordered breathing or other comorbidities, average physical activity and depressive symptoms level.  
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In our elderly population, actigraphically assessed sleep duration and efficiency increased over the 
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obese) resulted in a decrease in SE over time (Figure 5.3.2b). 
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DISCUSSION 
In this population-based cohort, we replicated the strong cross-sectional associations of short and 
disturbed sleep with higher BMI found in previous studies. In longitudinal analyses, we found 
evidence for a complex bidirectional association between sleep and body size in the elderly. 
Actigraphic indices of good sleep (e.g. longer average sleep duration and higher average sleep 
efficiency), predicted a lower BMI across time. Additionally, a longer sleep duration and higher 
sleep efficiency slowed down the decrease in BMI across time observed in our elderly population. 
Converesly, a high average BMI was associated with shorter sleep duration over time. Higher BMI 
also had a negative effect on the changes in sleep duration and efficiency observed in our elderly 
population (e.g. obese participants had a decrease in sleep efficiency, as opposed to normal weight 
who had an increase over the follow-up).  
Multiple cross-sectional studies reported that short and fragmented sleep is associated with 
high BMI and obesity.16,29,31-33 Supported by evidence from longitudinal studies using subjective 
measures of sleep, short sleep is increasingly recognized as a potential risk factor for obesity.34 
Previous studies have also reported both short and long self-reported sleep duration to be 
associated with higher BMI.35,36 However, in a study among 612 older adults, Lauderdale et al. 
observed no association of objectively measured sleep duration and fragmentation with changes 
in BMI.25 Our prospective findings show that actigraphic indices of good sleep (e.g. longer average 
sleep duration and higher average sleep efficiency), as well as an increase in sleep efficiency over 
the follow-up, predicted a lower BMI across time. Additionally, indices of good sleep also slowed 
down the general decrease in BMI in the elderly over time. One of the factors that might 
contribute to the differences between studies is the age of the participants. It has been reported 
that the association between sleep and BMI differs with age,31 and very few studies in elderly 
populations have been performed.37,38 Compared to younger adults, older adults often have more 
difficulties sleeping,39 and might have more chronic diseases or different body composition.40 Our 
observation that longer sleep duration slows down the decrease in BMI might be specific to older 
adults. Longer sleep duration and a slightly higher BMI might be proxies for good health in the 
elderly, since weight loss at older age is often associated with disease. Other factors related to long 
sleep and high BMI, such as reduced physical activity or depression might also contribute to this 
association.41 Longer sleep measured with actigraphy may be a proxy of or associated with long 
periods of inactivity (i.e. awake in bed or sedentary time) leading to a slower decrease in BMI. 
However, our results could not be explained by controlling for these variables. Further, we cannot 
rule out that a residual confounder leads to higher BMI and longer sleep duration (e.g. genetic 
predisposition, stress, sleep disorders etc.).  
Many studies focused on the effect of sleep on weight or BMI, whereas the converse 
association has gained less attention. Only one previous study explored the direction of this 
association using subjective sleep measures.11 The authors reported that a higher BMI predicted a 
decrease in sleep duration over time, but not vice versa.11 We demonstrated that high BMI was 
associated with shorter objectively measured sleep duration, and vice versa short and inefficient 
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sleep was related to higher BMI across time. This indicates that previous cross-sectional studies 
reporting strong relations between short or disturbed sleep and higher BMI might have been 
affected by reverse causality (e.g. high BMI might lead to short sleep). Importantly, we showed 
that high BMI reduces any increase in sleep duration and efficiency over time. For example, if a 61 
year old overweight (30kg/m2) became obese (33 kg/m2), a steep reduction in sleep efficiency was 
observed over the follow-up. In contrast, a person of the same age with normal weight (20kg/m2) a 
3 kg/m2 increase in BMI was paralleled with a slight increase in sleep efficiency over time. 
The mechanisms underlying the association between obesity and sleep might be related to 
health status, as chronically ill people are more likely to experience sleep difficulties or 
disturbances.42 However, adjustments for chronic diseases and other health-related variables did 
not meaningfully change our results. Finally, people with higher BMI are also more likely to snore 
or experience symptoms of SDB symptoms, which in turn can result in shorter and more 
fragmented sleep.43 Almost 20% of our sample reported they have experienced long breathing 
pauses during sleep. Some of these persons may suffer from sleep apnea, which is likely to partly 
explain the longitudinal associations between high BMI and short or disturbed sleep.  
 To the best of our knowledge, there are no other observational studies exploring how 
changes in sleep parameters influence BMI, or vice versa, how changes in body size influence 
sleep. Some intervention studies examined the effect of weight loss on sleep,8-10,44 reporting that 
weight loss programs result in an increase self-reported sleep duration.8,10 In our study, an 
increase in BMI across the follow-up was related to longer sleep duration, but not with other sleep 
parameters. In the converse relation, only an increase in sleep efficiency was related to lower BMI 
across time. We measured sleep objectively in a general population of older persons. These 
associations confirm that the relation between sleep and body size is bidirectional, and regardless 
of the unestablished causality changes in either sleep or BMI are likely influence health through 
multiple pathways.  
Major strengths of our study are the prospective design with repeated measures of sleep and 
BMI across a follow-up of 6 years in a large sample of older adults from the general population. In 
contrast to the only previous longitudinal BMI study which measured sleep objectively,25 next to 
repeated anthropometric measures, we also had repeated measures of sleep, allowing us to 
accurately estimate average between-subject differences in both directions of the association. The 
longitudinal design of the study allowed us to explore changes over time, and to explore reverse 
causality, which may influence associations observed in cross-sectional studies.  
We acknowledge that our study has some methodological limitations. First, we did not have 
an objective measure of SDB, but relied on self-report. Furthermore, we only had information on 
the presence and not on the severity of chronic diseases. These two limitations might give rise to 
some degree of residual confounding. In our follow-up measurement we used two different 
devices to measure sleep, which might result in increased measurement error. In addition, our 
nonresponse analysis indicated that participants included in the study were more likely to highly 
educated, and this association might differ in populations with different socio-demographic 
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DISCUSSION 
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population (e.g. obese participants had a decrease in sleep efficiency, as opposed to normal weight 
who had an increase over the follow-up).  
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Previous studies have also reported both short and long self-reported sleep duration to be 
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observed no association of objectively measured sleep duration and fragmentation with changes 
in BMI.25 Our prospective findings show that actigraphic indices of good sleep (e.g. longer average 
sleep duration and higher average sleep efficiency), as well as an increase in sleep efficiency over 
the follow-up, predicted a lower BMI across time. Additionally, indices of good sleep also slowed 
down the general decrease in BMI in the elderly over time. One of the factors that might 
contribute to the differences between studies is the age of the participants. It has been reported 
that the association between sleep and BMI differs with age,31 and very few studies in elderly 
populations have been performed.37,38 Compared to younger adults, older adults often have more 
difficulties sleeping,39 and might have more chronic diseases or different body composition.40 Our 
observation that longer sleep duration slows down the decrease in BMI might be specific to older 
adults. Longer sleep duration and a slightly higher BMI might be proxies for good health in the 
elderly, since weight loss at older age is often associated with disease. Other factors related to long 
sleep and high BMI, such as reduced physical activity or depression might also contribute to this 
association.41 Longer sleep measured with actigraphy may be a proxy of or associated with long 
periods of inactivity (i.e. awake in bed or sedentary time) leading to a slower decrease in BMI. 
However, our results could not be explained by controlling for these variables. Further, we cannot 
rule out that a residual confounder leads to higher BMI and longer sleep duration (e.g. genetic 
predisposition, stress, sleep disorders etc.).  
Many studies focused on the effect of sleep on weight or BMI, whereas the converse 
association has gained less attention. Only one previous study explored the direction of this 
association using subjective sleep measures.11 The authors reported that a higher BMI predicted a 
decrease in sleep duration over time, but not vice versa.11 We demonstrated that high BMI was 
associated with shorter objectively measured sleep duration, and vice versa short and inefficient 
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sleep was related to higher BMI across time. This indicates that previous cross-sectional studies 
reporting strong relations between short or disturbed sleep and higher BMI might have been 
affected by reverse causality (e.g. high BMI might lead to short sleep). Importantly, we showed 
that high BMI reduces any increase in sleep duration and efficiency over time. For example, if a 61 
year old overweight (30kg/m2) became obese (33 kg/m2), a steep reduction in sleep efficiency was 
observed over the follow-up. In contrast, a person of the same age with normal weight (20kg/m2) a 
3 kg/m2 increase in BMI was paralleled with a slight increase in sleep efficiency over time. 
The mechanisms underlying the association between obesity and sleep might be related to 
health status, as chronically ill people are more likely to experience sleep difficulties or 
disturbances.42 However, adjustments for chronic diseases and other health-related variables did 
not meaningfully change our results. Finally, people with higher BMI are also more likely to snore 
or experience symptoms of SDB symptoms, which in turn can result in shorter and more 
fragmented sleep.43 Almost 20% of our sample reported they have experienced long breathing 
pauses during sleep. Some of these persons may suffer from sleep apnea, which is likely to partly 
explain the longitudinal associations between high BMI and short or disturbed sleep.  
 To the best of our knowledge, there are no other observational studies exploring how 
changes in sleep parameters influence BMI, or vice versa, how changes in body size influence 
sleep. Some intervention studies examined the effect of weight loss on sleep,8-10,44 reporting that 
weight loss programs result in an increase self-reported sleep duration.8,10 In our study, an 
increase in BMI across the follow-up was related to longer sleep duration, but not with other sleep 
parameters. In the converse relation, only an increase in sleep efficiency was related to lower BMI 
across time. We measured sleep objectively in a general population of older persons. These 
associations confirm that the relation between sleep and body size is bidirectional, and regardless 
of the unestablished causality changes in either sleep or BMI are likely influence health through 
multiple pathways.  
Major strengths of our study are the prospective design with repeated measures of sleep and 
BMI across a follow-up of 6 years in a large sample of older adults from the general population. In 
contrast to the only previous longitudinal BMI study which measured sleep objectively,25 next to 
repeated anthropometric measures, we also had repeated measures of sleep, allowing us to 
accurately estimate average between-subject differences in both directions of the association. The 
longitudinal design of the study allowed us to explore changes over time, and to explore reverse 
causality, which may influence associations observed in cross-sectional studies.  
We acknowledge that our study has some methodological limitations. First, we did not have 
an objective measure of SDB, but relied on self-report. Furthermore, we only had information on 
the presence and not on the severity of chronic diseases. These two limitations might give rise to 
some degree of residual confounding. In our follow-up measurement we used two different 
devices to measure sleep, which might result in increased measurement error. In addition, our 
nonresponse analysis indicated that participants included in the study were more likely to highly 
educated, and this association might differ in populations with different socio-demographic 
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characteristics. Furthermore, BMI does not indicate how the fat is distributed across the body. 
Nevertheless, BMI has been shown to be a reasonably good measure to assess adiposity.45 
Conclusions 
In conclusion, in this population of older adults there was a clear bidirectional association 
between sleep and body size across a follow-up of 6 years. Good sleep (e.g. longer sleep duration, 
higher sleep efficiency) predicted a lower BMI across time. Conversely, high BMI was associated 
with shorter sleep duration across time. We also observed that long and efficient sleep slowed 
down the decrease in BMI in the elderly. Vice versa, a high BMI had a negative influence on sleep 
parameters across time (e.g. obese older adults show a decrease in sleep efficiency over time, 
whereas older adults with normal weight have an increase). Furthermore, an increase in sleep 
efficiency was related to lower BMI, whereas an increase in BMI was related to a longer sleep 
duration. The findings from our general population sample suggest that sleep and body size have 
a complex intertwined relation to health in older adults. Although sleep has been implied as an 
important determinant of body size, a healthy BMI is also associated with better sleep indices in 
an age group with increasing sleep problems and disturbances.  
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characteristics. Furthermore, BMI does not indicate how the fat is distributed across the body. 
Nevertheless, BMI has been shown to be a reasonably good measure to assess adiposity.45 
Conclusions 
In conclusion, in this population of older adults there was a clear bidirectional association 
between sleep and body size across a follow-up of 6 years. Good sleep (e.g. longer sleep duration, 
higher sleep efficiency) predicted a lower BMI across time. Conversely, high BMI was associated 
with shorter sleep duration across time. We also observed that long and efficient sleep slowed 
down the decrease in BMI in the elderly. Vice versa, a high BMI had a negative influence on sleep 
parameters across time (e.g. obese older adults show a decrease in sleep efficiency over time, 
whereas older adults with normal weight have an increase). Furthermore, an increase in sleep 
efficiency was related to lower BMI, whereas an increase in BMI was related to a longer sleep 
duration. The findings from our general population sample suggest that sleep and body size have 
a complex intertwined relation to health in older adults. Although sleep has been implied as an 
important determinant of body size, a healthy BMI is also associated with better sleep indices in 
an age group with increasing sleep problems and disturbances.  
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Supplement 5.3.1. Flow chart of repeated sleep measures in the Rotterdam Study, 2004-2014 
 
 
153 Participants died in the period of April 2007 – 
February 2011 
1,785 Participants eligible for repeated 
measures 
Valid actigraphy data was collected for 
1,938 people between December 2004 – 
April 2007 
87 Participants were lost to follow-up between 
April 2007 - February 2011 
1,431 (80%) Participants were invited to 
participate in the follow-up actigraphy 
study 
Sd267 Participants were not invited due to logistic 
reasons 
1,031 (72%) Participants included in 
analyses 
184 participants refused to participate 
4 Participants were cognitively impaired to 
understand instructions 
212 Participants excluded: 
x No sleep diary (n=39) 
x Invalid sleep diary (n=38) 
x Not archived/corrupted files (n=94) 
x Less than 4 days at baseline (n=26) or 
follow-up (n=11) 
x No body mass index data at baseline  
(n =3) or follow up (n=1) 
1,243 Participants agreed to participate 
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Supplement 5.3.2. Linear Mixed Models equations 
Association Equation 
TST predicts 
BMI 
BMIij= (β0 + bi0) + β1TST_deltai + β2TST_avgi + β3TIMEij +  
β4(TST_avgi*TIMEij) + β5Xi + εij 
SE predicts BMI 
BMIij= (β0 + bi0) + β1SE_deltai + β2SE_avgi + β3TIMEij +  β4(SE_avgi*TIMEij) + 
β5Xi + εij 
WASO predicts 
BMI 
BMIij= (β0 + bi0) + β1WASO_deltai + β2WASO_avgi + β3TIMEij +  β4Xi + εij 
SOL predicts 
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Abbreviations: BMI, body mass index; SE, sleep efficiency; SOL, sleep onset latency; TST, total sleep time; WASO, wake after 
sleep onset 
yij = (β0 + bi0) + (β1 + bi1)tij + εij; 
where 
x i denotes the individual 
x j refers to the j-th assessment of the outcome 
x β’s are the fixed effects 
x b’s are the random effects 
x Xi is the design matrix of  the fixed effects, containing covariates assessed at baseline (see Methods) 
x εij, where  εij ~ N(0; Vi); denote the error terms 
x Final models were estimated using restricted maximum likelihood (REML) TST is total sleep time in hours 
x SE is sleep efficiency in % 
x WASO is wake after sleep onset 
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Supplement 5.3.4. Longitudinal association between actigraphically measured sleep parameters 
and BMI, stratified by sex 
  BMI (kg/m2)Total Sleep Time (hours) 
  Men (n=496) Women (n=535) 
  β 95% CI β 95% CI 
Total sleep time (TST), hours  
Average TST   -0.69 -1.07, -0.31 -0.81 -1.35, -0.27 
ѐ TST   -1.03 -3.25, 1.19 -2.71 -5.87, 0.45 
Time, years  -0.13 -0.30, 0.04 -0.28 -0.49, -0.06 
Average TST & Time 
Interaction 
 
0.01 -0.02, 0.04 0.04 0.003, 0.07 
ѐ TST & Time Interaction  -0.08 -0.24, 0.08 -0.02 -0.23, 0.18 
Sleep efficiency (SE), %  
Average SE   -0.02 -0.06, 0.01 -0.06 -0.12, -0.01 
ѐ SE  -0.18 -0.39, 0.03 -0.35 -0.68, -0.02 
Time, years  -0.16 -0.37, 0.06 -0.30 -0.58, -0.02 
Average SE & Time 
Interaction 
 
0.001 -0.001, 0.004 0.003 -0.0004, 0.007 
ѐ SE & Time Interaction  -0.005 -0.02, 0.011 -0.012 -0.03, 0.01 
Sleep onset latency (SOL)†, minutes  
Average SOL†   0.32 -0.19, 0.83 0.41 -0.25, 1.08 
ѐ SOL†   0.97 -1.29, 3.24 -0.25 -3.25, 2.76 
Time, years  -0.09 -0.20, 0.01 0.01 -0.11, 0.13 
Average SOL & Time 
Interaction 
 
0.01 -0.02, 0.05 -0.02 -0.06, 0.02 
ѐ SOL & Time Interaction  -0.10 -0.27, 0.07 0.04 -0.16, 0.23 
Wake after sleep onset (WASO), minutes  
Average WASO   -0.006 -0.02, 0.01 0.015 -0.004, 0.04 
ѐ WASO  0.08 -0.002, 0.16 -0.02 -0.14, 0.09 
Time, years  -0.02 -0.08, 0.03 -0.03 -0.11, 0.05 
Average WASO & Time 
Interaction 
 
-0.001 -0.001, 0.0004 -0.0002 -0.001, 0.001 
ѐ WASO & Time Interaction  0.003 -0.003, 0.01 0.006 -0.0007, 0.01 
β's are derived from linear mixed models.  Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time.  
The interaction term estimates how the effects of the average of the sleep parameter and time depend on each other.  
Models are adjusted for  age, cohort, actigraphy device at follow-up, smoking, education, employment, prevalent chronic 
disease(s), depressive symptoms, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed for analyses 
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Interaction 
 
0.01 -0.02, 0.04 0.04 0.003, 0.07 
ѐ TST & Time Interaction  -0.08 -0.24, 0.08 -0.02 -0.23, 0.18 
Sleep efficiency (SE), %  
Average SE   -0.02 -0.06, 0.01 -0.06 -0.12, -0.01 
ѐ SE  -0.18 -0.39, 0.03 -0.35 -0.68, -0.02 
Time, years  -0.16 -0.37, 0.06 -0.30 -0.58, -0.02 
Average SE & Time 
Interaction 
 
0.001 -0.001, 0.004 0.003 -0.0004, 0.007 
ѐ SE & Time Interaction  -0.005 -0.02, 0.011 -0.012 -0.03, 0.01 
Sleep onset latency (SOL)†, minutes  
Average SOL†   0.32 -0.19, 0.83 0.41 -0.25, 1.08 
ѐ SOL†   0.97 -1.29, 3.24 -0.25 -3.25, 2.76 
Time, years  -0.09 -0.20, 0.01 0.01 -0.11, 0.13 
Average SOL & Time 
Interaction 
 
0.01 -0.02, 0.05 -0.02 -0.06, 0.02 
ѐ SOL & Time Interaction  -0.10 -0.27, 0.07 0.04 -0.16, 0.23 
Wake after sleep onset (WASO), minutes  
Average WASO   -0.006 -0.02, 0.01 0.015 -0.004, 0.04 
ѐ WASO  0.08 -0.002, 0.16 -0.02 -0.14, 0.09 
Time, years  -0.02 -0.08, 0.03 -0.03 -0.11, 0.05 
Average WASO & Time 
Interaction 
 
-0.001 -0.001, 0.0004 -0.0002 -0.001, 0.001 
ѐ WASO & Time Interaction  0.003 -0.003, 0.01 0.006 -0.0007, 0.01 
β's are derived from linear mixed models.  Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time.  
The interaction term estimates how the effects of the average of the sleep parameter and time depend on each other.  
Models are adjusted for  age, cohort, actigraphy device at follow-up, smoking, education, employment, prevalent chronic 
disease(s), depressive symptoms, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed for analyses 
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Supplement 5.3.5. Cross-Sectional Associations Between Objective Sleep and Body Mass Index 
(kg/m2) at Two Time Points, Stratified by Device at Follow-Up, Rotterdam Study, 2004-2014 
Actiwatch 
N=592 
Associations at T1   Associations at T2 
B 95% CI P-value   B 95% CI P-value 
TST, hours -0.35 -0.73, 0.03 0.07 -0.49 -0.86, -0.11 0.011 
SOL†, min 0.02 0.005, 0.04 0.014 0.01 -0.01, 0.03 0.21 
SE, % -0.03 -0.07, 0.01 0.17   -0.04 -0.07, 0.003 0.07 
WASO, min 0.01 -0.003; 0.023 0.15  0.005 -0.008; 0.017 0.46 
      
GeneActiv 
N=439 
Associations at T1 Associations at T2 
B 95% CI P-value B 95% CI P-value 
TST, hours -0.69 -1.18, -0.20 0.005 -0.69 -1.15, -0.23 0.004 
SOL†, min -0.01 -0.03, 0.01 0.44 0.02 -0.01, 0.05 0.27 
SE, % 0.003 -0.05, 0.05 0.91 -0.05 -0.10, 0.001 0.053 
WASO, min -0.007 -0.02; 0.009 0.40  0.004 -0.01; 0.02 0.68 
Abbreviations: BMI, body mass index; SE, sleep efficiency; SOL, sleep onset latency; T, time point; TST, total sleep time; WC, 
waist circumference. 
Models are adjusted for sex, age, cohort, smoking, education, employment, physical activity (at T2 only), prevalent chronic 
disease(s), CES-Depression score, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed for analyses 
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Supplement 5.3.5. Cross-Sectional Associations Between Objective Sleep and Body Mass Index 
(kg/m2) at Two Time Points, Stratified by Device at Follow-Up, Rotterdam Study, 2004-2014 
Actiwatch 
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B 95% CI P-value   B 95% CI P-value 
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SE, % -0.03 -0.07, 0.01 0.17   -0.04 -0.07, 0.003 0.07 
WASO, min 0.01 -0.003; 0.023 0.15  0.005 -0.008; 0.017 0.46 
      
GeneActiv 
N=439 
Associations at T1 Associations at T2 
B 95% CI P-value B 95% CI P-value 
TST, hours -0.69 -1.18, -0.20 0.005 -0.69 -1.15, -0.23 0.004 
SOL†, min -0.01 -0.03, 0.01 0.44 0.02 -0.01, 0.05 0.27 
SE, % 0.003 -0.05, 0.05 0.91 -0.05 -0.10, 0.001 0.053 
WASO, min -0.007 -0.02; 0.009 0.40  0.004 -0.01; 0.02 0.68 
Abbreviations: BMI, body mass index; SE, sleep efficiency; SOL, sleep onset latency; T, time point; TST, total sleep time; WC, 
waist circumference. 
Models are adjusted for sex, age, cohort, smoking, education, employment, physical activity (at T2 only), prevalent chronic 
disease(s), CES-Depression score, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed for analyses 
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Supplement 5.3.7. Longitudinal association between actigraphically measured sleep parameters 
and BMI, stratified by actigraphy device at follow-up 
  BMI (kg/m2)Total Sleep Time (hours) 
  Actiwatch (n=592) GeneActiv (n=439) 
  β 95% CI β 95% CI 
Total sleep time (TST), hours  
Average TST   -0.57 -1.00, -0.14 -0.98 -1.51, -0.45 
ѐ TST   -1.73 -4.23, 0.77 -1.69 -4.78, 1.39 
Time, years  -0.21 -0.38, -0.04 -0.21 -0.42, 0.01 
Average TST & Time 
Interaction 
 
0.03 -0.002, 0.05 0.02 -0.01, 0.06 
ѐ TST & Time Interaction  -0.12 -0.29, 0.05 0.04 -0.17, 0.25 
Sleep efficiency (SE), %  
Average SE   -0.05 -0.10, -0.01 -0.03 -0.09, 0.02 
ѐ SE  -0.16 -0.40, 0.08 -0.31 -0.64, 0.01 
Time, years  -0.39 -0.61, -0.17 -0.001 -0.29, 0.28 
Average SE & Time 
Interaction 
 
0.005 0.002, 0.008 -0.001 -0.004, 0.003 
ѐ SE & Time Interaction  -0.01 -0.03, 0.007 -0.008 -0.03, 0.014 
Sleep onset latency (SOL)†, minutes  
Average SOL†   0.62 0.09, 1.15 0.18 -0.54, 0.89 
ѐ SOL†   -1.52 -4.00, 0.96 1.85 -1.15, 4.85 
Time, years  0.04 -0.06, 0.15 -0.16 -0.29, -0.02 
Average SOL & Time 
Interaction 
 
-0.03 -0.07, 0.002 0.04 -0.01, 0.09 
ѐ SOL & Time Interaction  -0.01 -0.18, 0.16 -0.01 -0.21, 0.19 
Wake after sleep onset (WASO), minutes  
Average WASO   0.012 -0.002, 0.03 -0.007 -0.03, 0.01 
ѐ WASO  0.003 -0.08, 0.09 0.010 -0.10, 0.13 
Time, years  0.020 -0.04, 0.09 -0.09 -0.17, -0.02 
Average WASO & Time 
Interaction 
 
-0.001 -0.002, -0.0002 0.001 -0.003, 0.002 
ѐ WASO & Time Interaction  0.003 -0.003, 0.01 0.009 0.002, 0.02 
β's are derived from linear mixed models.  Time is expressed as 0=baseline and DateBMI_T2 – DateBMI_T1=follow-up, average BMI 
is expressed as (BMIT2 + BMIT1)/2, Delta BMI is expressed as (BMIT2 - BMIT1)/follow-up time,.  
The interaction term estimates how the effects of the average of the sleep parameter and time depend on each other.  
Models are adjusted for  sex, age, cohort, smoking, education, employment, prevalent chronic disease(s), CES-Depression 
score, self-reported frequency of sleep disordered breathing, and frequency of napping 
† SOL was log-transformed for analyses
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The main aim of this thesis was to study factors associated with activity in older age and to 
examine the association of activity domains with mortality, cardiovascular disorders and mental 
health outcomes. The activity domains of interest were physical activity, sedentary behavior, and 
sleep. Together complete the daily 24-hour activity cycle. Specific findings and discussion points 
from these analyses are described in the previous chapters. In this general discussion, the findings 
of this thesis will be summarized, and a general discussion of the major methodological 
considerations will be provided. Thereafter, public health implications and directions for future 
research will be discussed. 
 
Factors associated with activity  
Until a decade ago, physical activity was most often measured by questionnaires, which are 
subject to reporting bias and social desirable answers.1 More recently, the use of accelerometers to 
measure physical activity has increased.2,3 Accelerometers have the advantage that they can 
measure intensity and duration of activity without biases that are associated with self-report. 
However, questionnaires are currently still needed to gain more insight in the type and context of 
activity. The different measurement characteristics between questionnaire and accelerometer are 
reflected in the generally low agreement between the two measurement techniques. Therefore, to 
gain more knowledge on the disagreement, we studied the agreement between physical activity 
derived from questionnaires and the wrist-worn GeneActiv accelerometers, and whether the 
disagreement was related to health and lifestyle factors in Chapter 2.1. We observed that for every 
hour more physical activity measured by the accelerometer, the questionnaire underestimated 
physical activity levels more by 29 minutes. This might reflect that questionnaires do not capture 
all activities that are measured by the accelerometer. For example, climbing stairs and walking 
within shops were not included in the questionnaire used in this study. Furthermore, participants 
with more depressive symptoms, more disability and with a higher body mass index 
underestimated their self-reported physical activity levels more than the reference groups, 
indicating that perceived health might also affect the judgement of physical activity levels.  
The low agreement between the questionnaire and accelerometer indicates that people 
classified as highly active by the questionnaire, are not necessarily categorized as highly active by 
the accelerometer. Consequently, the factors associated with objectively measured activity in older 
age might slightly differ from the known factors associated with questionnaire-derived physical 
activity.4,5 Therefore, in Chapter 2.2, we examined the activity distribution of objectively measured 
physical activity, sedentary behavior and sleep in older adults, and we examined the demographic 
and health factors associated with these activity measures. Similar to the factors related to the 
disagreement, we observed that body mass index and disability were related to activity levels. 
Sedentary behavior was higher across higher levels of body mass index and across increasing age-
categories, which was at the expense of light and moderate-to-vigorous physical activity. 
Additionally, in contrast to previous literature using questionnaires,4,5 objectively measured 
physical activity levels were higher in women compared to men. 
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 Next, we examined which external factors are related to activity, by examining the seasonal 
patterns of objective measures of physical activity, sedentary behavior, and sleep according to an 
age-specific approach in Chapter 2.3. In adults up to 75 years, we observed a seasonal pattern for 
physical activity, with higher levels in the summer, at the expense of sleep duration. The seasonal 
patterns were mostly explained by ambient temperature and sunlight hours. In contrast, sedentary 
behavior showed no seasonal pattern, suggesting that this is a behavior that is ingrained in daily 
life and not easily influenced by whether conditions. We observed no seasonal pattern for adults 
aged 75 and over, which might be because most of their physical activity takes place indoors. 
Taken together, these results suggest that body mass index and disability are important 
factors to consider when examining activity patterns, since both were independently related to a 
larger underestimation of physical activity levels in the questionnaire, and with lower objectively 
measured activity levels in older adults. Furthermore, the fact that we observed higher objectively 
measured physical activity levels for women compared to men might reflect the traditional 
household pattern, in which women do more domestic chores than men. We did not observe any 
sex-differences on the disagreement between questionnaire and accelerometer, indicating that 
questionnaires and accelerometers capture the physical activity levels of men and women 
similarly. However, considering the increase in the use of accelerometers in current research, 
researchers need to be aware that results between studies using either questionnaire or 
accelerometer should be compared with caution. Furthermore, the observation that light physical 
activity had the largest seasonality suggests that this is behavior that is easily adapted to external 
conditions. Breaking up sedentary behavior with light physical activity might be a good starting 
point for public health institutions.  
Activity and mortality 
Low levels of physical activity and high levels of sedentary behavior have both been related to a 
higher mortality risk.6,7 In this thesis, we extended the knowledge on these topics by examining 
specific causes of death related to physical activity, as well as examining the physical activity types 
associated with all-cause mortality in Chapter 3.1. Furthermore, we examined the association 
between objectively measured sedentary behavior and mortality with a longer follow-op than 
previously reported in literature, and by carefully adjusting for confounders in Chapter 3.2. We 
found physical activity to be associated with lower risk of mortality related to all-causes, 
cardiovascular diseases, chronic lung diseases, infections and mortality from other causes. All 
physical activity types contributed to the lower all-cause mortality risk, supporting that 
engagement in any physical activity, including physical activity as part of a daily living, might be 
conducive to reduce mortality risk in older adults. Furthermore, we found higher levels of 
sedentary behavior to be associated with a higher all-cause mortality risk. However, this 
association was clearly attenuated after adjusting for other measures of activity, including  
disability and physical activity. In this study, we again showed the importance of disability in the 
analyses of an activity measure. The reason not to adjust for a measure of disability in the analyses 
between physical activity and mortality is related to the overlap between the physical activity 
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questionnaire and the activities of daily living questionnaire used to quantify disability status. 
Both questionnaires include questions on walking, cycling, and doing household work. Therefore, 
adjusting for activities of daily living in the analyses between physical activity and mortality was 
considered over adjustment. In future studies using activity measures, adjustment for a measure 
for disability should be carefully considered. 
Together, the findings from the studies in Chapter 3.1 and Chapter 3.2 illustrate the 
complicated relation between physical activity and sedentary behavior; persons with a low level of 
sedentary behavior do not necessarily have high levels of physical activity. Recently, a large meta-
analysis including more than 1 million men and women indicated that physical activity can 
eliminate the higher mortality risk associated with high sedentary time.8 However, the mortality 
risk associated with television viewing was not eliminated by adjusting for physical activity.8 This 
suggests that not all types of sedentary behavior are similarly related to mortality and that 
watching television might carry risks above and beyond overall sedentary behavior. This is in 
contrast to physical activity, for which we observed a risk reduction in all-cause mortality for all 
physical activity types. Therefore, further investigation is needed to examine whether overall 
sedentary behavior and several types of sedentary behavior are a risk factor for mortality, distinct 
from the effect of other measures of activity. 
Activity and cardiovascular health 
Many epidemiological studies have examined the association between physical activity and 
cardiovascular diseases.9,10 However, only few examined the association between specific physical 
activity types and cardiovascular health outcomes.11-13 Since older adults do not engage in sports 
an exercise as much as younger adults,14 the health effects of other physical activity types are of 
importance. Therefore, we explored the association of total physical activity, and of walking, 
cycling, domestic work, gardening and sports with coronary heart disease in Chapter 4.1, with 
atrial fibrillation in Chapter 4.2, and with the average years lived with and without cardiovascular 
disease in Chapter 4.3. We observed that specifically domestic work and cycling were 
independently associated with a reduction in the risk of coronary heart disease, and with large 
increases in total life expectancy, and extending life expectancy without cardiovascular disease. 
However, we observed no association between physical activity and risk of atrial fibrillation. Since 
active individuals might be more health conscious, they might visit their general practitioner more 
frequently and could therefore more often be evaluated by- and diagnosed with cardiac 
arrhythmias,15 and this might have influenced the results.  
The fact that specifically domestic work and cycling were associated with cardiovascular 
outcomes might be related to the intensity, frequency, and duration in which is engaged in these 
physical activity types. For example, almost all participants (96.7%) engaged in domestic work (see 
Figure 6.1), and it contributed up to 44% of the total physical activity level (expressed in 
MET·hours·week-1). For cycling, the relatively high intensity might contribute to better 
cardiorespiratory fitness, which is related to lower incidence of cardiovascular disease and 
mortality.16,17 The fact that we did not observe an association between walking and cardiovascular 
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events might be related to the heterogeneity regarding the intensity in which is engaged in 
walking. For example, it is possible that two participants both reported 1 hour of walking per 
week, with one participants walking 4 km within this time frame, whereas another walked 6 km. 
Consequently, the participants had a different walking pace, and this has been shown to be more 
strongly associated with cardiovascular disease than frequency and duration.18  
Furthermore, it has been suggested that physical activity might reduce risk of cardiovascular 
disease associated with overweight and obesity.19 In Chapter 4.4 we evaluated the joint effects of 
physical activity and body mass index with cardiovascular disease risk. We showed that 
individuals who engaged in higher levels of total physical activity were not at increased risk of 
cardiovascular disease, regardless of being overweight or obese. In contrast, overweight and obese 
individuals with lower total physical activity levels were at significantly higher risk of 
cardiovascular disease. Additionally, the cardiovascular disease risk between normal weight 
participants with low levels of physical activity was comparable to the risk of obese adults with 
high levels of physical activity. These findings highlight the importance of promoting physical 
activity levels across all normal weight, overweight and obese individuals. Moreover, since 
domestic work and cycling are activities which are accessible for most older adults, our findings 
indicate that these activities could be promoted in the elderly, with the aim to prevent 
cardiovascular disease and improve life expectancy. 
 
 
Figure 6.1 Participation in physical activity types 
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Sedentary behavior and physical activity have also been associated with health-related quality of 
life20,21 and mental health outcomes as depression, anxiety and cognitive function.22-24 In Chapter 
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explored whether different types of physical activity are associated with health-related quality of 
life before and after retirement age. We observed a dose-response relation between total physical 
activity and better health-related quality of life. Additionally, we found that sport was associated 
with better mobility, self-care, daily activities and mood, and less pain in middle-aged adults, 
whereas cycling was associated strongest with these health-related quality of life domains in the 
elderly. These results suggest that different activities should be promoted to different age groups, 
to improve health-related quality of life. 
In Chapter 5.2, we examined the association between actigraphically measured sedentary 
behavior and several measures of mental health and cognition. We observed that higher levels of 
sedentary behavior were associated with more depressive symptoms, higher odds of having a 
prevalent anxiety disorder and with worse cognitive function. However, these associations were 
explained by other factors, including disability, occupational status and smoking. Furthermore, 
we observed no association between sedentary behavior and changes in depressive symptoms or 
cognitive function over time, nor did we find an association between sedentary behavior and 
incident anxiety disorders. Previous studies using self-reported measures that do report an 
association might be explained by residual confounding, because most of these did not adjust for 
disability status. It is also possible that the associations were driven by the context in which the 
sedentary behavior takes place.25 In this case, not sedentary behavior itself, but the situation in 
which is engaged in sedentary behavior might be related to mental health measures. For example 
all the studies observing a longitudinal association between sedentary behavior and mental health 
or cognition included watching television in their measure, whereas the studies using computer or 
internet use as a proxy for sitting time more often observed null associations with mental 
health.22,23,26,27 In line with the finding that television viewing might carry risks over and beyond 
sitting in the association with mortality,8 this might also be the case for mental health. 
In Chapter 5.3, we used actigraphy to obtain an objective measure of sleep. Sleep has been 
identified as a possible modifiable behavior that can influence body weight.28,29 However, the 
possibility that the association is bidirectional – sleep influencing body weight and body weight 
influencing sleep – has gained less attention.30-32 We observed a bidirectional association between 
objectively measured sleep indices and body mass index, indicating that sleep can influence body 
mass index and vice versa. A higher average body mass index was associated with a decline in 
sleep duration over time. Conversely, longer sleep duration and higher sleep efficiency slowed 
down the decrease in body mass index across time over a period of 6 years. The findings from this 
general population sample of older adults suggest that among other health benefits, a healthy body 
mass index is associated with better sleep indices in an age group with increasing sleep problems 
and disturbances.  
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METHODOLOGICAL CONSIDERATIONS 
Strengths and limitations of the specific studies included in this thesis have been discussed in the 
corresponding chapters. This section addresses some general methodological issues related to 
study design, assessment of activity, assessment of cardiovascular disease and mortality, reverse 
causation and confounding.  
Study design 
All the studies included in this thesis were performed in the Rotterdam Study, a prospective 
population-based cohort in Rotterdam. A prospective cohort design is particularly useful to 
examine potential risk factors for common diseases, although the observational nature challenges 
any direct conclusion regarding the temporality of the association. However, the fact that 
exposure variables, including physical activity, sedentary behavior and sleep, can be measured 
before the outcomes of interest have developed, minimizes recall bias and allows to determine 
whether the exposure of interest precedes the outcome.33  
A specific strength of the Rotterdam Study lies in the assessment of the disease outcomes. 
Information on many common diseases were collected by an automated follow-up system with 
digital linkage of the study database to medical records maintained by general practitioners in the 
research area. Trained research assistants collected outpatient clinic reports, hospital discharge 
letters, electrocardiograms, imaging results and notes from general practitioners and hospitals. In 
a next step, research physicians independently adjudicated all data on potential events. Finally, 
medical specialists whose judgments are considered definitive reviewed the potential cases. For 
information on vital status, information was additionally obtained from the central registry of the 
municipality of the city of Rotterdam.  
Assessment of activity by questionnaire 
For practical reasons, physical activity is often measured subjectively by questionnaire.3 Specific 
questionnaires have been developed for target populations, including children, young adults and 
elderly adults. These questionnaires usually measure the duration and frequency of several types 
of physical activity through self-report or interview. Subsequently, an intensity score can be 
attributed to each of these activities, by using the Compendium of Physical Activities.34 The 
activity is usually expressed in metabolic equivalent of task (MET) or calories.35 The hours per 
week spent in each activity is then multiplied by the intensity score (e.g. MET·hours·week-1) and 
the different physical activity types in the questionnaire can be summed to create an overall 
physical activity score. The advantages of questionnaires include cost effectiveness and ease of 
administration.36 Currently questionnaires are still needed to obtain information on the types of 
physical activity that adults engage in. However, self-reported physical activity can suffer from 
reporting bias, partially attributable to the cognitive challenge of estimating the frequency, 
intensity and duration of physical activity.1 Moreover, activities of light intensity are hard to recall 
and might not be reported.37,38 This is especially relevant in older adults, because the higher 
likelihood of cognitive impairment might lead to more recall bias and reporting errors.34 
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Furthermore, the use of the Compendium of Physical Activities34 has a few drawbacks. First, it 
might not capture the energy expenditure of older adults accurately.34 Second, there probably is 
some heterogeneity in the intensity in which participants engage in different activity types, which 
can lead to misclassification of participants with either higher or lower intensity levels than the 
assigned values. In longitudinal studies, this misclassification would likely be non-differential, and 
could bias estimates of particular associations towards the null hypothesis.  
In the Rotterdam Study, we assessed physical activity by an adapted version of the Zutphen 
Physical Activity Questionnaire39 and in later years by the LASA physical activity questionnaire 
(LAPAQ).40 The Zutphen questionnaire has been validated in which the test-retest reliability was 
0.93 and the correlation with doubly labelled water was 0.61.2 The original questionnaire contains 
questions regarding walking, cycling, sports, gardening and hobbies. For the Rotterdam Study 
questions on housekeeping activities were added to attain a more complete assessment of physical 
activity levels of older adults. Participants were asked how many hours per week they spent in 
each activity in the past year. To address seasonal variability in physical activity, participants were 
asked whether they only participated in a particular activity during summer or winter (e.g. for 
sports and gardening). When answered confirmative, we calculated a weighted estimate by 
dividing the reported time by two. Furthermore, the questionnaire provided two questions in 
which participants could mention sports that were not captured by previous questions.  
In 2006, with the start of an additional cohort (RS-III), the LAPAQ was introduced in the 
Rotterdam Study; this measure has also been used in the subsequent measurement waves. The 
LAPAQ was developed and validated in the Longitudinal Aging Study Amsterdam (LASA); the 
test-retest reliability was reasonably good (0.65–0.75) and the correlations with the pedometer and 
7-day diary were 0.56 and 0.68, respectively.40 Similar to the Zutphen questionnaire, the LAPAQ 
consists of questions on the frequency and duration of walking, cycling, sports, gardening and 
housework, and participants are asked how many hours per week they spend on average in each of 
these activities in the past two weeks. Furthermore, the LAPAQ also provided two questions 
where participants could mention other sports they participated in that were not captured by 
previous questions.  
For both questionnaires, we assigned MET-values to all activities mentioned in the 
questionnaires, according to the 2011 updated version of the Compendium of Physical 
Activities.35 There are, however, also some differences between the questionnaires. We observed 
generally higher levels of physical activity measured by the Zutphen Physical Activity 
Questionnaire compared to the LAPAQ. This might be related to several characteristics of these 
questionnaires. The Zutphen Physical Activity Questionnaire requires participants to indicate the 
average time spent in physical activity in the past year and addresses seasonal variation. A 
limitation of the long time span is the higher likelihood for bias when information is remembered 
inaccurately. In contrast, the LAPAQ infers about the past two weeks and does not take into 
account the fact that physical activity levels might be different in the summer compared to the 
winter. In longitudinal analyses, when the outcome is measured after the exposure, it can be 
expected that those with disease did not only complete the questionnaire in the winter, where 
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generally lower physical activity levels are observed.41,42 Therefore, it’s unlikely that the differences 
between the questionnaires have influenced the associations. Another difference between the 
questionnaires is the way in which questions regarding walking and cycling were phrased. In the 
Zutphen Physical Activity Questionnaire, all walking and cycling is combined and no 
differentiation is made between walking for cycling for commuting or for sports. In the LAPAQ, 
this differentiation is made and consequently, a more accurate picture of physical activity levels 
can be created. Due to these differences, we were unable to track questionnaire-assessed physical 
activity levels through time. 
 
Assessment of activity by accelerometer 
Accelerometers offer a solution to problems associated with self-report and can give objective 
estimates on duration and intensity of physical activity. Therefore, they are increasingly being 
used in research.2,3 An accelerometer is a small device worn on the body that measures changes in 
gravitational acceleration. Common methods to place an accelerometer are the hip and the wrist.  
However, the placement of the accelerometer will likely lead to the problem that not all 
physical activity can be measured accurately.43,44 For example, compared to a hip-worn device, 
accelerometer placement on the wrist  provides only a poor estimate of lower-body activity during 
dynamic activities like cycling. Consequently, physical activity performed solely by the legs might 
be underestimated with these accelerometers.43-45 Additionally, physical activity levels might also 
be underestimated while the wrist is constrained during physical activity, for example while 
pushing a wheelchair.46 On the other hand, a wrist-worn accelerometer also has advantages over a 
hip-worn accelerometer, because it allows for 24-hours of data-collection per day, including times 
of water-based activities. Consequently, this can lead to a comprehensive overview of daily 
activity. Moreover, the use of a waterproof wrist-worn accelerometer ensured high compliance in 
our study population. In consequence, this high compliance led to few non-wear periods, thus 
minimizing the times for which assumptions had to be made on whether this time was spent 
active or sedentary.47,48 As a result, activity is generally assessed more precisely.48 This is in 
contrast with hip-worn devices, which usually have to be removed during the night and are not 
waterproof.  
Some general limitations association with physical activity assessment by accelerometry 
should also be mentioned. First, the activity levels observed by the accelerometer are only a 
snapshot and might not accurately reflect the general activity level. During the wearing week, 
participants might have a higher or lower activity level than their usual pattern. Since it is unlikely 
that this pattern would be related to the outcome, this bias would be non-differential. 
Furthermore, upon wearing the device, participants might show social desirable behavior, since 
most adults know that being physically active is beneficial for health. In the data used for Chapter 
2.1 in the current thesis, we observed subtle changes from the first 24-hour wearing day up to the 
last 24-hour wearing day. For example, time spent in light and moderate intensity physical activity 
was up to 6 minutes more on the first day compared to the last, and sedentary behavior was up to 
30 minutes less on the first wearing day (Data not shown). Since these differences were relatively 
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these activities in the past two weeks. Furthermore, the LAPAQ also provided two questions 
where participants could mention other sports they participated in that were not captured by 
previous questions.  
For both questionnaires, we assigned MET-values to all activities mentioned in the 
questionnaires, according to the 2011 updated version of the Compendium of Physical 
Activities.35 There are, however, also some differences between the questionnaires. We observed 
generally higher levels of physical activity measured by the Zutphen Physical Activity 
Questionnaire compared to the LAPAQ. This might be related to several characteristics of these 
questionnaires. The Zutphen Physical Activity Questionnaire requires participants to indicate the 
average time spent in physical activity in the past year and addresses seasonal variation. A 
limitation of the long time span is the higher likelihood for bias when information is remembered 
inaccurately. In contrast, the LAPAQ infers about the past two weeks and does not take into 
account the fact that physical activity levels might be different in the summer compared to the 
winter. In longitudinal analyses, when the outcome is measured after the exposure, it can be 
expected that those with disease did not only complete the questionnaire in the winter, where 
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generally lower physical activity levels are observed.41,42 Therefore, it’s unlikely that the differences 
between the questionnaires have influenced the associations. Another difference between the 
questionnaires is the way in which questions regarding walking and cycling were phrased. In the 
Zutphen Physical Activity Questionnaire, all walking and cycling is combined and no 
differentiation is made between walking for cycling for commuting or for sports. In the LAPAQ, 
this differentiation is made and consequently, a more accurate picture of physical activity levels 
can be created. Due to these differences, we were unable to track questionnaire-assessed physical 
activity levels through time. 
 
Assessment of activity by accelerometer 
Accelerometers offer a solution to problems associated with self-report and can give objective 
estimates on duration and intensity of physical activity. Therefore, they are increasingly being 
used in research.2,3 An accelerometer is a small device worn on the body that measures changes in 
gravitational acceleration. Common methods to place an accelerometer are the hip and the wrist.  
However, the placement of the accelerometer will likely lead to the problem that not all 
physical activity can be measured accurately.43,44 For example, compared to a hip-worn device, 
accelerometer placement on the wrist  provides only a poor estimate of lower-body activity during 
dynamic activities like cycling. Consequently, physical activity performed solely by the legs might 
be underestimated with these accelerometers.43-45 Additionally, physical activity levels might also 
be underestimated while the wrist is constrained during physical activity, for example while 
pushing a wheelchair.46 On the other hand, a wrist-worn accelerometer also has advantages over a 
hip-worn accelerometer, because it allows for 24-hours of data-collection per day, including times 
of water-based activities. Consequently, this can lead to a comprehensive overview of daily 
activity. Moreover, the use of a waterproof wrist-worn accelerometer ensured high compliance in 
our study population. In consequence, this high compliance led to few non-wear periods, thus 
minimizing the times for which assumptions had to be made on whether this time was spent 
active or sedentary.47,48 As a result, activity is generally assessed more precisely.48 This is in 
contrast with hip-worn devices, which usually have to be removed during the night and are not 
waterproof.  
Some general limitations association with physical activity assessment by accelerometry 
should also be mentioned. First, the activity levels observed by the accelerometer are only a 
snapshot and might not accurately reflect the general activity level. During the wearing week, 
participants might have a higher or lower activity level than their usual pattern. Since it is unlikely 
that this pattern would be related to the outcome, this bias would be non-differential. 
Furthermore, upon wearing the device, participants might show social desirable behavior, since 
most adults know that being physically active is beneficial for health. In the data used for Chapter 
2.1 in the current thesis, we observed subtle changes from the first 24-hour wearing day up to the 
last 24-hour wearing day. For example, time spent in light and moderate intensity physical activity 
was up to 6 minutes more on the first day compared to the last, and sedentary behavior was up to 
30 minutes less on the first wearing day (Data not shown). Since these differences were relatively 
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small, and we used the mean time spent in activity in most analyses, it is unlikely that this would 
have influenced our associations. 
In the studies included in this thesis, we used two different wrist-worn devices to measure 
activity objectively, which is due to the moment of introduction of objective measurements in the 
Rotterdam Study. Initially, the Actiwatch was introduced in the Rotterdam Study in 2004 to 
obtain objective measurements of sleep. The Actiwatch is a one-dimensional device, which 
measures acceleration and transforms these to counts per 30 seconds on the device. There is 
currently limited knowledge on the ability of the Actiwatch to measure physical activity. However, 
since sedentary behavior is a form of inactivity similar to sleep, the Actiwatch can also be used to 
measure inactivity during day-time. Therefore we used the information from the Actiwatch to 
obtain a proxy of sedentary behavior. In later years, the GeneActiv device became available and 
was introduced in the Rotterdam Study in 2011. The GeneActiv measures acceleration in three 
axes and stores the raw signal on the device. The advantage of the GeneActiv over the Actiwatch is 
the use of raw signal in three axes, and the validated use of the device to measure physical activity. 
For both devices, we used cut-offs based on previous literature to categorize activity as sleep 
and sedentary behavior, and for the data obtained from the GeneActiv, we additionally 
categorized activity into light, moderate, and vigorous intensity physical activity. For the 
Actiwatch, time spent awake and in bed was defined based on sleep start and sleep end. These 
times were derived from the event marker buttons on the Actiwatch device, and if these data were 
not available, these data were derived from the sleep diary.49 Subsequently, we used a cut-off of 
<20 counts per minute to classify activity as sleep, based on an algorithm validated against 
polysomnography, the golden standard of measuring sleep, at the highest sensitivity.49,50 For 
sedentary behavior, we used the standard count-based intensity cut-off of <199 counts per 
minute.51 Whereas actigraphy has been recognized as a valid method to measure sleep,52 it can 
also overestimate sleep if participants lie motionless but awake in bed. Moreover, by using 
actigraphy, no information on posture can be obtained and we can thus not infer whether a 
participant was sitting, standing, or lying down when sedentary. 
To analyze the GeneActiv data, we used two analysis methods. First, we used the Pampro 
software, a program for the systematic analysis of physical activity data collected in 
epidemiological studies.53 This software includes cut-offs to define sedentary behavior and light, 
moderate and vigorous intensity physical activity. These cut-offs were derived from a validation 
study, in which participants wore a GeneActiv device around the wrist and performed a treadmill 
test to provide a signal of individually calibrated physical activity energy expenditure. In addition 
to wearing the GeneActiv wrist-worn accelerometer, participants wore a heart rate monitor and 
trunk acceleration was measured. With the combined measurements an equation was developed 
from which cut-points were derived to estimate physical activity intensity by the GeneActiv. The 
obtained cut-offs were applied to the data from all participants in the Rotterdam Study. However, 
using uniform cut-off values to define physical activity intensity in all individuals is less accurate 
than using individually calibrated cut-off values,54 especially when the age-range is large. 
However, we were unable to perform individual calibration procedures in the participants in the 
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studies included in the current thesis. Therefore,  there might be some misclassification of time 
spent in light, moderate and vigorous physical activity. 
A limitation of the sedentary time as obtained by the Pampro software, is that is does not 
differentiate between daytime and nighttime, and hence sleep is also categorized as sedentary 
behavior. To be able to distinguish between sleep and sedentary behavior, we additionally used an 
algorithm from the GGIR package to obtain information on sleep duration.55 In the GGIR 
package, diary estimates of bed time and waking time are used to define the night period. 
Subsequently, sleep duration is estimated based on a specific time of inactivity, in combination 
with a specified wrist angle. According to a validation study in which the algorithm was validated 
against polysomnography, an inactive time of 10 minutes in combination with a wrist angle of 5 
degrees is most sensitive to estimate sleep duration,55 and these are also the parameters used in the 
research in this thesis. However, estimating sleep by using this algorithm is relatively new and the 
parameters have not been firmly established. Therefore, we might have over- or underestimated 
sleep duration. Subsequently, we cannot be completely certain about the observed seasonal 
pattern for sleep in Chapter 2.3, and we cannot be entirely certain that there were no demographic 
and lifestyle factors associated with sleep duration in Chapter 2.2. Future developments in 
accelerometry might provide more accurate estimates of sleep duration as measured by the 
GeneActiv. Moreover, if algorithms to estimate sedentary behavior would also make use of the 
wrist angle, more information on posture might also be obtained from triaxial accelerometers, 
such as the GeneActiv. This could provide additional information on the association of sedentary 
behavior with mortality and mental health. 
Confounding 
One of the main limitations of observational research is the high risk of bias due to confounding. 
Confounding can occur when variables are associated with both the outcome and the exposure, 
and are not on the causal pathway between the exposure and outcome variable.56,57 This can 
particularly be a problem for lifestyle variables as physical activity, since they often cluster 
together with other lifestyle factors, including diet and smoking habits. Furthermore, underlying 
diseases or disabilities can both affect the level of physical activity, as well as several health 
outcomes. Therefore, these lifestyle and health variables and sociodemographic factors are 
considered potential confounders in the association between activity and health outcomes. 
Importantly, a potential confounder should not be on the causal pathway between the exposure 
and the outcome.58 In this case, the variable is an intermediate and adjusting for such variable in 
the analysis would attenuate the true association.59 This can become problematic, when it is not 
completely clear what the position of a particular variable is. If a variable is strongly related to the 
exposure, and less strong to the outcome, then the variable might be midway between an 
intermediate and a confounder. As an illustration from this thesis, disability is considered a 
confounder in the association between sedentary behavior and mental health in Chapter 5.2, 
because it is associated with both sedentary behavior and mental health (See Figure 6.2a).60-63 
However, if the association between disability and mental health would be very weak, then 
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small, and we used the mean time spent in activity in most analyses, it is unlikely that this would 
have influenced our associations. 
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obtain objective measurements of sleep. The Actiwatch is a one-dimensional device, which 
measures acceleration and transforms these to counts per 30 seconds on the device. There is 
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since sedentary behavior is a form of inactivity similar to sleep, the Actiwatch can also be used to 
measure inactivity during day-time. Therefore we used the information from the Actiwatch to 
obtain a proxy of sedentary behavior. In later years, the GeneActiv device became available and 
was introduced in the Rotterdam Study in 2011. The GeneActiv measures acceleration in three 
axes and stores the raw signal on the device. The advantage of the GeneActiv over the Actiwatch is 
the use of raw signal in three axes, and the validated use of the device to measure physical activity. 
For both devices, we used cut-offs based on previous literature to categorize activity as sleep 
and sedentary behavior, and for the data obtained from the GeneActiv, we additionally 
categorized activity into light, moderate, and vigorous intensity physical activity. For the 
Actiwatch, time spent awake and in bed was defined based on sleep start and sleep end. These 
times were derived from the event marker buttons on the Actiwatch device, and if these data were 
not available, these data were derived from the sleep diary.49 Subsequently, we used a cut-off of 
<20 counts per minute to classify activity as sleep, based on an algorithm validated against 
polysomnography, the golden standard of measuring sleep, at the highest sensitivity.49,50 For 
sedentary behavior, we used the standard count-based intensity cut-off of <199 counts per 
minute.51 Whereas actigraphy has been recognized as a valid method to measure sleep,52 it can 
also overestimate sleep if participants lie motionless but awake in bed. Moreover, by using 
actigraphy, no information on posture can be obtained and we can thus not infer whether a 
participant was sitting, standing, or lying down when sedentary. 
To analyze the GeneActiv data, we used two analysis methods. First, we used the Pampro 
software, a program for the systematic analysis of physical activity data collected in 
epidemiological studies.53 This software includes cut-offs to define sedentary behavior and light, 
moderate and vigorous intensity physical activity. These cut-offs were derived from a validation 
study, in which participants wore a GeneActiv device around the wrist and performed a treadmill 
test to provide a signal of individually calibrated physical activity energy expenditure. In addition 
to wearing the GeneActiv wrist-worn accelerometer, participants wore a heart rate monitor and 
trunk acceleration was measured. With the combined measurements an equation was developed 
from which cut-points were derived to estimate physical activity intensity by the GeneActiv. The 
obtained cut-offs were applied to the data from all participants in the Rotterdam Study. However, 
using uniform cut-off values to define physical activity intensity in all individuals is less accurate 
than using individually calibrated cut-off values,54 especially when the age-range is large. 
However, we were unable to perform individual calibration procedures in the participants in the 
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studies included in the current thesis. Therefore,  there might be some misclassification of time 
spent in light, moderate and vigorous physical activity. 
A limitation of the sedentary time as obtained by the Pampro software, is that is does not 
differentiate between daytime and nighttime, and hence sleep is also categorized as sedentary 
behavior. To be able to distinguish between sleep and sedentary behavior, we additionally used an 
algorithm from the GGIR package to obtain information on sleep duration.55 In the GGIR 
package, diary estimates of bed time and waking time are used to define the night period. 
Subsequently, sleep duration is estimated based on a specific time of inactivity, in combination 
with a specified wrist angle. According to a validation study in which the algorithm was validated 
against polysomnography, an inactive time of 10 minutes in combination with a wrist angle of 5 
degrees is most sensitive to estimate sleep duration,55 and these are also the parameters used in the 
research in this thesis. However, estimating sleep by using this algorithm is relatively new and the 
parameters have not been firmly established. Therefore, we might have over- or underestimated 
sleep duration. Subsequently, we cannot be completely certain about the observed seasonal 
pattern for sleep in Chapter 2.3, and we cannot be entirely certain that there were no demographic 
and lifestyle factors associated with sleep duration in Chapter 2.2. Future developments in 
accelerometry might provide more accurate estimates of sleep duration as measured by the 
GeneActiv. Moreover, if algorithms to estimate sedentary behavior would also make use of the 
wrist angle, more information on posture might also be obtained from triaxial accelerometers, 
such as the GeneActiv. This could provide additional information on the association of sedentary 
behavior with mortality and mental health. 
Confounding 
One of the main limitations of observational research is the high risk of bias due to confounding. 
Confounding can occur when variables are associated with both the outcome and the exposure, 
and are not on the causal pathway between the exposure and outcome variable.56,57 This can 
particularly be a problem for lifestyle variables as physical activity, since they often cluster 
together with other lifestyle factors, including diet and smoking habits. Furthermore, underlying 
diseases or disabilities can both affect the level of physical activity, as well as several health 
outcomes. Therefore, these lifestyle and health variables and sociodemographic factors are 
considered potential confounders in the association between activity and health outcomes. 
Importantly, a potential confounder should not be on the causal pathway between the exposure 
and the outcome.58 In this case, the variable is an intermediate and adjusting for such variable in 
the analysis would attenuate the true association.59 This can become problematic, when it is not 
completely clear what the position of a particular variable is. If a variable is strongly related to the 
exposure, and less strong to the outcome, then the variable might be midway between an 
intermediate and a confounder. As an illustration from this thesis, disability is considered a 
confounder in the association between sedentary behavior and mental health in Chapter 5.2, 
because it is associated with both sedentary behavior and mental health (See Figure 6.2a).60-63 
However, if the association between disability and mental health would be very weak, then 
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disability could be considered an antecedent of sedentary behavior and in that situation the 
analyses should not have been adjusted for disability status (See Figure 6.2b). In a final example, it 
could even be argued that sedentary behavior might lead to disability, which in turn might 
influence mental health (See Figure 6.2c). In this example, disability could be considered an 
intermediate and adjusting for this variable would be over adjustment. However, considering the 
literature on disability, sedentary behavior and mental health, we carefully evaluated the position 
of disability in these analyses and considered it a confounding factor. 
In the work present in this thesis, the possibility of confounding is reduced as much as 
possible, by adjusting for relevant factors. However, some potential relevant factors have not 
always been measured. For example, there was no information on the type of occupation 
participants engaged in, whereas this can be a major contributor to overall physical activity levels, 
and it can also be associated with health. Additionally, for some studies included in this thesis, 
information on diet quality and recent information on the status of the presence of chronic 
disease was not available at the time of the study. These factors might also be associated with both 
activity levels and health. The fact that we did not have information on these factors might have 
led to residual confounding. Residual confounding takes place when a confounder is not 
considered in the analysis, or when it cannot directly or accurately be measured in the study.56
Although extensive efforts are made within the Rotterdam Study to collect the most relevant 
information that might contribute as confounders in the association between an exposure and 
outcome, residual confounding might still be present in the observed associations presented in the 
work in this thesis. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Causal diagrams showing three possible underlying associations connecting sedentary 
behavior, disability status and mental health. 
Disability 
status 
Sedentary 
behavior 
Mental 
health 
Disability 
status 
Sedentary 
behavior 
Mental 
health 
(a) (b) 
Sedentary 
behavior 
Disability 
status 
Mental 
health 
(c) 
Discussion 
361 
Reverse causation 
Another limitation of observational research is the possibility for reverse causation. Reverse 
causation refers to the phenomenon that two factors are associated, but not in the direction that 
was expected. In cross-sectional studies this is an issue when the inferred direction of the 
association is opposite to the true direction of the association. In longitudinal studies, reverse 
causation is present when the disease or subclinical forms of disease occur before the 
measurement of the exposure, and influences the exposure. As an example from this thesis, poor 
cardiovascular health might reduce physical activity levels and simultaneously increase the risk for 
cardiovascular disease. As a consequence, the observed association between low physical activity 
levels and a higher risk of cardiovascular disease might be the result of the underlying – but not 
yet diagnosed – disease. To minimize the possibility of longitudinal associations being influenced 
by reversed causation, it is warranted to examine the association between exposure and outcome 
over a longer follow-up period. Moreover, in several chapters of this thesis, we have excluded the 
first 2 years of follow-up to account for the possibility of reversed causation. We have also tried to 
reduce the possibility of reverse causation by repeating analyses in those without disease at 
baseline.  
On the other hand, physical activity levels might also increase once a person is diagnosed 
with (higher risk of) disease. For example, if an individual has a high blood pressure or 
dyslipidemia, the first advice is to improve physical activity levels and diet quality.64 Moreover, 
physical activity is also recommended when trying to lose weight.65 Subsequently, individuals in 
relatively poor health might show high physical activity levels when physical activity is assessed 
after the initiation of a healthier lifestyle. In this case, the high physical activity group includes 
individuals with higher and lower risk of disease and this might make it more difficult to observe 
an association.  
 
Selective participation and survival bias 
Another source of bias might be selective participation of participants in the study, which occurs 
when there is a difference between characteristics for people included in the study and those who 
were not.66 In the studies with objectively measured activity included in this thesis, participants 
were asked to wear an accelerometer for one week and to complete a sleep diary. In all studies, we 
observed that those that agreed to participate were more often male and showed better health 
characteristics than those who refused to participate. Therefore, the information on objective 
activity is derived from the healthiest participants in the Rotterdam Study and might not be 
generalizable to the general population. Selection can also have occurred for outcome measures, 
such as cognitive function. Only the healthiest participants completed all tests in the test battery to 
obtain an overall cognitive factor. This might also affect the generalizability of the findings. 
Survival bias is another form of selective participations, and occurs when it is ignored that a 
person had to survive to be able to have an assessment of the exposure of interest,67 for example 
physical activity. In the Rotterdam Study, participants were included in the original cohort if they 
were 55 years or older. In this case, only persons that survived up to that age could participate in 
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activity levels and health. The fact that we did not have information on these factors might have 
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cardiovascular health might reduce physical activity levels and simultaneously increase the risk for 
cardiovascular disease. As a consequence, the observed association between low physical activity 
levels and a higher risk of cardiovascular disease might be the result of the underlying – but not 
yet diagnosed – disease. To minimize the possibility of longitudinal associations being influenced 
by reversed causation, it is warranted to examine the association between exposure and outcome 
over a longer follow-up period. Moreover, in several chapters of this thesis, we have excluded the 
first 2 years of follow-up to account for the possibility of reversed causation. We have also tried to 
reduce the possibility of reverse causation by repeating analyses in those without disease at 
baseline.  
On the other hand, physical activity levels might also increase once a person is diagnosed 
with (higher risk of) disease. For example, if an individual has a high blood pressure or 
dyslipidemia, the first advice is to improve physical activity levels and diet quality.64 Moreover, 
physical activity is also recommended when trying to lose weight.65 Subsequently, individuals in 
relatively poor health might show high physical activity levels when physical activity is assessed 
after the initiation of a healthier lifestyle. In this case, the high physical activity group includes 
individuals with higher and lower risk of disease and this might make it more difficult to observe 
an association.  
 
Selective participation and survival bias 
Another source of bias might be selective participation of participants in the study, which occurs 
when there is a difference between characteristics for people included in the study and those who 
were not.66 In the studies with objectively measured activity included in this thesis, participants 
were asked to wear an accelerometer for one week and to complete a sleep diary. In all studies, we 
observed that those that agreed to participate were more often male and showed better health 
characteristics than those who refused to participate. Therefore, the information on objective 
activity is derived from the healthiest participants in the Rotterdam Study and might not be 
generalizable to the general population. Selection can also have occurred for outcome measures, 
such as cognitive function. Only the healthiest participants completed all tests in the test battery to 
obtain an overall cognitive factor. This might also affect the generalizability of the findings. 
Survival bias is another form of selective participations, and occurs when it is ignored that a 
person had to survive to be able to have an assessment of the exposure of interest,67 for example 
physical activity. In the Rotterdam Study, participants were included in the original cohort if they 
were 55 years or older. In this case, only persons that survived up to that age could participate in 
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the study. Although the response rate was 72% (14,926 of 20,744 invited individuals), which is 
considered quite good, the included participants might not be a good representation of the general 
population. It has been shown that cohort studies tend to represent a healthier population than 
the underlying general population that was eligible for inclusion in the study.68 In the Rotterdam 
Study, participants had a slightly lower cardiovascular risk compared to all individuals that were 
invited, and nonparticipation was associated with mortality risk.68 The selective participation of 
healthier individuals might have resulted in higher estimated physical activity levels among the 
included participants compared to the general population.   
The problem of survival bias is most important in cross-sectional studies, in which healthy 
individuals are compared to individuals with prevalent diseases who survived this disease. In these 
studies, individuals who die soon after the onset of disease are never included. In longitudinal 
studies, participants with prevalent diseases are excluded at baseline. Subsequently, statistical 
methods as Cox proportional hazard models are used to estimate the risk of incident disease over 
time.69 In the majority of this thesis, we conducted longitudinal analyses to examine the 
association with health outcomes. However, some chapters, including Chapter 5.1 on the 
association between physical activity types and health-related quality of life, we cannot rule out 
the possibility of survival bias. 
Selective participation can also occur due to loss to follow-up.70 Participants might refuse to 
participate in subsequent visits, might not be in sufficiently good health to participate, or might 
have moved across the country. If the loss to follow-up or withdrawal to participation is different 
for different exposure categories (i.e. levels of physical activity, sedentary behavior or sleep), this 
might introduce a significant bias in the study. If the tendency to attend a research visit is different 
across different levels of exposure, this can result in an over- or under-estimation of the true 
effect. For example, in the study on the association of sedentary behavior with mental health and 
cognition, we observed that participants with a follow-up measurement on depression, anxiety, or 
cognition had on average lower levels of sedentary behavior at baseline. In this regard, only the 
healthiest participants had follow-up measurements and could be included in the longitudinal 
analyses. The lack of heterogeneity in levels of sedentary behavior might also have made it more 
difficult to observe an association. We can therefore not completely rule out the possibility that 
the null finding in this study is related to this selective participation. 
 
IMPLICATIONS FOR PUBLIC HEALTH AND FUTURE RESEARCH 
Physical activity 
With our results, we ultimately hope to reach the general public directly or indirectly, e.g. by 
improving guidelines and recommendations. For physical activity it is currently recommended to 
engage in 30 minutes of moderate-to-vigorous physical activity on most days of the week.71 
Depending on the specific guideline, this might also include work in and around the house, and 
physical activity by active transportation. In this thesis we provided evidence that in addition to 
Discussion 
363 
exercise, domestic work and cycling were strongly associated with several health outcomes, 
including coronary heart disease, cardiovascular disease, all-cause mortality and health-related 
quality of life. Importantly, already low levels of cycling were associated with better health 
outcomes. One of the benefits of cycling is that it does not put weight stress on the joints, which 
makes it an activity easily accessible for heavier adults. Moreover, the current increase in the use 
of electric-bikes, which are bicycles that are moved forward by human pedaling, complemented by 
electrical power from a storage battery, makes cycling more accessible for those in poorer health.72 
In several countries, cycling is a common way of commuting and the infrastructure invites 
individuals to engage in cycling in the Netherlands, Denmark and Germany.73 Since all 
individuals have to engage in some form of transportation to go from one place to another, 
recommending cycling as a way of active transportation, but also as a form of leisure time activity 
or exercise, could be an important step to increase physical activity levels. Indeed, already in 1996, 
the US surgeon general specifically recommended cycling for practical, daily travels as an ideal 
approach to improve physical activity levels.74 Although the estimated inhaled doses of air 
pollution and the risk of dying from a traffic accident were higher when cycling compared to 
driving a car,75 a review reported that the beneficial effect of increased physical activity due to 
cycling resulted in approximately 9 times more gains in life-years than the losses in years due to 
more inhaled doses of air pollution and traffic accidents. Additionally, the fact that domestic work 
was also associated with several health outcomes indicates that activities that are part of daily 
living can also contribute to health benefits. We do recognize that the physical activity levels of the 
participants of the studies included in the current thesis were quite high, and almost all 
participants engaged in 150 minutes of moderate to vigorous physical activity per week. If future 
studies consistently find health benefits associated with all forms of physical activity, it might be 
that the current guidelines recommending 150 minutes of moderate to vigorous physical activity 
per week might need to be re-evaluated. By a combination of active transportation, sports and 
work in and around the house 150 minutes per week could easily be accumulated. Therefore, if 
these different physical activity types contribute to beneficial health effects, this should be 
specifically mentioned in the guidelines and the limit of 150 minutes might be set to a higher 
value. The use of objective measurement methods of activity might also be useful to this aim, since 
this can provide information beyond the perceived time spent in physical activity. It can also 
provide information on the absolute time and intensity in which is engaged in physical activity.  
In Chapter 2.1 in the current thesis, we showed a large discrepancy between objective and 
subjective measures of physical activity. Therefore, since the use of accelerometers is increasing, 
researchers and policy makers need to be aware that the results obtained from questionnaire and 
accelerometers should be combined and/or compared with caution. Moreover, future meta-
analyses and reviews need to address objective and subjective methods separately. To improve the 
agreement between the two measurement methods, more detailed instructions in the 
questionnaire may be required76 and questionnaires could be improved to better capture the 
overall physical activity pattern of older adults. In the current thesis, individuals with a higher 
disability score, more depressive symptoms and a higher body mass index more often 
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exercise, domestic work and cycling were strongly associated with several health outcomes, 
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quality of life. Importantly, already low levels of cycling were associated with better health 
outcomes. One of the benefits of cycling is that it does not put weight stress on the joints, which 
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of electric-bikes, which are bicycles that are moved forward by human pedaling, complemented by 
electrical power from a storage battery, makes cycling more accessible for those in poorer health.72 
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individuals have to engage in some form of transportation to go from one place to another, 
recommending cycling as a way of active transportation, but also as a form of leisure time activity 
or exercise, could be an important step to increase physical activity levels. Indeed, already in 1996, 
the US surgeon general specifically recommended cycling for practical, daily travels as an ideal 
approach to improve physical activity levels.74 Although the estimated inhaled doses of air 
pollution and the risk of dying from a traffic accident were higher when cycling compared to 
driving a car,75 a review reported that the beneficial effect of increased physical activity due to 
cycling resulted in approximately 9 times more gains in life-years than the losses in years due to 
more inhaled doses of air pollution and traffic accidents. Additionally, the fact that domestic work 
was also associated with several health outcomes indicates that activities that are part of daily 
living can also contribute to health benefits. We do recognize that the physical activity levels of the 
participants of the studies included in the current thesis were quite high, and almost all 
participants engaged in 150 minutes of moderate to vigorous physical activity per week. If future 
studies consistently find health benefits associated with all forms of physical activity, it might be 
that the current guidelines recommending 150 minutes of moderate to vigorous physical activity 
per week might need to be re-evaluated. By a combination of active transportation, sports and 
work in and around the house 150 minutes per week could easily be accumulated. Therefore, if 
these different physical activity types contribute to beneficial health effects, this should be 
specifically mentioned in the guidelines and the limit of 150 minutes might be set to a higher 
value. The use of objective measurement methods of activity might also be useful to this aim, since 
this can provide information beyond the perceived time spent in physical activity. It can also 
provide information on the absolute time and intensity in which is engaged in physical activity.  
In Chapter 2.1 in the current thesis, we showed a large discrepancy between objective and 
subjective measures of physical activity. Therefore, since the use of accelerometers is increasing, 
researchers and policy makers need to be aware that the results obtained from questionnaire and 
accelerometers should be combined and/or compared with caution. Moreover, future meta-
analyses and reviews need to address objective and subjective methods separately. To improve the 
agreement between the two measurement methods, more detailed instructions in the 
questionnaire may be required76 and questionnaires could be improved to better capture the 
overall physical activity pattern of older adults. In the current thesis, individuals with a higher 
disability score, more depressive symptoms and a higher body mass index more often 
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underestimated their physical activity levels compared to their counterparts. Future studies might 
examine other factors, such as anxiety, pain perception and medication use, that might also be 
relevant in this association. More information on this topic could help health care providers 
working in clinical practice to be aware that those individuals might not have a realistic view of 
their physical activity levels. Additionally, information obtained from accelerometers could also 
be improved in future studies. Specified algorithms could be identified and used to recognize the 
type of physical activity in which participants engage (e.g. walking, cycling), taking into account 
their specific rhythm when wearing an accelerometer. On the other hand, the differences in 
physical activity levels obtained from questionnaire and accelerometer can also be a source of 
information. Whereas accelerometers provide an accurate distribution of intensity and duration, 
questionnaires might more accurately reflect the perceived levels and intensity of physical activity, 
as well as the types of physical activity in which adults engage in. In order to be able to influence 
the physical activity levels of individuals, both sources of information are important. We would 
therefore currently recommend to use questionnaires and accelerometers to gain the most 
information.  
Sedentary behavior 
For sedentary behavior, there currently are no clear recommendations, other than ‘not to engage 
in too much sitting’.77 In one of our studies we showed that engaging in more than 11 hours of 
sedentary behavior per day was associated with 64% higher risk of mortality. Moreover, other 
work in this thesis indicated that the levels of sedentary behavior in older adults were high (up to 
80% of the waking day) and that they were ingrained in daily life. Since we did not examine the 
number or duration of the sedentary bouts, we cannot make clear recommendations on what 
would be the best method to reduce sedentary behavior. However, in one of our studies, we 
showed a large seasonal variation for light physical activity, indicating that this is a behavior that 
is easily changed. Therefore, interrupting sedentary behavior with short bouts of light physical 
activity (e.g. housework, walking) might be a first step to reducing sedentary behavior in older 
adults. To be able to work towards a concrete recommendation regarding sedentary behavior, 
future studies should put more focus on the association between patterns of sedentary behavior 
and health. Moreover, with the advancement of algorithms for accelerometers, the posture might 
also be obtained from the accelerometer-signal, thereby providing more information on the 
sedentary activity in which the individual is engaged (e.g. passively standing, sitting or lying 
down). However, as with physical activity, we also stress the importance of measuring sedentary 
behavior by questionnaire, since this provides information on the context of the sedentary 
behavior. In this thesis, we observed no association between objectively measured of sedentary 
behavior with depression, anxiety or cognition, whereas previous studies using self-report did 
observe associations.22-24 The studies in which more sitting was associated with poor mental health 
and cognition all included television watching in their proxy of sedentary behavior, indicating 
that the context might be of importance.78 Therefore, we also recommend to use both subjective 
and objective methods to obtain the most detailed information on sedentary behavior. Moreover, 
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the agreement between objectively and subjectively sedentary behavior should also be evaluated. 
Nevertheless, one thing that is currently clear, is that interrupting sedentary time with short bouts 
of activity on a regular basis is unlikely to induce harm and can be encouraged in older adults. 
Sleep 
There is currently extensive evidence that a sleep duration between 7-8 hours is associated with 
health benefits.79,80 In the current thesis, we observed a seasonal pattern for sleep duration, with 
lower levels in the summer compared to the winter, which was mostly related to the ambient 
temperature. This indicates that ensuring an optimal thermal sleep environment might be 
beneficial to increasing sleep duration in warm summer months. Policies aimed to address the 
reduction in sleep duration in the summer should therefore account for sleep hygiene.79,81 
Furthermore, in the current thesis we observed a bidirectional association between objectively 
measured sleep indices and body mass index, indicating that sleep can influence body mass index 
and vice versa. A higher average body mass index was associated with a decline in sleep duration 
over time. Conversely, longer sleep duration and higher sleep efficiency slowed down the decrease 
in body mass index across time. Together, these results highlight a complicated relation. In older 
adults, the balance between fat and muscle changes and body mass index might not accurately 
reflect that.82 Consequently, a reduction in body mass index might also be a proxy of the loss of 
muscle mass.83 Future studies should evaluate whether sleep duration and sleep efficiency are 
association with a slower decline in fat or fat free mas. Additionally, the fact that higher body mass 
index is associated with a decline in sleep duration, emphasizes the importance of maintaining a 
healthy body weight across all ages. This health consequence could be highlighted in addition to 
the benefits of a healthy weight associated with cardiovascular disease and mortality.84,85 
 
The results from this thesis show that in older adults, several physical activity types are associated 
with health benefits. Older adults can be encouraged to engage in physical activity that they enjoy 
and that they are capable of doing. In the future, the use of objective measures of activity will 
enhance the current knowledge on patterns of physical activity, sedentary behavior, and sleep. 
With advancing technology, more information can be obtained by accelerometers, including 
information on types of physical activity. However, the use of questionnaires remains important, 
to be able to gain information on the types of activity in which adults engage that cannot be 
captured by accelerometer (e.g. sitting in front of the television versus sitting in front of the 
computer), as well as how the activity is perceived. Future efforts should examine to what extent 
the associations of objective and subjective activity measures with health are similar. Together, 
this information can aid public health instances in creating targeted recommendations to enhance 
health in older adults. 
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Summary 
The aim of this thesis, described in Chapter 1, was to extend the existing knowledge on the 
association of sedentary behavior, physical activity and sleep with a broad spectrum of health 
outcomes in older adults. These activity domains were measured subjectively by questionnaire, or 
objectively by actigraphy and accelerometry. 
In the second chapter, we focused on factors associated with objective and subjective 
measures of activity. In Chapter 2.1, we observed that physical activity levels assessed by 
questionnaire were generally underestimated compared to a wrist-worn accelerometer. We also 
showed that adults with more depressive symptoms, more disability and individuals with a higher 
body mass index underestimated their self-reported physical activity levels more than the 
reference groups, indicating that perceived health might also affect the judgement of physical 
activity levels.  
Further, in Chapter 2.2 we examined the activity distribution of objectively measured 
physical activity, sedentary behavior and sleep in elderly adults and examined with which 
demographic and health factors these activity domains were associated. We showed that sedentary 
behavior increased across increasing age-categories and across higher levels of body mass index, at 
the expense of light and moderate-to-vigorous physical activity, but we observed no clear 
differences between categories for sleep duration. Moreover, individuals with prevalent chronic 
disease and those with disability showed higher levels of sedentary behavior and lower levels of 
physical activity than their healthier counterparts. We also observed that women have higher 
levels of physical activity than men. 
In Chapter 2.3, we examined the seasonal pattern of objective measures of physical activity, 
sedentary behavior and sleep according to an age-specific approach. Moreover, we examined 
which meteorological factors were related to these seasonal patterns and we modeled the all-cause 
mortality related to the seasonality. In adults up to 75 years, physical activity levels were highest in 
the summer, at the extent of sleep duration. Sedentary behavior showed no seasonal pattern, 
suggesting that this is a behavior very ingrained in daily life. The seasonality of physical activity 
and nighttime sleep duration was mostly explained by ambient temperature and sunlight hours. 
Moreover, we demonstrated that the accumulation of low levels of physical activity and high levels 
of sedentary behavior might lead to a higher all-cause mortality risk in winter.  
In Chapter 3, we examined the association of physical activity and sedentary behavior with 
mortality. First, we assessed the association of total physical activity and physical activity types 
with all-cause and cause-specific mortality in Chapter 3.1. We observed that total physical activity 
was associated with lower mortality risk related to all-causes, cardiovascular diseases, chronic lung 
diseases, infections and mortality from other causes. All activity types were associated with a 
reduction in all-cause mortality.  
Next, we examined the association between actigraphically measured sedentary behavior 
and all-cause mortality in Chapter 3.2 and observed a higher all-cause mortality risk for 
participants with the highest levels of sedentary behavior. However, after adjusting for other 
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measures of activity, including disability and physical activity, the association between sedentary 
behavior and mortality was clearly attenuated.  
In the fourth chapter, we focused on physical activity and cardiovascular health outcomes. 
We explored the association of total physical activity, and of walking, cycling, domestic work, 
gardening and sports with coronary heart disease in Chapter 4.1, with atrial fibrillation in Chapter 
4.2 and with life expectancy with and without cardiovascular disease in Chapter 4.3. We showed 
that cycling and domestic work were activity types most strongly related to a reduction in 
coronary heart disease incidence and with increases in total life expectancy, and extending life 
expectancy without cardiovascular disease. In contrast, we observed no association of total 
physical activity or any of the physical activity types with atrial fibrillation incidence.  
In Chapter 4.4 we evaluated the joint effects of physical activity and body mass index with 
cardiovascular disease risk. We showed that individuals who engaged in higher levels of total 
physical activity were not at increased risk of cardiovascular disease, regardless of being 
overweight or obese. In contrast, overweight and obese individuals with lower total physical 
activity levels were at significantly higher risk of cardiovascular disease. Additionally, the 
cardiovascular disease risk between normal weight participants with low levels of physical activity 
was comparable to the risk of obese adults with high levels of physical activity.  
In the fifth chapter of this thesis, we examined associations between activity and mental 
health and wellbeing. In Chapter 5.1, we examined the association between physical activity types 
and health-related quality of life according to an age-specific approach. We observed a dose-
response relation between total physical activity and better health-related quality of life. 
Additionally, we found that sport was associated with better mobility, self-care, daily activities, 
mood and less pain in middle-aged adults, whereas cycling was associated strongest with these 
health-related quality of life domains in elderly people.  
In Chapter 5.2, we examined the association of actigraphically measured sedentary behavior 
with depression, anxiety and cognition. We observed that higher levels of sedentary behavior were 
associated with more depressive symptoms, higher odds of having a prevalent anxiety disorder 
and with worse cognitive function. However, these associations were completely explained by 
other factors, including disability, occupational status and smoking. Furthermore, we observed no 
association between sedentary behavior and changes in depressive symptoms or cognitive 
function over time, nor did we find an association between sedentary behavior and incident 
anxiety disorders.  
In Chapter 5.3, we examined the bidirectionality of the association between actigraphically 
measured sleep with body mass index. We observed that long and efficient sleep slow down the 
general decrease in body mass index over time. Additionally, we observed that higher baseline 
body mass index had a negative influence on sleep duration and quality over a period of 6 years.  
In Chapter 6, we discussed the results of the studies described in this thesis in a broader 
perspective. Moreover, relevant methodological consideration, clinical implications and directions 
for future research are discussed. 
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Samenvatting 
Het doel van deze scriptie, beschreven in hoofdstuk 1, was om de bestaande kennis over de 
associatie tussen sedentair gedrag, lichamelijke activiteit en slaap en een brede range van 
gezondheidsuitkomsten onder ouderen uit te breiden. Deze verschillende soorten activiteit zijn 
gemeten met een vragenlijst, of objectief door middel van actigrafie of een accelerometer. 
In het tweede hoofdstuk hebben we gefocust op factoren die gerelateerd zijn aan objectief en 
subjectief gemeten activiteit. In hoofdstuk 2.1, laten we zien dat de gerapporteerde hoeveelheid 
lichamelijke activiteit zoals gemeten door middel van vragenlijst over het algemeen lager is dan 
die gemeten door een om de pols gedragen accelerometer. Verder vinden we dat volwassenen met 
meer depressieve klachten, lichamelijke beperkingen of een hoger body mass index (BMI) hun 
lichamelijke activiteit nog meer onderschatten dan de referentie groep. Dit impliceert dat de 
perceptie van eigen gezondheid invloed heeft op het schatten van de hoeveelheid lichamelijke 
activiteit. 
In hoofdstuk 2.2, hebben we de distributie van objectief gemeten lichamelijke activiteit, 
sedentair gedrag en slaap onderzocht. Daarnaast hebben we onderzocht met welke demografische 
en gezondheidsfactoren deze domeinen gerelateerd waren. We vinden dat de hoeveelheid 
sedentair gedrag toeneemt met de leeftijd en BMI, ten koste van lichamelijke activiteit. We laten 
ook zien dat er geen duidelijke verschillen zijn voor slaapduur tussen de verschillende 
demografische en gezondheidsfactoren. Verder vinden we dat ouderen met een bestaande 
chronische ziekte, of met meer lichamelijke beperkingen een hogere hoeveelheid sedentair gedrag 
hebben, en een lagere hoeveelheid lichamelijke activiteit dan de referentie groep. Tot slot viel ons 
op dat vrouwen meer lichamelijk actief zijn dan mannen. 
In hoofdstuk 2.3 onderzochten we het patroon van objectieve maten van lichamelijke 
activiteit, sedentair gedrag en slaap gedurende het jaar. Hierbij keken we ook naar welke 
meteorologische factoren gerelateerd waren aan dit seizoensgebonden patroon en modelleerden 
we hoe dit de kans op overlijden kan beïnvloeden. Ouderen tot de leeftijd van 75 jaar hadden de 
grootste hoeveelheid lichamelijke activiteit in de zomer, terwijl de slaapduur toen juist lager was. 
Voor sedentair gedrag vonden we geen seizoensgebonden patroon. Dit suggereert dat sedentair 
gedrag is ingebakken in het dagelijkse leven. De fluctuaties van fysieke activiteit en slaap 
gedurende het jaar werden vooral verklaard door de buitentemperatuur en de hoeveelheid 
zonlicht. De combinatie van lage hoeveelheid lichamelijke activiteit en hoge hoeveelheid sedentair 
gedrag kan zorgen voor een hogere kans op overlijden in de winter. 
In het derde hoofdstuk hebben we de associatie tussen lichamelijke activiteit en sedentair 
gedrag met het risico op overlijden onderzocht. In hoofdstuk 3.1 onderzochten we allereerst de 
associatie tussen totale lichamelijke activiteit en verschillende typen activiteit met sterfte door alle 
oorzaken en sterfte door specifieke oorzaken. Een hogere hoeveelheid totale lichamelijke activiteit 
was gerelateerd aan een kleinere kans op sterfte door alle oorzaken, en een kleinere kans op 
overlijden veroorzaakt door hart- en vaatziekten (HVZ), chronische longziekten, infecties of 
andere oorzaken. Alle typen lichamelijke activiteit waren geassocieerd met een vermindering in de 
kans op sterfte door alle oorzaken.  
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Vervolgens onderzochten we de associatie tussen sedentair gedrag, objectief gemeten met 
actigrafie, en het risico op overlijden in hoofdstuk 3.2. We laten zien dat grotere hoeveelheden 
sedentair gedrag gerelateerd zijn aan een grotere kans op overlijden. Echter, na het corrigeren 
voor andere vormen van activiteit, zoals activiteiten van het dagelijks leven en lichamelijke 
activiteit, was de associatie duidelijk afgezwakt. 
In het vierde hoofdstuk hebben wij ons gericht op lichamelijke activiteit en HVZ. We 
bestudeerden de relatie tussen totale fysieke activiteit, en specifiek met lopen, fietsen, 
huishoudelijk werk, tuinieren en sport met coronaire hartziekten in hoofdstuk 4.1, met atrium 
fibrilleren in hoofdstuk 4.2 en met de levensverwachting met en zonder HVZ in hoofdstuk 4.3. 
We laten zien dat fietsen en huishoudelijk werk sterk geassocieerd zijn met een lagere kans op 
coronaire hartziekten, en met een grotere totale levensverwachting, en levensverwachting zonder 
HVZ. Echter vonden we geen relatie tussen totale lichamelijke activiteit of één van de types 
lichamelijke activiteit en atrium fibrilleren.  
In hoofdstuk 4.4 hebben we het gezamenlijke effect van lichamelijke activiteit en BMI op het 
risico op HVZ geëvalueerd. Uit ons onderzoek blijkt dat ouderen die veel bewegen geen 
verhoogde kans hebben op HVZ, ongeacht of ze overgewicht of obesitas hebben. Echter, ouderen 
met overgewicht en obesitas en met een lage hoeveelheid lichamelijke activiteit hebben wel een 
hogere kans hebben op HVZ. We laten ook zien dat de kans op HVZ voor mensen met een 
normaal gewicht en een lage hoeveelheid lichamelijke activiteit vergelijkbaar was met die voor 
ouderen met obesitas en een hoge hoeveelheid lichamelijke activiteit. 
In het vijfde hoofdstuk hebben we de associatie tussen verschillende vormen van activiteit 
en maten van mentale gezondheid en welzijn onderzocht. In hoofdstuk 5.1 kijken we naar de 
relatie tussen lichamelijke activiteit en gezondheid-gerelateerde kwaliteit van leven, volgens een 
leeftijdsspecifieke benadering. We vinden een dosis-responsrelatie tussen de hoeveelheid totale 
lichamelijke activiteit en een betere gezondheid-gerelateerde kwaliteit van leven. Tevens was sport 
gerelateerd aan betere mobiliteit, zelfzorg, dagelijkse activiteit, stemming en minder pijn in 
volwassenen van middelbare leeftijd, terwijl fietsen het sterkst gerelateerd was aan deze factoren in 
ouderen. 
In hoofdstuk 5.2 onderzochten we de relatie tussen actigrafisch gemeten sedentair gedrag 
met depressie, angst en cognitie. Wanneer deze factoren op hetzelfde tijdstip (cross-sectioneel) 
werden gemeten, vonden we dat sedentair gedrag gerelateerd was aan meer depressieve 
symptomen, een grotere kans op een angststoornis en slechtere cognitieve prestatie. Deze 
associaties konden echter allemaal worden verklaard door andere factoren, zoals lichamelijke 
beperkingen, werkstatus en rookgedrag. We laten ook zien dat er geen longitudinaal verband is 
tussen sedentair gedrag en veranderingen in depressieve symptomen of cognitieve prestatie, en 
dat sedentair gedrag niet gerelateerd is aan het ontwikkelen van een angststoornis. 
In hoofdstuk 5.3 onderzochten we of de associatie tussen actigrafische maten van slaap en 
BMI mogelijk twee kanten op gaat; dat slaap BMI beïnvloedt en dat BMI slaap beïnvloedt. We 
vinden dat een langere en efficiëntere slaapduur was geassocieerd met een langzamere daling in 
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BMI over de tijd. Ook laten we zien dat een hogere BMI op baseline is geassocieerd met een 
vermindering van slaapduur en slaapkwaliteit gedurende een periode van 6 jaar. 
In hoofdstuk 6 bespreken we de resultaten van de studies in deze thesis in een breder 
perspectief. Relevante methodologische overwegingen, klinische implicaties en mogelijkheden tot 
vervolgonderzoek worden ook besproken. 
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